Reasons for exclusion

No cancer
keyword in
Technically title or
not
abstract or No
possible
keywords
hypothesis Review

Include

Clinical
trial/ case
study

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X

X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X

X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16

17
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X

X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X

X
X
X
X
X
X
X
X
X
X
X
X

X
X
3
X
5
6
7
8
9
10
11
12
13
14
15
16
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X

X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X

X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X

X
X
X
17
X
X
18
X
19

DOI
Title
Journal
10.1038/natu A coding-independent function of gene and p NATURE
10.1016/j.cel A Chromatin-Mediated Reversible Drug-TolerantCELL
10.1038/natu Long non-coding RNA HOTAIR reprograms chrom
NATURE
10.1016/j.ccr Leukemic IDH1 and IDH2 Mutations Result in a CANCER CELL
10.1038/natu Tumour vascularization via endothelial differentNATURE
10.1038/natu Diverse somatic mutation patterns and pathwaNATURE
10.1016/j.cel Kinase-Dead BRAF and Oncogenic RAS Cooperat
CELL
10.1038/natu RAF inhibitors prime wild-type RAF to activa NATURE
10.1038/ncb2 Wnt activity defines colon cancer stem cells a NATURE CELL
10.1038/natu The transcriptional network for mesenchymal tNATURE
10.1038/natu melanomas acquire resistance to b-raf(v600e) Nature
i
10.1038/natu COT drives resistance to RAF inhibition throu NATURE
10.1016/j.cel A Myc Network Accounts for Similarities betw CELL
10.1038/natu raf inhibitors transactivate raf dimers and erk sNature
10.1126/scie Coadministration of a Tumor-Penetrating Pepti SCIENCE
10.1016/j.ccr The Common Feature of Leukemia-Associated ID
CANCER CELL
10.1038/natu Impaired hydroxylation of 5-methylcytosine in NATURE
10.3322/caac cancer statistics, 2010
CA Cancer Journ
10.1038/nbt. transcript assembly and quantification by rna-sNature Biotec
10.1002/ijc.2 Estimates of worldwide burden of cancer in
INTERNATIONA
10.1056/nejmImproved Survival with Ipilimumab in Patients NEW ENGLAND
10.1056/nejmEarly Palliative Care for Patients with Metasta NEW ENGLAND
10.1016/j.cel Cell Signaling by Receptor Tyrosine Kinases
CELL
10.1038/natu The landscape of somatic copy-number altera NATURE
10.1056/nejmInhibition of Mutated, Activated BRAF in Meta NEW ENGLAND
10.1038/natu A comprehensive catalogue of somatic mutat NATURE
10.1016/j.ccr Integrated Genomic Analysis Identifies Clinic CANCER CELL
10.1056/nejmAnaplastic Lymphoma Kinase Inhibition in Non NEW ENGLAND
10.1101/gr.1 The Genome Analysis Toolkit: A MapReduce fr GENOME RESE
10.1038/natu A small-cell lung cancer genome with complexNATURE
10.1038/natu Genome remodelling in a basal-like breast can NATURE
10.1038/nrg2 VIEWPOINT Missing heritability and strategies NATURE REVIE
10.1056/nejmSipuleucel-T Immunotherapy for Castration-ResNEW ENGLAND
10.1016/s014 Clinical assessment incorporating a personal LANCET
10.1126/scie Structures of the CXCR4 Chemokine GPCR withSCIENCE
10.1038/nmetDirect detection of DNA methylation during si NATURE METH
10.1056/nejmGefitinib or Chemotherapy for Non-Small-Cell NEW ENGLAND

10.1016/j.cel Genetic Heterogeneity in Human Disease

CELL
10.1056/nejmBody-Mass Index and Mortality among 1.46 MillNEW ENGLAND
10.1016/j.ejc Estimates of cancer incidence and mortality inEUROPEAN JOU
10.1038/natu Clinical efficacy of a RAF inhibitor needs br
NATURE
10.1016/s014 Trastuzumab in combination with chemotherapy
LANCET
10.1038/natu role of tet proteins in 5mc to 5hmc conversion,Nature
10.1016/j.cel c-Myc Regulates Transcriptional Pause Release CELL
10.1056/nejmOral Fingolimod or Intramuscular Interferon forNEW ENGLAND
10.1038/natu nanoscale architecture of integrin-based cell Nature
10.1016/s147 Gefitinib versus cisplatin plus docetaxel in p LANCET ONCO
10.1056/nejmHuman Papillomavirus and Survival of Patient NEW ENGLAND
10.1016/s014 Efficacy and safety of more intensive lowering LANCET
10.1038/natu International network of cancer genome projecNATURE
10.1016/j.ccr Integrative Genomic Profiling of Human Prosta CANCER CELL
10.1038/natu single-cell nf-b dynamics reveal digital activa Nature
10.1038/natu The Amphimedon queenslandica genome and th
NATURE
10.1038/nrg2 Tackling the widespread and critical impact of NATURE REVIE
10.1038/natu Distant metastasis occurs late during the geneNATURE
10.1038/natu Signatures of mutation and selection in the c NATURE
10.1038/natu opposing microrna families regulate self-rene Nature
10.1056/nejmDNMT3A Mutations in Acute Myeloid Leukemia.NEW ENGLAND
10.1016/j.ccr Identification of a CpG Island Methylator Phen CANCER CELL
10.1038/natu thousands of chemical starting points for antima
Nature
10.1073/pnas Detection of MLV-related virus gene sequencesPROCEEDINGS
10.1093/ije/d brain tumour risk in relation to mobile telepho International J
10.1038/natu The mutation spectrum revealed by paired ge NATURE
10.1038/ng.6 exome sequencing identifies mll2 mutations a Nature genetic
10.1016/j.cel a large intergenic noncoding rna induced by p Cell
10.1038/natu Systematic sequencing of renal carcinoma reveNATURE
10.1126/scisi Quantitative Phosphoproteomics Reveals WidesSCIENCE SIGN
10.1038/nmatPorous metal-organic-framework nanoscale carri
NATURE MATER
10.1038/ncb2 pink1/parkin-mediated mitophagy is dependenNature Cell Bi
10.1093/nar/ Database resources of the National Center for NUCLEIC ACID
10.1038/natu genome, epigenome and rna sequences of monoz
Nature
10.1200/jco.2 Pazopanib in Locally Advanced or Metastatic ReJOURNAL OF C
10.1016/s014 C-reactive protein concentration and risk of co LANCET
10.1038/natu genome-wide association study of cnvs in 16, Nature
10.1038/natu human host factors required for influenza virusNature
10.1038/nbt. Quantitative comparison of genome-wide DNA NATURE BIOT
10.1038/natu zebrafish heart regeneration occurs by cardiomNature
10.1016/s014 Once-only flexible sigmoidoscopy screening in LANCET
10.1016/j.ste a mesenchymal-to-epithelial transition initiat Cell Stem Cell
10.1038/natu Population diversity and the portfolio effect in NATURE

10.1016/j.cel virus-plus-susceptibility gene interaction det Cell

10.1016/s014 Oral poly(ADP-ribose) polymerase inhibitor ola LANCET
10.1038/ng.5 Nucleosome dynamics define transcriptional e NATURE GENET
10.1038/natu innate production of th 2 cytokines by adipose Nature
10.1038/natu The patterns and dynamics of genomic instabiliNATURE
10.1016/j.mol simple combinations of lineage-determining traMolecular Cell
10.1038/ncb2 A distinctive role for focal adhesion proteins in NATURE CELL
10.1038/ng.5 Variance component model to account for samp
NATURE GENET
10.1371/journFailure to Detect the Novel Retrovirus XMRV i PLOS ONE
10.1016/j.ceb Mammalian autophagy: core molecular machine
CURRENT OPIN
10.1126/scie Frequent Mutations of Chromatin Remodeling GSCIENCE
10.1016/j.ste functional genomics reveals a bmp-driven mesen
Cell Stem Cell
10.1186/bcr2 Phenotypic and molecular characterization of tBREAST CANC
10.1016/j.cel nucleosome-interacting proteins regulated by Cell
10.1101/gr.1 A ChIP-seq defined genome-wide map of vitamin
GENOME RESE
10.1056/nejmTelaprevir for Previously Treated Chronic HCV I NEW ENGLAND
10.1016/j.bio A Meta-Analysis of Cytokines in Major Depress BIOLOGICAL P
10.1016/j.cel dendritic function of tau mediates amyloid-?? Cell
10.1016/s014 Prednisone plus cabazitaxel or mitoxantrone foLANCET
10.1038/ng.5 Somatic mutations altering EZH2 (Tyr641) in folNATURE GENET
10.1038/natu Glioblastoma stem-like cells give rise to tumo NATURE
10.1126/scit metabolic modulation of glioblastoma with dic Science Transl
10.1038/natu OncomiR addiction in an in vivo model of mic NATURE
10.1016/j.cel A Temporarily Distinct Subpopulation of Slow- CELL
10.1038/ng.6 Estimation of effect size distribution from gen NATURE GENET
10.1016/j.cel 53BP1 Inhibits Homologous Recombination in Br
CELL
10.1038/natu Selective inhibition of BET bromodomains
NATURE
10.1038/natu oxidant stress evoked by pacemaking in dopami
Nature
10.1038/natu Human melanoma-initiating cells express neura
NATURE
10.1016/s147 Radiotherapy plus cetuximab for locoregionall LANCET ONCO
10.1016/j.mol Activation of a Metabolic Gene Regulatory N MOLECULAR C
10.1016/j.ccr Acquired Resistance to BRAF Inhibitors Media CANCER CELL
10.1038/natu role of conserved non-coding dna elements in tNature
10.1016/j.ste Identification and Classification of Chromosom CELL STEM CE
10.1016/j.mol Genome-wide Identification of Polycomb-AssocMOLECULAR C
10.1038/ng.6 Inactivating mutations of the histone methylt NATURE GENET
10.1016/s147 Effects of KRAS, BRAF, NRAS, and PIK3CA mutat
LANCET ONCO
10.1016/j.cel A MicroRNA Targeting Dicer for Metastasis ContCELL
10.1158/0008Drug Combination Studies and Their Synergy QCANCER RESE
10.1126/scie evidence for an alternative glycolytic pathway Science
i
10.1021/cr90 fluorescent indicators for intracellular ph
Chemical Revi
10.1016/s014 Antitumour activity of MDV3100 in castration-rLANCET
10.1016/j.cel Dietary and Genetic Obesity Promote Liver In CELL

10.1038/ncb2 miR-9, a MYC/MYCN-activated microRNA, regulaNATURE CELL

10.1056/nejmCisplatin plus Gemcitabine versus GemcitabineNEW ENGLAND
10.1016/j.mol Molecular Interplay of the Noncoding RNA ANRIMOLECULAR C
10.1038/natu spatial control of egf receptor activation by revNature
10.1200/jco.2 American Society of Clinical Oncology/College JOURNAL OF C
10.1056/nejmARID1A Mutations in Endometriosis-Associate NEW ENGLAND
10.1038/nrd3 Development trends for human monoclonal antNATURE REVIE
10.1038/nmatPorous metal-organic-framework nanoscale carri
NATURE MATER
10.1074/jbc. srt1720, srt2183, srt1460, and resveratrol are n
Journal of Biol
10.1200/jco.2 Phase I Study of Single-Agent Anti-ProgrammedJOURNAL OF C
10.1001/jamaAssociation of Risk-Reducing Surgery in BRCA1JAMA-JOURNAL
10.1016/s014 Common genetic determinants of vitamin D insLANCET
10.1016/j.ymeAnalysis of circulating microRNA biomarkers i METHODS
10.1038/nbt. The MicroArray Quality Control (MAQC)-IIII st NATURE BIOT
10.1200/jco.2 Updated Response Assessment Criteria for Hi JOURNAL OF C
10.1038/nbt. Therapeutic silencing of miR-10b inhibits me NATURE BIOT
10.1126/scie essential role of the histone methyltransferaseScience
10.1016/j.ste BRCA1 Basal-like Breast Cancers Originate from
CELL STEM CE
10.1016/j.jal 2010 alzheimer's disease facts and figures
Alzheimer's a
10.1073/pnas Isolation of circulating tumor cells using a mi PROCEEDINGS
10.1056/nejmEffect of Screening Mammography on Breast-Ca
NEW ENGLAND
10.1056/nejmEffect of Dutasteride on the Risk of Prostate C NEW ENGLAND
10.1016/s014 Oral poly(ADP-ribose) polymerase inhibitor ola LANCET
10.1017/s000 Prebiotic effects: metabolic and health benefit BRITISH JOURN
10.1038/nmetsuper-silac mix for quantitative proteomics of Nature Method
10.1038/ncb2 The selective autophagy substrate p62 activate
NATURE CELL
10.1038/natu ephrin-b2 controls vegf-induced angiogenesis Nature
10.1016/j.cel Decoding Cell Death Signals in Inflammation CELL
10.1038/natu Bone progenitor dysfunction induces myelodysNATURE
10.1016/j.mol Secreted Monocytic miR-150 Enhances Targeted
MOLECULAR C
10.1038/natu Control of mammary stem cell function by sterNATURE
10.1016/j.ccr Phenotypic Heterogeneity among Tumorigenic CANCER
Me
CELL
10.1210/jc.20 Testosterone Therapy in Men with Androgen Def
JOURNAL OF C
10.1126/scit development of personalized tumor biomarkersScience Transl
10.1097/pas. The Origin and Pathogenesis of Epithelial Ova AMERICAN JOU
10.1038/natu quantitative reactivity profiling predicts funct Nature
10.1200/jco.2 Randomized Study of Lapatinib Alone or in Co JOURNAL OF C
10.1016/j.ccr A Hierarchy of Self-Renewing Tumor-Initiating CCANCER CELL
10.1073/pnas Core epithelial-to-mesenchymal transition int PROCEEDINGS
10.1074/jbc. Secretory Mechanisms and Intercellular TransfeJOURNAL OF B
10.1038/natu Progesterone induces adult mammary stem celNATURE
10.1056/nejmSafety and Efficacy of INCB018424, a JAK1 andNEW
J
ENGLAND
10.1073/pnas Inhibition of lactate dehydrogenase A induces PROCEEDINGS

10.1021/nn10graphene-based antibacterial paper

ACS Nano
10.1038/natu Targeting Bcr-Abl by combining allosteric with ANATURE
10.1016/s014 Long-term effect of aspirin on colorectal canceLANCET
10.2337/dc10 Diabetes and Cancer A consensus report
DIABETES CAR
10.1016/s147 Erlotinib as maintenance treatment in advanceLANCET ONCO
10.1038/natu il25 elicits a multipotent progenitor cell popu Nature
10.1038/nbt. single-molecule enzyme-linked immunosorbentNature Biotec
10.1016/j.ccr Cancer-Associated Fibroblasts Are Activated i CANCER CELL
10.1007/s109 Epithelial-Mesenchymal Transition in Cancer: JOURNAL OF M
10.1016/s147 Human papillomavirus genotype attribution in L
i ANCET ONCO
10.1200/jco.2 Denosumab Compared With Zoledronic Acid forJOURNAL OF C
10.3322/caac Exciting New Advances in Neuro-Oncology TheCA-A CANCER
10.1038/nsmb53BP1 loss rescues BRCA1 deficiency and is asNATURE STRUC
10.1056/nejmPerformance of Common Genetic Variants in BrNEW ENGLAND
10.1016/j.ste an oct4-centered protein interaction network i Cell Stem Cell
10.1038/nm.2Real-time imaging reveals the single steps of NATURE MEDIC
10.1200/jco.2 Molecular Mechanisms of Resistance to Cetux JOURNAL OF C
10.1016/j.cmemechanisms of life span extension by rapamycin
Cell Metabolis
10.1007/s002 FDG PET and PET/CT: EANM procedure guideline
EUROPEAN JOU
10.1016/j.cel Monoacylglycerol Lipase Regulates a Fatty Ac CELL
10.1016/s014 Targeted intraoperative radiotherapy versus who
LANCET
10.1016/j.ccr Preexistence and Clonal Selection of MET AmplCANCER CELL
10.1016/j.mol STAT3 Activation of miR-21 and miR-181b-1 viaMOLECULAR C
10.1016/j.cel Natural Mutagenesis of Human Genomes by E CELL
10.1016/j.ste Lgr5(+ve) Stem Cells Drive Self-Renewal in theCELL STEM CE
10.1001/archdIncidence Estimate of Nonmelanoma Skin Cance
ARCHIVES OF
10.1016/j.cel a region of the human hoxd cluster that conf Cell
10.1083/jcb. proteasome and p97 mediate mitophagy and de
Journal of Cell
10.1038/sj.bj Guidelines for the welfare and use of animals BRITISH JOUR
10.1186/1742Absence of xenotropic murine leukaemia virus-r
RETROVIROLO
10.1038/natu Targeted deletion of the 9p21 non-coding corona
NATURE
no doi10
Regularization Paths for Generalized Linear M JOURNAL OF S
10.3322/caac Diabetes and Cancer: A Consensus Report
CA-A CANCER
10.1126/scie atm activation by oxidative stress
Science
10.1126/scie permissive secondary mutations enable the evol
Science
10.1126/scie Identification of a Cell of Origin for Human Pro SCIENCE
10.1038/ng.6 Somatic mutations of the histone methyltrans NATURE GENET
10.1038/natu Therapeutic antibody targeting of individual N NATURE
10.1056/nejmQuality Indicators for Colonoscopy and the RiskNEW ENGLAND
10.1038/natu proviral silencing in embryonic stem cells requNature
10.1126/scie suppression of antitumor immunity by stromal Science
c
10.1016/j.ccr DNA Methylation Signatures Identify Biological CANCER CELL
10.1182/bloo Tissue macrophages act as cellular chaperonesBLOOD

10.1073/pnas Mitochondrial metabolism and ROS generationPROCEEDINGS

a
10.1016/j.cro The second European evidence-based ConsensJOURNAL OF C
10.1200/jco.2 Randomized, Phase III Trial of Panitumumab WitJOURNAL OF C
10.1016/j.cel Long Noncoding RNAs with Enhancer-like FunctCELL
10.1200/jco.2 Phase III Study of Bevacizumab Plus DocetaxelJOURNAL OF C
10.1056/nejmBrentuximab Vedotin (SGN-35) for Relapsed C NEW ENGLAND
10.1016/s147 Efficacy of human papillomavirus testing for thLANCET ONCO
10.1038/ng.5 Genome-wide association study identifies five n
NATURE GENET
10.1053/j.gas Inflammation and Colon Cancer
GASTROENTER
10.1038/natu Skp2 targeting suppresses tumorigenesis by A NATURE
10.1016/j.ccr The DLEU2/miR-15a/16-1 Cluster Controls B CelCANCER CELL
10.1021/nl10 Graphene in Mice: Ultrahigh In Vivo Tumor Upt NANO LETTERS
10.1249/mss. American College of Sports Medicine RoundtablMEDICINE AND
10.1016/j.ccr SIRT3 Is a Mitochondria-Localized Tumor SupprCANCER CELL
10.1161/circr Circulating MicroRNAs in Patients With CoronarCIRCULATION
10.1002/ijc.2 Regulatory T cells in tumor immunity
INTERNATIONA
10.1038/embonix is a selective autophagy receptor for mito EMBO Reports
10.1016/j.immhuman cd14dim monocytes patrol and sense nucl
Immunity
10.1073/pnas Activatable cell penetrating peptides linked t PROCEEDINGS
10.1056/nejmAnti-GD2 Antibody with GM-CSF, Interleukin-2, NEW ENGLAND
10.1016/j.eur EAU Guidelines on Renal Cell Carcinoma: The EUROPEAN UR
10.1084/jem. Cancer-associated metabolite 2-hydroxyglutar JOURNAL OF E
10.1200/jco.2 Overall Survival Analysis of a Phase II Random JOURNAL OF C
10.1038/nri27Strategies and challenges for the next generatNATURE REVI
10.1016/j.ccr An Integrated Network of Androgen Receptor, CANCER CELL
10.1073/pnas Therapeutic potential of appropriately evaluatePROCEEDINGS
10.1200/jco.2 Breast Cancer Subtypes and the Risk of Local JOURNAL OF C
10.1016/j.ste generation of induced pluripotent stem cells fr Cell Stem Cell
10.1126/scie mTORC1-Mediated Cell Proliferation, But Not Ce
SCIENCE
10.1016/j.cel miR-328 Functions as an RNA Decoy to ModulatCELL
10.1016/j.cel caspase-3 activation via mitochondria is requi Cell
10.1021/nn90Interaction of Gold Nanoparticles with Commo ACS NANO
10.1056/nejmEverolimus for Subependymal Giant-Cell AstrocNEW ENGLAND
10.1002/ijc.2 Plasma microRNAs are promising novel biomarke
INTERNATIONA
10.1016/s147 Prognostic and predictive value of the 21-gen LANCET ONCO
10.1016/s147 investigation of lgi1 as the antigen in limbic e The Lancet Ne
10.1016/s147 Tumour response and secondary resectability oLANCET ONCO
10.1038/natu tgf-??-foxo signalling maintains leukaemia-init Nature
10.1016/s147 Angiotensin-receptor blockade and risk of cancLANCET ONCO
10.1016/j.ijr radiation dose-volume effects in the lung
International J
10.1038/natu sphingosine-1-phosphate is a missing cofactor Nature
f
10.1001/jamaAssociation of KRAS p.G13D Mutation With OutJAMA-JOURNAL
10.1016/j.cln Consensus definition of sarcopenia, cachexia aCLINICAL NUTR

10.1038/natu HnRNP proteins controlled by c-Myc deregulateNATURE

10.1101/gr.1 Age-dependent DNA methylation of genes thatGENOME
a
RESE
10.1016/j.immThe mTOR Kinase Determines Effector versus M
IMMUNITY
10.1038/natu ephrin-b2 regulates vegfr2 function in devel Nature
10.1016/j.cel reversal of cancer cachexia and muscle wasting
Cell
10.1016/j.ste Reprogramming of Human Primary Somatic CeCELL STEM CE
10.1373/clin The MicroRNA Spectrum in 12 Body Fluids
CLINICAL CHE
10.1021/ja91 Nuclear Targeting of Gold Nanoparticles in Ca JOURNAL OF T
10.1038/natu Subtypes of medulloblastoma have distinct de NATURE
10.1093/brai n-methyl-d-aspartate antibody encephalitis: teBrain
10.1016/j.ste An Expanded Oct4 Interaction Network: ImplicaCELL STEM CE
10.1200/jco.2 Prognostic Role of KRAS and BRAF in Stage II a JOURNAL OF C
10.1016/s147 Discontinuation of imatinib in patients with c LANCET ONCO
10.1016/j.bio Effects of particle size and surface charge on BIOMATERIALS
10.1016/j.ste Endothelial Cells Are Essential for the SelfCELL STEM CE
10.1016/s147 Mortality results from the Goteborg randomised
LANCET ONCO
10.1016/j.cel atm-dependent chromatin changes silence trans
Cell
10.1056/nejmTumor-Associated Macrophages and Survival i NEW ENGLAND
10.1002/smll Functional Graphene Oxide as a Nanocarrier foSMALL
10.1038/nm.2Rearrangements of the RAF kinase pathway in NATURE MEDIC
10.1021/ja90 Uniform Mesoporous Dye-Doped Silica Nanopart
JOURNAL OF T
10.1038/ni.18Negative regulation of TLR4 via targeting of NATURE IMMU
10.1172/jci40 Inhibition of vasculogenesis, but not angiogeneJOURNAL OF CL
10.1007/s002 Prospective Randomized Study of Doxorubicin-E
CARDIOVASCUL
10.1016/j.mol the nuclear-retained noncoding rna malat1 regu
Molecular Cell
10.1056/nejmEML4-ALK Mutations in Lung Cancer That Confer
NEW ENGLAND
10.1007/s110 toxicity and cellular uptake of gold nanopartic Journal of Nan
10.1161/circr Plasma MicroRNA Profiling Reveals Loss of End CIRCULATION
10.1016/s147 Ipilimumab monotherapy in patients with pret LANCET ONCO
10.1038/ng.5 Meta-analysis and imputation refines the asso NATURE GENET
10.1200/jco.2 Serum MicroRNA Signatures Identified in a GenJOURNAL OF C
10.1056/nejmComparison of Ustekinumab and Etanercept forNEW ENGLAND
10.1016/j.cel Reconstitution of the RIG-I Pathway Reveals a CELL
10.1038/embogenome-wide analysis of ets-family dna-binding
EMBO Journal
10.1200/jco.2 Efficacy of Neoadjuvant Cisplatin in Triple-Neg JOURNAL OF C
10.1016/j.jco Size and shape effects in the biodistribution of JOURNAL OF C
10.1021/ar90 aptamers generated from cell-selex for molecuAccounts of C
10.1038/nm.2microrna-132-mediated loss of p120rasgap actiNature Medici
10.1097/mpa.The Pathologic Classification of Neuroendocri PANCREAS
10.1158/1078CXCL12 (SDF-1)/CXCR4 Pathway in Cancer
CLINICAL CAN
10.1093/nar/ Examination of the specificity of DNA methyla NUCLEIC ACID
10.1002/cncr. Phase 3 Trial of Everolimus for Metastatic RenaCANCER
10.1523/jneurcell-produced ?-synuclein is secreted in a
Journal of Neu

10.1200/jco.2 Clinical Results of Long-Term Follow-Up of a La JOURNAL OF C

10.1001/jamaEstrogen Plus Progestin and Breast Cancer In JAMA-JOURNAL
10.1371/journThe Behaviour of 5-Hydroxymethylcytosine in BPLOS ONE
10.1172/jci39 cxcr1 blockade selectively targets human breas
Journal of Clin
10.3945/ajcn Accruing evidence on benefits of adherence toAMERICAN JOU
10.1001/jamaStereotactic Body Radiation Therapy for Inope JAMA-JOURNAL
10.1002/smll Biocompatibility, Biodistribution, and Drug-Del SMALL
10.1124/dmd.identification of the human cytochrome p450 en
Drug Metabolis
10.1200/jco.2 Defective Mismatch Repair As a Predictive Mark
JOURNAL OF C
10.1038/ncb2 Bmi1 is essential in Twist1-induced epithelial NATURE CELL
10.1016/j.ygc neuroendocrinology of reproduction in teleost fGeneral and C
10.1136/bmj. selective serotonin reuptake inhibitors and br BMJ (Online)
10.1523/jneurdysregulation of mtor signaling in fragile x sy Journal of Neu
10.1073/pnas The RAF inhibitor PLX4032 inhibits ERK signali PROCEEDINGS
10.1016/s014 Vaginal brachytherapy versus pelvic external bLANCET
10.1021/nl90 subthreshold regime has the optimal sensitivit Nano Letters
10.1161/circu Television Viewing Time and Mortality The AustCIRCULATION
10.2214/ajr.0 Innovations in CT Dose Reduction Strategy: Appl
AMERICAN JO
10.1038/natu Heteroplasmic mitochondrial DNA mutations inNATURE
10.1056/nejmtrajectories of disability in the last year of life New England Jo
10.1200/jco.2 Phase III Trial of Bevacizumab Plus Interferon JOURNAL OF C
10.1002/stemexcision of reprogramming transgenes improves
Stem
t Cells
10.1016/j.ccr Modulation of K-Ras-Dependent Lung TumorigeCANCER CELL
10.1016/j.bmcCarbonic anhydrase inhibitors
BIOORGANIC &
10.1200/jco.2 Phase III Trial of Bevacizumab Plus Interferon JOURNAL OF C
10.1016/s147 Sentinel-lymph-node resection compared with LANCET
co
ONCO
10.1016/j.cmeMetformin, Independent of AMPK, Inhibits mT CELL METABOL
10.1038/natu long-term potentiation depends on release of dNature
10.1097/sla. Circulating microRNAs as Novel Minimally Inva ANNALS OF SU
10.1093/annoOverall survival with cisplatin-gemcitabine andANNALS OF O
10.1038/nm.2Genomic instability and myelodysplasia with NATURE MEDIC
10.1126/scit frequent and focal fgfr1 amplification associa Science Transl
10.1101/gr.1 Changes in the pattern of DNA methylation assGENOME RESE
10.1200/jco.2 Significant and Sustained Antitumor Activity i JOURNAL OF C
10.1200/jco.2 Phase II Multicenter Study of Abiraterone Acet JOURNAL OF C
10.1038/ng.5 Subtle variations in Pten dose determine cancer
NATURE GENET
10.1056/nejmReduced Mortality after Allogeneic Hematopoiet
NEW ENGLAND
10.1126/scie Frequent Mutation of BAP1 in Metastasizing U SCIENCE
10.1093/nar/ COSMIC (the Catalogue of Somatic Mutations inNUCLEIC ACID
10.1016/j.ste the distinct metabolic profile of hematopoietic Cell Stem Cell
10.1073/pnas miR-221 overexpression contributes to liver t PROCEEDINGS
10.1038/ni.18influenza virus activates inflammasomes via it Nature Immun
10.1200/jco.2 IDH1 and IDH2 Gene Mutations Identify Novel JOURNAL OF C

10.1056/nejmefficacy of gene therapy for x-linked severe

New England Jo
10.1056/nejmNeoadjuvant Chemotherapy or Primary SurgeryNEW ENGLAND
10.1200/jco.2 Phase II Trial of Pertuzumab and Trastuzumab JOURNAL OF C
10.1038/nm.2Effective and selective targeting of leukemia c NATURE MEDIC
10.1101/gr.1 Human aging-associated DNA hypermethylation
GENOME RESE
10.1164/rccm Lung Pathology in Fatal Novel Human InfluenzaAMERICAN JOU
10.1158/1078Aldehyde Dehydrogenase 1-Positive Cancer SteCLINICAL CAN
10.1161/circr bone marrow mesenchymal stem cells stimulate
Circulation
c
Re
10.1200/jco.2 Poly(ADP)-Ribose Polymerase Inhibition: Frequ JOURNAL OF C
10.1200/jco.2 Meta-Analysis of Breast Cancer Outcomes in AdJOURNAL OF C
10.1093/eurheCirculating microRNA: a novel potential biomarEUROPEAN HEA
10.1109/tmagBiomedical Nanomagnetics: A Spin Through Poss
IEEE TRANSAC
10.1126/scie tuberculous granuloma induction via interaction
Science
10.1016/j.bio dual-modality in vivo imaging using rare-earth Biomaterials
10.1158/0008AZD8055 Is a Potent, Selective, and Orally Bio CANCER RESE
10.1021/nn1 Engineered Design of Mesoporous Silica Nanopa
ACS NANO
10.1200/jco.2 Azacitidine Prolongs Overall Survival Compar JOURNAL OF C
10.1038/ng.5 Germline mutations in breast and ovarian cancNATURE GENET
10.1038/ng.5 A genome-wide association study identifies pa NATURE GENET
10.1016/j.cyt dangerous liaisons: stat3 and nf-??b collaboratCytokine and G
10.1073/pnas glutaminase 2, a novel p53 target gene regulaProceedings of
10.1200/jco.2 Comparison of Two Neoadjuvant Chemoradiother
JOURNAL OF C
10.1021/ac10 Sensitive Immunosensor for Cancer Biomarker ANALYTICAL C
10.1002/ijc.2 Diagnostic and prognostic implications of micr INTERNATIONA
10.1002/stemNOTCH Pathway Blockade Depletes CD133-Positi
STEM CELLS
10.1097/ede. Assessing the Performance of Prediction ModelEPIDEMIOLOGY
10.1053/j.gas Aging of Hepatitis C Virus (HCV)-Infected Pers GASTROENTER
10.1016/s147 Surgical treatment of gastric cancer: 15-year LANCET ONCO
10.1016/j.immIdentification and Characterization of Enhanc IMMUNITY
10.1056/nejmLong-Term Results of Hypofractionated Radiati NEW ENGLAND
10.1126/scie Requirement of Prorenin Receptor and VacuolarSCIENCE
10.1200/jco.2 Daily Oral Everolimus Activity in Patients With JOURNAL OF C
10.1021/ja10 enantioselective ?-benzylation of aldehydes Journal of the
10.1200/jco.2 Metastatic Behavior of Breast Cancer Subtype JOURNAL OF C
10.1084/jem. Human CD141(+) (BDCA-3)(+) dendritic cells (D
JOURNAL OF E
10.1038/cr.20 overview of macroautophagy regulation in ma Cell Research
10.1210/jc.20 A Consensus on Criteria for Cure of Acromegal JOURNAL OF C
10.1200/jco.2 Meta-Analysis of Concomitant Versus SequentiJOURNAL OF C
10.1016/s014 Colorectal cancer
LANCET
10.1016/s147 Relation between microRNA expression and prog
LANCET ONCO
10.1136/ard. drug-specific risk of tuberculosis in patients w Annals of the
10.1021/ja90 gold nanoparticles for the improved anticancerJournal of the
10.1073/pnas PD-1 and CTLA-4 combination blockade expands
PROCEEDINGS

10.1016/s014 lithium plus valproate combination therapy verThe Lancet

10.1016/s147 Breast cancer molecular profiling with single s LANCET ONCO
10.1126/scie Arsenic Trioxide Controls the Fate of the PML- SCIENCE
10.1016/j.bcp design of curcumin-loaded plga nanoparticles fo
Biochemical P
10.1093/jnci/ Impact of Human Papillomavirus (HPV)-6/11/16JOURNAL OF T
10.1038/nm.2Identification of miR-145 and miR-146a as me NATURE MEDIC
10.1038/nnancarbon nanotubes degraded by neutrophil myeNature Nanote
10.1016/j.ccr genetic dissection of the oncogenic mtor pathwCancer Cell
10.1038/sj.bj Circulating microRNAs in plasma of patients wiBRITISH JOUR
10.1016/j.bio the effect of the shape of mesoporous silica naBiomaterials
10.1084/jem. the nlrp3 inflammasome functions as a negative
Journal of Exp
10.1093/hmg/Genome-wide association study of circulating vHUMAN MOLEC
10.1097/gme.Estrogen and progestogen use in postmenopauMENOPAUSE-TH
10.1021/nn90a drug-loaded aptamer - gold nanoparticle bio ACS Nano
10.1038/natu Deubiquitinase USP9X stabilizes MCL1 and proNATURE
10.1021/cr90 imaging and photodynamic therapy: mechanism
Chemical Revi
10.1161/circr relative roles of direct regeneration versus pa Circulation Re
10.1200/jco.2 Molecular Predictors of Outcome With Gefitini JOURNAL OF C
10.1038/nche a causative link between the structure of aberrNature Chemica
10.1093/hmg/mitofusin 1 and mitofusin 2 are ubiquitinated Human Molecul
10.1084/jem. miR-21 mediates fibrogenic activation of pulmoJOURNAL OF E
10.1200/jco.2 Phase I Study of Trastuzumab-DM1, an HER2 An
JOURNAL OF C
10.1200/jco.2 Phase III Trial of Bevacizumab Plus Interferon JOURNAL OF C
10.1038/ng.5 Genome-wide association study identifies five lNATURE GENET
10.1200/jco.2 Randomized Phase III Study of Panitumumab Wit
JOURNAL OF C
10.1073/pnas bifurcation of insulin signaling pathway in rat Proceedings of
10.1126/scie An Autophagy-Enhancing Drug Promotes Degrada
SCIENCE
10.1016/j.ajh a versatile gene-based test for genome-wide aAmerican Jour
10.1016/s014 First-line treatment with zoledronic acid as c LANCET
10.1200/jco.2 Time Trends and Local Variation in Primary Tre JOURNAL OF C
10.1200/jco.2 IDH1 and IDH2 Mutations Are Frequent GeneticJOURNAL OF C
10.1111/j.136The relation between different dimensions of ADDICTION
10.1056/nejmMutations in GNA11 in Uveal Melanoma.
NEW ENGLAND
10.1038/natu rank ligand mediates progestin-induced mammar
Nature
10.1016/j.jbi multicellular tumor spheroids: an underestimatJournal of Bio
10.1158/0008MicroRNA-155 Functions as an OncomiR in BreaCANCER RESE
10.1038/ng.5 Sequence variants at CHRNB3-CHRNA6 and CYP
NATURE GENET
10.1158/1535mk-2206, an allosteric akt inhibitor, enhances Molecular Canc
10.1038/ng.5 Mutation of the RAD51C gene in a Fanconi anem
NATURE GENET
10.3322/caac American Cancer Society Guideline for the Ear CA-A CANCER
10.1200/jco.2 Cetuximab and First-Line Taxane/Carboplatin CJOURNAL OF C
10.1200/jco.2 adherence is the critical factor for achieving Journal of Clin
10.1200/jco.2 Vandetanib for the Treatment of Patients With JOURNAL OF C

10.1038/onc. Regression of murine lung tumors by the let-7 ONCOGENE

10.1038/mt.2 Case Report of a Serious Adverse Event Follow MOLECULAR T
10.1053/j.gas Role of the Serrated Pathway in Colorectal Ca GASTROENTER
10.1073/pnas Mechanism of active targeting in solid tumors PROCEEDINGS
10.1073/pnas The Bruton tyrosine kinase inhibitor PCI-32765PROCEEDINGS
10.1200/jco.2 Phase II Study of Cediranib, an Oral Pan-VasculJOURNAL OF C
10.1002/art.2 direct comparison of treatment responses, remis
Arthritis and
10.1182/bloo clinical-grade production of human mesenchyma
Blood
10.1101/gad. A coordinated phosphorylation by Lats and CK1GENES & DEV
10.1038/mt.2 Systemic Delivery of Synthetic MicroRNA-16 Inh
MOLECULAR T
10.1053/j.gas hereditary and familial colon cancer
Gastroenterol
10.1038/natu Chronic active B-cell-receptor signalling in di NATURE
10.1084/jem. Autoantibodies against IL-17A, IL-17F, and IL JOURNAL OF E
10.1158/0008Development of a Lung Cancer Therapeutic BaCANCER RESE
10.1126/scie The Wnt/beta-Catenin Pathway Is Required for SCIENCE
10.1523/jneurCellular and Synaptic Mechanisms of Anti-NMDJOURNAL OF N
10.1016/j.ccr FcR gamma Activation Regulates InflammationCANCER CELL
10.1093/hmg/A window into third-generation sequencing
HUMAN MOLEC
10.1158/0008Selective BRAF(V600E) Inhibition Enhances T-CCANCER RESE
10.1021/nn90In Vivo Biodistribution and Clearance Studies ACS NANO
10.1016/s147 antibodies to the gabab receptor in limbic enceThe Lancet Ne
10.1093/jnci/ Protection From Right- and Left-Sided Colorec JOURNAL OF T
10.1148/radiothe national lung screening trial: overview an Radiology
10.1158/1940Update of the National Surgical Adjuvant BreasCANCER PREV
10.1097/sla. Locoregional Recurrence After Sentinel Lymph ANNALS OF SU
10.1200/jco.2 Phase I Clinical Trial of the CYP17 Inhibitor A JOURNAL OF C
10.1016/j.ijr DIAGNOSIS-SPECIFIC PROGNOSTIC FACTORS, I INTERNATIONA
10.1021/ja10 Autonomous in Vitro Anticancer Drug Release JOURNAL OF T
10.1002/hep. evolution of inflammation in nonalcoholic fatty Hepatology
10.1016/j.bio pet/nirf/mri triple functional iron oxide nanoparBiomaterials
10.1200/jco.2 Prognosis of Women With Metastatic Breast CaJOURNAL OF C
10.1016/j.cho Merkel Cell Polyomavirus and Two Previously CELL HOST &
10.1073/pnas hippo signaling is a potent in vivo growth an Proceedings of
10.1200/jco.2 Phase III Study of Carboplatin and Paclitaxel JOURNAL OF C
10.1200/jco.2 Gemcitabine Plus Bevacizumab Compared WithJOURNAL
G
OF C
10.1016/s014 Neoadjuvant chemotherapy with trastuzumab fol
LANCET
10.1158/1078IDH1 and IDH2 Mutations Are Prognostic but noCLINICAL CAN
10.1073/pnas promotion of direct reprogramming by transfo Proceedings of
10.1084/jem. chronic mucocutaneous candidiasis in apeced Journal of Exp
10.1001/jamaAdjuvant Chemotherapy With Fluorouracil Plus JAMA-JOURNAL
10.1073/pnas Constitutively active androgen receptor splice PROCEEDINGS
10.1021/nl90 A Comparison Study of the Catalytic Properti NANO LETTERS
10.1200/jco.2 Phase I/IIa Study of Cilengitide and Temozol
JOURNAL OF C

10.1182/bloo Preclinical characterization of the selective J BLOOD

10.1200/jco.2 Multicenter Phase III Comparison of Cisplatin/ JOURNAL OF C
10.1182/bloo Molecular response to treatment redefines all BLOOD
10.1182/bloo Long-term outcome of EBV-specific T-cell infusiBLOOD
10.1021/ja10 noninvasive remote-controlled release of drug Journal of the
10.1002/hep. effects of microrna-29 on apoptosis, tumorigenHepatology
10.1182/bloo increasing the efficacy of cd20 antibody thera Blood
10.1053/j.gas Radioembolization for Hepatocellular Carcino GASTROENTER
10.1038/natu osteoclast differentiation factor rankl contr
Nature
10.1021/nn10temperature sensing using fluorescent nanot ACS Nano
10.1158/0008the ac133 epitope, but not the cd133 protein, iCancer Resear
10.1158/0008rg7204 (plx4032), a selective brafv600e inhibi Cancer Resear
10.1093/carci miR-124 and miR-203 are epigenetically silen CARCINOGENES
10.1158/0008microrna-145 suppresses cell invasion and meta
Cancer Resear
10.1016/j.cel Biological and Molecular Heterogeneity of Bre CELL
10.1200/jco.2 Randomized Trial Comparing Conventional-Dose
JOURNAL OF C
no doi5
the choice between p53-induced senescence an
Aging
10.3322/caac Cancer Screening in the United States, 2010 A CA-A CANCER
10.1200/jco.2 American Society of Clinical Oncology Clinica JOURNAL OF C
10.1002/hep. The Incidence and Risk Factors of HepatocellulHEPATOLOGY
10.1200/jco.2 Phase III Study Comparing Gemcitabine Plus C JOURNAL OF C
10.1158/1940Metformin and Cancer Risk in Diabetic Patient CANCER PREV
10.1056/nejmPreoperative Biliary Drainage for Cancer of th NEW ENGLAND
10.1002/stemnotch promotes radioresistance of glioma stemStem Cells
10.1016/j.jac myocardial scar visualized by cardiovascular Journal of the
10.1073/pnas paradoxical suppression of cellular senescenc Proceedings of
10.1172/jci40 the unfolded protein response protects human Journal of Clin
10.1086/6505delayed clearance of viral load and marked cytClinical Infect
10.1200/jco.2 Ofatumumab As Single-Agent CD20 Immunother
JOURNAL OF C
10.1093/hmg/SDHA is a tumor suppressor gene causing par HUMAN MOLEC
10.1200/jco.2 Neratinib, an Irreversible ErbB Receptor Tyrosi JOURNAL OF C
10.1200/jco.2 Rituximab Plus Fludarabine and Cyclophospham
JOURNAL OF C
10.1016/s147 Vandetanib plus docetaxel versus docetaxel asLANCET ONCO
10.1021/nn90hollow/rattle-type mesoporous nanostructures A
bCS Nano
10.1148/radiolow-tube-voltage, high-tube-current multidetectRadiology
10.1200/jco.2 pancreatic endocrine tumors: expression profilJournal of Clin
10.1103/revmMean-field theory of hard sphere glasses and REVIEWS OF M
10.1111/j.160A Phase III Study of Belatacept Versus Cyclosp AMERICAN JOU
10.4049/jimmcutting edge: mast cells express il-17a in rheu Journal of Imm
10.1016/j.immtumor-induced tolerance and immune suppressi
Immunity
10.1016/j.bio Co-delivery of siRNA and paclitaxel into can
BIOMATERIALS
10.1200/jco.2 Pathologic Complete Response Rates in Young JOURNAL OF C
10.1038/nm.2resolvins rve1 and rvd1 attenuate inflammatory
Nature Medici

10.2337/dc09 Long-Term Metformin Use Is Associated With D DIABETES CAR

10.1200/jco.2 outcomes for children and adolescents with can
Journal of Clin
10.1053/j.gas Microsatellite Instability in Colorectal Cancer GASTROENTER
10.1093/brai antibodies to kv1 potassium channel-complex p
Brain
10.1002/bjs.7 Five-year follow-up of the Medical Research Cou
BRITISH JOUR
10.1093/neuotumor invasion after treatment of glioblastom Neuro-Oncolog
10.1172/jci41 Castration resistance in human prostate cancerJOURNAL OF CL
10.1158/1078A Novel, Highly Sensitive Antibody Allows fo CLINICAL CAN
10.1016/j.jtbi Using the concept of Chou's pseudo amino acidJOURNAL OF T
10.1056/nejmcrizotinib in alk-rearranged inflammatory myofNew England Jo
10.1111/j.175Characterization of R132H Mutation-specific I BRAIN PATHOL
10.1016/s014 Comparative effectiveness of MRI in breast canLANCET
10.1200/jco.2 clinical definition of acquired resistance to ep Journal of Clin
10.1021/nn10Core/Shell Structured Hollow Mesoporous Nanoc
ACS NANO
10.1038/nnanDesign considerations for tumour-targeted nanNATURE NANO
10.1002/eji.2 hierarchy of immunosuppressive strength amon
European Jour
10.1002/smll Gold Nanocages as Photothermal Transducers SMALL
10.1016/j.bio long-term in vivo biodistribution imaging and Biomaterials
10.1021/ja90 fabrication of ag@sio2@y2o3: er nanostructures
Journal of the
10.1200/jco.2 Integrated Molecular Genetic Profiling of Pedi JOURNAL OF C
10.1126/scie Inhibition of NF-kappa B Signaling by A20 Thr SCIENCE
10.1086/6522causes of death in hiv-1-infected patients trea Clinical Infect
10.1038/nm.2a p53-dependent mechanism underlies macrocNature Medici
10.1038/nm.2epithelial cell cycle arrest in g2/m mediates kidNature Medici
10.1101/gad. IL-4 induces cathepsin protease activity in t
GENES & DEV
10.1158/0008myeloid-derived suppressor cells inhibit t-cell Cancer Resear
10.1002/hep. decreased survival of subjects with elevated li Hepatology
10.1158/1078prevalence and heterogeneity of kras, braf, a Clinical Cance
10.1016/s007 melatonin: a multitasking molecule
Progress in Br
10.1016/j.eur Every Minute Counts When the Renal Hilum Is EUROPEAN UR
10.1200/jco.2 comparison of two doses of imatinib for the tr Journal of Clin
10.1038/nche highly enantioselective synthesis and cellular Nature Chemis
10.1038/jid.2 circulating th17, th22, and th1 cells are increa Journal of Inv
10.1002/path driver mutations in tp53 are ubiquitous in hig Journal of Path
10.1158/0008mir-146a suppresses invasion of pancreatic canCancer Resear
10.2337/dc09 Metformin Associated With Lower Cancer Mortal
DIABETES CAR
10.1016/j.hrt j wave syndromes
Heart Rhythm
10.1007/s004 her2 diagnostics in gastric cancer-guideline
Virchows Archi
10.1158/0008MicroRNA-375 Is Downregulated in Gastric CarcCANCER RESE
10.1002/hep. Long-Term Entecavir Therapy Results in the RevHEPATOLOGY
10.1002/ijc.2 elevated expression of micrornas 155, 203, 210International J
10.1093/jnci/ diabetes and cardiovascular disease during anJournal of the
10.1182/bloo phosphatidylinositol 3-kinase-?? inhibitor cal-1 Blood

10.1172/jc13 CXCR1 blockade selectively targets human breas

JOURNAL OF CL
10.1002/ijc.2 mir-145, mir-133a and mir-133b: tumor-suppreInternational J
10.1021/cr90 coordinating radiometals of copper, gallium, i Chemical Revi
10.1182/bloo Eradication of B-lineage cells and regression BLOOD
10.1073/pnas ATM signals to TSC2 in the cytoplasm to regu PROCEEDINGS
10.1371/journgenome-wide association study in asian populaPLoS Genetics
10.1158/0008gemcitabine sensitivity can be induced in pancCancer Resear
10.1038/ng.5 germline mutations in tmem127 confer suscepNature Geneti
10.1016/j.jur nephrectomy induced chronic renal insufficiencJournal of Urol
10.1002/smll rattle-type fe3o4@sio2 hollow mesoporous spher
Small
10.1158/0008microrna-21 in pancreatic cancer: correlation Cancer Resear
10.1016/j.hea second intermacs annual report: more than 1,00
Journal of Hea
10.1021/cr90 activatable photosensitizers for imaging and t Chemical Revi
10.1158/0008AACR Centennial Series: The Biology of CancerCANCER RESE
10.1084/jem. hif-1? regulates function and differentiation Journal of Exp
10.1182/bloo Long-term outcome of patients in the LNH-98. BLOOD
10.1210/en.2 glucagon-like peptide-1 receptor agonists activa
Endocrinology
no doi11
The choice between p53-induced senescence aAGING-US
10.1038/sj.bj the effects of adding zoledronic acid to neoad British Journal
10.1093/humrembryo development of fresh 'versus' vitrified Human Reprod
10.1016/s147 Effect of anastrozole and tamoxifen as adjuvant
LANCET ONCO
10.4161/cc.9. gamma H2AX foci analysis for monitoring DNA CELL
d
CYCLE
10.1016/j.bbr circulating microrna-1 as a potential novel bio Biochemical a
10.1523/jneurneurokinin b and dynorphin a in kisspeptin neur
Journal of Neu
10.1007/s004 patients with idh1 wild type anaplastic astroc Acta Neuropat
no doi4
fda licensure of bivalent human papillomaviru Morbidity and
10.1002/caac Cancer Statistics, 2010
CA-A CANCER
10.1038/natu RNAi screen identifies Brd4 as a therapeutic t NATURE
10.1016/j.cel BET Bromodomain Inhibition as a Therapeutic SCELL
10.1016/j.cel Biomechanical Remodeling of the MicroenvironCELL
10.1126/scit discovery and preclinical validation of drug i Science Transl
10.1038/natu Selective killing of cancer cells by a small mo NATURE
10.1038/natu Functional genomics reveal that the serine synNATURE
10.1016/j.cel Coding-Independent Regulation of the Tumor CELL
10.1016/j.ccr Oncometabolite 2-Hydroxyglutarate Is a Compe
CANCER CELL
10.1038/natu Oncogene-induced Nrf2 transcription promotesNATURE
10.1038/natu BRCA1 tumour suppression occurs via heterochNATURE
10.1038/nm.2The microRNA miR-34a inhibits prostate cancerNATURE MEDIC
10.1038/natu inhibition of bet recruitment to chromatin as a Nature
10.1038/natu CCL2 recruits inflammatory monocytes to facil NATURE
10.1016/j.cel An Extensive MicroRNA-Mediated Network of RN
CELL
10.1073/pnas Normal and neoplastic nonstem cells can spontPROCEEDINGS
10.1038/natu An endogenous tumour-promoting ligand of th NATURE

10.1038/natu Senescence surveillance of pre-malignant hepaNATURE

10.3322/caac Global Cancer Statistics
CA-A CANCER
10.1016/s014 Minimum amount of physical activity for reducLANCET
10.1056/nejmChimeric Antigen Receptor-Modified T Cells in NEW ENGLAND
10.3322/caac The Impact of Eliminating Socioeconomic and RCA-A CANCER
10.1056/nejmReduced Lung-Cancer Mortality with Low-Dos NEW ENGLAND
10.1001/arch Dietary Supplements and Mortality Rate in O ARCHIVES OF
10.1038/natu mapping and analysis of chromatin state dynam
Nature
10.1016/j.cel A ceRNA Hypothesis: The Rosetta Stone of a CELL
10.1038/natu Integrated genomic analyses of ovarian carci NATURE
10.1371/journA User's Guide to the Encyclopedia of DNA E PLOS BIOLOGY
10.1038/natu Tumour evolution inferred by single-cell seque NATURE
10.1001/jamaVitamin E and the Risk of Prostate Cancer The JAMA-JOURNAL
10.1038/natu immunogenicity of induced pluripotent stem ceNature
10.1038/natu Clearance of p16(Ink4a)-positive senescent celNATURE
10.1126/scit T Cells with Chimeric Antigen Receptors Have SCIENCE TRAN
10.1038/natu Telomerase reactivation reverses tissue degen NATURE
10.1038/natu Somatic coding mutations in human induced plNATURE
10.1016/s014 Effect of daily aspirin on long-term risk of dea LANCET
10.1016/j.cel Reconstitution of the Mouse Germ Cell SpecificCELL
10.1038/natu Initial genome sequencing and analysis of mu NATURE
10.1038/natu Somatic retrotransposition alters the genetic NATURE
10.1038/natu Charting a course for genomic medicine from bNATURE
10.1056/nejmTelaprevir for Previously Untreated Chronic Hepa
NEW ENGLAND
10.1056/nejmAbiraterone and Increased Survival in MetastatNEW ENGLAND
10.1038/natu The genomic complexity of primary human proNATURE
10.1126/scie Recombinant Origin of the Retrovirus XMRV
SCIENCE
10.1038/natu Paneth cells constitute the niche for Lgr5 stemNATURE
10.1038/natu Role of YAP/TAZ in mechanotransduction
NATURE
10.1038/natu Telomere dysfunction induces metabolic and NATURE
10.1016/s014 The effects of lowering LDL cholesterol with si LANCET
10.1038/natu Intravenous delivery of a multi-mechanistic ca NATURE
10.1152/phys physiology of microglia
Physiological
10.1056/nejmIpilimumab plus Dacarbazine for Previously U NEW ENGLAND
10.1038/natu Human metabolic individuality in biomedical NATURE
10.1038/natu Whole-genome sequencing identifies recurrentNATURE
10.1038/natu tet1 and hydroxymethylcytosine in transcriptioNature
10.1001/jamagait speed and survival in older adults
JAMA - Journal
10.1038/natu de novo cardiomyocytes from within the activat
Nature
10.1038/natu dynamic regulation of 5-hydroxymethylcytosine
Nature
10.1038/natu Exome sequencing identifies frequent mutatio NATURE
10.1016/s014 Obesity 2 Health and economic burden of the pLANCET
10.1038/natu tlr signalling augments macrophage bactericida
Nature

10.1038/natu Frequent pathway mutations of splicing machi NATURE

10.1038/natu Reprogramming transcription by distinct class NATURE
10.1038/natu ?-synuclein occurs physiologically as a helica Nature
10.1200/jco.2 Human Papillomavirus and Rising Oropharyngea
JOURNAL OF C
10.1093/nar/ Database resources of the National Center for NUCLEIC ACID
10.1126/scie The Mutational Landscape of Head and Neck SCIENCE
10.1056/nejmRadical Prostatectomy versus Watchful WaitingNEW ENGLAND
10.1126/scie Multi-Input RNAi-Based Logic Circuit for Identif SCIENCE
10.1016/s014 Long-term effect of aspirin on cancer risk in c LANCET
10.1038/natu Direct reprogramming of somatic cells is promoNATURE
10.1001/jamaAxillary Dissection vs No Axillary Dissection
JAMA-JOURNAL
10.1126/scie phosphorylation of ulk1 (hatg1) by amp-activa Science
10.1016/j.eur the size and burden of mental disorders and otEuropean Neu
10.1016/j.cel Massive Genomic Rearrangement Acquired in aCELL
10.1016/s014 Breast and cervical cancer in 187 countries b LANCET
10.1126/scie tet-mediated formation of 5-carboxylcytosine Science
10.1056/nejmFOLFIRINOX versus Gemcitabine for MetastaticNEW ENGLAND
10.1038/nm.2the cancer stem cell: premises, promises and Nature Medici
10.1016/s147 Erlotinib versus chemotherapy as first-line t LANCET ONCO
10.1126/scie The Genetic Landscape of the Childhood Canc SCIENCE
10.1126/scie Exome Sequencing of Head and Neck Squamous
SCIENCE
10.1038/ncb2 MicroRNAs are transported in plasma and delive
NATURE CELL
10.1093/nar/ COSMIC: mining complete cancer genomes in tNUCLEIC ACID
10.1016/j.ste reprogramming of mouse and human cells to pCell Stem Cell
10.1038/natu A decade's perspective on DNA sequencing te NATURE
10.1038/nmatNanoparticles that communicate in vivo to ampNATURE MATER
10.1056/nejmIncidence of Adenocarcinoma among Patients w
NEW ENGLAND
10.1016/j.cel Thymine DNA Glycosylase Is Essential for Act CELL
10.1016/j.ste Dynamic Changes in the Copy Number of PluripCELL STEM CE
10.1016/s147 Delivering affordable cancer care in high-inco LANCET ONCO
10.1038/ng.8 Increased methylation variation in epigenetic NATURE GENET
10.1016/j.mol genomic maps of long noncoding rna occupancy
Molecular Cell
10.1038/natu Evolution of human BCR-ABL1 lymphoblastic leu
NATURE
10.1056/nejmlebrikizumab treatment in adults with asthma New England Jo
10.1126/scie tet proteins can convert 5-methylcytosine to 5 Science
10.1038/nm.2Stem cell gene expression programs influence NATURE MEDIC
10.1038/nmatThe targeted delivery of multicomponent cargos
NATURE MATER
10.1016/j.cmecalorie restriction-like effects of 30 days of
Cell Metabolis
10.1038/natu mutations causing syndromic autism define anNature
10.1016/j.pro chitosan - a versatile semi-synthetic polymer i Progress in Po
10.1038/natu Genome-wide mapping of 5-hydroxymethylcytos
NATURE
10.1056/nejmEverolimus for Advanced Pancreatic NeuroendoNEW ENGLAND
10.1038/ni.20Fatty acid-induced NLRP3-ASC inflammasome act
NATURE IMMU

10.1038/nm.2Intraoperative tumor-specific fluorescence imag

NATURE MEDIC
10.1001/jamaUse of Whole-Genome Sequencing to DiagnoseJAMA-JOURNAL
10.1038/natu Frequent mutation of histone-modifying gene NATURE
10.1126/scie CD40 Agonists Alter Tumor Stroma and Show EfSCIENCE
10.1056/nejmAssociation between Body-Mass Index and RiskNEW ENGLAND
10.1126/scie DAXX/ATRX, MEN1, and mTOR Pathway Genes SCIENCE
Are
10.1056/nejmIncorporation of Bevacizumab in the Primary T NEW ENGLAND
10.1016/s014 Denosumab versus zoledronic acid for treatmen
LANCET
10.1038/msb. the quantitative proteome of a human cell lineMolecular Syst
10.1126/scie Acetylcholine-Synthesizing T Cells Relay NeuralSCIENCE
10.1056/nejmAdjuvant Trastuzumab in HER2-Positive Breast NEW ENGLAND
10.1038/nrd3 how were new medicines discovered?
Nature Review
10.1056/nejmBreast-Cancer Adjuvant Therapy with ZoledronNEW ENGLAND
10.1056/nejmA Mosaic Activating Mutation in AKT1 Associat NEW ENGLAND
10.1093/nar/ Reactome: a database of reactions, pathways aNUCLEIC ACID
10.1126/scie Phosphoproteomic Analysis Identifies Grb10 asSCIENCE
10.1056/nejmSunitinib Malate for the Treatment of Pancrea NEW ENGLAND
10.1172/jci45 Identification of human triple-negative breast JOURNAL OF CL
10.1093/nar/gCharacterization of extracellular circulating m NUCLEIC ACID
10.1152/phys micrornas in development and disease
Physiological
10.1038/natu raf inhibitor resistance is mediated by dimeriz Nature
10.1038/natu Oncogenically active MYD88 mutations in hu NATURE
10.1056/nejmIniparib plus Chemotherapy in Metastatic Tripl NEW ENGLAND
10.1016/j.eur Cost of disorders of the brain in Europe 2010 EUROPEAN NE
10.1016/j.ccr AKT Inhibition Relieves Feedback Suppression oCANCER CELL
10.1158/2159Leukocyte Complexity Predicts Breast Cancer CANCER DISCO
10.1038/nbt. an unbiased genome-wide analysis of zinc-finge
Nature Biotec
10.1056/nejmA Phase 3 Trial of Bevacizumab in Ovarian CanNEW ENGLAND
10.1016/j.cel The Lin28/let-7 Axis Regulates Glucose MetaboCELL
10.1016/j.bbi immune modulation of learning, memory, neura
Brain, Behavio
10.1016/s014 Worldwide burden of disease from exposure to LANCET
10.1038/natu Genetic variegation of clonal architecture and NATURE
10.1016/j.cel Nucleotide Deficiency Promotes Genomic Instab
CELL
10.1056/nejmefficacy of quadrivalent hpv vaccine against h New England Jo
10.1038/cr.20 atp-dependent chromatin remodeling: geneti Cell Research
10.1016/s014 Priority actions for the non-communicable disea
LANCET
10.1056/nejmHPV Vaccine against Anal HPV Infection and Ana
NEW ENGLAND
10.1038/natu linear ubiquitination prevents inflammation a Nature
10.1056/nejmExemestane for Breast-Cancer Prevention in NEW ENGLAND
10.1038/embosmall rna-mediated regulation of ips cell generEMBO Journal
10.1038/ng.7 Exome sequencing identifies somatic mutatio NATURE GENET
10.1038/nm.2adipocytes promote ovarian cancer metastasisNature Medici
10.1073/pnas direct reprogramming of mouse fibroblasts to Proceedings of

10.1056/nejmClinical Effect of Point Mutations in Myelodysp NEW ENGLAND

10.1038/nm.2Cancer genomics: from discovery science to p NATURE MEDIC
10.1126/scit Genotypic and Histological Evolution of Lung CSCIENCE TRAN
10.1038/natu CTCF-promoted RNA polymerase II pausing linkNATURE
10.1101/gad. genome-wide analysis of 5-hydroxymethylcytosin
Genes and De
10.1093/annoStrategies for subtypes-dealing with the diver ANNALS OF O
10.1200/jco.2 Cetuximab Plus Irinotecan, Fluorouracil, and L JOURNAL OF C
10.1016/s014 Relevance of breast cancer hormone receptorsLANCET
a
10.1126/scie The mTOR-Regulated Phosphoproteome Reveals
SCIENCE
10.1038/nm.2A human memory T cell subset with stem cell-lNATURE MEDIC
10.1056/nejmSF3B1 and Other Novel Cancer Genes in ChronNEW ENGLAND
10.1016/j.cel Amyloid-like Aggregates Sequester Numerous Me
CELL
10.1126/scie Interconversion Between Intestinal Stem Cell PSCIENCE
10.1016/s014 effect of radiotherapy after breast-conserving The Lancet
10.1038/ng.7 Silencing of microRNA families by seed-targeti NATURE GENET
10.1126/scit Growth Hormone Receptor Deficiency Is Associa
SCIENCE TRAN
10.1038/ncb2 Incomplete DNA methylation underlies a transcNATURE CELL
10.1038/ng.8 Analysis of the coding genome of diffuse larg NATURE GENET
10.1093/cid/c Clinical Practice Guideline for the Use of Ant CLINICAL INFE
10.1038/ng.8 Phosphoglycerate dehydrogenase diverts glycol
NATURE GENET
10.1001/jamaEffect of Screening on Ovarian Cancer Mortali JAMA-JOURNAL
10.1161/str. diagnosis and management of cerebral venousStroke
t
10.1016/s014 Cancer survival in Australia, Canada, DenmarkLANCET
10.1126/scie phosphorylation of the autophagy receptor optiScience
10.1002/admananomaterials: applications in cancer imaging Advanced Mate
10.1038/natu Distinct stem cells contribute to mammary g NATURE
10.1038/natu DMRT1 prevents female reprogramming in the NATURE
10.1038/natu the role of tet3 dna dioxygenase in epigeneti Nature
10.1016/j.mol genome-wide regulation of 5hmc, 5mc, and gen
Molecular Cell
10.1056/nejmBRAF Mutations in Hairy-Cell Leukemia
NEW ENGLAND
10.1038/natu DICER1 deficit induces Alu RNA toxicity in age NATURE
10.1016/j.cel Pyruvate Kinase M2 Is a PHD3-Stimulated Coact
CELL
10.1038/nco 5-hydroxymethylcytosine in the mammalian zyg
Nature Commun
10.1126/scie Altered Telomeres in Tumors with ATRX and D SCIENCE
10.1053/j.gas Pancreatitis, Pancreatic, and Thyroid Cancer GASTROENTER
10.1056/nejmDiabetes Mellitus, Fasting Glucose, and Risk o NEW ENGLAND
10.1056/nejmpioglitazone for diabetes prevention in impair New England Jo
10.1038/msb. Deep proteome and transcriptome mapping of MOLECULAR SY
10.1146/annuraerobic glycolysis: meeting the metabolic requiAnnual Review
10.1038/natu Structure of mammalian AMPK and its regulati NATURE
10.1200/jco.2 Medulloblastoma Comprises Four Distinct Molec
JOURNAL OF C
10.1126/scit personalized oncology through integrative hig Science Transl
10.1038/ng.9 Frequent mutations of chromatin remodeling gen
NATURE GENET

10.1038/ng.7 FOXA1 is a key determinant of estrogen receptNATURE GENET

10.1016/j.eur EAU Guidelines on Prostate Cancer. Part 1: Scr EUROPEAN UR
10.1021/jm10Organometallic Anticancer Compounds
JOURNAL OF M
10.1038/natu a reserve stem cell population in small intestinNature
10.1056/nejmgp100 Peptide Vaccine and Interleukin-2 in P NEW ENGLAND
10.1016/j.ccr HRG Inhibits Tumor Growth and Metastasis by CANCER CELL
10.1002/jbmr.the amazing osteocyte
Journal of Bon
10.1093/jnci/dAnnual Report to the Nation on the Status of JOURNAL OF T
10.1016/j.eur EAU Guidelines on Non-Muscle-Invasive UrothelEUROPEAN UR
10.1038/nbt. Therapeutic siRNA silencing in inflammatory NATURE BIOT
10.1016/j.ccr selective killing of mixed lineage leukemia cell Cancer Cell
10.1200/jco.2 Dissecting Therapeutic Resistance to RAF Inhi JOURNAL OF C
10.1016/j.cel Genome-wide Translocation Sequencing ReveaCELL
10.1073/pnas Multistage nanoparticle delivery system for dePROCEEDINGS
10.1016/j.ste The Intestinal Stem Cell Signature Identifies CELL STEM CE
10.4161/epi.6Validation of a DNA methylation microarray f EPIGENETICS
10.1038/nbt. Transcriptome sequencing across a prostate caNATURE BIOT
10.1016/j.jal 2011 alzheimer's disease facts and figures
Alzheimer's a
10.1126/scie natural aryl hydrocarbon receptor ligands contrScience
10.1016/j.cel Activation of mTORC2 by Association with the CELL
10.1016/j.ccr Reciprocal Feedback Regulation of PI3K and AnCANCER CELL
10.1101/gad. Activated Ras requires autophagy to maintain GENES & DEV
10.1056/nejmInterleukin-2 and Regulatory T Cells in Graft-v NEW ENGLAND
10.1016/j.cel In Vivo Identification of Tumor-Suppressive
CELL
10.1038/natu SMAD4-dependent barrier constrains prostate NATURE
10.3322/caac Photodynamic Therapy of Cancer: An Update CA-A CANCER
10.1016/j.ccr Direct Signaling between Platelets and Cancer CANCER CELL
10.1242/jcs.0 The regulation of autophagy - unanswered queJOURNAL OF C
10.1016/j.cel Yap1 Acts Downstream of alpha-Catenin to Cont
CELL
10.1371/journWhat Is New for an Old Molecule? Systematic PLOS ONE
10.1016/j.ccr Tet2 Loss Leads to Increased Hematopoietic StCANCER CELL
10.1016/j.cel hydroxylation of 5-methylcytosine by tet1 promCell
10.1038/natu Habenular alpha 5 nicotinic receptor subunit siNATURE
10.1056/nejmInflammatory Cortical Demyelination in Early Mu
NEW ENGLAND
10.1056/nejmchanges in forced expiratory volume in 1 seco New England Jo
10.1111/j.152the clinicopathologic spectrum of focal cortic Epilepsia
10.1073/pnas Argonaute2 complexes carry a population of c PROCEEDINGS
10.1016/s014 osteoporosis: now and the future
The Lancet
10.1038/natu Tumour-infiltrating regulatory T cells stimul
NATURE
10.1016/s014 Early effect of the HPV vaccination programmeLANCET
o
10.1056/nejmevidence for human lung stem cells
New England Jo
10.1038/natu Tumour hypoxia promotes tolerance and angiog
NATURE
10.1002/admahyaluronic acid hydrogels for biomedical appli Advanced Mate

10.1038/natu mmset regulates histone h4k20 methylation a Nature

10.1016/j.ste Tet1 and Tet2 Regulate 5-Hydroxymethylcytosin
CELL STEM CE
10.1038/natu SCFFBW7 regulates cellular apoptosis by targetNATURE
10.1016/j.cel Stochastic State Transitions Give Rise to PhenoCELL
10.1038/nnanaccumulation of sub-100 nm polymeric micelleNature Nanote
10.1016/s014 Addition of cetuximab to oxaliplatin-based fir LANCET
10.1038/nbt. Chemoproteomics profiling of HDAC inhibitors NATURE BIOT
10.1056/nejmInducible Apoptosis as a Safety Switch for Ado NEW ENGLAND
10.1073/pnas MicroRNA signatures in tissues and plasma pr PROCEEDINGS
10.1038/ng.8 Exome sequencing identifies GRIN2A as frequ NATURE GENET
10.1200/jco.2 Randomized, Double-Blind Study of Denosumab
JOURNAL OF C
10.1038/nri29diversity and dialogue in immunity to helminthNature Review
10.1093/gero Rapamycin, But Not Resveratrol or SimvastatinJOURNALS OF
10.1101/gad. Pancreatic cancers require autophagy for tumoGENES & DEV
10.1056/nejmtiotropium versus salmeterol for the preventio New England Jo
10.1016/s014 Comparative effectiveness of axitinib versus s LANCET
10.1200/jco.2 Tumor Regression in Patients With Metastatic JOURNAL OF C
10.1111/j.160regulatory t cells and foxp3
Immunological
10.1126/scie K+ Channel Mutations in Adrenal Aldosterone SCIENCE
10.1038/natu catalytic activity of the caspase-8-flip l compl Nature
10.1016/j.ccr TET2 Inactivation Results in Pleiotropic Hem CANCER CELL
10.1038/nn.2 characterizing the rna targets and position-de Nature Neuros
10.1056/nejmSomatic SF3B1 Mutation in Myelodysplasia withNEW ENGLAND
10.1016/j.cel Paracrine and Autocrine Signals Induce and MaCELL
10.1016/j.ccr mosaic amplification of multiple receptor tyro Cancer Cell
10.1038/natu Inactivating mutations of acetyltransferase g NATURE
10.1016/s014 Efficacy and safety of belimumab in patients wLANCET
10.1021/nl20 Photoluminescence from Chemically Exfoliate NANO LETTERS
10.1182/bloo The 2008 WHO classification of lymphoid neoplBLOOD
10.1038/natu A novel tumour-suppressor function for the N NATURE
10.1016/s147 Parotid-sparing intensity modulated versus co LANCET ONCO
10.1016/j.ccr SIRT3 Opposes Reprogramming of Cancer Cell C
MANCER CELL
10.1200/jco.2 Reduced Melanoma After Regular Sunscreen UsJOURNAL OF C
10.1158/1078Durable Complete Responses in Heavily Pretre CLINICAL CAN
10.3322/caac cancer screening in the united states, 2011: a CA Cancer Journ
10.1084/jem. Mitochondrial reactive oxygen species promot JOURNAL OF E
10.1038/nm.2EGFR and EphA2 are host factors for hepatitis C
NATURE MEDIC
10.1016/j.ste bone marrow-derived cell therapy stimulates Cell Stem Cell
10.1200/jco.2 antiemetics: american society of clinical oncol Journal of Clin
10.1016/s147 Effect of crizotinib on overall survival in pat
LANCET ONCO
10.1200/jco.2 Phase III Trial Assessing Bevacizumab in StagesJOURNAL OF C
10.1126/scie Inhibition of Pyruvate Kinase M2 by Reactive SCIENCE
10.1093/nar/gantiSMASH: rapid identification, annotation a NUCLEIC ACID

10.1038/natu Sensitivity to antitubulin chemotherapeutics NATURE

10.1038/nrd3 Targeting G-quadruplexes in gene promoters: aNATURE REVIE
10.1038/nbt. A targeted proteomics-based pipeline for verif NATURE BIOT
10.1084/jem. Analysis of the chronic lymphocytic leukemia JOURNAL OF E
10.1038/natu Adherens junction protein nectin-4 is the epitheNATURE
10.1053/j.gas Proinflammatory Cytokines in the Pathogenesi GASTROENTER
10.1038/ncb2 53BP1 nuclear bodies form around DNA lesionsNATURE CELL
10.1158/0008Breast Cancer Stem Cells Are Regulated by M CANCER RESE
10.1016/j.ste proliferative neural stem cells have high endo Cell Stem Cell
10.1038/natu sharpin forms a linear ubiquitin ligase complexNature
10.1021/bc20 theranostics: combining imaging and therapy Bioconjugate
10.1038/nm.2Combating trastuzumab resistance by targeti NATURE MEDIC
10.1038/ng.9 Exome sequencing identifies frequent mutationNATURE GENET
10.1126/scie Differences in Thermal Tolerance Among Sock SCIENCE
10.1161/circu One-Year Outcomes of Cohort 1 in the EdwardsCIRCULATION
10.1016/j.mr Induction and repair of DNA double strand br MUTATION RE
10.1038/nm.2Breast cancer cells produce tenascin C as a m NATURE MEDIC
10.1146/annucross talk between o-glcnacylation and phosphor
Annual Review
10.1038/natu antidiabetic actions of a non-agonist ppar?? l Nature
10.1038/natu sharpin is a component of the nf-??b-activatin Nature
10.1523/jneuramyloid-??/fyn-induced synaptic, network, andJournal of Neu
10.1001/jamaAssociation Between Opioid Prescribing Patte JAMA-JOURNAL
10.1038/ni.19Deep-sequencing identification of the genomicNATURE IMMU
10.1016/s147 Prevalence of depression, anxiety, and adjustmLANCET ONCO
10.1016/j.eur EAU Guidelines on Prostate Cancer. Part II: Tr EUROPEAN UR
10.1016/j.mol ciaps block ripoptosome formation, a rip1/caspa
Molecular Cell
10.1158/2159The BATTLE Trial: Personalizing Therapy for Lu CANCER DISCO
10.1001/jamaImmunosuppression in Patients Who Die of Seps
JAMA-JOURNAL
10.1073/pnas Therapeutic strategies to overcome crizotinib PROCEEDINGS
10.1016/j.ste tet1 is dispensable for maintaining pluripoten Cell Stem Cell
10.1073/pnas Inducible formation of breast cancer stem cell PROCEEDINGS
10.1007/s002 cytotoxicity and genotoxicity of silver nanopar Archives of Tox
10.1016/s014 Everolimus plus octreotide long-acting repeat LANCET
10.1038/nrcli immune parameters affecting the efficacy of Nature Reviews
10.1073/pnas Targeted delivery of a cisplatin prodrug for sa PROCEEDINGS
10.1073/pnas Anti-VEGF treatment reduces blood supply andPROCEEDINGS
10.1021/ja20 Ultrasmall Reduced Graphene Oxide with High JOURNAL OF T
10.1200/jco.2 Phase II Study of the Antibody Drug Conjugate JOURNAL OF C
10.1182/bloo Tregs prevent GVHD and promote immune recons
BLOOD
10.1200/jco.2 RIBBON-1: Randomized, Double-Blind, Placebo-C
JOURNAL OF C
10.1186/gb-20DNA methylation patterns associate with genetGENOME BIOL
10.1016/j.ccr Bone Marrow-Derived Myofibroblasts Contribu CANCER CELL
10.1038/nm.2Direct targeting of Sec23a by miR-200s influe NATURE MEDIC

10.1200/jco.2 Integrative Genomic Analysis of Medulloblasto JOURNAL OF C

10.1016/j.ajh Tobacco-Smoking-Related Differential DNA Meth
AMERICAN JOU
10.1016/s014 Helicobacter pylori eradication with a capsule LANCET
10.1021/ar20 multifunctional mesoporous silica nanocomposit
Accounts of C
10.1016/j.ijr palliative radiotherapy for bone metastases: a International J
10.1371/journTumor Cell Marker PVRL4 (Nectin 4) Is an Epithe
PLOS PATHOG
10.1073/pnas Transdifferentiation of glioblastoma cells into vPROCEEDINGS
10.1056/nejmRadiotherapy and Short-Term Androgen Deprivat
NEW ENGLAND
10.1038/ng.8 Principles for the post-GWAS functional characte
NATURE GENET
10.1038/natu Cell-type-specific replication initiation programNATURE
10.1038/natu functional complementation between fadd andNature
10.1146/annuhmgb1 is a therapeutic target for sterile infla Annual Review
10.1210/jc.20 Diagnosis and Treatment of Hyperprolactinemia:
JOURNAL OF C
10.1016/j.ccr coexistence of lmpp-like and gmp-like leukemi Cancer Cell
10.1038/natu Recapitulation of premature ageing with iPSCs NATURE
10.1084/jem. integrating mechanisms of pulmonary fibrosis Journal of Exp
10.1016/j.ejc 2010 update of EORTC guidelines for the use ofEUROPEAN JOU
10.1021/nl10 selective targeting of gold nanorods at the mitNano Letters
10.1056/nejmSTAT1 Mutations in Autosomal Dominant ChronNEW ENGLAND
10.1021/ar20 mechanized silica nanoparticles: a new frontie Accounts of C
10.1038/nm.2mir-499 regulates mitochondrial dynamics by tNature Medici
10.1136/ard. 2010 update of the asas/eular recommendation
Annals of the
10.1016/j.jbi miRWalk - Database: Prediction of possible mi JOURNAL OF B
10.2337/dc10 Risk of Bladder Cancer Among Diabetic Patients
DIABETES CAR
10.1182/bloo Somatic mutations at EZH2 Y641 act dominantly
BLOOD
10.1084/jem. miR-146a is a significant brake on autoimmunitJOURNAL OF E
10.1146/annunatural innate and adaptive immunity to canceAnnual Review
10.1073/pnas R-spondins function as ligands of the orphan PROCEEDINGS
10.1038/emboThe oncometabolite 2-hydroxyglutarate inhibitEMBO REPORT
10.1146/annuhydrogen sulfide and cell signaling
Annual Review
10.1038/onc. Long non-coding RNA ANRIL is required for the ONCOGENE
10.1016/j.mol The Ripoptosome, a Signaling Platform that AsMOLECULAR C
10.1016/j.hu Molecular pathogenesis and extraovarian origin
HUMAN PATHO
10.1172/jci35 Human chronic myeloid leukemia stem cells are
JOURNAL OF CL
10.1056/nejmTrends in Hospital Volume and Operative MortalNEW ENGLAND
10.1016/j.eur European Guidelines for the Diagnosis and Ma EUROPEAN UR
10.1146/annuthe inflammasome nlrs in immunity, inflammatAnnual Review
10.1021/ar20 surface-engineered magnetic nanoparticle pla Accounts of C
10.1146/annumolecular genetics of colorectal cancer
Annual Review
10.1039/c1cc yolk/shell nanoparticles: new platforms for nanChemical Comm
10.1056/nejmEffect of Occult Metastases on Survival in No NEW ENGLAND
10.1016/j.ccr Identification of miRNomes in Human Liver an CANCER CELL
10.1038/nnanExchange-coupled magnetic nanoparticles for e
NATURE NANO

10.1016/j.bio Drug delivery with upconversion nanoparticles BIOMATERIALS

10.1016/j.tox in vitro toxicity evaluation of graphene oxide oToxicology Lett
10.1200/jco.2 Gene Expression Signature to Improve Prognosis
JOURNAL OF C
10.1073/pnas Mouse telomerase reverse transcriptase (mTert)
PROCEEDINGS
10.1016/j.bio Pyruvate kinase type M2: A key regulator of t INTERNATIONA
10.1016/s147 Olaparib in patients with recurrent high-grade LANCET ONCO
10.1126/scie Autophagy-Dependent Anticancer Immune Resp
SCIENCE
10.1016/j.mol Oncogenic Ras-Induced Expression of Noxa andMOLECULAR C
10.1200/jco.2 Safety and Efficacy of TG101348, a Selective JAJOURNAL OF C
10.1261/rna. Widespread regulatory activity of vertebrate RNA-A PUBLIC
10.1093/jnci/ projections of the cost of cancer care in the u Journal of the
10.1146/annuhiv infection, inflammation, immunosenescencAnnual Review
10.1002/hep. Micro-RNA Profiling Reveals a Role for miR-29 HEPATOLOGY
10.1126/scie Aberrant Overexpression of Satellite Repeats i SCIENCE
10.1021/ja10 Nanoporous Anatase TiO2 Mesocrystals: Additiv
JOURNAL OF T
10.1126/scie Mutations in CIC and FUBP1 Contribute to Hu SCIENCE
10.1158/1078Aberrations of EZH2 in Cancer
CLINICAL CAN
10.1523/jneurhdac3 is a critical negative regulator of long Journal of Neu
10.1038/ng.7 genome-wide association study identifies 12 new
Nature genetic
10.1200/jco.2 Prognostic and Clinicopathologic Associations JOURNAL OF C
10.1093/annoWorldwide burden of cervical cancer in 2008 ANNALS OF O
10.1056/nejmvitamin d insufficiency
New England Jo
10.1001/jamaKIT as a Therapeutic Target in Metastatic Mel JAMA-JOURNAL
10.1200/jco.2 Perioperative Chemotherapy Compared With Sur
JOURNAL OF C
10.1593/neo. Analysis of Cancer Metabolism by Imaging Hyper
NEOPLASIA
10.1016/j.eur Magnetic Resonance Imaging for the DetectionEUROPEAN UR
10.3171/2011An extent of resection threshold for newly dia JOURNAL OF
10.1016/s147 Treatment with trastuzumab for 1 year after adLANCET ONCO
10.1002/ijc.2 Meta-analysis of observational studies of ser INTERNATIONA
10.1016/j.eur Treatment of Muscle-invasive and Metastatic BEUROPEAN UR
10.1038/ng.7 Mutations of the SLX4 gene in Fanconi anemia NATURE GENET
10.1038/natu dual functions of tet1 in transcriptional regul Nature
10.1016/s014 Eribulin monotherapy versus treatment of physLANCET
10.1016/j.jac omega-3 fatty acids and cardiovascular disease
Journal of the
10.1016/j.ijp Stimuli-responsive magnetic particles for biomINTERNATIONA
10.1084/jem. p53 regulates epithelial-mesenchymal transit JOURNAL OF E
10.1002/ijc.2 Human papillomavirus type distribution in 30,8INTERNATIONA
10.1038/natu CREBBP mutations in relapsed acute lymphobl NATURE
10.1038/leu.2Recurrent DNMT3A mutations in patients with LEUKEMIA
10.1016/s014 Incidence and clearance of genital human papilLANCET
10.1101/gad. Autophagy-deficient mice develop multiple liv GENES & DEV
10.1021/ar20 theranostic nanoshells: from probe design to Accounts of C
10.1016/j.jco Glutathione-responsive nano-vehicles as a prom
JOURNAL OF C

10.1093/jnci/ Associations of Breast Cancer Risk Factors Wi JOURNAL OF T

10.1182/bloo The lymph node microenvironment promotes B-ce
BLOOD
10.1158/0008A Novel ALK Secondary Mutation and EGFR Sign
CANCER RESE
10.1158/0008PTEN Loss Confers BRAF Inhibitor Resistance t CANCER RESE
10.1038/mt.2 Systemic Delivery of Tumor Suppressor microRN
MOLECULAR T
10.1016/s147 Preoperative radiotherapy combined with totalLANCET ONCO
10.1126/scie The Growth Factor Progranulin Binds to TNF Rec
SCIENCE
10.1016/j.ccr Cell Autonomous Role of PTEN in Regulating CaCANCER CELL
10.1016/s014 new insights into the immunology of chronic o The Lancet
10.1001/jamaSpectrum of Cancer Risk Among US Solid Organ
JAMA-JOURNAL
10.1016/j.bio A graphene functionalized electrochemical aptas
BIOMATERIALS
10.1161/circr Intramyocardial, Autologous CD34+Cell TherapCIRCULATION
10.1093/annoEfficacy according to biomarker status of cetu ANNALS OF O
10.1016/j.cho IFI16 Acts as a Nuclear Pathogen Sensor to I CELL HOST &
10.1016/j.ccr Stat3/Socs3 Activation by IL-6 Transsignaling CANCER CELL
10.1093/hmg/dj-1 acts in parallel to the pink1/parkin pathw Human Molecul
10.1097/mpa.international consensus diagnostic criteria for Pancreas
10.1200/jco.2 Predicting Chemotherapy Toxicity in Older AdulJOURNAL OF C
10.1200/jco.2 Biomarker Analyses and Final Overall Survival R
JOURNAL OF C
10.1186/1471external review and validation of the swedish nBMC Public Hea
10.1021/ar10 metal complexes as dna intercalators
Accounts of C
10.1200/jco.2 Identification of Patients With Acute Myelobl JOURNAL OF C
10.1002/ijc.2 Circulating miRNAs are correlated with tumor pINTERNATIONA
10.1182/bloo CAL-101, a p110 delta selective phosphatidylinos
BLOOD
10.1200/jco.2 Philadelphia-Negative Classical Myeloprolif
JOURNAL OF C
10.1084/jem. Human B1 cells in umbilical cord and adult p JOURNAL OF E
10.1146/annuhepcidin and disorders of iron metabolism
Annual Review
10.1016/j.eur A Prospective, Randomised EORTC Intergroup PEUROPEAN UR
10.1200/jco.2 prognostic value of a combined estrogen recepJournal of Clin
10.7326/0003Protection From Colorectal Cancer After Colon ANNALS OF IN
10.1016/s147 Survival after neoadjuvant chemotherapy or c LANCET ONCO
10.1200/jco.2 Adjuvant Whole-Brain Radiotherapy Versus Obse
JOURNAL OF C
10.1002/path IDH1 and IDH2 mutations are frequent events JOURNAL OF P
10.1200/jco.2 Bevacizumab in Combination With Chemotherapy
JOURNAL OF C
10.1200/jco.2 Histopathologic-Based Prognostic Factors of C JOURNAL OF C
10.1158/1078Phase I Trial of Hedgehog Pathway Inhibitor Vi CLINICAL CAN
10.1200/jco.2 Targeted Therapy With the T-Cell-Engaging An JOURNAL OF C
10.1038/ng.8 interaction between erap1 and hla-b27 in ankylNature Geneti
10.1093/jnci/dHypertension as a Biomarker of Efficacy in Pat JOURNAL OF T
10.1016/j.bio fluorine-18-labeled gd3+/yb3+/er3+ co-doped Biomaterials
10.1200/jco.2 Tumor-Infiltrating CD8(+) Lymphocytes Predict JOURNAL OF C
10.1038/ng.7 Common variants near ATM are associated with
NATURE GENET
10.1200/jco.2 Gemcitabine Plus nab-Paclitaxel Is an Active ReJOURNAL OF C

10.1038/ncb2 p53 regulates epithelial-mesenchymal transiti NATURE CELL

10.1021/ar20 polymeric vesicles: from drug carriers to nanore
Accounts of C
10.1038/bmt. European guidelines for antifungal managemenBONE MARROW
10.1039/c0jm Mesoporous silica nanoparticle based nano drug
JOURNAL OF M
10.1200/jco.2 Randomized Phase II Study of Erlotinib Plus TivJOURNAL OF C
10.1038/clpt. clinical pharmacogenetics implementation consClinical Pharm
10.1182/bloo Safety and persistence of adoptively transferr BLOOD
10.1002/art.3 A phase III, randomized, placebo-controlled st ARTHRITIS AN
10.1016/s014 Pancreatic cancer
LANCET
10.1200/jco.2 Four-Year Follow-Up of Trastuzumab Plus Adju JOURNAL OF C
10.1053/j.gas three-year efficacy and safety of tenofovir dis Gastroenterol
10.1016/j.hu Update on the serrated pathway to colorectal HUMAN PATHO
10.1158/0008Clinical Impact of Different Classes of Infiltra CANCER RESE
10.1093/rheu anti-tnf therapy is associated with an increasedRheumatology
10.1158/0008Targeting Tumor Hypoxia: Suppression of BreasCANCER RESE
10.2174/138 the targets of curcumin
Current Drug T
10.1200/jco.2 Clinical Characteristics of Patients With Lun
JOURNAL OF C
10.1039/c0lc Deformability-based cell classification and enriLAB ON A CHIP
10.1002/cncr. First-Line Chemotherapy With Capecitabine anCANCER
10.1016/s147 Adjuvant endocrine therapy plus zoledronic a LANCET ONCO
10.1016/j.bio Near-infrared light induced in vivo photodyna BIOMATERIALS
10.1158/1535PIK3CA Mutations in Patients with Advanced CaMOLECULAR C
10.1016/s147 Cervical cancer risk for women undergoing conc
LANCET ONCO
10.1073/pnas Defects in succinate dehydrogenase in gastroi PROCEEDINGS
10.1007/s004 Analysis of BRAF V600E mutation in 1,320 nervACTA NEUROP
10.1200/jco.2 Phase II Study of Bevacizumab Plus TemozolomJOURNAL OF C
10.1016/j.jur Predicting 15-Year Prostate Cancer Specific MorJOURNAL OF U
10.1200/jco.2 Active Surveillance Program for Prostate Canc JOURNAL OF C
10.1200/jco.2 Incidence and Prognostic Influence of DNMT3AJOURNAL OF C
10.1146/annurthe ins and outs of the epithelial to mesenchym
Annual Review
10.1007/s101 japanese classification of gastric carcinoma: 3rGastric Cancer
10.1016/j.bio Meta-Analysis of Cytokine Alterations in SchizoBIOLOGICAL P
10.1200/jco.2 Phase I Study of Navitoclax (ABT-263), a Novel JOURNAL OF C
10.1158/1078HSP90 Inhibition Is Effective in Breast Cancer CLINICAL CAN
10.1053/j.gas Intestinal Inflammation and Cancer
GASTROENTER
10.1111/j.147quantitative targeted absolute proteomics of hJournal of Neu
10.1002/ijc.2 Coordinated epigenetic repression of the miR- INTERNATIONA
10.1002/anie facile preparation of multifunctional upconve Angewandte Che
10.2217/nnm.Graphene in biomedicine: opportunities and chNANOMEDICIN
10.2217/nnm.Graphene in biomedicine: opportunities and chNANOMEDICIN
10.1053/j.gas analysis of administrative data finds endoscopGastroenterol
10.1200/jco.2 DIPSS Plus: A Refined Dynamic International PrJOURNAL OF C
10.1016/s147 Extra-pleural pneumonectomy versus no extra-LANCET ONCO

10.1021/ar20 gold nanocages: from synthesis to theranostic Accounts of C

10.1136/gut. Molecular pathological epidemiology of colorect
GUT
10.1038/ng.8 Exome sequencing identifies MAX mutations a NATURE GENET
10.1021/nn20protein corona-mediated mitigation of cytotoxiACS Nano
10.1038/ng.9 Germline mutations in BAP1 predispose to melNATURE GENET
10.1200/jco.2 congestive heart failure risk in patients with Journal of Clin
10.1158/1535Cabozantinib (XL184), a Novel MET and VEGFR2
MOLECULAR C
10.1186/1471Type 2 diabetes increases and metformin reduce
BMC CANCER
10.1200/jco.2 American Society of Clinical Oncology Provisio JOURNAL OF C
10.1038/onc. PI3K inhibition results in enhanced HER signa ONCOGENE
10.1182/bloo bruton tyrosine kinase represents a promising Blood
10.1021/ar20 nanoscale metal-organic frameworks for biomeAccounts of C
10.1016/j.ejc a five-microrna signature identified from geno European Journ
10.1146/annumesenchymal stem cells: mechanisms of infl Annual Review
10.1038/modpimpact of proposed iaslc/ats/ers classification Modern Pathol
10.1002/pds. Validation of the National Health Insurance Re PHARMACOEPI
10.1200/jco.2 Phase II, Open-Label, Single-Arm Trial of Imat JOURNAL OF C
10.1021/ac10 Functionalized Graphene Oxide as a NanocarrieANALYTICAL C
10.1093/ije/d cohort profile: the study of health in pomerani International J
10.1002/mc.2Circulating MicroRNAs, miR-21, miR-122, and mMOLECULAR C
10.1016/j.eur Zero Ischemia Partial Nephrectomy: Novel Lap EUROPEAN UR
10.1007/s106 The Rotterdam Study: 2012 objectives and desEUROPEAN JOU
10.2337/dc10 assessing the association of pioglitazone use Diabetes Care
10.1016/j.jur Comparison of Cold and Warm Ischemia DuringJOURNAL
P
OF U
10.1200/jco.2 Primary Tumor Response to Preoperative Chemor
JOURNAL OF C
10.1093/jjco/ Cancer Incidence and Incidence Rates in JapanJAPANESE JOU
10.1016/j.ameSedentary Behaviors and Subsequent Health Ou
AMERICAN JOU
10.1016/j.cis Magnetic fluid hyperthermia: Focus on superpaADVANCES IN
10.1038/nbt. Comprehensive assay of kinase catalytic activity
NATURE BIOT
10.1016/j.ahj interleukin-1?? inhibition and the prevention American Heart
10.1038/nm.2Dominant TNF-alpha(+) Mycobacterium tuberculo
NATURE MEDIC
10.1021/nn20F-18-Labeled Magnetic-Upconversion Nanophos
ACS NANO
10.1097/pas. Subclassification of Non-small Cell Lung Carc AMERICAN JOU
10.1160/ths1 Platelets, inflammation and tissue regeneratio THROMBOSIS
10.1001/jamaCancer Risks Associated With Germline Mutat JAMA-JOURNAL
10.1172/jci46 CD28 costimulation improves expansion and per
JOURNAL OF CL
10.1097/jto. Correlation of IHC and FISH for ALK Gene Rear JOURNAL OF T
10.1053/j.gas Durability of Radiofrequency Ablation in Barre GASTROENTER
10.1002/(issn Physical illness in patients with severe mental WORLD PSYCHI
10.1200/jco.2 Induction of CD8(+) T-Cell Responses Against NJOURNAL OF C
10.1021/ja20 Tailor-Made Dual pH-Sensitive Polymer-Doxorubi
JOURNAL OF T
10.1182/bloo prognostic factors for response and overall surBlood
10.1158/1078Resistance to CYP17A1 Inhibition with Abirater CLINICAL CAN

10.1097/jto. Screening of Anaplastic Lymphoma Kinase RearJOURNAL OF T

10.1016/j.eur laparoendoscopic single-site surgery in urologyEuropean Urol
10.1021/tx10 Danthron, an Anthraquinone Derivative, Induc CHEMICAL RES
10.4143/crt.2 Cancer Statistics in Korea: Incidence, Mortalit CANCER RESE
10.1093/jnci/dcancer burden in the hiv-infected population inJournal of the
10.1177/140 the danish cancer registry
Scandinavian J
no doi3
recommendations on the use of quadrivalent hMorbidity and
10.1038/natu A restricted cell population propagates gliob NATURE
10.1038/natu Defining the mode of tumour growth by clonal NATURE
10.1038/natu Systematic identification of genomic markers of
NATURE
10.1126/scie Lineage Tracing Reveals Lgr5(+) Stem Cell Act SCIENCE
10.1073/pnas The CD47-signal regulatory protein alpha (SIRPPROCEEDINGS
10.1038/natu Tumour micro-environment elicits innate resistNATURE
10.1126/scie Intestinal Inflammation Targets Cancer-Inducing
SCIENCE
10.1038/nm.2Melanoma exosomes educate bone marrow proge
NATURE MEDIC
10.1038/natu Interactions between cancer stem cells and theNATURE
10.1038/natu Melanoma genome sequencing reveals frequenNATURE
10.1038/natu Unresponsiveness of colon cancer to BRAF(V600
NATURE
10.1038/natu Widespread potential for growth-factor-driven rNATURE
10.1038/natu IDH mutation impairs histone demethylation and
NATURE
10.1016/j.cel Transcriptional Amplification in Tumor Cells wi CELL
10.1016/j.cel Sequential Application of Anticancer Drugs En CELL
10.1101/gr.1 Fusobacterium nucleatum infection is prevalenGENOME RESE
10.1038/natu an integrated encyclopedia of dna elements Nature
10.1001/arch red meat consumption and mortality: results f Archives of Int
10.3322/caac Cancer Statistics, 2012
CA-A CANCER
10.1016/s014 Effect of physical inactivity on major non-com LANCET
10.1056/nejmEffect of Three Decades of Screening MammogNEW ENGLAND
10.1016/s014 A comparative risk assessment of burden of dise
LANCET
10.1016/s014 Radiation exposure from CT scans in childhoodLANCET
10.1016/j.cel genomic landscape of non-small cell lung can Cell
10.1056/nejmpatients' expectations about effects of chemo New England Jo
10.1038/natu The genomic and transcriptomic architecture oNATURE
10.1056/nejmRadical Prostatectomy versus Observation for NEW ENGLAND
10.1038/natu impact of caloric restriction on health and sur Nature
10.1038/natu Comprehensive molecular portraits of human NATURE
10.1136/bmjohypnotics' association with mortality or cance BMJ Open
10.1038/cr.20 Exogenous plant MIR168a specifically targets CELL RESEARC
10.1056/nejmstatin use and reduced cancer-related mortalit New England Jo
10.1038/natu Comprehensive molecular characterization of NATURE
10.1056/nejmIntratumor Heterogeneity and Branched EvolutNEW ENGLAND
10.1056/nejmPreoperative Diagnosis of Benign Thyroid NoduNEW ENGLAND
10.1126/scit the predictive capacity of personal genome s Science Transl

10.1016/s147 Global cancer transitions according to the H LANCET ONCO

10.1056/nejmSafety and Activity of Anti-PD-L1 Antibody in NEW ENGLAND
10.1161/cir. heart disease and stroke statistics-2012 updat Circulation
10.1056/nejmSafety, Activity, and Immune Correlates of Ant NEW ENGLAND
10.1016/s014 Short-term effects of daily aspirin on cancer i LANCET
10.1136/heartAssociations of dietary calcium intake and cal HEART
10.1056/nejmthrombotic stroke and myocardial infarction w New England Jo
10.1126/scit tracking a hospital outbreak of carbapenem-r Science Transl
10.1016/s014 Effect of daily aspirin on risk of cancer metast LANCET
10.1016/s147 global burden of cancers attributable to infect The Lancet On
10.1016/s014 The effects of lowering LDL cholesterol with st LANCET
10.1016/s014 Global and regional mortality from 235 causes LANCET
10.1038/natu Comprehensive genomic characterization of sqNATURE
10.1038/natu Exercise-induced BCL2-regulated autophagy isNATURE
10.1056/nejmColorectal-Cancer Incidence and Mortality wit NEW ENGLAND
10.1056/nejmCombined BRAF and MEK Inhibition in Melano NEW ENGLAND
10.1126/scie a logic-gated nanorobot for targeted transport Science
10.1056/nejmAspirin Use, Tumor PIK3CA Mutation, and ColorNEW ENGLAND
10.1073/pnas Distinct DNA methylomes of newborns and cenPROCEEDINGS
10.1056/nejmColonoscopic Polypectomy and Long-Term Preve
NEW ENGLAND
10.1016/j.cel The Life History of 21 Breast Cancers
CELL
10.1056/nejmPertuzumab plus Trastuzumab plus Docetaxel fNEW ENGLAND
10.1038/natu The clonal and mutational evolution spectrum o
NATURE
10.1038/natu Pancreatic cancer genomes reveal aberrations NATURE
10.1056/nejmIncreased Survival with Enzalutamide in Prost NEW ENGLAND
10.1056/nejmProstate-Cancer Mortality at 11 Years of FollowNEW ENGLAND
10.1038/natu Clonal evolution in relapsed acute myeloid l NATURE
10.1056/nejmBasal Insulin and Cardiovascular and Other O NEW ENGLAND
10.1126/scie compartmentalized control of skin immunity b Science
10.1056/nejmImproved Survival with MEK Inhibition in BRA NEW ENGLAND
10.1056/nejmEverolimus in Postmenopausal Hormone-Recept
NEW ENGLAND
10.1016/j.ccr Cancer Stem Cells: Impact, Heterogeneity, andCANCER CELL
10.1016/j.ccr Metabolic Reprogramming: A Cancer Hallmark CANCER CELL
10.1016/j.cel Mutational Processes Molding the Genomes of CELL
10.1056/nejmColonoscopy versus Fecal Immunochemical Test
NEW ENGLAND
10.1038/natu host-microbe interactions have shaped the genNature
10.1038/natu Sequence analysis of mutations and translocatNATURE
10.1056/nejmTrastuzumab Emtansine for HER2-Positive Adv NEW ENGLAND
10.1016/j.ccr Accessories to the Crime: Functions of Cells R CANCER CELL
10.1038/natu The landscape of cancer genes and mutationalNATURE
10.1056/nejmBone-Density Testing Interval and Transition NEW ENGLAND
10.1038/nbt. FLASH assembly of TALENs for high-throughpu NATURE BIOT
10.1038/natu chromatin-modifying enzymes as modulators Nature

10.1016/j.cel A Landscape of Driver Mutations in Melanoma CELL

10.1056/nejmSurvival in BRAF V600-Mutant Advanced MelanNEW ENGLAND
10.1001/jamaPrevalence of Oral HPV Infection in the United JAMA-JOURNAL
10.1016/s014 Embryonic stem cell trials for macular degenerLANCET
10.1016/j.cel Genome Sequencing of Pediatric Medulloblast CELL
10.1016/s014 Years lived with disability (YLDs) for 1160 se LANCET
10.1038/natu The molecular evolution of acquired resistanceNATURE
10.3322/caac American Cancer Society Guidelines on NutritioCA-A CANCER
10.1038/natu oligodendroglia metabolically support axons a Nature
10.1038/natu Differential oestrogen receptor binding is asso NATURE
10.1038/natu Driver mutations in histone H3.3 and chromati NATURE
10.1038/nrc3 Cancer stem cells: an evolving concept
NATURE REVI
10.1056/nejmprednisone, azathioprine, and n-acetylcysteineNew England Jo
10.1016/j.cel Single-Cell Exome Sequencing and MonoclonalCELL
10.1056/nejmPonatinib in Refractory Philadelphia Chromoso NEW ENGLAND
10.1016/j.cel Mapping the Hallmarks of Lung Adenocarcinoma
CELL
10.1016/j.cel extensive promoter-centered chromatin interacti
Cell
10.1093/jnci/dProstate Cancer Screening in the Randomized Pr
JOURNAL OF T
10.1038/natu The Cancer Cell Line Encyclopedia enables pred
NATURE
10.1038/natu Whole-genome analysis informs breast cancer NATURE
10.1126/scie rapamycin-induced insulin resistance is media Science
10.1016/s014 the interleukin-6 receptor as a target for pre The Lancet
10.1038/natu Medulloblastoma exome sequencing uncovers N
s ATURE
10.1126/scie landscape of somatic retrotransposition in hu Science
10.1038/natu Novel mutations target distinct subgroups of NATURE
10.1038/nbt. Absolute quantification of somatic DNA altera NATURE BIOT
10.1016/j.cel Spatial Organization of the Mouse Genome andCELL
10.3322/caac cancer treatment and survivorship statistics, CA Cancer Journ
10.1016/j.cel Single-Cell Exome Sequencing Reveals Single-NCELL
10.1200/jco.2 American Society of Clinical Oncology ProvisionJOURNAL OF C
10.1016/s147 Effects of regular aspirin on long-term cancer LANCET ONCO
10.1038/natu A novel retinoblastoma therapy from genomic NATURE
10.1038/natu Emergence of KRAS mutations and acquired resi
NATURE
10.1016/j.ste Direct Reprogramming of Mouse and Human Fibro
CELL STEM CE
10.1038/natu Sequencing of neuroblastoma identifies chromo
NATURE
10.1056/nejmPreoperative Chemoradiotherapy for Esophagea
NEW ENGLAND
10.1056/nejmPlacebo-Controlled Phase 3 Study of Oral BG-12
NEW ENGLAND
10.1056/nejmClonal Architecture of Secondary Acute Myelo NEW ENGLAND
10.1126/scit preclinical development and clinical translatio Science Transl
10.1056/nejmABVD Alone versus Radiation-Based Therapy i NEW ENGLAND
10.1056/nejmRAS Mutations in Cutaneous Squamous-Cell Carc
NEW ENGLAND
10.1016/j.cel c-Myc Is a Universal Amplifier of Expressed G CELL
10.1016/j.jal 2012 alzheimer's disease facts and figures
Alzheimer's a

10.1038/ng.1 Exome sequencing identifies recurrent mutatioNATURE GENET

10.1056/nejmPrognostic Relevance of Integrated Genetic ProNEW ENGLAND
10.1016/s147 Cross-protective efficacy of HPV-16/18 AS04-adLANCET ONCO
10.1038/natu DNA breaks and chromosome pulverization from
NATURE
10.1038/natu Dissecting the genomic complexity underlyin NATURE
10.1056/nejmeffect of cinacalcet on cardiovascular disease New England Jo
10.1038/natu A microRNA regulon that mediates endothelial NATURE
10.1016/s014 Comparisons between different polychemotherLANCET
10.1038/natu Reductive glutamine metabolism by IDH1 mediNATURE
10.1016/s014 Lapatinib with trastuzumab for HER2-positive eLANCET
10.1038/natu Inflammasome-mediated dysbiosis regulates pNATURE
10.1016/j.cel The Transcriptional and Epigenomic FoundationCELL
10.1016/s014 cardiovascular benefits and diabetes risks of stThe Lancet
10.1038/nm.2A brain tumor molecular imaging strategy usi NATURE MEDIC
10.1016/j.cel loss of 5-hydroxymethylcytosine is an epigene Cell
10.1056/nejmEfficacy and Safety of Vismodegib in AdvancedNEW ENGLAND
10.1038/natu structure of the chemokine receptor cxcr1 in pNature
10.1038/natu IDH1 mutation is sufficient to establish the
NATURE
10.1016/s147 Overall efficacy of HPV-16/18 AS04-adjuvantedLANCET
v
ONCO
10.1038/nm.2Identification of new ALK and RET gene fusionsNATURE MEDIC
10.1016/j.cel p53 Opens the Mitochondrial Permeability Trans
CELL
10.1038/nnanMolecularly self-assembled nucleic acid nanopar
NATURE NANO
10.1038/natu A call for transparent reporting to optimize theNATURE
10.1038/natu pgc7 binds histone h3k9me2 to protect againsNature
10.1016/j.cel Slug and Sox9 Cooperatively Determine the M CELL
10.1038/natu The translational landscape of mTOR signallingNATURE
10.1038/ng.1 Exome sequencing identifies recurrent soma NATURE GENET
10.1038/ng.1 somatic histone h3 alterations in pediatric dif Nature Geneti
10.1016/j.cel Systemic Elevation of PTEN Induces a Tumor-S CELL
10.1038/natu Reductive carboxylation supports growth in tu NATURE
10.1172/jci59 Macrophage plasticity and polarization: in vivoJOURNAL OF CL
10.1126/scie wnt/??-catenin signaling regulates telomerase Science
10.1021/nl20 graphene quantum dots derived from carbon fiNano Letters
10.1073/pnas Aristolochic acid-associated urothelial cancer PROCEEDINGS
10.1038/natu goblet cells deliver luminal antigen to cd103 +Nature
10.1038/natu Clonal selection drives genetic divergence of NATURE
10.1038/nnanrole of cell cycle on the cellular uptake and dil Nature Nanote
10.1038/natu EZH2 inhibition as a therapeutic strategy for NATURE
10.1371/journSingle Cell Profiling of Circulating Tumor Cells PLOS ONE
10.1016/j.cel The Origin and Evolution of Mutations in Acut CELL
10.1073/pnas In vitro microvessels for the study of angioge PROCEEDINGS
10.1016/j.cel Tumor Suppression in the Absence of p53-Media
CELL
10.1126/scie Metabolite Profiling Identifies a Key Role for Gl SCIENCE

10.1038/natu Maintenance of muscle stem-cell quiescence NATURE

10.1016/s014 Dabrafenib in BRAF-mutated metastatic melanom
LANCET
10.1101/gr.1 genome-wide analysis of long noncoding rna stGenome Resea
10.1038/natu Cancer exome analysis reveals a T-cell-depe NATURE
10.1016/j.cel regulation of the hippo-yap pathway by g-proteCell
10.1136/bmj. the use of pioglitazone and the risk of bladder BMJ (Online)
10.1056/nejmBevacizumab Added to Neoadjuvant Chemother
NEW ENGLAND
10.1038/natu Validation of ITD mutations in FLT3 as a thera NATURE
10.1001/jamaCharacteristics of Clinical Trials Registered in JAMA-JOURNAL
10.1016/s014 Dabrafenib in patients with melanoma, untreate
LANCET
10.1111/j.146The economic cost of brain disorders in EuropeEUROPEAN JO
10.1056/nejmNeoadjuvant Chemotherapy and Bevacizumab NEW
f
ENGLAND
10.1056/nejmJAK Inhibition with Ruxolitinib versus Best Avai NEW ENGLAND
10.1016/s147 Erlotinib versus standard chemotherapy as firsLANCET ONCO
10.1038/natu Subgroup-specific structural variation acros
NATURE
10.1038/nche Small-molecule-induced DNA damage identifiesNATURE CHEMI
10.1056/nejmingenol mebutate gel for actinic keratosis
New England Jo
10.1056/nejmMYD88 L265P Somatic Mutation in Waldenstro NEW ENGLAND
10.1038/natu The genetic basis of early T-cell precursor ac NATURE
10.1016/j.cel a cxcl1 paracrine network links cancer chemorCell
10.1126/scit novel adenovirus-based vaccines induce broadScience Transl
10.1126/scie Structural Basis of Wnt Recognition by FrizzledSCIENCE
10.1056/nejmA Double-Blind, Placebo-Controlled Trial of RuxoNEW ENGLAND
10.1016/j.cel A Differentiation Checkpoint Limits Hematopo CELL
10.1038/natu phase transitions in the assembly of multivalenNature
10.1016/j.ccr Pericyte Depletion Results in Hypoxia-Associa CANCER CELL
10.1016/j.cel EMT and Dissemination Precede Pancreatic Tu CELL
10.1126/scie structure of an intermediate state in protein f Science
10.1101/gr.1 A transforming KIF5B and RET gene fusion in GENOME RESE
10.1016/s014 post-mortem imaging as an alternative to autop
The Lancet
10.1016/j.cel U1 snRNP Determines mRNA Length and Regula
CELL
10.1038/natu topology of the human and mouse m 6 a rna mNature
10.1073/pnas Discovery and prioritization of somatic mutat PROCEEDINGS
10.1016/s014 Denosumab and bone-metastasis-free survivalLANCET
in
10.1038/ng.9 Regions of focal DNA hypermethylation and lonNATURE GENET
10.1038/nm.2RET, ROS1 and ALK fusions in lung cancer
NATURE MEDIC
10.1038/ng.1 Amplification of siRNA in Caenorhabditis elega NATURE GENET
10.1038/natu DNA damage defines sites of recurrent chromoNATURE
10.1016/j.cel Wnt Signaling through Inhibition of beta-CatenCELL
10.1056/nejmOlaparib Maintenance Therapy in Platinum-SenNEW ENGLAND
10.1101/gr.1 Genomic analysis identifies association of Fus GENOME RESE
10.1038/nm.2Multipeptide immune response to cancer vaccin
NATURE MEDIC
10.1016/j.immcytometry by time-of-flight shows combinatoriaImmunity

10.1093/jnci/ the diesel exhaust in miners study: a nested c Journal of the

10.1038/nrg3 uncovering the role of 5-hydroxymethylcytosi Nature Review
10.1056/nejmGermline Mutations in HOXB13 and Prostate-CaNEW ENGLAND
10.1056/nejmInhibiting the Hedgehog Pathway in Patients wNEW ENGLAND
10.1016/s147 Focal therapy for localised unifocal and multi LANCET ONCO
10.1007/s004 Molecular subgroups of medulloblastoma: the ACTA NEUROP
10.1016/j.ccr Transient Low Doses of DNA-Demethylating Agen
CANCER CELL
10.1016/j.cel Dynamic Reprogramming of the Kinome in Respo
CELL
10.1016/j.cel Mutant p53 Disrupts Mammary Tissue ArchitecCELL
10.1126/scie a lineage of myeloid cells independent of myb Science
10.1101/gr.1 varscan 2: somatic mutation and copy numberGenome Resea
10.1016/j.ccr VEGF Inhibits Tumor Cell Invasion and Mesen CANCER CELL
10.1038/ncb2 Telomeric DNA damage is irreparable and causNATURE CELL
10.1056/nejmfingolimod for multiple sclerosis
New England Jo
10.1016/j.ccr Enzymatic Targeting of the Stroma Ablates PhyCANCER CELL
10.1038/nm.2egfr and met receptor tyrosine kinase-altered Nature Medici
10.7326/0003overdiagnosis of invasive breast cancer due Annals of Inte
10.1038/nm.2KIF5B-RET fusions in lung adenocarcinoma
NATURE MEDIC
10.1038/natu The mutational landscape of lethal castration- NATURE
10.1016/j.ophranibizumab and bevacizumab for treatment ofOphthalmolog
10.3945/ajcn amount of time spent in sedentary behaviors an
American Journa
10.1016/s147 Association between endometriosis and risk of LANCET ONCO
10.1038/ng.1 Recurrent mutations in the U2AF1 splicing fac NATURE GENET
10.1038/ng.2 Activation of the AXL kinase causes resistance NATURE GENET
10.1038/ng.2 Integrated analysis of somatic mutations and NATURE GENET
10.1038/nnanNormalization of tumour blood vessels improv NATURE NANO
10.1016/j.cel The Pan-ErbB Negative Regulator Lrig1 Is an InCELL
10.3322/caac Cancers with increasing incidence trends in t CA-A CANCER
10.1126/scit Mechanisms of Acquired Crizotinib Resistance SCIENCE TRAN
10.1038/natu pathogen-induced human t h17 cells produce ifn
Nature
10.1001/jamaIntensity-Modulated Radiation Therapy, Proton JAMA-JOURNAL
10.1056/nejmSemuloparin for Thromboprophylaxis in Patien NEW ENGLAND
10.1056/nejmrecurrent somatic dicer1 mutations in nonepithNew England Jo
10.1038/ng.2 Exome sequencing of gastric adenocarcinoma NATURE
id
GENET
10.1038/ni.22NLRC4-driven production of IL-1 beta discrim NATURE IMMU
10.1007/s003 ESUR prostate MR guidelines 2012
EUROPEAN RA
10.1056/nejmRadiotherapy with or without Chemotherapy inNEW ENGLAND
10.1038/natu burkitt lymphoma pathogenesis and therapeutic
Nature
10.1038/natu Pathway complexity in supramolecular polymerNATURE
10.1016/j.cel The Poly(A)-Binding Protein Nuclear 1 Suppres CELL
10.1056/nejmImmunologic Correlates of the Abscopal Effect NEW ENGLAND
10.1073/pnas Antiangiogenic agents increase breast cancer PROCEEDINGS
10.1056/nejmablation with low-dose radioiodine and thyrotroNew England Jo

10.1016/j.cel Oncogenic Kras Maintains Pancreatic Tumors t CELL

10.1038/ng.2 de novo germline and postzygotic mutations i Nature Geneti
10.1056/nejmLenalidomide after Stem-Cell Transplantation NEW ENGLAND
10.1016/s014 Hepatocellular carcinoma
LANCET
10.1073/pnas the intestinal stem cell markers bmi1 and lgr5 Proceedings of
10.1136/bmj. Effect of hormone replacement therapy on car BRITISH MEDI
10.1038/ng.2 Exome sequencing identifies recurrent somat NATURE GENET
10.1016/j.immoxidized mitochondrial dna activates the nlrp Immunity
10.1101/gr.1 Global DNA hypomethylation coupled to represGENOME RESE
10.1038/nbt. Conjugation site modulates the in vivo stabilit NATURE BIOT
10.1038/natu Structure of the agonist-bound neurotensin re NATURE
10.1016/j.cmeGlucose-Independent Glutamine Metabolism via
CELL
T METABOL
10.1073/pnas MicroRNAs bind to Toll-like receptors to induc PROCEEDINGS
10.1016/s147 Efficacy and safety of neoadjuvant pertuzumabLANCET ONCO
10.1038/ng.2 Detectable clonal mosaicism from birth to old aNATURE GENET
10.1038/natu infection regulates pro-resolving mediators thaNature
10.1038/nm.2A common BIM deletion polymorphism mediates
NATURE
in
MEDIC
10.1016/j.cel Glycine Decarboxylase Activity Drives Non-Smal
CELL
10.1158/2159the cbio cancer genomics portal: an open plat Cancer Discov
10.1136/bmj. venous thrombosis in users of non-oral hormonBMJ (Clinical r
10.1016/j.ccr Hotspot Mutations in H3F3A and IDH1 Define DiCANCER CELL
10.1038/nm.2Identification of a mutation in the extracellu NATURE MEDIC
10.1093/nar/ PhosphoSitePlus: a comprehensive resource forNUCLEIC ACID
10.1200/jco.2 Addition of Aflibercept to Fluorouracil, Leucov JOURNAL OF C
10.1101/gr.1 Mutual exclusivity analysis identifies oncogen GENOME RESE
10.1172/jci57 an anti-diabetes agent protects the mouse braiJournal of Clin
10.1016/j.cel membrane tension maintains cell polarity by co
Cell
10.1002/admamesoporous silica nanoparticles: synthesis, bi Advanced Mate
10.1038/nm.2inhibition of the lsd1 (kdm1a) demethylase reac
Nature Medici
10.1093/jnci/ the diesel exhaust in miners study: a cohort m Journal of the
10.1016/s147 Temozolomide chemotherapy alone versus radio
LANCET ONCO
10.1038/natu znrf3 promotes wnt receptor turnover in an r- Nature
10.1056/nejmContinuous Lenalidomide Treatment for Newly NEW ENGLAND
10.1038/natu Recurrent R-spondin fusions in colon cancer NATURE
10.1056/nejmStrategies of Radioiodine Ablation in Patients NEW ENGLAND
10.1111/j.160nf-??b and the link between inflammation and Immunological
10.1038/ng.1 Whole-genome sequence of Schistosoma hae NATURE GENET
10.1016/j.ccr Activation of p53 by SIRT1 Inhibition Enhance CANCER CELL
10.1158/1078Mechanisms of Resistance to Crizotinib in Pat CLINICAL CAN
10.1038/ncb2 syndecan-syntenin-alix regulates the biogenesNature Cell Bi
10.1038/natu AMPK regulates NADPH homeostasis to promote
NATURE
10.1007/s001 International evidence-based recommendations
INTENSIVE CA
10.1111/j.147Rapamycin slows aging in mice
AGING CELL

10.1038/ncb2 single-molecule transcript counting of stem-ceNature Cell Bi

10.1038/ng.1 Genome-wide association analysis identifies thNATURE GENET
10.1056/nejmLenalidomide Maintenance after Stem-Cell TranNEW ENGLAND
10.1101/gr.1 Genome-scale analysis of aberrant DNA methyla
GENOME RESE
10.1038/nm.2In vivo photodynamic therapy using upconversNATURE MEDIC
10.1038/natu A murine lung cancer co-clinical trial identifie NATURE
10.1038/mt.2 mesenchymal stem/stromal cells (mscs): role aMolecular The
10.1038/ng.2 Detectable clonal mosaicism and its relationshNATURE GENET
10.1016/j.ccr Tumor-Derived Granulocyte-Macrophage ColonyCANCER CELL
10.1038/ng.2 Mutations affecting components of the SWI/SNNATURE GENET
10.1016/j.mol Pyruvate Kinase M2 Regulates Gene TranscriptiMOLECULAR C
10.1200/jco.2 Vandetanib in Patients With Locally Advanced oJOURNAL OF C
10.1200/jco.2 ROS1 Rearrangements Define a Unique MoleculJOURNAL OF C
10.1016/j.ccr Rapid Decrease in Delivery of Chemotherapy toCANCER CELL
10.1016/s014 Pazopanib for metastatic soft-tissue sarcoma ( LANCET
10.1158/1078failure of iniparib to inhibit poly(adp-ribose) p Clinical Cance
10.1016/j.cel host genotype-specific therapies can optimize Cell
10.1309/ajcptAmerican Cancer Society, American Society forAMERICAN JOU
10.1016/s147 Maintenance therapy with pemetrexed plus best
LANCET ONCO
10.1038/ng.2 Exome sequencing identifies recurrent SPOP, NATURE GENET
10.1016/s147 Human papillomavirus testing for the detectionLANCET ONCO
10.3945/ajcn Vitamin D deficiency and mortality risk in the AMERICAN JOU
10.1126/scie Tumor Necrosis Factor Signaling Requires iRhom
SCIENCE
10.7326/0003Screening for Prostate Cancer: US Preventive ANNALS OF IN
10.1016/j.immf-actin is an evolutionarily conserved damage- Immunity
10.1016/s147 Anal human papillomavirus infection and assocLANCET ONCO
10.1073/pnas the human circadian metabolome
Proceedings of
10.1016/j.mol Inhibition of Homologous Recombination by theMOLECULAR C
10.1038/nmatbiodegradable poly(amine-co-ester) terpolymerNature Materia
10.1126/scit colocalization of inflammatory response with Science Transl
10.1016/j.cel the mitochondrial phosphatase pgam5 functionCell
10.1200/jco.2 Colorectal and Other Cancer Risks for Carrier JOURNAL OF C
10.1016/j.bre 1st international consensus guidelines for adv Breast
10.1074/jbc. ?-synuclein in central nervous system and fr Journal of Biol
10.1101/gad. Cell detachment activates the Hippo pathway vGENES & DEV
10.1200/jco.2 Results of a Pivotal Phase II Study of Brentux JOURNAL OF C
10.1200/jco.2 Improved Survival for Children and Adolescen JOURNAL OF C
10.1101/gr.1 A DNA methylation fingerprint of 1628 human GENOME RESE
10.1038/nco melanoma whole-exome sequencing identifies Nature
v6
Commun
10.1158/1940Blood Cell Origin of Circulating MicroRNAs: A CANCER PREV
10.1093/carci microrna involvement in human cancer
Carcinogenesi
10.1016/j.fert Consensus on women's health aspects of pol FERTILITY AND
10.1001/jamaAssociation Between BRCA1 and BRCA2 Mutation
JAMA-JOURNAL

10.1016/s147 Ipilimumab in patients with melanoma and braiLANCET ONCO

10.1101/cshp signaling in innate immunity and inflammationCold Spring Ha
10.1038/bjc.2 Changes in circulating microRNA levels associ BRITISH JOUR
10.1158/2159EGFR-Mediated Reactivation of MAPK SignalingCANCER
C
DISCO
10.1182/bloo B-cell depletion and remissions of malignancy a
BLOOD
10.1001/jamaOne vs Three Years of Adjuvant Imatinib for O JAMA-JOURNAL
10.1016/j.cel mixed lineage kinase domain-like protein mediCell
10.1016/j.phy Higgs mass implications on the stability of t PHYSICS LETTE
10.1016/s147 Participation and yield of colonoscopy versus LANCET ONCO
10.1038/natu IDH1(R132H) mutation increases murine haemat
NATURE
10.1002/ajh.2Acute myeloid leukemia: 2012 update on diagno
AMERICAN JOU
10.1038/natu Notch-dependent VEGFR3 upregulation allows NATURE
10.1200/jco.2 Definition and Impact of Pathologic Complete JOURNAL OF C
10.1016/j.ste Low Incidence of DNA Sequence Variation in H CELL STEM CE
10.1038/nm.2il-17a produced by ??? t cells drives airwa
Nature Medici
10.1371/journThe Viral and Cellular MicroRNA Targetome in PLOS PATHOG
10.1200/jco.2 Phase III Trial Comparing Capecitabine Plus C JOURNAL OF C
10.1158/1078Hsp90 Molecular Chaperone Inhibitors: Are We CLINICAL CAN
10.1200/jco.2 Preoperative Versus Postoperative Chemoradiot
JOURNAL OF C
10.1007/s004 Molecular subgroups of medulloblastoma: an inACTA NEUROP
10.1101/gr.1 global profiling of dna methylation erasure in Genome Resea
10.1371/journneutrophil extracellular traps directly induce e PLoS ONE
10.1200/jco.2 RAS Mutations Are Associated With the DeveloJOURNAL OF C
10.7326/0003Screening for Cervical Cancer: US Preventive ANNALS OF IN
10.1016/s147 EGFR expression as a predictor of survival for LANCET ONCO
10.1021/nl20 Mesoporous Multifunctional Upconversion LumiNANO LETTERS
10.1073/pnas Intratumoral heterogeneity of receptor tyrosin PROCEEDINGS
10.1200/jco.2 OCEANS: A Randomized, Double-Blind, Placebo-Co
JOURNAL OF C
10.1158/1535Combinations of BRAF, MEK, and PI3K/mTOR InMOLECULAR C
10.1093/cid/c risk of anal cancer in hiv-infected and hiv-unin Clinical Infect
10.1016/j.bio Multifunctional nanoprobes for upconversion f BIOMATERIALS
10.1093/nar/gmirdeep2 accurately identifies known and hundNucleic Acids
10.1158/2159Suppression of Tumor Invasion and Metastasis CANCER DISCO
10.1002/adfmBiocompatible Nanoparticles with Aggregation-IADVANCED FUN
10.1038/modpconsensus statement on the pathology of igg4-Modern Pathol
10.7326/0003new protease inhibitors for the treatment of chr
Annals of Inte
10.1111/j.175free radicals and antioxidants: updating a per Nutrition Revi
10.1200/jco.2 assessment of bcr-abl1 transcript levels at 3 mJournal of Clin
10.1158/1078Selective BRAF Inhibitors Induce Marked T-cell CLINICAL CAN
10.1016/s147 Afatinib for patients with lung adenocarcinomaLANCET ONCO
10.1172/jci61 Imiquimod clears tumors in mice independent of
JOURNAL OF CL
10.1053/j.gas next-generation stool dna test accurately det Gastroenterol
10.1074/jbc. exosome-associated tau is secreted in tauopath
Journal of Biol

10.1016/j.eur Perioperative Outcomes of Robot-Assisted Rad EUROPEAN UR

10.1136/annr european league against rheumatism recommend
Annals of the
10.1002/admaMesoporous Silica-Coated Gold Nanorods as a LADVANCED MA
10.1200/jco.2 Summary Report on the Graded Prognostic Asses
JOURNAL OF C
10.1016/j.ccr Oncogenic Kras-Induced GM-CSF Production PrCANCER CELL
10.1200/jco.2 Prospective Study Evaluating the Impact of Tis JOURNAL OF C
10.1053/j.gas Guidelines for Colonoscopy Surveillance After GASTROENTER
10.1182/bloo Clonal competition with alternating dominanc BLOOD
10.1097/sla. Right Portal Vein Ligation Combined With In Si ANNALS OF SU
10.1016/s014 Adjuvant capecitabine and oxaliplatin for gast LANCET
10.1056/nejmcombination chemotherapy in advanced adreno
New England Jo
10.1084/jem. inflammation switches the differentiation pro Journal of Exp
10.1002/admaMultimodal Imaging Guided Photothermal TherADVANCED MA
10.1200/jco.2 First-SIGNAL: First-Line Single-Agent Iressa V JOURNAL OF C
10.1073/pnas Feedback upregulation of HER3 (ErbB3) expressi
PROCEEDINGS
10.1055/s-00 The EFSUMB Guidelines and RecommendationsULTRASCHALL
on
10.1016/j.immThe Transcription Factors T-bet and Eomes ContIMMUNITY
10.1016/j.mol hydrogen sulfide-linked sulfhydration of nf-??b Molecular Cell
10.1002/admanear-infrared light-triggered, targeted drug d Advanced Mate
10.1200/jco.2 Pretreatment Epidermal Growth Factor Receptor
JOURNAL OF C
10.1016/s147 Abiraterone acetate for treatment of metastatiLANCET ONCO
10.1039/c1m Attributes of short linear motifs
MOLECULAR B
10.1097/gme the 2012 hormone therapy position statement Menopause
10.1038/ng.2 BAP1 loss defines a new class of renal cell ca NATURE GENET
10.1016/j.pre The molecular basis of retinal ganglion cell d PROGRESS IN
10.1200/jco.2 Randomized Phase II Trial of Everolimus in Co JOURNAL OF C
10.1136/gutjnAssessment of colorectal cancer molecular featGUT
10.1002/admaSmall Adsorbate-Assisted Shape Control of Pd ADVANCED MA
10.1073/pnas High-grade serous ovarian cancer arises from PROCEEDINGS
10.1093/jnci/ CYP2D6 Genotype and Tamoxifen Response in P
JOURNAL OF T
10.1016/j.bcp The flavonoid quercetin in disease prevention BIOCHEMICAL
10.1038/natu a unifying model for mtorc1-mediated regulatioNature
10.1200/jco.2 association of kras g13d tumor mutations with Journal of Clin
10.1158/1078CTLA-4 Blockade with Ipilimumab: Long-term FCLINICAL CAN
10.1016/j.eur Prospective Assessment of Prostate Cancer Ag EUROPEAN UR
10.1182/bloo Mutations of NOTCH1 are an independent predic
BLOOD
10.1038/ng.2 Whole-genome sequencing of liver cancers ident
NATURE GENET
10.1016/j.vac global epidemiology of hepatitis b virus infec Vaccine
10.2337/dc11 Mortality After Incident Cancer in People With DIABETES CAR
10.1159/0003ENETS Consensus Guidelines for the Managemen
NEUROENDOCR
10.1158/0008ARN-509: A Novel Antiandrogen for Prostate C CANCER RESE
10.1158/1535Identification and Characterization of NVP-BKM1
MOLECULAR C
10.1002/humuSomatic Mutations in the Chromatin Remodeli HUMAN MUTAT

10.1101/gad. nf-??b, the first quarter-century: remarkable Genes and De

10.1093/ije/d Predictors of global methylation levels in blo INTERNATIONA
10.1001/jamaLong-term Survival Following Partial vs Radic JAMA-JOURNAL
10.1038/natu Transformation by the (R)-enantiomer of 2-hydrNATURE
10.1073/pnas Class III PI3K Vps34 plays an essential role in PROCEEDINGS
10.1038/ajg.2Risk of Hepatocellular Carcinoma in Diabetic P AMERICAN JO
10.1002/anie in vitro and in vivo uncaging and bioluminesc Angewandte Che
10.1182/bloo Mutations in the spliceosome machinery, a no BLOOD
10.1007/s120 asian-pacific consensus statement on the manHepatology Int
10.1200/jco.2 Randomized, Double-Blind, Placebo-Controlled JOURNAL OF C
10.1039/c2cc Designing organometallic compounds for catalCHEMICAL CO
10.1016/s014 Chronic obstructive pulmonary disease
LANCET
10.1039/c1cc one-step synthesis of amino-functionalized flu Chemical Comm
10.1200/jco.2 Substantial Susceptibility of Chronic LymphocytJOURNAL OF C
10.1200/jco.2 Defucosylated Anti-CCR4 Monoclonal Antibody JOURNAL OF C
10.1016/j.cct The VITamin D and OmegA-3 TriaL (VITAL): RatiCONTEMPORARY
10.1021/ja21 Nuclear-Targeted Drug Delivery of TAT Peptide JOURNAL OF T
10.1016/j.mol Leucyl-tRNA Synthetase Controls TORC1 via t MOLECULAR C
10.1182/bloo JAK inhibitors for myeloproliferative neoplasmsBLOOD
10.1182/bloo The Bruton tyrosine kinase inhibitor PCI-32765 BLOOD
10.1016/j.bio Three-dimensional paper-based electrochemiluBIOMATERIALS
10.1038/emboEBV and human microRNAs co-target oncogenic
EMBO JOURNA
10.1146/annuampk and mtor in cellular energy homeostasisAnnual Review
10.1200/jco.2 Brentuximab Vedotin (SGN-35) in Patients WithJOURNAL OF C
10.1016/j.bio Multifunctional nanoparticles for upconversi BIOMATERIALS
10.1182/bloo The clinically active BTK inhibitor PCI-32765 BLOOD
10.1200/jco.2 clinical significance and molecular characteristJournal of Clin
10.1161/circu vascular klotho deficiency potentiates the dev Circulation
10.1002/path Concurrent CIC mutations, IDH mutations, and JOURNAL OF P
10.1200/jco.2 Phase I, Dose-Escalation Study of BKM120, an O
JOURNAL OF C
10.1007/s001 Pioglitazone and risk of bladder cancer among DIABETOLOGIA
10.1016/s147 Afatinib versus placebo for patients with advanLANCET ONCO
10.1002/ijc.2 Identification of ten serum microRNAs from a INTERNATIONA
10.1016/s016 Management of HCC
JOURNAL OF H
10.1016/j.bio The influence of surface chemistry and size o BIOMATERIALS
10.1016/j.eur International Variation in Prostate Cancer Inci EUROPEAN UR
10.1146/annuprogramming of dna methylation patterns
Annual Review
10.1002/admaMn2+ Dopant-Controlled Synthesis of NaYF4:Yb
ADVANCED MA
10.1093/jnci/da three-gene model to robustly identify breas Journal of the
10.1093/eurheevaluation of risk stratification schemes for iscEuropean Heart
10.1016/j.cpc CALYPSO: A method for crystal structure predicCOMPUTER PH
10.1681/asn. Suppression of microRNA-29 Expression by TGFJOURNAL OF T
10.1016/j.bio The triggering of apoptosis in macrophages b BIOMATERIALS

10.1084/jem. Expression of the zinc finger transcription fact JOURNAL OF E

10.1016/j.bio PEGylated dendrimer-entrapped gold nanopartiBIOMATERIALS
10.1200/jco.2 New Comprehensive Cytogenetic Scoring SysteJOURNAL OF C
10.1148/radioShear-wave Elastography Improves the SpecificRADIOLOGY
10.1038/leu.2risk of progression and survival in multiple m Leukemia
10.1093/bja/arandomized controlled trial of intraoperative goBritish Journal
10.1021/ac20 Amplified Detection of DNA through the Enz ANALYTICAL C
10.1002/ijc.2 Circulating micro-RNA expression profiles in eaINTERNATIONA
10.1371/journklc1-alk: a novel fusion in lung cancer identif PLoS ONE
10.1053/j.gas Frequent Detection of Pancreatic Lesions in As GASTROENTER
10.1038/onc. Concurrent loss of the PTEN and RB1 tumor s ONCOGENE
10.1007/s104 binding and neutralization of vascular endotheAngiogenesis
10.2967/jnumFirst Clinical Experience with Integrated Who JOURNAL OF N
10.1053/j.gas consensus statements for management of barre
Gastroenterol
10.1016/s014 Lapatinib versus trastuzumab in combination LANCET ONCO
10.1373/clin Serum MicroRNA Expression Profile as a BiomarCLINICAL CHE
10.1200/jco.2 Loss of Human Epidermal Growth Factor ReceptJOURNAL OF C
10.1002/med.circulating micrornas: a novel class of bioma Medicinal Res
10.1016/s147 Activity and safety of crizotinib in patients w LANCET ONCO
10.1016/s147 Activity of the oral MEK inhibitor trametinib i LANCET ONCO
10.1200/jco.2 PI3K/AKT/mTOR Inhibitors in Patients With Bre JOURNAL OF C
10.1136/gut. The putative tumour suppressor microRNA-124GUT
10.1158/0008Curcumin Analogue CDF Inhibits Pancreatic T CANCER RESE
10.1016/j.eur Infectious Complications and Hospital AdmissioEUROPEAN UR
10.1158/1078Clarifying the Spectrum of Driver Oncogene M CLINICAL CAN
10.1093/jnci/ CYP2D6 and UGT2B7 Genotype and Risk of Recur
JNCI-JOURNAL
10.1158/1078Phase II, Open-Label, Randomized Trial of th CLINICAL CAN
10.1245/s104 a randomized trial comparing postoperative adAnnals of Surg
10.1136/gutjnMicroRNA-375 inhibits tumour growth and metas
GUT
10.1016/s147 Inotuzumab ozogamicin, an anti-CD22-calechea
LANCET ONCO
10.1200/jco.2 Randomized, Double-Blind, Placebo-Controlled JOURNAL OF C
10.1111/j.147impaired mitochondrial biogenesis contributes Journal of Neu
10.1016/j.can Genome-wide microRNA profiles identify miR-37
CANCER LETTE
10.1200/jco.2 Phase III Trial of Cetuximab With Continuous orJOURNAL OF C
no doi2
cell cycle arrest is not yet senescence, which isAging
10.1200/jco.2 Phase II Study of the Mammalian Target of RapJOURNAL OF C
10.1002/cncr. Comparison of tumor response by Response Eval
CANCER
10.1007/s004 Immunohistochemical testing of BRAF V600E sta
ACTA NEUROP
10.1158/1078lifetime cancer risks in individuals with germl Clinical Cance
10.1016/s147 Combined immunotherapy with granulocyte-macro
LANCET ONCO
10.1021/nn30Up-Conversion Cell Imaging and pH-Induced T ACS NANO
10.1007/s101 Japanese Society for Cancer of the Colon and RINTERNATIONA
10.1016/s147 risk of recurrence of gastrointestinal stromal The Lancet On

10.1016/j.hrt Distinguishing "benign" from "malignant early HEART RHYTH

10.1002/cncr. NRAS mutation status is an independent prognCANCER
10.1200/jco.2 Bevacizumab in Combination With Chemotherapy
JOURNAL OF C
10.1097/jto. Dual IHC and FISH Testing for ALK Gene Rearr JOURNAL OF T
10.1021/ar20 recent advances in nonviral vectors for gene dAccounts of C
10.1038/nrm3PI3K signalling: the path to discovery and und NATURE REVIE
10.1016/j.jur Zero Ischemia Anatomical Partial NephrectomyJOURNAL OF U
10.1172/jci63 Essential metabolic, anti-inflammatory, and antJOURNAL OF CL
10.1182/bloo Simple genetic diagnosis of hairy cell leukemi BLOOD
10.1101/gad. on par with parp: cellular stress signaling thr Genes and De
10.1002/cncr. predicting the risk of chemotherapy toxicity i Cancer
10.1002/ijc.2 Brain accumulation of sunitinib is restricted
INTERNATIONA
10.1016/j.gie eus-guided fna for diagnosis of solid pancreat Gastrointestin
10.1021/ol20 highly selective fluorescence turn-on chemod Organic Letter
10.4161/cc.11using the "reverse warburg effect" to identify Cell Cycle
10.1016/s147 Ipilimumab and a poxviral vaccine targeting pro
LANCET ONCO
10.1200/jco.2 Targeting the Interleukin-6/Jak/Stat Pathway JOURNAL OF C
10.1055/s-00 Management of precancerous conditions and leENDOSCOPY
10.1200/jco.2 Phase II, Open-Label, Randomized, MulticenterJOURNAL OF C
10.1634/theonFrequent Mutation of Isocitrate Dehydrogenas ONCOLOGIST
10.1039/c2sc A highly selective ratiometric near-infrared fl CHEMICAL SCI
10.1002/jbmr five years of denosumab exposure in women wit
Journal of Bon
10.1002/ajh.2polycythemia vera and essential thrombocytheAmerican Jour
10.1166/jbn. Chemiluminescence Molecular Detection of Se JOURNAL OF B
10.4143/crt.2 Cancer Statistics in Korea: Incidence, Mortalit CANCER RESE
10.1158/1078A Phase I Weekly Dosing Study of BrentuximabCLINICAL CAN
10.1016/j.fert Live birth after ovarian tissue autotransplanta FERTILITY AND
no doi1
induction of apoptosis in tumor cells by natur Asian Pacific J
10.1615/critr targeting pi3 kinase/akt/mtor signaling in cancCritical Revie
10.1059/0003Overdiagnosis of Invasive Breast Cancer Due ANNALS OF IN

Correspondin
Publisher
Authors
g author
Email
Keywords
NATURE PUBL Poliseno, L; S Pandolfi, PP (re ppandolf@bidCOMPARATIVE
CELL PRESS Sharma, SV; Le
Classon, M (repr classon@helixSTEM-CELLS;
NATURE PUBL Gupta, RA; Sha
Chang, HY (repri howchang@sta
AGGRESSIVE B
CELL PRESS Figueroa, ME; Thompson, CB (re
craig@mail.mACUTE MYELOI
NATURE PUBL Ricci-Vitiani, De Maria, R (rep pallini@rm.uniVASCULOGENIC
NATURE PUBL Kan, ZY; JaiswSeshagiri, S (re sekar@gene. SINGLE NUCLE
CELL PRESS Heidorn, SJ; MMarais, R (repri richard.marai B-RAF; K-RAS
NATURE PUBL Hatzivassiliou Hatzivassiliou, hatzivassilio PROTEIN-KINA
NATURE PUBL Vermeulen, L; Medema, JP (rep J.P.Medema@aHEPATOCYTE G
NATURE PUBL Carro, MS; LimCalifano, A (rep califano@c2b GROWTH-FACTO
NA
Nazarian R., SNA
NA
NA
NATURE PUBL Johannessen, C
Garraway, LA (reLevi_GarrawayB-RAF; TUMOR
CELL PRESS Kim, J; Woo, AOrkin, SH (repri stuart_orkin@HISTONE ACET
NA
Poulikakos P.I NA
NA
NA
AMER ASSOC Sugahara, KN;Ruoslahti, E (re ruoslahti@bu ENDOTHELIAL
CELL PRESS Ward, PS; PateThompson, CB (re
craig@mail.mISOCITRATE D
NATURE PUBL Ko, M; Huang, Rao, A (reprint a maciejj@ccf.o DNA METHYLAT
NA
Jemal A., SiegeNA
NA
NA
NA
Trapnell C., W NA
NA
NA
WILEY-BLACK Ferlay, J; Shi Ferlay, J (reprin ferlay@iarc.fr 18 MAJOR CAN
MASSACHUSET
Hodi, FS; O'DaHodi, FS (reprin stephen_hodi@
T-LYMPHOCYTE
MASSACHUSET
Temel, JS; Gre Temel, JS (repri jtemel@partneQUALITY-OF-L
CELL PRESS Lemmon, MA; Lemmon,
S
MA (repr
mlemmon@mail
EPIDERMAL-G
NATURE PUBL Beroukhim, R;Lander, ES (repr lander@broadiACUTE LYMPH
MASSACHUSET
Flaherty, KT; Flaherty, KT (re kflaherty@parMISMATCH REP
NATURE PUBL Pleasance, ED;Stratton, MR (re paf@sanger.acNUCLEOTIDE E
CELL PRESS Verhaak, RGW;Hayes, DN (repri hayes@med.uNEURAL STEMMASSACHUSET
Kwak, EL; Bang
Kwak, EL (reprin ekwak@partne
EML4-ALK FUS
COLD SPRING McKenna, A; Ha
DePristo, MA (re depristo@broaSTRUCTURAL V
NATURE PUBL Pleasance, ED;Campbell, PJ (re pc8@sanger.aACUTE MYELOI
NATURE PUBL Ding, L; Ellis Wilson, RK (repr rwilson@wustlMYELOID-LEUK
NATURE PUBL Eichler, EE; F Eichler, EE (rep eee@gs.washin
SINGLE-NUCLE
MASSACHUSET
Kantoff, PW; HKantoff, PW (rep philip_kantof MITOXANTRONE
ELSEVIER SCI Ashley, EA; BuAshley, EA (repr euan@stanforRIGHT-VENTRI
AMER ASSOC Wu, BL; Chien,Stevens, RC (reprstevens@scri PROTEIN-COUP
NATURE PUBL Flusberg, BA; Turner, SW (repristurner@pacifPOLYMERASE M
MASSACHUSET
Maemondo, M;Inoue,
I
A (reprin akinoue@idac.GROWTH-FACTO

CELL PRESS McClellan, J; McClellan, J (re drjack@uw.edCOLORECTAL-C

MASSACHUSET
de Gonzalez, Ade Gonzalez, AB berringtona@m
RANDOMIZED C
ELSEVIER SCI Ferlay, J; Par Ferlay, J (reprin ferlay@iarc.fr BREAST-CANCE
NATURE PUBL Bollag, G; Hir Bollag, G (reprin gbollag@plex HUMAN CANCER
ELSEVIER SCI Bang, YJ; Van Bang, YJ (reprin NA
METASTATIC B
NA
Ito S., Daless NA
NA
NA
CELL PRESS Rahl, PB; Lin, Young, RA (repri young@wi.mitRNA-POLYMERA
MASSACHUSET
Cohen, JA; Bark
Cohen, JA (reprincohenj@ccf.orEXPERIMENTAL
NA
Kanchanawong
NA
NA
NA
ELSEVIER SCI Mitsudomi, T; Mitsudomi, T (re mitsudom@aich
PREVIOUSLY T
MASSACHUSET
Ang, KK; HarriGillison, ML (re maura.gillis SQUAMOUS-CEL
ELSEVIER SCI Baigent, C; Bl Baigent, C (repri NA
CORONARY-HEA
NATURE PUBL Hudson, TJ; AnHudson, TJ (repr tom.hudson@o
MYELOID-LEUK
CELL PRESS Taylor, BS; Sc Sawyers, CL (repsawyersc@msk
WATCHFUL WA
NA
Tay S., HugheyNA
NA
NA
NATURE PUBL Srivastava, M;Srivastava, M (r mansi@wi.mitSPONGE GEODI
NATURE PUBL Leek, JT; SchaIrizarry, RA (re rafa@jhu.edu OVARIAN-CANC
NATURE PUBL Yachida, S; Jo Iacobuzio-Donahu
ciacobu@jhmiCARCINOMA;
NATURE PUBL Bignell, GR; G Stratton, MR (re paf@sanger.acSOMATIC FRAM
NA
Melton C., JudsNA
NA
NA
MASSACHUSET
Ley, TJ; Ding, Ley, TJ (reprint timley@wustl DNA METHYLAT
CELL PRESS Noushmehr, H;Laird, PW (repri plaird@usc.edINTEGRATED G
NA
Gamo F.-J., Sa NA
NA
NA
NATL ACAD S Lo, SC; Pripuz Lo, SC (reprint shyhching.lo@MURINE LEUKE
NA
Cardis E.
NA
NA
NA
NATURE PUBL Lee, W; Jiang, Zhang, ZM (reprizemin@gene. MYELOID-LEUK
NA
Ng S.B., BighaNA
NA
NA
NA
Huarte M., GutNA
NA
NA
NATURE PUBL Dalgliesh, GL; Teh, B (reprint Bin.Teh@vai.oCELL CARCINO
AMER ASSOC Olsen, JV; Ver Mann, M (reprintmmann@bioch
CELL-CYCLE;
NATURE PUBL Horcajada, P; C
Horcajada, P (rephorcajada@chiBONE-MARROW
NA
Geisler S., HolNA
NA
NA
OXFORD UNIVSayers, EW; Ba
Sayers, EW (reprsayers@ncbi.nONLINE MENDE
NA
Baranzini S.E. NA
NA
NA
AMER SOC CL Sternberg, CN;Sternberg, CN (recstern@mclinkINTERFERON-A
ELSEVIER SCI Kaptoge, S; DiKaptoge, S (repr erfc@phpc.ca LOW-DENSITY
NA
Craddock N., HNA
NA
NA
NA
Konig R., Ster NA
NA
NA
NATURE PUBL Bock, C; Tomaz
Bock, C (reprint cbock@broadin
CPG ISLAND S
NA
Jopling C., Sl NA
NA
NA
ELSEVIER SCI Atkin, WS; Edw
Atkin, WS (repri w.atkin@imperBASE-LINE FI
NA
Li R., Liang J. NA
NA
NA
NATURE PUBL Schindler, DE;Schindler, DE (r deschind@u.wPACIFIC SALM

NA
Cadwell K., PaNA
NA
NA
ELSEVIER SCI Tutt, A; Robso Tutt, A (reprint andrew.tutt@iHOMOLOGY-DIR
NATURE PUBL He, HSHS; Meye
Liu, XS (reprint myles_brown@d
ANDROGEN RE
NA
Moro K., Yamad
NA
NA
NA
NATURE PUBL Campbell, PJ; Futreal, PA (rep ciacobu@jhmi.COPY NUMBER
NA
Heinz S., Benne
NA
NA
NA
NATURE PUBL Fraley, SI; Fe Wirtz, D (reprin glongmor@dom
FIBRONECTIN
NATURE PUBL Kang, HM; Sul,Sabatti, C (repri sabatti@stanfCANCER SUSCE
PUBLIC LIBRA Erlwein, O; KaErlwein, O (repri m.mcclure@im
RANDOMIZED C
CURRENT BIO Yang, ZF; Klio Klionsky, DJ (rep klionsky@umiBCL-X-L; BEC
AMER ASSOC Jones, S; WangKinzler, KW (rep kinzlke@jhmi.COLORECTAL C
NA
Samavarchi-Teh
NA
NA
NA
BIOMED CENTPrat, A; ParkerPerou, CM (repri cperou@med.EPITHELIAL-M
NA
Bartke T., Ver NA
NA
NA
COLD SPRING Ramagopalan,Ramagopalan,
S
SVsreeramr@well
SUSCEPTIBILI
MASSACHUSET
McHutchison, M
J cHutchison, JG mchut001@mc
CHRONIC HEPA
ELSEVIER SCI Dowlati, Y; HeLanctot, KL (rep krista.lancto NECROSIS-FAC
NA
Ittner L.M., KeNA
NA
NA
ELSEVIER SCI de Bono, JS; Ode Bono, JS (rep johann.de-bonEVERY 3 WEEK
NATURE PUBL Morin, RD; JohMarra, MA (repri mmarra@bcgsGROUP PROTEI
NATURE PUBL Wang, R; Chada
Tabar, V (reprin tabarv@mskccNERVOUS-SYST
NA
Michelakis E.DNA
NA
NA
NATURE PUBL Medina, PP; NoSlack, FJ (repri frank.slack@yONCOGENE ADD
CELL PRESS Roesch, A; FukHerlyn, M (reprinherlynm@wista
CANCER STEMNATURE PUBL Park, JH; WachChatterjee, N (r chattern@mailBREAST-CANCE
CELL PRESS Bunting, SF; CNussenzweig, A (andre_nussenCLASS-SWITCH
NATURE PUBL FilippakopouloKnapp, S (reprin stefan.knapp@
ABL TYROSINE
NA
Guzman J.N., Sa
NA
NA
NA
NATURE PUBL Boiko, AD; RazBoiko, AD (repri aboiko@stanfoCANCER STEMELSEVIER SCI Bonner, JA; HaBonner, JA (repr jabonner@ua EPIDERMAL-G
CELL PRESS Duvel, K; Yeci Murphy, LO (reprleon.murphy@TUBEROUS SCL
CELL PRESS Villanueva, J; Herlyn, M (reprinherlynm@wista
GROWTH-FACTO
NA
Zheng Y., Jose NA
NA
NA
CELL PRESS Mayshar, Y; BeBenvenisty, N (renissimb@cc.huj
COPY NUMBER
CELL PRESS Zhao, J; Ohsum
Lee, JT (reprint lee@molbio.mEMBRYONIC ST
NATURE PUBL Ernst, T; ChasCross, NCP (rep ncpc@soton.aACQUIRED UNI
ELSEVIER SCI De Roock, W; C
Tejpar, S (repri NA
GROWTH-FACT
CELL PRESS Martello, G; R Piccolo, S (repri piccolo@bio.un
BREAST-CANCE
AMER ASSOC Chou, TC
Chou, TC (reprin chout@mskcc.MICHAELIS-ME
NA
Vander HeidenNA
NA
NA
NA
Han J., BurgesNA
NA
NA
ELSEVIER SCI Scher, HI; BeeScher, HI (repri scherh@mskcc
CIRCULATING
CELL PRESS Park, EJ; Lee, Karin, M (reprin karinoffice@u INDUCED INSU

NATURE PUBL Ma, L; Young, Weinberg, RA (reweinberg@wi.HUMAN BREAST

MASSACHUSET
Valle, J; Wasa Bridgewater, J ( j.bridgewater RANDOMIZED P
CELL PRESS Yap, KL; Li, S Walsh, MJ (repri martin.walsh CORONARY-AR
NA
Chung I., Akit NA
NA
NA
AMER SOC CL Hammond, MEH;
Hammond, MEH (re
guidelines@asCENTRALLY RE
MASSACHUSET
Wiegand, KC; S
Huntsman, DG (re
dhuntsma@bcc
CLEAR-CELL C
NATURE PUBL Nelson, AL; DhReichert, JM (re janice.reicher HUMAN-HUMAN
NATURE PUBL Horcajada, P; C
Horcajada, P (rephorcajada@chiBONE-MARROW
NA
Pacholec M., BNA
NA
NA
AMER SOC CL Brahmer, JR; DTopalian, SL (re stopali1@jhmiCELL IMMUNOT
AMER MEDICADomchek, SM;Rebbeck,
F
TR (repreb-beck@maiBILATERAL P
ELSEVIER SCI Wang, TJ; Zhan
Spector, TD (rep tjwang@partne
D-BINDING PR
ACADEMIC PRE
Kroh, EM; ParkTewari, M (repri mtewari@fhcrCANCER; QUAN
NATURE PUBL Shi, LM; Campb
Shi, LM (reprint leming.shi@fdGENE-EXPRESS
AMER SOC CL Wen, PY; MacdWen, PY (reprint pwen@partnerRECURRENT MA
NATURE PUBL Ma, L; ReinharWeinberg, RA (reweinberg@wi.BREAST-CANCE
NA
Maze I., CovinNA
NA
NA
CELL PRESS Molyneux, G; G
Smalley, MJ (rep matthew.smallESTROGEN-REC
NA
[No author naNA
NA
NA
NATL ACAD S Stott, SL; Hsu Isselbacher, KJ kisselbacher@RESISTANT PR
MASSACHUSET
Kalager, M; Z Kalager, M (repr mkalager@hspSWEDISH RAN
MASSACHUSET
Andriole, GL; Andriole, GL (re andrioleg@wus
5-ALPHA-REDU
ELSEVIER SCI Audeh, MW; Car
Audeh, MW (repriwilliam.audehHOMOLOGY-DIR
CAMBRIDGE URoberfroid, M;NA
NA
INFLAMMATORY
NA
Geiger T., CoxNA
NA
NA
NATURE PUBL Komatsu, M; Ku
Komatsu, M (reprkomatsu-ms@ig
CUL3-BASED E
NA
Wang Y., Nakay
NA
NA
NA
CELL PRESS Zitvogel, L; K Zitvogel, L (repr zitvogel@igr. TUMOR-CELLS;
NATURE PUBL Raaijmakers, M
Raaijmakers, MHhraaijmakers STEM-CELL NI
CELL PRESS Zhang, YJ; Liu,Zhang, JF (reprinjfzhang@nju.eC-MYB; CIRC
NATURE PUBL Asselin-Labat,Lindeman, GJ (rep
lindeman@weh
ESTROGEN-REC
CELL PRESS Quintana, E; SMorrison, SJ (re seanjm@umicACUTE MYELOI
ENDOCRINE SBhasin, S; Cu Bhasin, S (repri govt-prof@endPROSTATE-SPE
NA
Leary R.J., Kin NA
NA
NA
LIPPINCOTT WKurman, RJ; ShKurman, RJ (repr rkurman@jhmiPROPHYLACTIC
NA
Weerapana E.,NA
NA
NA
AMER SOC CL Blackwell, KL; Blackwell, KL (r black034@mc.PHASE-II; 1S
CELL PRESS Chen, RH; NishPhillips, HS (re hsp@gene.co CANCER STEMNATL ACAD S Taube, JH; HerWeinberg, RA (reweinberg@wi.TRANSCRIPTIO
AMER SOC BI Kosaka, N; IguOchiya, T (reprintochiya@ncc.gTUMOR-DERIVE
NATURE PUBL Joshi, PA; Jac Khokha, R (repri rkhokha@uhnrBREAST-CANCE
MASSACHUSET
Verstovsek, S;Verstovsek, S (r sverstov@mdaINTERNATIONA
NATL ACAD S Le, A; Cooper,Semenza, GL (rep
gsemenza@jhm
AEROBIC GLYC

NA
Hu W., Peng C.NA
NA
NA
NATURE PUBL Zhang, JM; AdrAdrian, FJ (repr fadrian@gnf.oCHRONIC MYEL
ELSEVIER SCI Rothwell, PM; Rothwell, PM (reppeter.rothwel TRANSIENT IS
AMER DIABET Giovannucci, EGiovannucci, E ( egiovann@hspACTIVATED RE
ELSEVIER SCI Cappuzzo, F; CCappuzzo, F (reprf.cappuzzo@usCISPLATIN PL
NA
Saenz S.A., Si NA
NA
NA
NA
Rissin D.M., KaNA
NA
NA
CELL PRESS Erez, N; Truit Hanahan, D (reprdh@ucsf.edu COLITIS-ASSO
SPRINGER/PL Micalizzi, DS; Ford, HL (reprin heide.ford@u GROWTH-FACTO
ELSEVIER SCI de Sanjose, S;de Sanjose, S (r s.sanjose@icoHIGH-RISK; I
AMER SOC CL Stopeck, AT; LiStopeck, AT (rep astopeck@azcPLACEBO-CONT
WILEY-BLACK Van Meir, EG; Van Meir, EG (re evanmei@emor
PHASE-II TRI
NATURE PUBL Bouwman, P; Al
Jonkers, J (repr madalena.tarsCONDITIONAL
MASSACHUSET
Wacholder, S; Wacholder, S (re wacholds@mai
GENOME-WIDE
NA
van den Berg D
NA
NA
NA
NATURE PUBL Kienast, Y; vo Winkler, F (repr frank.winkle MELANOMA ME
AMER SOC CL Bardelli, A; Si Bardelli, A (repr a.bardelli@irccGROWTH-FACTO
NA
Bjedov I., Toiv NA
NA
NA
SPRINGER
Boellaard, R; Boellaard, R (re r.boellaard@v POSITRON-EMI
CELL PRESS Nomura, DK; Lo
Cravatt, BF (reprcravatt@scripENZYME-ACTIV
ELSEVIER SCI Vaidya, JS; Jo Vaidya, JS (repri jayant.vaidya ENERGY X-RAY
CELL PRESS Turke, AB; Zej Engelman, JA (rejengelman@par
GROWTH-FACTO
CELL PRESS Iliopoulos, D; Struhl, K (repri kevin@hms.haNF-KAPPA-B;
CELL PRESS Iskow, RC; McC
Devine, SE (repr sdevine@som.TRANSPOSABLE
CELL PRESS Barker, N; HucClevers, H (repr h.clevers@hubEPITHELIAL-C
AMER MEDICARogers, HW; We
Rogers, HW (reprrogershoward INCREASING I
NA
Woo C.J., KharNA
NA
NA
NA
Tanaka A., CleNA
NA
NA
NATURE PUBL Workman, P; Ab
Workman, P (reprPaul.Workman@
PANCREATIC
BIOMED CENTGroom, HCT; Bo
Bishop, KN (reprikbishop@nimrPROSTATE-CAN
NATURE PUBL Visel, A; Zhu, Pennacchio, LA ( LAPennacchioCHROMOSOME 9
JOURNAL STATFriedman, J; Ha
Friedman, J (reprhastie@stanfoPENALIZED LO
WILEY-BLACKWGiovannucci, EGiovannucci, E ( egiovann@hspACTIVATED RE
NA
Guo Z., KozlovNA
NA
NA
NA
Bloom J.D., GoNA
NA
NA
AMER ASSOC Goldstein, AS;Witte, ON (repri owenwitte@me
STEM-CELLS;
NATURE PUBL Nikoloski, G; Jansen, JH (repr j.jansen@labgTUMOR-SUPPRE
NATURE PUBL Wu, Y; Cain-HoSiebel, CW (repr csiebel@geneINHIBITS TUM
MASSACHUSET
Kaminski, MF; Regula, J (repri jregula@coi.wSOCIETY TASK
NA
Matsui T., Leu NA
NA
NA
NA
Kraman M., Bam
NA
NA
NA
CELL PRESS Figueroa, ME; Delwel, R (repri h.delwel@era GENE-EXPRESS
AMER SOC HEFantin, A; Viei Ruhrberg, C (rep c.ruhrberg@ucEXPERIMENTAL

NATL ACAD S Weinberg, F; Chandel, NS (repnav@northwesGLUTAMINE-ME

ELSEVIER SCI Dignass, A; VaDignass, A (repr axel.dignass@INFLAMMATORY
AMER SOC CL Douillard, JY; Douillard, JY (re jy-douillard@nCETUXIMAB PL
CELL PRESS Orom, UA; Derr
Shiekhattar, R (r shiekhattar@wEPITHELIAL-M
AMER SOC CL Miles, DW; Cha
Miles, DW (repri david.miles@dTUMOR ANGIOG
MASSACHUSET
Younes, A; BarYounes, A (repr ayounes@mdaLARGE-CELL L
ELSEVIER SCI Ronco, G; Giorg
Ronco, G (reprintguglielmo.ron LIQUID-BASED
NATURE PUBL Turnbull, C; A Easton, DF (repr douglas@srl.cCOMMON VARIA
W B SAUNDERS
Terzic, J; Griv Karin, M (reprin karinoffice@u NF-KAPPA-B;
NATURE PUBL Lin, HK; Chen,Pandolfi, PP (re ppandolf@bidONCOGENE-IND
CELL PRESS Klein, U; Lia, Dalla-Favera, R rd10@columbiTUMOR-SUPPR
AMER CHEMICYang, K; ZhangLiu, ZA (reprint zliu@suda.eduWALLED CARBO
LIPPINCOTT WSchmitz, KH; CNA
NA
RANDOMIZED C
CELL PRESS Kim, HS; PatelDeng, CX (reprinchuxiad@mail.DNA-DAMAGE R
LIPPINCOTT WFichtlscherer, Dimmeler, S (repdimmeler@em.u
ACUTE MYOCAR
JOHN WILEY &Nishikawa, H; Nishikawa, H (re nisihiro@clin. IMMUNOLOGICA
NA
Novak I., Kirki NA
NA
NA
NA
Cros J., CagnarNA
NA
NA
NATL ACAD S Olson, ES; Jia Tsien, RY (reprin rtsien@ucsd. MATRIX METAL
MASSACHUSET
Yu, AL; GilmanYu, AL (reprint aliceyu@ucsd CHILDRENS ON
ELSEVIER SCI Ljungberg, B; Ljungberg, B (re borje.ljungbe PHASE-III TR
ROCKEFELLERGross, S; Cair Mak, TW (reprintValeria.fanti CODON 132 MU
AMER SOC CL Kantoff, PW; SGodfrey, WR (repwayne.godfre COLONY-STIMU
NATURE PUBL Beck, A; Wurch
Beck, A (reprint alain.beck@piMONOCLONAL-A
CELL PRESS Yu, JD; Yu, JJ Chinnaiyan, AM (arul@umich.eEMBRYONIC ST
NATL ACAD S Tsuji, O; Miur Nakamura, M (rep
masa@sc.itc.ke
CENTRAL-NERV
AMER SOC CL Voduc, KD; ChVoduc, KD (repri dvoduc@bccan
INVASIVE DU
NA
Seki T., Yuasa NA
NA
NA
AMER ASSOC Dowling, RJO; Sonenberg, N (renahum.sonenbINSULIN-RESI
CELL PRESS Eiring, AM; HaPerrotti, D (rep danilo.perrot CHRONIC MYEL
NA
Li Z., Jo J., J NA
NA
NA
AMER CHEMICLacerda, SHD;Lacerda, SHD (resilvia.lacerd HUMAN CARBO
MASSACHUSET
Krueger, DA; CFranz, DN (repri tsclinic@cchmPULMONARY LY
JOHN WILEY &Huang, ZH; Hua
Du, X (reprint a dx2008cn@yaREAL-TIME PC
ELSEVIER SCI Albain, KS; BaAlbain, KS (repr kalbain@lumcINTERNATIONA
NA
Lai M., Huijbe NA
NA
NA
ELSEVIER SCI Folprecht, G; Folprecht, G (re Gunnar.Folpre1ST-LINE TRE
NA
Naka K., HoshiNA
NA
NA
ELSEVIER SCI Sipahi, I; Deb Sipahi, I (repri ilkesipahi@gmCHRONIC HEAR
NA
Marks L.B., BeNA
NA
NA
NA
Alvarez S.E., HNA
NA
NA
AMER MEDICADe Roock, W; JTejpar, S (reprin a.bardelli@uniGROWTH; OXAL
CHURCHILL L Muscaritoli, MMuscaritoli, M (r maurizio.muscC-REACTIVE P

NATURE PUBL David, CJ; CheManley, JL (repr jlm2@columbiTRACT-BINDIN

COLD SPRING Teschendorff, Widschwendter, M
m.widschwendOVARIAN-CANC
CELL PRESS Rao, RR; Li, Q Shrikant, PA (re protul.shrika CUTTING EDGE
NA
Sawamiphak S.,
NA
NA
NA
NA
Zhou X., WangNA
NA
NA
CELL PRESS Zhu, SY; Li, WDing, S (reprint sding@scrippsPLURIPOTENT
AMER ASSOC C
Weber, JA; BaxWang, K (reprint kwang@system
EMBRYONIC ST
AMER CHEMICKang, B; MackEl-Sayed, MA (re melsayed@gatPHOTOTHERMAL
NATURE PUBL Gibson, P; TonGilbertson, RJ ( Richard.Gilbe BRAIN-STEM;
NA
Irani S.R., Be NA
NA
NA
CELL PRESS Pardo, M; LangPardo, M (reprin NA
TRANSCRIPTIO
AMER SOC CL Roth, AD; TejpRoth, AD (reprin arnaud.roth@ METASTATIC C
ELSEVIER SCI Mahon, FX; Rea,
Mahon, FX (repri francois-xavi COMPLETE CYT
ELSEVIER SCI He, CB; Hu, YP;
Yin, CH (reprint chyin@fudan. RECEPTOR-MED
CELL PRESS Butler, JM; No Rafii, S (reprin srafii@med.coBONE-MARROW
ELSEVIER SCI Hugosson, J; CHugosson, J (rep NA
FECAL OCCULT
NA
Shanbhag N.M.,
NA
NA
NA
MASSACHUSET
Steidl, C; Lee Gascoyne, RD (rergascoyn@bccREGULATORY T
WILEY-V C H Zhang, LM; XiaZhang, ZJ (repri zjzhang2007@GRAPHITE OXI
NATURE PUBL Palanisamy, N;Chinnaiyan, AM (arul@umich.eETS TRANSCRI
AMER CHEMICLee, JE; Lee, Hyeon, T (reprintthyeon@snu.aMRI CONTRAST
NATURE PUBL Sheedy, FJ; PaO'Neill, LAJ (rep laoneill@tcd.i NF-KAPPA-B;
AMER SOC CLIKioi, M; Vogel Brown, JM (repri mbrown@stanf
MARROW-DERIV
SPRINGER
Lammer, J; MalLammer, J (repri johannes.lam HEPATIC ARTE
NA
Tripathi V., El NA
NA
NA
MASSACHUSET
Choi, YL; SodaMano, H (reprint hmano@jichi.aCHRONIC MYEL
NA
Alkilany A.M., NA
NA
NA
LIPPINCOTT WZampetaki, A;Mayr, M (reprint manuel.mayr@
CARDIOVASCUL
ELSEVIER SCI Wolchok, JD; NWolchok, JD (rep wolchokj@mskMETASTATIC M
NATURE PUBL Liu, JZ; Tozzi Marchini, J (repr clyde.francks GENOME-WIDE
AMER SOC CL Hu, ZB; Chen, Shen, HB (reprin hbshen@njmu.BRONCHIOALVE
MASSACHUSET
Griffiths, CEM Griffiths, CEM ( christopher.g INTERLEUKINCELL PRESS Zeng, WW; Sun,
Chen, ZJJ (reprin zhijian.chen@TUMOR-SUPPRE
NA
Wei G.-H., BadNA
NA
NA
AMER SOC CL Silver, DP; Ri Garber, JE (repr judy_garber@d
ESTROGEN-REC
ELSEVIER SCI Decuzzi, P; God
Decuzzi, P (repr Paolo.Decuzz DRUG-DELIVER
NA
Fang X., Tan WNA
NA
NA
NA
Anand S., MajeNA
NA
NA
LIPPINCOTT WKlimstra, DS; Klimstra, DS (re klimstrd@mskPANCREATIC E
AMER ASSOC Teicher, BA; FrTeicher, BA (rep Beverly.Teic CHEMOKINE RE
OXFORD UNIVJin, SG; KadamPfeifer, GP (rep gpfeifer@coh.BINDING; CAN
JOHN WILEY &Motzer, RJ; Es Motzer, RJ (repr motzerr@mskc
RANDOMIZEDNA
Emmanouilidou
NA
NA
NA

AMER SOC CL Klotz, L; Zha Klotz, L (reprin Laurence.klo EXPECTANT M

AMER MEDICAChlebowski, RT
Chlebowski, RT ( rchlebowski@ HORMONE-REPL
PUBLIC LIBRA Huang, Y; PastHuang, Y (reprin arao@idi.harvACUTE MYELOI
NA
Ginestier C., NA
NA
NA
AMER SOC NUSofi, F; AbbateSofi, F (reprint NA
CORONARY-HEA
AMER MEDICATimmerman, R;
Timmerman, R (re
robert.timme PHASE-II; CL
WILEY-V C H Lu, J; Liong, MTamanoi, F (repr fuyut@microbiOPERATED MEC
NA
Kazui M., NishiNA
NA
NA
AMER SOC CL Sargent, DJ; MSargent, DJ (rep sargent.dani TUMOR MICROS
NATURE PUBL Yang, MH; Hsu,Yang, MH (reprintmhyang2@vght
CANCER STEMNA
Zohar Y., MunoNA
NA
NA
NA
Kelly C.M., JuuNA
NA
NA
NA
Sharma A., Hoe
NA
NA
NA
NATL ACAD S Joseph, EW; Pra
Rosen, N (reprin rosenn@mskcc
KINASE KINAS
ELSEVIER SCI Nout, RA; SmitNout, RA (reprin r.a.nout@lumcPOSTOPERATIV
NA
Gao X.P.A., ZhNA
NA
NA
LIPPINCOTT WDunstan, DW; Dunstan,
B
DW (repr
david.dunstanALL-CAUSE MO
AMER ROENTGSilva, AC; LawSilva, AC (repri silva.alvin@mRADIATION-EX
NATURE PUBL He, YP; Wu, J; Vogelstein, B (r vogelbe@jhmiPOINT MUTATI
NA
Gill T.M., GahbNA
NA
NA
AMER SOC CL Escudier, B; BEscudier, B (rep escudier@igr.fSEQUENTIAL T
NA
Sommer C.A., NA
S
NA
NA
CELL PRESS Hatley, ME; PaOlson, EN (repri eric.olson@ut TUMOR-SUPPRE
PERGAMON-ELSupuran, CTSuSupuran, CT (reprclaudiu.supuraPATHOGENS CA
AMER SOC CL Rini, BI; HalabRini, BI (reprin rinib2@ccf.orgENDOTHELIAL
ELSEVIER SCI Krag, DN; Ande
Krag, DN (reprin david.krag@uTECHNICAL OU
CELL PRESS Kalender, A; SThomas, G (reprin
thomasg4@ucACTIVATED PR
NA
Henneberger C.
NA
NA
NA
LIPPINCOTT WHeneghan, HM;
Miller, N (reprint nicola.miller@GENE-EXPRESS
OXFORD UNIVReck, M; von PReck, M (reprin dr.martin.rec METASTATIC C
NATURE PUBL Stein, S; Ott, Grez, M (reprint grez@em.uni-fACUTE MYELOI
NA
Weiss J., Sos NA
NA
NA
COLD SPRING Javierre, BM; Ballestar, E (re eballestar@idiT-CELLS; DEM
AMER SOC CL Reid, AHM; Attde Bono, JS (rep johann.de-bonCIRCULATING
AMER SOC CL Danila, DC; MoScher, HI (repri Scherh@mskcc
CIRCULATING
NATURE PUBL Alimonti, A; C Pandolfi, PP (re ppandolf@bidTUMOR SUPPRE
MASSACHUSET
Gooley, TA; ChMcDonald, GB (reNA
VERSUS-HOSTAMER ASSOC Harbour, JW; OHarbour, JW (repharbour@visioUBIQUITIN HY
OXFORD UNIVForbes, SA; TaFutreal, PA (rep paf@sanger.a NA
NA
Simsek T., KocNA
NA
NA
NATL ACAD S Pineau, P; Vol Croce, CM (repri carlo.croce@oHUMAN HEPATO
NA
Ichinohe T., PaNA
NA
NA
AMER SOC CL Marcucci, G; MBloomfield, CD ( clara.bloomf ACUTE MYELOG

NA
Hacein-Bey-Abi
NA
NA
NA
MASSACHUSET
Vergote, I; Tr Vergote, I (repr ignace.vergo EPITHELIAL O
AMER SOC CL Baselga, J; GeBaselga, J (repri jbaselga@vheADJUVANT CHE
NATURE PUBL Janes, MR; LimFruman, DA (repridfruman@uci.ACUTE LYMPHO
COLD SPRING Rakyan, VK; Do
Rakyan, VK (reprv.rakyan@qmuEMBRYONIC ST
AMER THORACMauad, T; HajjMauad, T (reprin tmauad@usp.VIRUS-INFECT
AMER ASSOC Charafe-Jauffre
Charafe-Jauffret, jauffrete@mars
ACUTE MYELO
NA
Hatzistergos KNA
NA
NA
AMER SOC CL Fong, PC; Yap,Kaye, SB (reprin stan.kaye@rmPOLY(ADP-RIB
AMER SOC CL Dowsett, M; Cu
Dowsett, M (reprmitch.dowsettPOSTMENOPAU
OXFORD UNIVWang, GK; Zhu,
Qin, YW (reprint ywqin1@yahoo
ANIMAL DEVEL
IEEE-INST EL Krishnan, KMKKrishnan, KM (re kannanmk@u.w
SUPERPARAMAG
NA
Volkman H.E., NA
NA
NA
NA
Zhou J., Sun Y.NA
NA
NA
AMER ASSOC Chresta, CM; DChresta, CM (repChristine.Chr MESSENGER-RN
AMER CHEMICMeng, HA; Liong
Nel, AE (reprint anel@mednet.MULTIDRUG-RE
AMER SOC CL Fenaux, P; MufFenaux, P (repri pierre.fenaux RISK MYELODY
NATURE PUBL Meindl, A; Hel Meindl, A (repri alfons.meindl FANCONI-ANEM
NATURE PUBL Petersen, GM; Chanock, SJ (rep chanocks@mai
BASE-LINE CH
NA
Grivennikov S.NA
NA
NA
NA
Hu W., Zhang N
CA
NA
NA
AMER SOC CL Gerard, JP; Az Gerard, JP (repr jean-pierre.geTOTAL MESORE
AMER CHEMICDu, D; Zou, ZXLin, YH (reprint yuehe.lin@pnlTUMOR-NECROS
JOHN WILEY &Schaefer, A; J Jung, K (reprint klaus.jung@chDOWN-REGULAT
ALPHAMED PRFan, X; Khaki, Fan, X (reprint xingf@umich. STEM-LIKE CE
LIPPINCOTT WSteyerberg, E Steyerberg, EW (e.steyerberg NONSEMINOMAT
W B SAUNDERS
Davis, GL; Alt Davis, GL (repri GaryDav@Bayl
CHRONIC LIVE
ELSEVIER SCI Songun, I; PutSongun, I (repri ilfet.songun@zDISEASE-SPEC
CELL PRESS Ghisletti, S; B Natoli, G (reprin gioacchino.naNF-KAPPA-B;
MASSACHUSET
Whelan, TJ; Pi Whelan, TJ (repr tim.whelan@jcRANDOMIZED C
AMER ASSOC Cruciat, CM; ONiehrs, C (repri niehrs@dkfz-h(PRO)RENIN R
AMER SOC CL Yao, JC; LombaYao, JC (reprint jyao@mdander
ISLET-CELL-C
NA
Shih H.-W., Va NA
NA
NA
AMER SOC CL Kennecke, H; Kennecke, H (rephkennecke@bc
CENTRAL-NER
ROCKEFELLERJongbloed, SL;Radford, KJ (repr kradford@mmr
TOLL-LIKE RE
NA
Mehrpour M., E
NA
NA
NA
ENDOCRINE SGiustina, A; C Giustina, A (repr a.giustina@libGROWTH-FACTO
AMER SOC CL Auperin, A; LeAuperin, A (repri auperin@igr.frRANDOMIZED P
ELSEVIER SCI Cunningham, D;
Cunningham, D (rDavid.cunnin III COLON-CA
ELSEVIER SCI Ueda, T; Volin Croce, CM (repri carlo.croce@ DIFFUSE-TYPE
NA
Dixon W.G., HyNA
NA
NA
NA
Brown S.D., NaNA
NA
NA
NATL ACAD S Curran, MA; Mo
Allison, JP (rep allisonj@mskcCOLONY-STIMU

NA
Geddes J.R., GNA
NA
NA
ELSEVIER SCI Weigelt, B; MaReis, JS (reprin Jorge.Reis-Fil GENE-EXPRESS
AMER ASSOC Zhang, XW; Yan
Chen, SJ (reprin sjchen@stn.shACUTE PROMYE
NA
Anand P., NairNA
NA
NA
OXFORD UNIVMunoz, N; KjaeMunoz, N (reprintnubia.munoz@f
RANDOMIZED C
NATURE PUBL Starczynowski,Karsan, A (repri akarsan@bccrACUTE MYELOI
NA
Kagan V.E., Kon
NA
NA
NA
NA
Hsieh A.C., CoNA
NA
NA
NATURE PUBL Tsujiura, M; I Ichikawa, D (rep ichikawa@kotoSQUAMOUS-CEL
NA
Huang X., Teng
NA
NA
NA
NA
Allen I.C., Tek NA
NA
NA
OXFORD UNIVAhn, J; Yu, K; Albanes, D (repr daa@nih.gov D-BINDING PR
LIPPINCOTT WUtian, WH; Bac
Utian, WH (repri NA
HORMONE-REP
NA
Kim D., Jeong N
YA
NA
NA
NATURE PUBL Schwickart, M;Dixit, VM (repri dixit@gene.c MULTIPLE-MYE
NA
Celli J.P., Spr NA
NA
NA
NA
Chimenti I., S NA
NA
NA
AMER SOC CL Douillard, JY; Kim, ES (reprint edkim@mdand
GROWTH-FACTO
NA
Campioni S., Ma
NA
NA
NA
NA
Gegg M.E., Coo
NA
NA
NA
ROCKEFELLERLiu, G; Frigge Liu, G (reprint gliu@uab.edu GROWTH-FACTO
AMER SOC CL Krop, IE; Beer Krop, IE (reprin Ian_krop@dfciMONOCLONAL-A
AMER SOC CL Rini, BI; HalabRini, BI (reprin rinib2@ccf.orgENDOTHELIAL
NATURE PUBL Repapi, E; SayTobin, MD (reprinian.hall@nott ADVANCED GLY
AMER SOC CL Peeters, M; Pr Peeters, M (repr Marc.Peeters CETUXIMAB PL
NA
Li S., Brown M.NA
NA
NA
AMER ASSOC Hidvegi, T; EwPerlmutter, DH (rdavid.perlmu ALPHA(1)-ANT
NA
Liu J.Z., McRa NA
NA
NA
ELSEVIER SCI Morgan, GJ; DaMorgan, GJ (repr gareth.morganEARLY BREAST
AMER SOC CL Cooperberg, MR
Cooperberg, MR (mcooperberg@
RANDOMIZED C
AMER SOC CL Paschka, P; ScDohner, K (repri konstanze.doeNADP(+)-DEPE
WILEY-BLACK Rehm, J; BaliuRehm, J (reprint jtrehm@aol.c CORONARY-HEA
MASSACHUSET
Van Raamsdonk,
Van Raamsdonk, bastianb@msk
C
SOMATIC MUTA
NA
Gonzalez-Suarez
NA
NA
NA
NA
HirschhaeuserNA
NA
NA
AMER ASSOC Jiang, SA; ZhaLiu, MF (reprint mfliu@sibs.acINFLAMMATORY
NATURE PUBL Thorgeirsson, Stefansson, K (r unnur.thorste GENOME-WIDE
NA
Hirai H., Soot NA
NA
NA
NATURE PUBL Vaz, F; HanenbMathew, CG (reprhelmut.hanenb
MAMMALIAN-CE
WILEY-BLACK Wolf, AMD; Wen
Brooks, DD (reprdurado.brook DIGITAL RECT
AMER SOC CL Lynch, TJ; Pat Lynch, TJ (repri thomas.lynch GROWTH-FACTO
NA
Marin D., BazeNA
NA
NA
AMER SOC CL Wells, SA; Gosn
Wells, SA (repri wellss@wudosi
RET PROTOONC

NATURE PUBL Trang, P; MediBader, AG (repri abader@mirnar

MOUSE MODELS
NATURE PUBL Morgan, RA; YaMorgan, RA (reprrmorgan@mailMONOCLONAL-A
W B SAUNDERS
Leggett, B; WhLeggett, B (repr Barbara_Legge
ISLAND METHY
NATL ACAD S Choi, CHJ; Ala Davis, ME (repri mdavis@cheme
IN-VIVO; CAN
NATL ACAD S Honigberg, LA;Buggy, JJ (repri jbuggy@pcyc COLLAGEN-IND
AMER SOC CL Batchelor, TT;Batchelor, TT (r tbatchelor@paANTIANGIOGEN
NA
Hetland M.L., NA
NA
NA
NA
Tarte K., Gaill NA
NA
NA
COLD SPRING Zhao, B; Li, L Guan, KL (reprin kuguan@ucsdCELL CONTACT
NATURE PUBL Takeshita, F; Ochiya, T (reprintochiya@ncc.gCHRONIC LYMP
NA
Jasperson K.W.NA
NA
NA
NATURE PUBL Davis, RE; NgoStaudt, LM (repr lstaudt@mail.BRUTONS TYRO
ROCKEFELLERPuel, A; Doffi Puel, A (reprint anne.puel@insHYPER-IGE SY
AMER ASSOC Wiggins, JF; R Bader, AG (repri abader@mirnaIN-VITRO; CY
AMER ASSOC Wang, YZ; KrivArmstrong, SA (rscott.armstro ACUTE MYELOI
SOC NEUROSCHughes, EG; Pe
Balice-Gordon, Rrbaliceg@mai EATON-MYASTH
CELL PRESS Andreu, P; JohCoussens, LM (relisa.coussens K14-HPV16 TR
OXFORD UNIVSchadt, EE; TuSchadt, EE (reprieschadt@pacifSINGLE-MOLEC
AMER ASSOC Boni, A; CogdiWargo, JA (repri jwargo@partne
THERAPY; CAN
AMER CHEMICKumar, R; Roy,Prasad, PN (repr pnprasad@bufQUANTUM DOT
NA
Lancaster E., NA
NA
NA
OXFORD UNIVBrenner, H; HoBrenner, H (repr h.brenner@dkfSCREENING CO
NA
Gatsonis C.A.,NA
NA
NA
AMER ASSOC Vogel, VG; CosWickerham, DL (re
larry.wickerh MAMMARY-CAR
LIPPINCOTT WGiuliano, AE; Giuliano, AE (re giulianoa@jwcBREAST-CANCE
AMER SOC CL Ryan, CJ; SmitRyan, CJ (reprin ryanc@mediciMITOXANTRON
ELSEVIER SCI Sperduto, PW;Sperduto, PW (repsperduto@mRANDOMIZED P
AMER CHEMICMeng, HA; Xue,
Zink, JI (reprin zink@chem.ucPOLYMERIC MI
NA
Tilg H., MoschNA
NA
NA
NA
Xie J., Chen K.NA
NA
NA
AMER SOC CL Dawood, S; Bro
Giordano, SH (re sgiordan@mda
COST-EFFECTI
CELL PRESS Schowalter, R Buck, CB (reprin buckc@mail.nJC-VIRUS; BK
NA
Lu L., Li Y., K NA
NA
NA
AMER SOC CL Scagliotti, G; Scagliotti, G (re scagliotti@ihnENDOTHELIAL
AMER SOC CL Kindler, HL; N Kindler, HL (rep hkindler@medi
ENDOTHELIAL
ELSEVIER SCI Gianni, L; Eie Gianni, L (reprin luca.gianni@isPHASE-III TR
AMER ASSOC van den Bent,van den Bent, MJm.vandenben CODON 132 M
NA
Nakagawa M.,NA
T
NA
NA
NA
Kisand K., BoeNA
NA
NA
AMER MEDICANeoptolemos, Neoptolemos,
J
JP j.p.neoptolem CURATIVE RE
NATL ACAD S Watson, PA; Ch
Sawyers, CL (repsawyersc@msk
MESSENGER-RI
AMER CHEMICZeng, J; ZhangXia, YN (reprint xia@biomed.wIMMUNO GOLD
AMER SOC CL Stupp, R; HegiStupp, R (reprin roger.stupp@cMGMT PROMOTE

AMER SOC HEQuintas-Cardama

Verstovsek, S (r jfridman@inc TYROSINE KIN
AMER SOC CL Ajani, JA; Rod Ajani, JA (repri jajani@mdandS-1 PLUS CIS
AMER SOC HEConter, V; BarBiondi, A (reprin abiondi.unim MINIMAL-RESI
AMER SOC HEHeslop, HE; SlHeslop, HE (repr hheslop@bcmEPSTEIN-BARR
NA
Thomas C.R., Fe
NA
NA
NA
NA
Xiong Y., Fang NA
NA
NA
NA
Mossner E., BrNA
NA
NA
W B SAUNDERS
Salem, R; Lewa
Salem, R (reprin r-salem@northINTRAHEPATIC
NA
Schramek D., N
LA
NA
NA
NA
Vetrone F., Na NA
NA
NA
NA
Kemper K., SprNA
NA
NA
NA
Yang H., Higgi NA
NA
NA
OXFORD UNIVFuruta, M; Koza
Inazawa, J (repr johinaz.cgen@HUMAN CANCER
NA
Sachdeva M., N
MA
NA
NA
CELL PRESS Pece, S; TosoniPece, S (reprint salvatore.pec MAMMARY-GLAN
AMER SOC CL Zietman, AL; BZietman, AL (repazietman@parEXTERNAL-BEA
NA
Korotchkina L.NA
NA
NA
WILEY-BLACK Smith, RA; Co Smith, RA (repri robert.smith@SERVICES TAS
AMER SOC CL Burstein, HJ; Burstein, HJ (re NA
QUALITY-OF-L
JOHN WILEY &Ascha, MS; Han
Zein, NN (reprin zeinn@ccf.orgUNITED-STATE
AMER SOC CL Philip, PA; Be Philip, PA (repr philipp@karm GROWTH-FACT
AMER ASSOC DeCensi, A; PuDeCensi, A (repr andrea.decensACTIVATED PR
MASSACHUSET
van der Gaag,Gouma, DJ (reprid.j.gouma@am
GEMCITABINE
NA
Wang J., Wakem
NA
NA
NA
NA
Bruder O., Wag
NA
NA
NA
NA
Demidenko Z.N
NA
NA
NA
NA
Rouschop K.M.A
NA
NA
NA
NA
To K.K.W., Hung
NA
NA
NA
AMER SOC CL Wierda, WG; KiWierda, WG (reprwwierda@mdaPROGRESSIVE
OXFORD UNIVBurnichon, N; Burnichon, N (re nelly.burnich SUCCINATE-U
AMER SOC CL Burstein, HJ; Burstein, HJ (re hburstein@parPHASE-II; AD
AMER SOC CL Robak, T; Dmos
Robak, T (reprin robaktad@csk.MONOCLONAL-A
ELSEVIER SCI Herbst, RS; SuHerbst, RS (repr rherbst@mdanQUALITY-OF-L
NA
Chen Yu., Chen
NA
NA
NA
NA
Marin D., NelsNA
NA
NA
NA
Missiaglia E., NA
NA
NA
AMER PHYSIC Parisi, G; ZamParisi, G (reprin giorgio.parisi RANDOM CLOSE
WILEY-BLACKWDurrbach, A; PDurrbach, A (reprantoine.durrb POSTTRANSPLA
NA
Hueber A.J., AsNA
NA
NA
NA
Marigo I., BosiNA
NA
NA
ELSEVIER SCI Zhu, CH; Jung,Zhong, ZY (repri zyzhong@suda
BLOCK-COPOLY
AMER SOC CL Byrski, T; Gro Narod, S (reprin steven.narod@
OVARIAN-CANC
NA
Xu Z.-Z., Zhang
NA
NA
NA

AMER DIABET Bodmer, M; Mei

Meier, CR (repri meierch@uhbsPRACTICE RES
NA
Smith M.A., SeNA
NA
NA
W B SAUNDERS
Boland, CR; GoBoland, CR (repr rickbo@baylorDNA MISMATCH
NA
Irani S.R., Ale NA
NA
NA
WILEY-BLACK Jayne, DG; ThoJayne, DG (reprinDavid.Jayne@lCOMPLETE MES
NA
De Groot J.F., NA
NA
NA
AMER SOC CLISun, SH; SprenPlymate, SR (repsplymate@u.wGROWTH-FACTO
AMER ASSOC Mino-Kenudson,
Iafrate, AJ (repr srodig@partneEML4-ALK FUS
ACADEMIC PRE
Esmaeili, M; Mohabatkar, H (re
mohabat@shira
PROTEIN STRU
NA
Butrynski J.E. NA
NA
NA
WILEY-BLACKWCapper, D; Weivon Deimling, A andreas.vond CODON 132 M
ELSEVIER SCI Turnbull, L; B Turnbull, L (rep l.w.turnbull@hFUNCTIONAL A
NA
Jackman D., Pao
NA
NA
NA
AMER CHEMICChen, Y; Chen,Chen, HR (reprinhrchen@mail.sSILICA NANOP
NATURE PUBL Choi, HS; Liu, Choi, HS (reprin jfrangio@bidmQUANTUM DOT
NA
Dolcetti L., Pe NA
NA
NA
WILEY-V C H Chen, JY; GlauChen, JY (reprin chenj@seas.wu
CELL LUNG-CA
NA
Xiong L., YangNA
NA
NA
NA
Zhang F., BrauNA
NA
NA
AMER SOC CL Paugh, BS; Qu,Baker, SJ (repri Suzanne.BakeGROWTH-FACT
AMER ASSOC Shembade, N;Shembade, N (rep
nshembade@m
CONJUGATING
NA
May M., Gill J NA
NA
NA
NA
Barlow J.L., D NA
NA
NA
NA
Yang L., BesscNA
NA
NA
COLD SPRING Gocheva, V; Wa
Joyce, JA (repri joycej@mskccRECOMBINANT
NA
Srivastava M.KNA
NA
NA
NA
Soderberg C., NA
NA
NA
NA
Baldus S.E., S NA
NA
NA
NA
Reiter R.J., Ta NA
NA
NA
ELSEVIER SCI Thompson, RH;
Thompson, RH (re
Thompson.robLAPAROSCOPIC
NA
Van Glabbeke NA
NA
NA
NA
Antonchick A.PNA
NA
NA
NA
Kagami S., Rizz
NA
NA
NA
NA
Ahmed A.A., EtNA
NA
NA
NA
Li Y., VandenBo
NA
NA
NA
AMER DIABET Landman, GWD;
Landman, GWD (rep
g.w.d.landmanPANCREATIC-C
NA
Antzelevitch CNA
NA
NA
NA
Ruschoff J., D NA
NA
NA
AMER ASSOC Tsukamoto, Y; Moriyama, M (repmmoriyam@med
COPY NUMBER
JOHN WILEY &Chang, TT; LiaChang, TT (repri ttchang@mailSTELLATE CEL
NA
Greither T., G NA
NA
NA
NA
Keating N.L., NA
NA
NA
NA
Herman S.E.M.,
NA
NA
NA

AMER SOC CLIGinestier, C; Wicha, MS (repri christophe.gi STEM/PROGENI

NA
Kano M., Seki NA
NA
NA
NA
Wadas T.J., WoNA
NA
NA
AMER SOC HEKochenderfer,Kochenderfer, JNkochendj@mail
CHIMERIC ANT
NATL ACAD S Alexander, A; Walker, CL (repr cwalker@wotaACTIVATED PR
NA
Yang W., ShenNA
NA
NA
NA
Ali S., Ahmad NA
NA
NA
NA
Qin Y., Yao L., NA
NA
NA
NA
Weight C.J., L NA
NA
NA
NA
Zhu Y., Ikoma NA
NA
NA
NA
Giovannetti E.NA
NA
NA
NA
Kirklin J.K., N NA
NA
NA
NA
Lovell J.F., Li NA
NA
NA
AMER ASSOC Talmadge, JE; Fidler, IJ (repr
ifidler@mdandENDOTHELIAL
NA
Corzo C.A., Con
NA
NA
NA
AMER SOC HECoiffier, B; T Coiffier, B (repr bertrand.coiff B-CELL LYMPH
NA
Knudsen L.B., NA
NA
NA
IMPACT JOURNKorotchkina, Blagosklonny, MVblagosklonny SMALL-MOLECU
NA
Coleman R.E., NA
NA
NA
NA
Rienzi L., Roma
NA
NA
NA
ELSEVIER SCI Cuzick, J; Ses Cuzick, J (repri NA
FIRST-LINE T
LANDES BIOS Lobrich, M; ShLobrich, M (repr lobrich@bio.t CELL-CYCLE;
NA
Ai J., Zhang R.NA
NA
NA
NA
Wakabayashi Y
NA
.
NA
NA
NA
Hartmann C., H
NA
NA
NA
NA
[No author naNA
NA
NA
WILEY-BLACK Jemal, A; Sieg Jemal, A (reprin ahmedin.jemaCURRENT CALE
NATURE PUBL Zuber, J; Shi, Vakoc, CR (repri lowe@cshl.ed TRANSCRIPTIO
CELL PRESS Delmore, JE; I Bradner, JE (rep james_bradnerB-CELL LINE;
CELL PRESS Goetz, JG; MinGoetz, JG (reprin jgoetz@igbmc.BREAST-CANCE
NA
Sirota M., DudlNA
NA
NA
NATURE PUBL Raj, L; Ide, T Lee, SW (reprint amandinova@pa
HUMAN TUMORNATURE PUBL Possemato, R;Sabatini, DM (re sabatini@wi.mGENE-EXPRESS
CELL PRESS Tay, Y; Kats, L Pandolfi, PP (re ppandolf@bidMICRORNA; EX
CELL PRESS Xu, W; Yang, H;
Guan, KL (reprin kuguan@ucsd.ACUTE MYELOI
NATURE PUBL De Nicola, GM;Tuveson, DA (repdavid.tuvesonK-RAS; PANCR
NATURE PUBL Zhu, Q; Pao, Pao, GM (reprint pao@salk.eduNEURAL STEMNATURE PUBL Liu, C; Kelnar Tang, DAG (repri dtang@mdande
TUMOR-INITIA
NA
Dawson M.A., N
PA
NA
NA
NATURE PUBL Qian, BZ; Li, Pollard, JW (rep pollard@aeco CHEMOATTRACT
CELL PRESS Sumazin, P; YaCalifano, A (repr califano@c2b2INTEGRATED G
NATL ACAD S Chaffer, CL; B Weinberg, RA (reweinberg@wi.IN-VITRO PRO
NATURE PUBL Opitz, CA; Lit Platten, M (repr m.platten@dkfREGULATORY T

NATURE PUBL Kang, TW; Yevs

Zender, L (repri Lars.Zender@h
MOUSE; RAS;
WILEY-BLACK Jemal, A; BrayJemal, A (reprin ahmedin.jemaHELICOBACTER
ELSEVIER SCI Wen, CP; Wai, Wen, CP (reprint cwengood@nhr
CORONARY-HEA
MASSACHUSET
Porter, DL; Le Porter, DL (repr david.porter CHRONIC LYMP
WILEY-BLACK Siegel, R; WarJemal, A (reprin ahmedin.jemaCURRENT CALE
MASSACHUSET
Aberle, DR; AdBerg, CD (reprin bergc@mail.niSOMATIC MUTA
AMER MEDICAMursu, J; Robi Mursu, J (reprint jaakko.mursu@
CORONARY-HEA
NA
Ernst J., Kher NA
NA
NA
CELL PRESS Salmena, L; Pol
Pandolfi, PP (re ppandolf@bidMAMMALIAN M
NATURE PUBL Bell, D; Berch Spellman, PT (repspellmap@ohsHIGH-THROUGH
PUBLIC LIBRA Myers, RM; StaMyers, RM (repri NA
EMBRYONIC S
NATURE PUBL Navin, N; KendWigler, M (repri wigler@cshl.eWHOLE GENOME
AMER MEDICAKlein, EA; Tho Klein, EA (repri kleine@ccf.or RANDOMIZED C
NA
Zhao T., ZhangNA
NA
NA
NATURE PUBL Baker, DJ; Wij van Deursen, JM vandeursen.j TUMOR-SUPPRE
AMER ASSOC Kalos, M; Levi June, CH (reprin cjune@exchanCHRONIC LYMP
NATURE PUBL Jaskelioff, M; DePinho, RA (repron_depinho@d
NEURAL STEMNATURE PUBL Gore, A; Li, Z Goldstein, LSB (rlgoldstein@u IPS CELLS; G
ELSEVIER SCI Rothwell, PM; Rothwell, PM (reppeter.rothwel LOW-DOSE ASP
CELL PRESS Hayashi, K; OhSaitou, M (repri saitou@anat2.GROUND-STATE
NATURE PUBL Chapman, MA;Golub,
L
TR (repri gadgetz@broad
B-CELL LYMPH
NATURE PUBL Baillie, JK; B Faulkner, GJ (re faulknergj@g L1 RETROTRAN
NATURE PUBL Green, ED; GuGreen, ED (repri egreen@nhgri.CHRONIC MYEL
MASSACHUSET
Jacobson, IM; Jacobson, IM (repimj2001@med.
ALPHA-2B PLU
MASSACHUSET
De Bono, JS; LDe Bono, JS (rep johann.de-bonANDROGEN-DEP
NATURE PUBL Berger, MF; LaRubin, MA (repri rubinma@med.c
MYELOID-LEU
AMER ASSOC Paprotka, T; DPathak, VK (repr vinay.pathak@CHRONIC-FATI
NATURE PUBL Sato, T; van EClevers, H (repr h.clevers@hubBETA-CATENIN
NATURE PUBL Dupont, S; MorDupont, S (reprindupont@bio.uni
EPITHELIAL-M
NATURE PUBL Sahin, E; Coll DePinho, RA (repron_depinho@d
HEART-FAILUR
ELSEVIER SCI Baigent, C; LaBaigent, C (repri sharpclinical@REQUIRING PR
NATURE PUBL Breitbach, CJ; Kirn, DH (reprin dkirn@jenner VACCINIA VIR
NA
Helmut K., Han
NA
NA
NA
MASSACHUSET
Robert, C; ThoWolchok, JD (rep wolchokj@mskRECOMBINANT
NATURE PUBL Suhre, K; ShinSuhre, K (reprin karsten@suhre
GENOME-WIDE
NATURE PUBL Puente, XS; PiCampo, E (reprinclo@uniovi.es CANCER GENOM
NA
Williams K., ChNA
NA
NA
NA
Studenski S., PNA
NA
NA
NA
Smart N., BolliNA
NA
NA
NA
Ficz G., Branc NA
NA
NA
NATURE PUBL Varela, I; Tar Teh, BT (reprint Bin.Teh@vai.oTUMOR-SUPPRE
ELSEVIER SCI Wang, YC; McPWang, YC (reprinycw2102@colBODY-MASS IN
NA
West A.P., Bro NA
NA
NA

NATURE PUBL Yoshida, K; SaOgawa, S (reprinsogawa-tky@uACUTE MYELOI

NATURE PUBL Wang, D; GarciFu, XD (reprint ibassets@ucs FORKHEAD BOX
NA
Bartels T., ChoNA
NA
NA
AMER SOC CL Chaturvedi, AKChaturvedi, AK ( chaturva@mail
SQUAMOUS-CEL
OXFORD UNIVSayers, EW; Ba
Sayers, EW (reprsayers@ncbi.nONLINE MENDE
AMER ASSOC Stransky, N; EGarraway, LA (relevi_garrawayTUMOR-SUPPRE
MASSACHUSET
Bill-Axelson, Bill-Axelson, A anna.bill.axe QUALITY-OF-L
AMER ASSOC Xie, Z; WrobleWeiss, R (reprin rweiss@mit.edMAMMALIAN-CE
ELSEVIER SCI Burn, J; GerdeBurn, J (reprint john.burn@nclLYNCH-SYNDR
NATURE PUBL Maekawa, M; YYamanaka, S (repr
n-goshima@ais
PLURIPOTENT
AMER MEDICAGiuliano, AE; Giuliano, AE (re giulianoa@jwcLYMPH-NODE;
NA
Egan D.F., ShaNA
NA
NA
NA
Wittchen H.U.,NA
NA
NA
CELL PRESS Stephens, PJ; Campbell, PJ (re pc8@sanger.aCELL LUNG-CA
ELSEVIER SCI Forouzanfar, MMurray, CJL (rep cjlm@u.washi DIAGNOSTIC G
NA
He Y.-F., Li B. NA
NA
NA
MASSACHUSET
Conroy, T; DesConroy, T (repri t.conroy@nancy
PHASE-III TR
NA
Clevers H.
NA
NA
NA
ELSEVIER SCI Zhou, CC; Wu,Zhou, CC (reprin caicunzhou@yFACTOR RECEP
AMER ASSOC Parsons, DW; LVogelstein, B (r vogelbe@gmail
MYELOID-LEUK
AMER ASSOC Agrawal, N; FrAgrawal, N (repr nagrawal@jhmHUMAN-PAPILL
NATURE PUBL Vickers, KC; Vickers, KC (rep vickerskc@nhlAPOLIPOPROTE
OXFORD UNIVForbes, SA; Bi Futreal, PA (rep paf@sanger.a HUMAN BREAS
NA
Miyoshi N., Is NA
NA
NA
NATURE PUBL Mardis, ER
Mardis, ER (repr emardis@wustHUMAN GENOME
NATURE PUBL von Maltzahn,von Maltzahn, G sbhatia@mit. TISSUE FACTO
MASSACHUSET
Hvid-Jensen, FFunch-Jensen, P funchjensen@HIGH-GRADE D
CELL PRESS Cortellino, S; Bellacosa, A (re alfonso.bella MAMMALIAN DE
CELL PRESS Laurent, LC; UlLaurent, LC (reprllaurent@ucsdEMBRYONIC ST
ELSEVIER SCI Sullivan, R; P Sullivan, R (rep richard.sulliv CELL LUNG-CA
NATURE PUBL Hansen, KD; TiIrizarry, RA (rep rafa@jhu.edu;EMBRYONIC ST
NA
Chu C., Qu K.,NA
NA
NA
NATURE PUBL Notta, F; Mull Dick, JE (reprint jdick@uhnres.HEMATOPOIETI
NA
Corren J., LemNA
NA
NA
NA
Ito S., Shen L. NA
NA
NA
NATURE PUBL Eppert, K; Tak Dick, JE (reprint jdick@uhnreseACUTE MYELOI
NATURE PUBL Ashley, CE; CaAshley, CE (repr ceashle@sandi
RESPONSIVE
NA
Timmers S., KoNA
NA
NA
NA
Auerbach B.D.,NA
NA
NA
NA
Dash M., ChiellNA
NA
NA
NATURE PUBL Pastor, WA; PaAgarwal, S (repr Suneet.Agarwa
DEVELOPMENTA
MASSACHUSET
Yao, JC; Shah, Yao, JC (reprint jyao@mdander
ISLET-CELL-C
NATURE PUBL Wen, HT; Gris,Ting, JPY (reprin jenny_ting@mINNATE IMMUN

NATURE PUBL van Dam, GM;van

T Dam, GM (rep
g.m.van.dam BREAST-CANCE
AMER MEDICAWelch, JS; West
Wilson, RK (repr rwilson@wustlACUTE PROMYE
NATURE PUBL Morin, RD; Men
Marra, MA (repri mmarra@bcgsB-CELL LYMPH
AMER ASSOC Beatty, GL; ChVonderheide, RH rhv@exchangeT-CELL HELP;
MASSACHUSET
Zheng, W; McLe
Zheng, W (reprinwei.zheng@van
PROSPECTIVE
AMER ASSOC Jiao, YC; Shi, Kinzler, KW (rep kinzlke@jhmi HISTONE METH
MASSACHUSET
Burger, RA; BrBurger, RA (repr robert.a.burg ENDOTHELIAL
ELSEVIER SCI Fizazi, K; Car Fizazi, K (reprin fizazi@igr.fr CONTROLLED P
NA
Beck M., Schmi
NA
NA
NA
AMER ASSOC Rosas-Ballina,Tracey, KJ (repr kjtracey@nsh NORADRENERGI
MASSACHUSET
Slamon, D; EieSlamon, D (repri dslamon@medn
MONOCLONALNA
Swinney D.C.,NA
NA
NA
MASSACHUSET
Coleman, RE; C
Moleman, RE (repr
r.e.coleman@sORAL CLODRON
MASSACHUSET
Lindhurst, MJ; Biesecker, LG (r leslieb@helix.MCCUNE-ALBRI
OXFORD UNIVCroft, D; O'Ke Stein, L (reprin Peter.D'Eusta COMMUNITY ST
AMER ASSOC Yu, YH; Yoon, SGygi, SP (reprin Steven_gygi@INHIBITION;
MASSACHUSET
Raymond, E; Da
Raymond, E (repreric.raymond@
ISLET-CELL-C
AMER SOC CLILehmann, BD;Pietenpol,
B
JA (r j.pietenpol@v EPITHELIAL-M
OXFORD UNIVTurchinovich, Turchinovich, A a.turchinovic BLOOD-BASED
NA
Sayed D., Abde
NA
NA
NA
NA
Poulikakos P.I NA
NA
NA
NATURE PUBL Ngo, VN; Young
Staudt, LM (repr lstaudt@mail.B-CELL LYMPH
MASSACHUSET
O'Shaughnessy,
O'Shaughnessy, Jjoyce.oshaug PHASE-II TRI
ELSEVIER SCI Gustavsson, A;Olesen, J (repri jeol@glo.regi QUALITY-OF-L
CELL PRESS Chandarlapaty,
Rosen, N (reprin rosenn@mskcc
FORKHEAD TRA
AMER ASSOC DeNardo, DG; Coussens,
B
LM (reLisa.CoussensTUMOR-ASSOC
NA
Gabriel R., Lo NA
NA
NA
MASSACHUSET
Perren, TJ; Sw Parmar, MKB (re mp@ctu.mrc.aGYNECOLOGICCELL PRESS Zhu, H; Shyh-C
Daley, GQ (repri george.daley@
LET-7 MICROR
NA
Yirmiya R., GoNA
NA
NA
ELSEVIER SCI Oberg, M; JaakPruss-Ustun, A ( pruessa@who.ENVIRONMENTA
NATURE PUBL Anderson, K; LGreaves, M (reprmel.greaves@iACUTE LYMPHO
CELL PRESS Bester, AC; R Kerem, B (reprin kerem@cc.huji.
ONCOGENE-IND
NA
Giuliano A.R., NA
NA
NA
NA
Hargreaves D.NA
NA
NA
ELSEVIER SCI Beaglehole, R;Beaglehole, R (r r.beaglehole@PREVENTING C
MASSACHUSET
Palefsky, JM; Palefsky, JM (re joel.palefsky HUMAN-PAPILL
NA
Gerlach B., CoNA
NA
NA
MASSACHUSET
Goss, PE; Ingl Goss, PE (reprin pgoss@partneQUALITY-OF-L
NA
Li Z., Yang C. NA
NA
NA
NATURE PUBL Yan, XJ; Xu, J; Chen, Z (reprint zchen@stn.sh.ACUTE MYELOI
NA
Nieman K.M., K
NA
NA
NA
NA
Kim J., Efe J. NA
NA
NA

MASSACHUSET
Bejar, R; Stev Ebert, BL (repri bebert@partne
PROGNOSTIC S
NATURE PUBL Chin, L; AnderChin, L (reprint lynda_chin@dfCELL LUNG-CA
AMER ASSOC Sequist, LV; WSequist, LV (rep lvsequist@parGROWTH-FACTO
NATURE PUBL Shukla, S; KavOberdoerffer, S shalini.oberd INSULATOR PR
NA
Wu H., D'AlessiNA
NA
NA
OXFORD UNIVGoldhirsch, A;Goldhirsch, A (rearon.goldhirs PATHOLOGIST
AMER SOC CL Van Cutsem, E;
Van Cutsem, E (reric.vancutse CHEMOTHERAPY
ELSEVIER SCI Davies, C; GodNA
NA
ESTROGEN-RE
AMER ASSOC Hsu, PP; Kang,Sabatini, DM (re sabatini@wi.mMESSENGER-RN
NATURE PUBL Gattinoni, L; LGattinoni, L (rep gattinol@mail.SUPERIOR ANT
MASSACHUSET
Wang, LL; Lawr
Wu, CJ (reprint cwu@partnersPRE-MESSENGE
CELL PRESS Olzscha, H; ScHayer-Hartl, M ( mhartl@biochMOLECULAR CH
AMER ASSOC Takeda, N; Jai Epstein, JA (repr epsteinj@mai PROGENITOR C
NA
Darby S., McGa
NA
NA
NA
NATURE PUBL Obad, S; dos SKauppinen, S (re sk@santaris. LOCKED NUCLE
AMER ASSOC Guevara-Aguirr
Guevara-Aguirre,jguevara@iemy
FORKHEAD TRA
NATURE PUBL Ohi, Y; Qin, H Song, JS (reprin SongJ@humgen
PLURIPOTENT
NATURE PUBL Pasqualucci, LPasqualucci, L ( lp171@columbACUTE MYELOI
OXFORD UNIVFreifeld, AG; Freifeld, AG (re afreifeld@un CELL TRANSPL
NATURE PUBL Locasale, JW; Locasale, JW (re jlocasal@bidmMASS ISOTOPO
AMER MEDICABuys, SS; PartBerg, CD (reprin bergc@mail.niNA
NA
Saposnik G., BNA
NA
NA
ELSEVIER SCI Coleman, MP; Coleman,
F
MP (repmichel.colem BREAST-CANCE
NA
Wild P., Farha NA
NA
NA
NA
Barreto J.A., NA
NA
NA
NATURE PUBL Van Keymeulen,
Blanpain, C (reprCedric.BlanpaBREAST-CANCE
NATURE PUBL Matson, CK; MZarkower, D (repbardw001@um
DM-DOMAIN GE
NA
Gu T.-P., Guo FNA
NA
NA
NA
Xu Y., Wu F., T NA
NA
NA
MASSACHUSET
Tiacci, E; Trif Falini, B (reprin faliniem@unipACUTE LYMPHO
NATURE PUBL Kaneko, H; DriAmbati, J (repri jamba2@emailEMBRYONIC ST
CELL PRESS Luo, WB; Hu, HSemenza, GL (rep
gsemenza@jhTUMOR-GROWTH
NA
Wossidlo M., NNA
NA
NA
AMER ASSOC Heaphy, CM; de
NA
npapado1@jhm
CELLS; H3.3
W B SAUNDERS
Elashoff, M; MButler, PC (repri pbutler@mednINCRETIN-BAS
MASSACHUSET
Seshasai, SRK;NA
NA
INDIVIDUAL P
NA
DeFronzo R.A.,NA
NA
NA
NATURE PUBL Nagaraj, N; WiMann, M (reprintmmann@bioch
RNA-SEQ; EXP
NA
Lunt S.Y., Van NA
NA
NA
NATURE PUBL Xiao, B; SandeCarling, D (repr david.carling ACTIVATED PR
AMER SOC CL Northcott, PA; Taylor, MD (repr mdtaylor@sickBETA-CATENIN
NA
RoychowdhuryNA
S.
NA
NA
NATURE PUBL Gui, YT; Guo, Cai, ZM (reprint wangj@genomi
SOMATIC MUTA

NATURE PUBL Hurtado, A; HoCarroll, JS (repr jason.carroll@BREAST-CANCE

ELSEVIER SCI Heidenreich, AHeidenreich, A ( aheidenreich DEFERRED AND
AMER CHEMICGasser, G; Ott,Gasser, G (repri NA
ESTROGEN-REC
NA
Tian H., Biehs NA
NA
NA
MASSACHUSET
Schwartzentrub
Schwartzentruber
dschwart@iuhe
METASTATIC M
CELL PRESS Rolny, C; MazzClaesson-Welsh, lena.welsh@igHISTIDINE-RI
NA
Bonewald L.F. NA
NA
NA
OXFORD UNIVKohler, BA; WaKohler, BA (repr bkohler@naacc
SERVICES TAS
ELSEVIER SCI Babjuk, M; OosBabjuk, M (repri marek.babjuk@
BACILLUS-CAL
NATURE PUBL Leuschner, F; Nahrendorf, M (r rweissleder@ LIPID-LIKE M
NA
Daigle S., Olh NA
NA
NA
AMER SOC CL Wagle, N; EmeGarraway, LA (relevi_garrawayCHRONIC MYEL
CELL PRESS Chiarle, R; Zh Zhang, Y (reprin zhang@idi.harEND-JOINING
NATL ACAD S Wong, C; StyliBawendi, MG (re mgb@mit.edu;METASTATIC B
CELL PRESS Merlos-Suarez,Batlle, E (reprin eduard.batlle COLON-CANCER
LANDES BIOS Sandoval, J; HEsteller, M (repr mesteller@idib
HUMAN CANCE
NATURE PUBL Prensner, JR; Chinnaiyan, AM (arul@umich.eLONG NONCODI
NA
Thies W., BleilNA
NA
NA
NA
Kiss E.A., Von NA
NA
NA
CELL PRESS Zinzalla, V; S Hall, MN (reprin m.hall@uniba DIAMOND-BLAC
CELL PRESS Carver, BS; ChSawyers, CL (repsawyersc@msk
DUAL PI3K/MT
COLD SPRING Guo, JY; Chen,White, E (reprin whiteei@umdnMICE; MITOCH
MASSACHUSET
Koreth, J; Mat Koreth, J (repri john_koreth@dBONE-MARROWCELL PRESS Karreth, FA; T Pandolfi, PP (re ppandolf@bidEPITHELIAL-M
NATURE PUBL Ding, ZH; Wu, DePinho, RA (replynda_chin@dfPHYSICIANS H
WILEY-BLACK Agostinis, P; Golab, J (reprin jakub.golab@ BASAL-CELL C
CELL PRESS Labelle, M; B Hynes, RO (repri rohynes@mit.TRANSFORMING
COMPANY OF B
Chen, YQ; KlioKlionsky, DJ (rep klionsky@umiPROTEIN-KINA
CELL PRESS Schlegelmilch,Camargo, FD (repfernando.cama
ORGAN SIZE C
PUBLIC LIBRA Vang, O; Ahmad
Vang, O (reprint ov@ruc.dk
CANCER CHEMO
CELL PRESS Moran-Crusio, Aifantis, I (repr iannis.aifant METHYLTRANSF
NA
Guo J.U., Su Y NA
NA
NA
NATURE PUBL Fowler, CD; LuKenny, PJ (reprin pjkenny@scri INTRACRANIAL
MASSACHUSET
Lucchinetti, C Lucchinetti, CF lucchinetti.c B-CELL FOLLI
NA
Vestbo J., EdwNA
NA
NA
NA
Blumcke I., ThNA
NA
NA
NATL ACAD S Arroyo, JD; Che
Tewari, M (repri mtewari@fhcrDIAGNOSTIC B
NA
Rachner T.D., NA
NA
NA
NATURE PUBL Tan, W; Zhang,Karin, M (reprin karinoffice@u BREAST-CANCE
ELSEVIER SCI Brotherton, JMBrotherton, JML (jbrother@vcs.PREDICTED I
NA
Kajstura J., Ro NA
NA
NA
NATURE PUBL Facciabene, A;Coukos, G (repri gcks@mail.meENDOTHELIAL
NA
Burdick J.A., NA
NA
NA

NA
Pei H., Zhang LNA
NA
NA
CELL PRESS Koh, KP; YabuuRao, A (reprint a arao@idi.harvDNA METHYLAT
NATURE PUBL Inuzuka, H; ShWei, WY (reprint wwei2@bidmc.
FBW7 UBIQUIT
CELL PRESS Gupta, PB; Fil Gupta, PB (repri pgupta@wi.mit
EMBRYONIC ST
NA
Cabral H., MatNA
NA
NA
ELSEVIER SCI Maughan, TS; Kaplan,
A
R (repri rk@ctu.mrc.acGROWTH-FACTO
NATURE PUBL Bantscheff, M;Bantscheff, M (r marcus.bants HISTONE DEAC
MASSACHUSET
Di Stasi, A; T Di Stasi, A (rep NA
ENGINEERED D
NATL ACAD S Boeri, M; Verr Croce, CM (repri carlo.croce@os
POSITRON-EMI
NATURE PUBL Wei, XM; WaliaSamuels, Y (repr samuelsy@mai
HUMAN CANCE
AMER SOC CL Henry, DH; Cos
Henry, DH (repri davidhenry@pKAPPA-B LIGA
NA
Allen J.E., Mai NA
NA
NA
OXFORD UNIVMiller, RA; Ha Miller, RA (repr millerr@umic CANCER-THERA
COLD SPRING Yang, SH; Wang
Kimmelman, AC (r
alec_kimmelmCELL-DEATH;
NA
Vogelmeier C.,NA
NA
NA
ELSEVIER SCI Rini, BI; Escu Rini, BI (reprin rinib2@ccf.orgIII TRIAL; S
AMER SOC CL Robbins, PF; MRobbins, PF (rep Paul_Robbins MODIFIED T-C
NA
Rudensky A.Y. NA
NA
NA
AMER ASSOC Choi, M; ScholLifton, RP (repr richard.lifton REMEDIABLE A
NA
Oberst A., Dil NA
NA
NA
CELL PRESS Quivoron, C; CBernard, OA (reprolivier.bernar ACUTE MYELOI
NA
Tollervey J.R. NA
NA
NA
MASSACHUSET
Papaemmanuil,
Campbell, PJ (re pc8@sanger.aACUTE MYELOI
CELL PRESS Scheel, C; Eato
Scheel, C (repri scheel@wi.mitSTEM/PROGENI
NA
Snuderl M., Faz
NA
NA
NA
NATURE PUBL Pasqualucci, LPasqualucci, L ( lp171@columbCREB-BINDING
ELSEVIER SCI Navarra, SV; GPetri, MA (repri mpetri@jhmi. B-LYMPHOCYTE
AMER CHEMICEda, G; Yamagu
Eda, G (reprint g.eda@nus.edTRANSITION-M
AMER SOC HECampo, E; Swer
Jaffe, ES (repri elainejaffe@n B-CELL LYMPH
NATURE PUBL Klinakis, A; LoAifantis, I (rep aklinakis@bio T-CELL DEVEL
ELSEVIER SCI Nutting, CM; MNutting, CM (reprchris.nutting QUALITY-OF-L
CELL PRESS Finley, LWS; Ca
Haigis, MC (repr marcia_haigi BROWN ADIPOS
AMER SOC CL Green, AC; WilGreen, AC (repri adele.green@SKIN-CANCER
AMER ASSOC Rosenberg, SA;
Rosenberg, SA (rsar@nih.gov TUMOR-INFIL
NA
Smith R.A., CoNA
NA
NA
ROCKEFELLERBulua, AC; SimSiegel, RM (repr rsiegel@nih.g CHRONIC GRAN
NATURE PUBL Lupberger, J; Baumert, TF (repthomas.baumer
EPIDERMAL-GR
NA
Loffredo F.S., NA
NA
NA
NA
Basch E., PresNA
NA
NA
ELSEVIER SCI Shaw, AT; Yeap
Shaw, AT (reprin ashaw1@partn
EML4-ALK FUS
AMER SOC CL Allegra, CJ; Y Allegra, CJ (rep Carmen.AllegrMETASTATIC C
AMER ASSOC Anastasiou, D;Cantley, LC (rep lewis_cantle OXIDATIVE ST
OXFORD UNIVMedema, MH; Takano,
Bl
E (repri e.takano@rug.POLYKETIDE S

NATURE PUBL Wertz, IE; Kus Wertz, IE (repri ingrid@gene. UBIQUITIN LIG
NATURE PUBL Balasubramania
Balasubramanian,
sb10031@cam.
C-MYC PROMOT
NATURE PUBL Whiteaker, JR;Paulovich, AG (r apaulovi@fhcrPEPTIDE IMMU
ROCKEFELLERFabbri, G; RasiDalla-Favera, R rd10@columbiNF-KAPPA-B;
NATURE PUBL Muhlebach, MD;
Cattaneo, R (rep Cattaneo.Rob ACTIVATION M
W B SAUNDERS
Strober, W; Fus
Strober, W (repr wstrober@niaiCELL-DEPENDE
NATURE PUBL Lukas, C; SaviBartek, J (repri jb@cancer.dk;ONCOGENE-IND
AMER ASSOC Liu, SL; Gines Wicha, MS (repri sulingl@med. TUMOR MICROE
NA
Le Belle J.E., NA
NA
NA
NA
Ikeda F., DeribNA
NA
NA
NA
Kelkar S.S., R NA
NA
NA
NATURE PUBL Zhang, SY; Hua
Yu, DH (reprint dyu@mdanderBREAST-CANCE
NATURE PUBL Wang, K; Kan, Leung, SY (repri jiangchun.xu@EPSTEIN-BARR
AMER ASSOC Eliason, EJ; C Eliason, EJ (rep eliason@zooloCLIMATE-CHAN
LIPPINCOTT WThomas, M; Sch
Thomas, M (reprimttwins@aol. CARDIAC-SURG
ELSEVIER SCI Mladenov, E; IIliakis, G (repr Georg.lliakis DEPENDENT PR
NATURE PUBL Oskarsson, T; Massague, J (repmassaguj@msk
IN-VITRO PRO
NA
Hart G.W., SlaNA
NA
NA
NA
Choi J.H., Ban NA
NA
NA
NA
Tokunaga F., NNA
NA
NA
NA
Roberson E.D.,NA
NA
NA
AMER MEDICABohnert, ASB; Bohnert, ASB (reamybohne@me
BREAKTHROUGH
NATURE PUBL Yamane, A; Res
Nussenzweig, MCnussen@mail.rCLASS-SWITCH
ELSEVIER SCI Mitchell, AJ; Mitchell, AJ (rep ajm80@le.ac. EARLY BREAST
ELSEVIER SCI Mottet, N; Bel Heidenreich, A ( aheidenreich INTERMITTENT
NA
Feoktistova M.NA
NA
NA
AMER ASSOC Kim, ES; HerbsHong, WK (repri whong@mdand
PHASE-III TRI
AMER MEDICABoomer, JS; ToHotchkiss, RS (r hotch@wustl. ANTIINFLAMMA
NATL ACAD S Katayama, R; E
Kngelman, JA (rejengelman@pa
ANAPLASTIC L
NA
Dawlaty M.M.,NA
NA
NA
NATL ACAD S Iliopoulos, D; Struhl, K (repri kevin@hms.haEPITHELIAL-M
NA
Foldbjerg R., NA
NA
NA
ELSEVIER SCI Pavel, ME; HaiYao, JC (reprint jyao@mdander
PROGRESSIONNA
Zitvogel L., K NA
NA
NA
NATL ACAD S Dhar, S; Kolis Lippard, SJ (rep lippard@mit.ePLGA-MPEG NA
NATL ACAD S Keunen, O; JohNiclou, SP (repr simone.niclouRECURRENT MA
AMER CHEMICRobinson, JT; Dai, HJ (reprint hdai@stanfor CARBON NANOT
AMER SOC CL Burris, HA; Ru Burris, HA (repr howard.burris MAYTANSINE;
AMER SOC HEDi Ianni, M; FaDi Ianni, M (repr mauro.diianni BONE-MARROWAMER SOC CL Robert, NJ; Di Robert, NJ (repri nicholas.robe PROGRESSIONBIOMED CENTBell, JT; Pai, Bell, JT (reprin jordana@well.TRANSCRIPTI
CELL PRESS Quante, M; Tu,Wang, TC (reprintcw21@columb
GASTRIC-CANC
NATURE PUBL Korpal, M; Ell, Kang, YB (reprintykang@princeEPITHELIAL-M

AMER SOC CL Cho, YJ; Tsher Pomeroy, SL (repscott.pomeroyCOPY NUMBER

CELL PRESS Breitling, LP; Breitling, LP (r l.breitling@dkGENOME-WIDE
ELSEVIER SCI Malfertheiner,Malfertheiner, P peter.malfer ANTIBIOTIC-R
NA
Lee J.E., Lee NNA
NA
NA
NA
Lutz S., Berk NA
NA
NA
PUBLIC LIBRA Noyce, RS; Bon
Noyce, RS (repri chris.richard HERPES-SIMPL
NATL ACAD S Soda, Y; Marum
Verma, IM (reprinverma@salk.eSTEM-LIKE CE
MASSACHUSET
Jones, CU; Hu Jones, CU (repri jonesc@radiolTHERAPY ONCO
NATURE PUBL Freedman, ML;Mills, IG (repri ian.mills@ncmHUMAN GENE-E
NATURE PUBL Letessier, A; Debatisse, M (repmichelle.debaDNA-REPLICAT
NA
Zhang H., Zhou
NA
NA
NA
NA
Andersson U., NA
NA
NA
ENDOCRINE SMelmed, S; CaMelmed, S (repri govt-prof@endRISPERIDONENA
Goardon N., Ma
NA
NA
NA
NATURE PUBL Liu, GH; BarkhBelmonte, JCI (rebelmonte@salMUSCLE-CELL
NA
Wynn T.A.
NA
NA
NA
ELSEVIER SCI Aapro, MS; Boh
Aapro, MS (reprinmaapro@genol
CELL LUNG-CA
NA
Wang L., Liu Y.NA
NA
NA
MASSACHUSET
van de Veerdon
van der Meer, JWj.vandermeer SYNDROME TYP
NA
Ambrogio M.W.,
NA
NA
NA
NA
Wang J.-X., JiaoNA
NA
NA
NA
Braun J., Van NA
NA
NA
ACADEMIC PRE
Dweep, H; SticSticht, C (repri harsh.dweep@m
MICRORNA TAR
AMER DIABET Lewis, JD; Fer Lewis, JD (reprin lewisjd@mail ACTIVATED RE
AMER SOC HEYap, DB; Chu, Aparicio, SAJR ( saparicio@bccHISTONE LYSI
ROCKEFELLERBoldin, MP; Ta Boldin, MP (repr mboldin@coh.o
NF-KAPPA-B;
NA
Vesely M.D., KNA
NA
NA
NATL ACAD S Carmon, KS; Go
Liu, QY (reprint qingyun.liu@uPROTEIN-COUP
NATURE PUBL Chowdhury, R;Schofield, CJ (r christopher.s HYPOXIA-INDU
NA
Li L., Rose P., NA
NA
NA
NATURE PUBL Kotake, Y; NakKitagawa, M (re kitamasa@ham
GENOME-WIDE
CELL PRESS Tenev, T; BianTenev, T (reprin tencho.tenev@
NF-KAPPA-B;
W B SAUNDERS
Kurman, RJ; ShKurman, RJ (repr NA
PROPHYLACTIC
AMER SOC CLICorbin, AS; AgDeininger, MW (rNA
CHRONIC MYEL
MASSACHUSET
Finks, JF; Osb Finks, JF (repri jfinks@umich NATIONAL TRE
ELSEVIER SCI Roupret, M; ZiRoupret, M (reprimorgan.roupreLAPAROSCOPIC
NA
Davis B.K., Wen
NA
NA
NA
NA
Xie J., Liu G., NA
NA
NA
NA
Fearon E.R. NA
NA
NA
NA
Liu J., Qiao S. NA
NA
NA
MASSACHUSET
Weaver, DL; As
Weaver, DL (reprdonald.weaveSENTINEL LY
CELL PRESS Hou, J; Lin, L Cao, XT (reprint caoxt@immuno
MICRORNA EXP
NATURE PUBL Lee, JH; Jang, Cheon, J (reprin jcheon@yonsei
NEAR-INFRARE

ELSEVIER SCI Wang, C; Cheng

Liu, ZA (reprint zliu@suda.eduPHOTODYNAMI
NA
Chang Y., YangNA
NA
NA
AMER SOC CL Salazar, R; RoSalazar, R (repri ramonsalazar@
COLON-CANCER
NATL ACAD S Montgomery, R
Breault, DT (rep david.breault HAIR FOLLICL
PERGAMON-ELMazurek, SMazMazurek, S (repr Sybille.Mazur ROUS-SARCOMA
ELSEVIER SCI Gelmon, KA; TiGelmon, KA (reprkgelmon@bcca
RIBOSE POLYM
AMER ASSOC Michaud, M; Mar
Zitvogel, L (repri zitvogel@igr. CELL-DEATH;
CELL PRESS Elgendy, M; ShMartin, SJ (reprinmartinsj@tcd.BH3-ONLY PRO
AMER SOC CL Pardanani, A; G
Tefferi, A (repr tefferi.ayal
INTERNATIONA
COLD SPRING Yang, JS; Phill Chen, KC (reprintkcchen@biolog
EMBRYONIC ST
NA
Mariotto A.B., NA
NA
NA
NA
Deeks S.G.
NA
NA
NA
JOHN WILEY &Roderburg, C; Luedde, T (repri tluedde@ukaaHEPATOCELLUL
AMER ASSOC Ting, DT; Lips Haber, DA (repri haber@helix. PERVASIVE TR
AMER CHEMICYe, JF; Liu, W; Qi, LM (reprint a liminqi@pku.eSENSITIZED S
AMER ASSOC Bettegowda, C;
Vogelstein, B (r vogelbe@jhmiC-MYC; GLIOM
AMER ASSOC Chase, A; Cro Chase, A (reprintachase@sotonPOLYCOMB-GRO
NA
McQuown S.C.,NA
NA
NA
NA
Mells G.F., Fl NA
NA
NA
AMER SOC CL Long, GV; Menz
Long, GV (reprin georgina.lon PRIMARY CUTA
OXFORD UNIVArbyn, M; CastArbyn, M (reprintmarc.arbyn@w
HUMAN-PAPILL
NA
Rosen C.J.
NA
NA
NA
AMER MEDICACarvajal, RD; Carvajal, RD (re carvajar@mskGASTROINTEST
AMER SOC CL Ychou, M; BoigYchou, M (reprintMYchou@valdor
LOCALLY ADV
NEOPLASIA P Kurhanewicz, JKurhanewicz, J ( John.KurhanewMAGNETIC-RE
ELSEVIER SCI Dickinson, L; Dickinson, L (re ldickinson@doACTIVE SURVE
AMER ASSOC Sanai, N; Poll Berger, MS (repr bergerm@neur
MALIGNANT G
ELSEVIER SCI Gianni, L; Daf Gianni, L (reprin gianni.luca@hs
1ST-LINE TRE
WILEY-BLACK Gandini, S; Bon
Autier, P (reprin philippe.autierVITAMIN-D ME
ELSEVIER SCI Stenzl, A; CowStenzl, A (repri Urologie@medTRANSITIONAL
NATURE PUBL Kim, Y; Lach, Smogorzewska, AasmogorzewskCANCER SUSCE
NA
Wu H., D'AlessiNA
NA
NA
ELSEVIER SCI Cortes, J; O'S Twelves, C (repri NA
IXABEPILONE
NA
Mozaffarian D.NA
NA
NA
ELSEVIER SCI Medeiros, SF; Elaissari, A (re elaissari@lageIRON-OXIDE N
ROCKEFELLERKim, T; Verones
Croce, CM (repri carlo.croce@ MIR-200 FAMI
JOHN WILEY &Li, N; FrancescClifford, GM (re clifford@iarc.f HPV TYPES; L
NATURE PUBL Mullighan, CG;Mullighan, CG (r charles.mulli RUBINSTEIN-T
NATURE PUBL Walter, MJ; DinGraubert, TA (re graubert@wusMETHYLTRANS
ELSEVIER SCI Giuliano, AR; Giuliano, AR (re anna.giuliano UNITED-STATE
COLD SPRING Takamura, A; KMizushima, N (renmizu.phy2@tREGULATES AU
NA
Bardhan R., Lal
NA
NA
NA
ELSEVIER SCI Cheng, R; Feng
Zhong, ZY (repri zyzhong@suda
CROSS-LINKED

OXFORD UNIVYang, XR; Chan

Yang, XR (reprin royang@mail.SINGLE-NUCLE
AMER SOC HEHerishanu, Y; Wiestner, A (rep wiestnera@mai
TOLL-LIKE RE
AMER ASSOC Sasaki, T; Koi Janne, PA (repri pjanne@partnCELL LUNG-CA
AMER ASSOC Paraiso, KHT; Smalley, KSM (rekeiran.smalle CUTANEOUS ME
NATURE PUBL Trang, P; WiggBader, AG (repri abader@mirnar
CELLULAR SEN
ELSEVIER SCI van Gijn, W; Mvan de Velde, CJ NA
SHORT-TERM R
AMER ASSOC Tang, W; Lu, Y;Liu, CJ (reprint chuanju.liu@ OLIGOMERIC M
CELL PRESS Mulholland, DJWu, H (reprint a hwu@mednet.EPITHELIAL A
NA
Brusselle G.G.NA
NA
NA
AMER MEDICAEngels, EA; Pf Engels, EA (repr engelse@exchUNITED-STATE
ELSEVIER SCI Feng, LY; ChenQu, XG (reprint xqu@ciac.jl.c CARBON NANOT
LIPPINCOTT WLosordo, DW; H
Losordo, DW (repd-losordo@no PERCUTANEOUS
OXFORD UNIVBokemeyer, C;Bokemeyer, C (rec.bokemeyer@MUTATION STA
CELL PRESS Kerur, N; VeetChandran, B (repbala.chandranCASPASE RECR
CELL PRESS Lesina, M; KurSchmid, RM (reprroland.schmidGROWTH-SUPPR
NA
Thomas K.J., MNA
NA
NA
NA
Shimosegawa NA
T.
NA
NA
AMER SOC CL Hurria, A; Tog Hurria, A (repri ahurria@coh.oGLOMERULAR-F
AMER SOC CL Fukuoka, M; Wu
Mok, TSK (reprin tony@clo.cuhkFACTOR-RECEP
NA
Ludvigsson J.FNA
NA
NA
NA
Liu H.-K., Sadle
NA
NA
NA
AMER SOC CL Burnett, AK; HiBurnett, AK (rep BurnettAK@car
ACUTE MYELO
JOHN WILEY &Brase, JC; Joh Brase, JC (repri j.brase@dkfz. DIAGNOSTIC B
AMER SOC HELannutti, BJ; Lannutti, BJ (re blannutti@ca PHOSPHOINOSI
AMER SOC CL Barbui, T; Bar Barosi, G (reprin barosig@smatt
INTERNATIONA
ROCKEFELLERGriffin, DO; HoRothstein, TL (re tr@nshs.edu CHRONIC LYMP
NA
Ganz T., NemeNA
NA
NA
ELSEVIER SCI Van Poppel, H;Van Poppel, H (r Hendrik.VanPo7 CM; TUMORS
NA
Cuzick J., Dows
NA
NA
NA
AMER COLL PHBrenner, H; ChBrenner, H (repr h.brenner@Dkf
SIDED COLONELSEVIER SCI Sjoquist, KM; Gebski, V (repri val@ctc.usyd.SQUAMOUS-CEL
AMER SOC CL Kocher, M; SofKocher, M (repri martin.kocherRECURSIVE PA
WILEY-BLACK Amary, MF; Bac
Flanagan, AM (rea.flanagan@ucENCHONDROMAT
AMER SOC CL Ohtsu, A; ShahKang, YK (reprin ykkang@amc.s
ENDOTHELIAL
AMER SOC CL Mlecnik, B; To Galon, J (reprin jerome.galon@
TUMOR-INFILT
AMER ASSOC LoRusso, PM; RReddy, JC (repri reddy.josina BASAL-CELL C
AMER SOC CL Topp, MS; KufeZugmaier, G (repgerhard.zugmCLINICAL-SIG
NA
Evans D.M., SpNA
NA
NA
OXFORD UNIVRini, BI; Cohe Rini, BI (reprin rinib2@ccf.orgENDOTHELIAL
NA
Zhou J., Yu M.,NA
NA
NA
AMER SOC CL Mahmoud, SMA;
Green, AR (repri andrew.green PATHOLOGICAL
NATURE PUBL Zhou, KX; BellPearson, ER (rep e.pearson@cpACTIVATED PR
AMER SOC CL Von Hoff, DD; Von Hoff, DD (re dvh@tgen.orgALBUMIN-BOUN

NATURE PUBL Chang, CJ; ChaHung, MC (reprinmhung@mdand

WILD-TYPE P5
NA
Tanner P., BauNA
NA
NA
NATURE PUBL Maertens, J; MCordonnier, C (r carlcord@club-LIPOSOMAL AM
ROYAL SOC C He, QJ; Shi, JL Shi, JL (reprint jlshi@sunm.shRESPONSIVE C
AMER SOC CL Sequist, LV; v Sequist, LV (rep lvsequist@parGROWTH-FACTO
NA
Relling M.V., NA
NA
NA
AMER SOC HEBrentjens, RJ; Brentjens, RJ (r brentjer@mskCHRONIC LYMP
WILEY-BLACK Furie, R; Petr Furie, R (reprin furie@nshs.e DISEASE-ACTI
ELSEVIER SCI Vincent, A; HeGoggins, M (reprmgoggins@jhm
PHASE-III TR
AMER SOC CL Perez, EA; Ro Perez, EA (reprinperez.edith@ TRIAL COMPAR
NA
Heathcote E.J.NA
NA
NA
W B SAUNDERS
Snover, DCSnoSnover, DC (reprNA
MICROSATELLI
AMER ASSOC Tosolini, M; K Galon, J (reprin jerome.galon@
LUNG-CANCER;
NA
Galloway J.B., NA
NA
NA
AMER ASSOC Lou, YM; McDon
Dedhar, S (repri sdedhar@bccrMONOCLONAL-A
NA
Zhou H., BeevNA
NA
NA
AMER SOC CL Paik, PK; Arcil Riely, GJ (repri rielyg@mskccRECEPTOR GEN
ROYAL SOC C Hur, SC; HendDi Carlo, D (repr dicarlo@seas.CIRCULATING
WILEY-BLACKWStrosberg, JR; Strosberg, JR (re jonathan.stro ISLET-CELL-C
ELSEVIER SCI Gnant, M; MlinGnant, M (reprin michael.gnan POSTMENOPAUS
ELSEVIER SCI Wang, C; Tao, Liu, Z (reprint
zliu@suda.eduFLUORESCENT
AMER ASSOC Janku, F; Tsim Kurzrock, R (rep rkurzroc@mdaCELL LUNG-CA
ELSEVIER SCI Katki, HA; Kin Katki, HA (repri katkih@mail.nRANDOMIZED C
NATL ACAD S Janeway, KA; KJaneway, KA (repkjaneway@parAPPARENTLY S
SPRINGER
Schindler, G; von Deimling, A andreas.vond ATYPICAL TER
AMER SOC CL Lai, A; Tran, Lai, A (reprint
albertlai@medADJUVANT TE
ELSEVIER SCI Eggener, SE; SStephenson, AJ ( stephea2@ccfBIOCHEMICAL
AMER SOC CL Tosoian, JJ; Tr Carter, HB (repr hcarter@jhmi RADICAL PROS
AMER SOC CL Thol, F; Damm,
Heuser, M (repri heuser.micha NORMAL CYTOG
NA
Nieto M.A.
NA
NA
NA
NA
Sano T., KoderNA
NA
NA
ELSEVIER SCI Miller, BJ; Buc Miller, BJ (repr brmiller@georSERUM-SOLUBL
AMER SOC CL Gandhi, L; Cam
Gandhi, L (repri NA
CONTINUAL RE
AMER ASSOC Modi, S; StopeModi, S (reprint modis@mskccADJUVANT CHE
W B SAUNDERS
Ullman, TA; It Itzkowitz, SH (r steven.itzkow NITRIC-OXIDE
NA
Uchida Y., OhtsNA
NA
NA
WILEY-BLACK Wiklund, ED; BKjems, J (reprin jk@mb.au.dk EPITHELIAL-M
NA
Cheng L., YangNA
NA
NA
FUTURE MEDIC
Feng, LZ; Liu, Liu, ZA (reprint zliu@suda.eduRESONANCE EN
FUTURE MEDIC
Feng, LZ; Liu, Liu, ZA (reprint zliu@suda.eduRESONANCE EN
NA
Baxter N.N., SNA
NA
NA
AMER SOC CL Gangat, N; CarTefferi, A (repri tefferi.ayal
MYELOID META
ELSEVIER SCI Treasure, T; L Treasure, T (rep tom.treasure DOSE HEMITHO

NA
Xia Y., Li W., NA
NA
NA
B M J PUBLIS Ogino, S; ChanOgino, S (reprin shuji_ogino@dISLAND METHY
NATURE PUBL Comino-Mendez,
Cascon, A (repri mrobledo@cniUNIPARENTAL
NA
Hu W., Peng C.NA
NA
NA
NATURE PUBL Wiesner, T; ObWiesner, T (repriwiesnert@mskc
PROTEIN FUNC
NA
Choueiri T.K., NA
NA
NA
AMER ASSOC Yakes, FM; Chen
Yakes, FM (reprinmyakes@exeliTYROSINE KIN
BIOMED CENTLee, MS; Hsu, Lee, MS (reprint mmsl@ndmctsPOLYCYSTIC-O
AMER SOC CL Keedy, VL; Te Keedy, VL (repri guidelines@asPLUS GEMCITA
NATURE PUBL Serra, V; Scal Baselga, J (repr jbaselga@vhioVIVO ANTITUM
NA
Herman S.E.M.,
NA
NA
NA
NA
Della Rocca J.,NA
NA
NA
NA
Liu R., Zhang NA
NA
NA
NA
Singer N.G., CNA
NA
NA
NA
Yoshizawa A., M
NA
NA
NA
WILEY-BLACK Cheng, CL; Kao,
Kao, YHY (reprintyhkao@mail.nACUTE MYOCAR
AMER SOC CL Guo, J; Si, L; Guo, J (reprint guoj307@126GASTROINTEST
AMER CHEMICDu, D; Wang, LLin, YH (reprint yuehe.lin@pnlMUTANT P53;
NA
Volzke H., Alt NA
NA
NA
WILEY-BLACK Xu, JA; Wu, C; Lin, DX (reprint NA
CELL LUNG-CA
ELSEVIER SCI Gill, IS; Eise Gill, IS (reprint gillindy@gmaiCONTROLLED H
SPRINGER
Hofman, A; van
Hofman, A (repri a.hofman@er BONE-MINERAL
NA
Piccinni C., MoNA
NA
NA
ELSEVIER SCI Lane, BR; RussCampbell, SC (recampbes3@ccf
NEPHRON SPA
AMER SOC CL Aschele, C; Ci Aschele, C (repri aschele@tin.itMEGAVOLTAGE
OXFORD UNIVMatsuda, T; Ma
Matsuda, T (repritomatsud@nccNA
ELSEVIER SCI Thorp, AA; OwDunstan, DW (rep
David.Dunsta RECREATIONAL
ELSEVIER SCI Laurent, S; DuMahmoudi, M (repr
mahmoudi@biPROSTATE-CAN
NATURE PUBL Anastassiadis,Peterson, JR (re jeffrey.peter INTERACTION
NA
Ridker P.M., ThNA
NA
NA
NATURE PUBL Harari, A; Roz Pantaleo, G (rep giuseppe.pan NECROSIS-FAC
AMER CHEMICLiu, Q; Sun, Y;Li, FY (reprint
fyli@fudan.ed PHOTODYNAMIC
LIPPINCOTT WMukhopadhyay,
Mukhopadhyay, S
mukhopas@upTRANSCRIPTIO
SCHATTAUER Nurden, ATNurNurden, AT (repr Alan.Nurden@c
SOLUBLE CD40
AMER MEDICABonadona, V; B
Lasset, C (repri lasset@lyon.fnNONPOLYPOSIS
AMER SOC CLISavoldo, B; RaDotti, G (reprin gdotti@bcm.t B-LINEAGE LE
LIPPINCOTT WYi, ES; Boland Yi, ES (reprint
yi.joanne@maEML4-ALK FUS
W B SAUNDERS
Shaheen, NJ; OShaheen, NJ (repnshaheen@meHIGH-GRADE D
ELSEVIER MA De Hert, M; CoDe Hert, M (repr NA
BONE-MINERAL
AMER SOC CL Okada, H; KaliOkada, H (reprin okadah@upmcCOLONY-STIMU
AMER CHEMICDu, JZ; Du, XJ Wang, J (reprint jwang699@ustCANCER STEM
NA
Itzykson R., T NA
NA
NA
AMER ASSOC Mostaghel, EAMostaghel, EA (r emostagh@fhc
GENE-EXPRESS

LIPPINCOTT WPaik, JH; Choe,Chung, JH (repri chungjh@snu.GROWTH-FACT

NA
Kaouk J.H., AutNA
NA
NA
AMER CHEMICChiang, JH; Ya Chung, JG (repri jgchung@mailENDOPLASMICKOREAN CANCJung, KW; Park,
Park, S (reprint shpark@ncc.reTHYROID-CANC
NA
Shiels M.S., PfNA
NA
NA
NA
Gjerstorff M.L.NA
NA
NA
NA
Dunne E.F., MaNA
NA
NA
NATURE PUBL Chen, J; Li, YJ Parada, LF (repr luis.parada@uEXPRESSING P
NATURE PUBL Driessens, G; Simons, BD (reprbds10@cam.ac.
CANCER STEMNATURE PUBL Garnett, MJ; E McDermott, U (reum1@sanger.aMESENCHYMAL
AMER ASSOC Schepers, AG;Clevers, H (repr h.clevers@hubCOLORECTAL-C
NATL ACAD S Willingham, SBWeissman, IL (re irv@stanford. INTEGRIN-ASS
NATURE PUBL Straussman, R;
Golub, TR (repri golub@broadin
C-MET; ACQU
AMER ASSOC Arthur, JC; Pe Jobin, C (reprin job@med.unc.ESCHERICHIANATURE PUBL Peinado, H; AlBromberg, J (rep bromberj@msk
PREMETASTATI
NATURE PUBL Malanchi, I; S Huelsken, J (rep joerg.huelske TUMOR-INITIA
NATURE PUBL Berger, MF; HoChin, L (reprint LChin@mdander
HUMAN CANCER
NATURE PUBL Prahallad, A; Bernards, R (rep r.bernards@nkMETASTATIC C
NATURE PUBL Wilson, TR; FriSettleman, J (re settleman.je RECEPTOR TYR
NATURE PUBL Lu, C; Ward, PThompson, CB (re
thompsonc@m
INTEGRATED G
CELL PRESS Lin, CY; Loven,Young, RA (repri young@wi.mitEMBRYONIC ST
CELL PRESS Lee, MJ; Ye, A Yaffe, MB (repri myaffe@mit.eGROWTH-FACTO
COLD SPRING Castellarin, M Holt, RA (reprin rholt@bcgsc.cORAL EPITHEL
NA
Dunham I., Kun
NA
NA
NA
NA
Pan A., Sun Q.NA
NA
NA
WILEY-BLACK Siegel, R; Nai Siegel, R (repri Rebecca.siegeBREAST-CANCE
ELSEVIER SCI Lee, IM; Shirom
Lee, IM (reprint ilee@rics.bwhALL-CAUSE MO
MASSACHUSET
Bleyer, A; WelBleyer, A (repri ableyer@gmaiRANDOMIZED-T
ELSEVIER SCI Lim, SS; Vos, Lim, SS (reprint stevelim@uw.CORONARY-HEA
ELSEVIER SCI Pearce, MS; SaPearce, MS (repr mark.pearce@COMPUTED-TOM
NA
Govindan R., DNA
NA
NA
NA
Weeks J.C., CaNA
NA
NA
NATURE PUBL Curtis, C; Sha Caldas, C (repri carlos.caldas GENE-EXPRESS
MASSACHUSET
Wilt, TJ; BraweWilt, TJ (reprint tim.wilt@va.g POSITIVE SUR
NA
Mattison J.A., NA
NA
NA
NATURE PUBL Koboldt, DC; FPerou, CM (repri cperou@med.BASAL-LIKE;
NA
Kripke D.F., LaNA
NA
NA
INST BIOCHEMZhang, L; Hou,Zhang, CY (repri jfzhang@nju.eAUTOSOMAL RE
NA
Nielsen S.F., NA
NA
NA
NATURE PUBL Muzny, DM; Bai
Kucherlapati, R rkucherlapati COLORECTAL-C
MASSACHUSET
Gerlinger, M; Swanton, C (reprcharles.swantCHRONIC MYEL
MASSACHUSET
Alexander, EK;Alexander, EK (r ekalexander@p
NEEDLE-ASPIR
NA
Roberts N.J., VNA
NA
NA

ELSEVIER SCI Bray, F; JemalBray, F (reprint brayf@iarc.fr NONCOMMUNICA

MASSACHUSET
Brahmer, JR; TBrahmer, JR (repNA
LYMPHOCYTE-A
NA
Roger V.L., GoNA
NA
NA
MASSACHUSET
Topalian, SL; Topalian, SL (re stopali1@jhmiCELL LUNG-CA
ELSEVIER SCI Rothwell, PM; Rothwell, PM (reppeter.rothwel LOW-DOSE ASP
B M J PUBLIS Li, KR; Kaaks, Rohrmann, S (repsabine.rohrm CORONARY-HEA
NA
Lidegaard O., NA
NA
NA
NA
Snitkin E.S., NA
NA
NA
ELSEVIER SCI Rothwell, PM; Rothwell, PM (reppeter.rothwel NONSTEROIDAL
NA
De Martel C., NA
NA
NA
ELSEVIER SCI Mihaylova, B; Mihaylova, B (repctt@ctsu.ox.a CORONARY-HEA
ELSEVIER SCI Lozano, R; NagMurray, CJL (rep cjlm@uw.edu COMMUNITY-AC
NATURE PUBL Hammerman, Meyerson,
PS;
M (repmatthew_meye
COPY-NUMBER
NATURE PUBL He, CC; Bassik,
Levine, B (repri beth.levine@uCAUSES INSUL
MASSACHUSET
Schoen, RE; PiSchoen, RE (reprNA
FECAL-OCCULT
MASSACHUSET
Flaherty, KT; Weber, J (reprin jeffrey.weber@DOSE-ESCALAT
NA
Douglas S.M., NA
NA
NA
MASSACHUSET
Liao, XY; LochChan, AT (reprin achan@partner
ISLAND METHY
NATL ACAD S Heyn, H; Li, N Wang, J (reprint wangj@genomic
PLURIPOTENT
MASSACHUSET
Zauber, AG; Wi
Zauber, AG (reprzaubera@mskc
FECAL-OCCULT
CELL PRESS Nik-Zainal, S; Campbell, PJ (re pc8@sanger.aACUTE MYELOI
MASSACHUSET
Baselga, J; Co Baselga, J (repr jbaselga@partEPIDERMAL-GR
NATURE PUBL Shah, SP; RothAparicio, S (rep carlos.caldas RETINOBLAST
NATURE PUBL Biankin, AV; WGrimmond, SM (re
s.grimmond@iDUCTAL ADENO
MASSACHUSET
Scher, HI; Fiz Scher, HI (repri scherh@mskcc
ANDROGEN-REC
MASSACHUSET
Schroder, FH; Schroder, FH (re secr.schrode RANDOMIZED C
NATURE PUBL Ding, L; Ley, Ley, TJ (reprint timley@wustl ACUTE MYELOG
MASSACHUSET
Gerstein, HC; Gerstein, HC (re origin@phri.c BLOOD-GLUCOS
NA
Naik S., BoulaNA
NA
NA
MASSACHUSET
Flaherty, KT; Flaherty, KT (rep kflaherty@parMUTATIONS; P
MASSACHUSET
Baselga, J; Ca Baselga, J (repr jbaselga@partFIRST-LINE T
CELL PRESS Magee, JA; PisMorrison, SJ (re sean.morriso ACUTE MYELOI
CELL PRESS Ward, PS; Th Thompson, CB (re
craig@mskcc.PYRUVATE-KIN
CELL PRESS Nik-Zainal, S; Stratton, MR (re mrs@sanger.aNONNEGATIVE
MASSACHUSET
Quintero, E; CCastells, A (repr equinter@gmai
OCCULT BLOOD
NA
Jostins L., Ri NA
NA
NA
NATURE PUBL Banerji, S; Ci Meyerson, M (repatoker@bidmcCELL LUNG-CA
MASSACHUSET
Verma, S; MileVerma, S (reprin sunil.verma@ PHASE-II; CAP
CELL PRESS Hanahan, D; Hanahan, D (reprdouglas.hana ENDOTHELIAL
NATURE PUBL Stephens, PJ; Stratton, MR (re mrs@sanger.aNUCLEOTIDE E
MASSACHUSET
Gourlay, ML; FiGourlay, ML (repmargaret_gouCUMULATIVE I
NATURE PUBL Reyon, D; TsaiJoung, JK (repri jsander@partnZINC-FINGER
NA
Onder T.T., Ka NA
NA
NA

CELL PRESS Hodis, E; WatsGarraway, LA (relevi_garrawayB-CELL LYMP

MASSACHUSET
Sosman, JA; KiSosman, JA (reprjeff.sosman@vMETASTATIC M
AMER MEDICAGillison, ML; Gillison, ML (re maura.gillis HUMAN-PAPILL
ELSEVIER SCI Schwartz, SD; Schwartz, SD (rep
schwartz@jseiRETINAL-PIGM
CELL PRESS Rausch, T; JonLichter, P (repr peter.lichter@LI-FRAUMENIELSEVIER SCI Vos, T; FlaxmaMurray, CJL (rep cjlm@uw.edu NEGLECTED TR
NATURE PUBL Diaz, LA; Willi Diaz, LA (reprin ldiaz1@jhmi. MET AMPLIFIC
WILEY-BLACK Kushi, LH; DoyDoyle, C (reprin colleen.doyle BODY-MASS I
NA
Lee Y., MorrisoNA
NA
NA
NATURE PUBL Ross-Innes, CS;
Carroll, JS (rep carlos.caldas@
GENE-EXPRESS
NATURE PUBL Schwartzentrub
Majewski, J (rep jacek.majewskINTEGRATED G
NATURE PUBL Nguyen, LV; VaEaves, CJ (repri ceaves@bccrcCHRONIC MYEL
NA
Raghu G., Anstr
NA
NA
NA
CELL PRESS Hou, Y; Song, Li, YR (reprint
wangj@genomi
MULTIPLE DIS
MASSACHUSET
Cortes, JE; Ka Cortes, JE (repr jcortes@mdanCHRONIC MYEL
CELL PRESS Imielinski, M; Meyerson, M (repmatthew_meye
GROWTH-FACTO
NA
Li G., Ruan X. NA
NA
NA
OXFORD UNIVAndriole, GL; Prorok, PC (repr prorokp@mail.COMORBIDITY
NATURE PUBL Barretina, J; Garraway, LA (rerobert.schleg MALIGNANT-ME
NATURE PUBL Ellis, MJ; Din Ellis, MJ (reprin NA
MYELOID-LEU
NA
Lamming D.W.,
NA
NA
NA
NA
Swerdlow D.I. NA
NA
NA
NATURE PUBL Pugh, TJ; WeerCho, YJ (reprint matthew_meyer
STRUCTURAL B
NA
Lee E., Iskow RNA
NA
NA
NATURE PUBL Robinson, G; PGilbertson, RJ ( Jinghui.Zhang BOX RNA HELI
NATURE PUBL Carter, SL; Ci Getz, G (reprint gadgetz@broad
COMPARATIVE
CELL PRESS Zhang, Y; McCo
Alt, FW (reprint alt@enders.t DOUBLE-STRAN
NA
Siegel R., Des NA
NA
NA
CELL PRESS Xu, X; Hou, Y; Wang, J (reprint wangj@genomic
MULTIPLE DIS
AMER SOC CL Smith, TJ; TemTemin, S (reprin guidelines@asRANDOMIZED C
ELSEVIER SCI Algra, AM; RotRothwell, PM (reppeter.rothwel NONSTEROIDAL
NATURE PUBL Zhang, JH; BenDyer, MA (reprin rwilson@wustlCHRONIC LYMP
NATURE PUBL Misale, S; Yae Solit, D (reprin solitd@mskcc.o
K-RAS MUTATI
CELL PRESS Ring, KL; TongHuang, YD (repriyhuang@gladsHUMAN SOMATI
NATURE PUBL Molenaar, JJ; Versteeg, R (rep j.j.molenaar@ACTIVATING M
MASSACHUSET
van Hagen, P; van der Gaast, Aa.vandergaas PHASE-III TR
MASSACHUSET
Fox, RJ; Mille Fox, RJ (reprint foxr@ccf.org DIMETHYL FUM
MASSACHUSET
Walter, MJ; ShGraubert, TA (re graubert@wusMYELODYSPLA
NA
Hrkach J., Von NA
NA
NA
MASSACHUSET
Meyer, RM; Gos
Meyer, RM (reprirmeyer@ctg.qCLINICAL-PRA
MASSACHUSET
Su, F; Viros, Ribas, A (reprin aribas@mednet
B-RAF; MELAN
CELL PRESS Nie, ZQ; Hu, GZhao, KJ (reprin zhaok@nhlbi.nGRAPHICAL US
NA
Thies W., BleilNA
NA
NA

NATURE PUBL Quesada, V; Co

Lopez-Otin, C (reecampo@clinic
PRE-MESSENGE
MASSACHUSET
Patel, JP; Gon Levine, RL (repr leviner@mskcNORMAL CYTOG
ELSEVIER SCI Wheeler, CM; C
Wheeler, CM (repcwheeler@salHUMAN-PAPILL
NATURE PUBL Crasta, K; GanPellman, D (repr david_pellmanKINETOCHORENATURE PUBL Jones, DTW; JaEils, R (reprint r.eils@dkfz-h TETRAPLOID T
NA
Chertow G.M.,NA
NA
NA
NATURE PUBL Png, KJ; HalbeTavazoie, SF (repstavazoie@mai
BREAST-CANC
ELSEVIER SCI Albain, K; AndAlbain, K (repri bc.overview@PHASE-III TR
NATURE PUBL Metallo, CM; GStephanopoulos,iliopoul@heli FATTY-ACID S
ELSEVIER SCI Baselga, J; Br Baselga, J (repr jbaselga@partADJUVANT CHE
NATURE PUBL Henao-Mejia, JFlavell, RA (rep richard.flavel NONALCOHOLIC
CELL PRESS Marks, H; KalkSmith, A (reprin austin.smith@EMBRYONIC ST
NA
Ridker P.M., P NA
NA
NA
NATURE PUBL Kircher, MF; d Gambhir, SS (repsgambhir@staLIVING MICE;
NA
Lian C.G., Xu NA
NA
NA
MASSACHUSET
Sekulic, A; Mi Sekulic, A (repr sekulic.alek SONIC-HEDG
NA
Park S.H., DasNA
NA
NA
NATURE PUBL Turcan, S; RohChan, TA (reprin mellingi@mskISLAND METHY
ELSEVIER SCI Lehtinen, M; PLehtinen, M (rep matti.lehtinenHUMAN-PAPIL
NATURE PUBL Lipson, D; CapStephens, PJ (re mcronin@founMUTATIONS; S
CELL PRESS Vaseva, AV; Ma
Moll, UM (reprin ute.moll@sbu FOCAL CEREBR
NATURE PUBL Lee, H; Lytton Anderson, DG (redgander@mit.RNAI THERAPE
NATURE PUBL Landis, SC; AmSilberberg, SD ( silberbs@nindRANDOMIZED C
NA
Nakamura T., LNA
NA
NA
CELL PRESS Guo, WJ; KeckeWeinberg, RA (reweinberg@wi.EPITHELIAL-M
NATURE PUBL Hsieh, AC; Liu Ruggero, D (reprchristian@int TOP MESSENGE
NATURE PUBL Nikolaev, SI; Nikolaev, SI (re serg.nikolaev FACIO-CUTANE
NA
Wu G., BroniscNA
NA
NA
CELL PRESS Garcia-Cao, I; Pandolfi, PP (re ppandolf@bidDNA-DAMAGE R
NATURE PUBL Mullen, AR; Wh
DeBerardinis, RJ nav@northwest
GLUTAMINE-ME
AMER SOC CLISica, A; MantoSica, A (reprint antonio.sica@TUMOR-ASSOCI
NA
Hoffmeyer K., NA
R
NA
NA
NA
Peng J., Gao WNA
NA
NA
NATL ACAD S Chen, CH; DickPu, YS (reprint a yspu@ntu.eduARISTOLACTAM
NA
McDole J.R., WNA
NA
NA
NATURE PUBL Wu, X; NorthcoTaylor, MD (repr mdtaylor@sickBEAUTY TRANS
NA
Kim J.A., Aber NA
NA
NA
NATURE PUBL McCabe, MT; Ot
Creasy, CL (repr caretha.l.cre HISTONE METH
PUBLIC LIBRA Powell, AA; Ta Powell, AA (repr dairkes@cpmcr
EPITHELIAL-M
CELL PRESS Welch, JS; LeyLey, TJ (reprint timley@wustl ACUTE PROMYE
NATL ACAD S Zheng, Y; Chen
Zheng, Y (reprin yingzy@uw.edENDOTHELIAL
CELL PRESS Li, TY; Kon, N; Gu, W (reprint a wg8@columbiLYSINE ACETY
AMER ASSOC Jain, M; Nilss Mootha, VK (reprvamsi@hms.ha
ANTICANCER

NATURE PUBL Cheung, TH; Qu

Rando, TA (repri rando@stanfoSATELLITE CE
ELSEVIER SCI Hauschild, A; Hauschild, A (re ahauschild@de
SOLID TUMORS
NA
Clark M.B., JohNA
NA
NA
NATURE PUBL Matsushita, H;Schreiber, RD (r schreiber@im ADAPTIVE IMM
NA
Yu F.-X., Zhao NA
NA
NA
NA
Azoulay L., YinNA
NA
NA
MASSACHUSET
Bear, HD; TangBear, HD (reprin hdbear@vcu. SURGICAL ADJ
NATURE PUBL Smith, CC; Wan
Shah, NP (reprin nshah@mediciTYROSINE KIN
AMER MEDICACaliff, RM; Za Califf, RM (repr robert.califf RANDOMIZED C
ELSEVIER SCI Falchook, GS; Falchook, GS (re gfalchoo@mdaRAF INHIBITO
WILEY-BLACK Olesen, J; GusOlesen, J (repri jeol@glo.regi BURDEN; DISE
MASSACHUSET
von Minckwitz,von Minckwitz, Ggunter.vonmi PHASE-III; T
MASSACHUSET
Harrison, C; K Harrison, C (rep claire.harriso INTERNATIONA
ELSEVIER SCI Rosell, R; Car Rosell, R (repri rrosell@iconcoGEFITINIB; CA
NATURE PUBL Northcott, PA;Marra, MA (repri mmarra@bcgsc
HEDGEHOG PAT
NATURE PUBL Rodriguez, R; Rodriguez, R (re sb10031@cam.
DOUBLE-STRAN
NA
Lebwohl M., S NA
NA
NA
MASSACHUSET
Treon, SP; Xu, Treon, SP (repri steven_treon@MARGINAL ZO
NATURE PUBL Zhang, JH; DinDowning, JR (repjames.downing
ACTIVATING F
NA
Acharyya S., ONA
NA
NA
NA
Barnes E., Fol NA
NA
NA
AMER ASSOC Janda, CY; Wag
Garcia, KC (repr kcgarcia@stanSIGNALING IN
MASSACHUSET
Verstovsek, S;Verstovsek, S (r sverstov@mdaINTERNATIONA
CELL PRESS Wang, JW; Sun,
Rudolph, KL (rep klrudolph@fli-TRANSCRIPTIO
NA
Li P., Banjade NA
NA
NA
CELL PRESS Cooke, VG; LeB
Kalluri, R (repri rkalluri@bidmENDOTHELIAL
CELL PRESS Rhim, AD; MireStanger, BZ (rep bstanger@excCANCER STEMNA
Neudecker P., NA
NA
NA
COLD SPRING Ju, YS; Lee, WC
Seo, JS (reprint jeongsun@snuGROWTH-FACTO
NA
Roberts I.S.D. NA
NA
NA
CELL PRESS Berg, MG; SingDreyfuss, G (rep gdreyfuss@hhPOLY(A) SITE
NA
Dominissini D.NA
NA
NA
NATL ACAD S Lohr, JG; Stoj Lander, ES (repr lander@broadiACUTE LYMPHO
ELSEVIER SCI Smith, MR; Saa
Smith, MR (repri smith.matthe SKELETAL-REL
NATURE PUBL Berman, BP; We
Laird, PW (repri plaird@usc.edBODY-SPECIFI
NATURE PUBL Takeuchi, K; S Takeuchi, K (reprkentakeuchi- EML4-ALK FUS
NATURE PUBL Gu, SG; Pak, J Fire, A (reprint afire@stanfor DOUBLE-STRAN
NATURE PUBL Hakim, O; Resc
Nussenzweig, MCnussen@rockef
CLASS-SWITCH
CELL PRESS Li, VSW; Ng, SMahmoudi, T (rept.mahmoudi@e
ADENOMATOUS
MASSACHUSET
Ledermann, J; Ledermann, J (re j.ledermann@c
POLY(ADP-RIB
COLD SPRING Kostic, AD; GeMeyerson, M (repmatthew_meye
HELICOBACTER
NATURE PUBL Walter, S; WeiSingh-Jasuja, H singh@immatiRENAL-CELL C
NA
Newell E.W., SNA
NA
NA

NA
Silverman D.T.NA
NA
NA
NA
Branco M.R., FNA
NA
NA
MASSACHUSET
Ewing, CM; Ray
Cooney, KA (reprkcooney@medGENOME-WIDE
MASSACHUSET
Tang, JY; MackEpstein, EH (rep eepstein@chorCARCINOMA SY
ELSEVIER SCI Ahmed, HU; Hin
Ahmed, HU (reprihashim.ahmedINTENSITY-FO
SPRINGER
Taylor, MD; NoTaylor, MD (repr mdtaylor@sickCENTRAL-NERV
CELL PRESS Tsai, HC; Li, H Baylin, SB (repr sbaylin@jhmi.ACUTE MYELOI
CELL PRESS Duncan, JS; Wh
Johnson, GL (rep glj@med.unc. RECEPTOR EXP
CELL PRESS Freed-Pastor, Prives, C (reprin clp3@columbiCOA REDUCTAS
NA
Schulz C., Per NA
NA
NA
NA
Koboldt D.C., NA
NA
NA
CELL PRESS Lu, KV; Chang,Bergers, G (reprigabriele.berg ENDOTHELIAL
NATURE PUBL Fumagalli, M; di Fagagna, FD (rfabrizio.dadd DOUBLE-STRAN
NA
Pelletier D., H NA
NA
NA
CELL PRESS Provenzano, PP
Hingorani, SR (r srh@fhcrc.orgINTERSTITIA
NA
Garofalo M., RNA
NA
NA
NA
Kalager M., AdNA
NA
NA
NATURE PUBL Kohno, T; Ichi Kohno, T (reprinttkkohno@ncc.CANCER; RET;
NATURE PUBL Grasso, CS; Wu
Pienta, KJ (repri kpienta@med.ANDROGEN REC
NA
Martin D.F., MaNA
NA
NA
NA
Matthews C.E.,NA
NA
NA
ELSEVIER SCI Pearce, CL; TePearce, CL (repr cpearce@usc.HOSPITAL DIS
NATURE PUBL Graubert, TA; Walter, MJ (repr mjwalter@dom
ACUTE MYELOI
NATURE PUBL Zhang, ZF; LeeBivona, TG (repr bh2376@colum
RECEPTOR TYR
NATURE PUBL Guichard, C; AZucman-Rossi, J zucman@cephb
P53 GENE; CA
NATURE PUBL Chauhan, VP; JSain, RK (reprin jain@steele.mVASCULAR NOR
CELL PRESS Powell, AE; WaCoffey, RJ (repri robert.coffey IMMUNOHISTOC
WILEY-BLACK Simard, EP; Wa
Simard, EP (repr edgar.simard@
B-VIRUS INFE
AMER ASSOC Katayama, R; E
Sngelman, JA (rejengelman@pa
ANAPLASTIC L
NA
Zielinski C.E. NA
NA
NA
AMER MEDICASheets, NC; Go
Chen, RC (reprin ronald_chen@QUALITY-OF-L
MASSACHUSET
Agnelli, G; Ge Agnelli, G (repri agnellig@unipMOLECULAR-WE
NA
Heravi-Moussav
NA
NA
NA
NATURE PUBL Zang, ZJ; CutcTan, P (reprint steve.rozen@dTUMOR-SUPPRE
NATURE PUBL Franchi, L; Ka Nunez, G (reprin bclx@umich.eIII SECRETIO
SPRINGER
Barentsz, JO; Barentsz, JO (re j.barentsz@raCONTRAST-ENH
MASSACHUSET
James, ND; Hus
James, ND (repri n.d.james@bhSYNCHRONOUS
NA
Schmitz R., YoNA
NA
NA
NATURE PUBL Korevaar, PA; De Greef, TFA (r t.f.a.d.greef@ SELF-ORGANIZ
CELL PRESS Jenal, M; Elko Agami, R (reprin r.agami@nki.nOCULOPHARYNG
MASSACHUSET
Postow, MA; Ca
Wolchok, JD (rep wolchokj@mskRENAL-CELL C
NATL ACAD S Conley, SJ; GhWicha, MS (repri mwicha@umicTYROSINE KIN
NA
Mallick U., Ha NA
NA
NA

CELL PRESS Ying, HQ; Kimm

Kimmelman, AC (r
alec_kimmelmN-LINKED CAR
NA
Riviere J.-B., NA
NA
NA
MASSACHUSET
McCarthy, PL; McCarthy, PL (re philip.mccart INTERGROUPE
ELSEVIER SCI Forner, A; LlovBruix, J (reprint jbruix@clinic. RANDOMIZED C
NA
Yan K.S., Chia NA
NA
NA
BMJ PUBLISHI Schierbeck, LL;
Schierbeck, LL ( louise.schier CORONARY-HEA
NATURE PUBL Krauthammer,Halaban,
M
R (repr ruth.halaban KINASE INHIB
NA
Shimada K., CrNA
NA
NA
COLD SPRING Hon, GC; Hawki
Ren, B (reprint a biren@ucsd.e NUCLEAR LAMI
NATURE PUBL Shen, BQ; Xu, Junutula, JR (re jagath@gene TARGETED CAN
NATURE PUBL White, JF; Noi Grisshammer, R (rkgriss@helix.PROTEIN-COUP
CELL PRESS Le, A; Lane, A Le, A (reprint au annele@jhmi. ISOTOPE-RESO
NATL ACAD S Fabbri, M; PaoFabbri, M (repri mfabbri@chla.STRANDED-RNA
ELSEVIER SCI Gianni, L; Pie Gianni, L (reprin gianni.luca@hs
TYROSINE KIN
NATURE PUBL Laurie, CC; LaLaurie, CC (repr cclaurie@u.waCHRONIC LYMP
NA
Chiang N., FreNA
NA
NA
NATURE PUBL Ng, KP; HillmeRuan, YJ (reprin dmolwt@nccs.c
CELL LUNG-CA
CELL PRESS Zhang, WC; Shy
Lim, EH (reprint elainelim77@ySTEM-CELL; N
NA
Cerami E., GaoNA
NA
NA
NA
Lidegaard O., NA
NA
NA
CELL PRESS Sturm, D; WittPlass, C (reprin c.plass@dkfz. INTEGRATED G
NATURE PUBL Montagut, C; D
Montagut, C (repcmontagut@hos
1ST-LINE TRE
OXFORD UNIVHornbeck, PV;Hornbeck, PV (rephornbeck@cePROTEIN-PHOS
AMER SOC CL Van Cutsem, E;
Van Cutsem, E (reric.vancutse ENDOTHELIAL
COLD SPRING Ciriello, G; C Ciriello, G (rep memo@cbio.mCANCER GENOM
NA
Bomfim T.R., FNA
NA
NA
NA
Houk A.R., Jil NA
NA
NA
NA
Tang F., Li L., NA
NA
NA
NA
Schenk T., Chen
NA
NA
NA
NA
Attfield M.D., NA
NA
NA
ELSEVIER SCI Wick, W; PlattWick, W (reprint wolfgang.wickNEWLY-DIAGNO
NA
Hao H.-X., Xie NA
NA
NA
MASSACHUSET
Palumbo, A; Ha
Palumbo, A (repriappalumbo@yPREDNISONE P
NATURE PUBL Seshagiri, S; Seshagiri, S (re sekar@gene. CIRCULAR BIN
MASSACHUSET
Schlumberger,Schlumberger, Mschlumbg@igr.RECOMBINANT
NA
Didonato J.A., NA
NA
NA
NATURE PUBL Young, ND; JexGasser, RB (repriwangjian@genHUMAN BLOOD
CELL PRESS Li, L; Wang, L Chen, WY (reprinwechen@coh.o
CHRONIC MYEL
AMER ASSOC Doebele, RC; PDoebele, RC (reprobert.doebe EML4-ALK FUS
NA
Baietti M.F., NA
NA
NA
NATURE PUBL Jeon, SM; ChanHay, N (reprint anhay@uic.eduFATTY-ACID S
SPRINGER
Volpicelli, G; Volpicelli, G (re gio.volpicell RESPIRATORYWILEY-BLACK Wilkinson, JE; Miller, RA (repr millerr@umic AMES DWARF M

NA
Itzkovitz S., NA
NA
NA
NATURE PUBL Ghoussaini, M;Easton, DF (repr douglas@srl.cHORMONE-REL
MASSACHUSET
Attal, M; LauwAttal, M (reprin attal.m@chu-tHIGH-DOSE CH
COLD SPRING Hinoue, T; WeiLaird, PW (repri plaird@usc.edLOW CIMP-LOW
NATURE PUBL Idris, NM; Gn Zhang, Y (reprin biezy@nus.edFLUORESCENT
NATURE PUBL Chen, Z; Cheng
Wong, KK (reprinandrew_kung@
STANDARDIZED
NA
Prockop D.J., NA
NA
NA
NATURE PUBL Jacobs, KB; YeChanock, SJ (rep chanocks@mai
CHRONIC LYMP
CELL PRESS Bayne, LJ; BeaVonderheide, RH rhv@exchangeSUPPRESSOR-C
NATURE PUBL Tsurusaki, Y; Matsumoto, N (r nmiyake@yoko
GENE; SCHWA
CELL PRESS Gao, XL; Wang,
Liu, ZR (reprint zliu8@gsu.ed SIGNAL TRANS
AMER SOC CL Wells, SA; RobWells, SA (repri wellss@mail.nENDOCRINE NE
AMER SOC CL Bergethon, K; Iafrate, AJ (repr aiafrate@partANAPLASTIC L
CELL PRESS Van der Veldt,Van der Veldt, A aam.vandervePOSITRON-EMI
ELSEVIER SCI van der Graaf,van der Graaf, Ww.vandergraa EUROPEAN-ORG
NA
Patel A.G., De NA
NA
NA
NA
Tobin D.M., Roc
NA
NA
NA
AMER SOC CLISaslow, D; SolSaslow, D (repri debbie.saslowHUMAN-PAPILL
ELSEVIER SCI Paz-Ares, L; d Paz-Ares, L (repr luis.pazares. III TRIAL; 1
NATURE PUBL Barbieri, CE; Rubin, MA (repri rubinma@med.c
ETS GENE FUS
ELSEVIER SCI Rijkaart, DC; Meijer, CJLM (re cjlm.meijer@vRISK HUMAN-P
AMER SOC NUZittermann, A;Gandini, S (repri sara.gandini@iSERUM 25-HYD
AMER ASSOC Adrain, C; Zet Freeman, M (reprMF1@mrc-lmb.
FACTOR-ALPHA
AMER COLL PHMoyer, VA
Moyer, VA (repri NA
ANDROGEN DEP
NA
Ahrens S., ZelNA
NA
NA
ELSEVIER SCI Machalek, DA;Grulich, AE (rep agrulich@kirbSQUAMOUS INT
NA
Dallmann R., VNA
NA
NA
CELL PRESS Moldovan, GL;D'Andrea, AD (realan_dandrea@
STRAND-BREAK
NA
Zhou J., Liu J. NA
NA
NA
NA
Taube J.M., AnNA
NA
NA
NA
Wang Z., JiangNA
NA
NA
AMER SOC CL Win, AK; YoungJenkins, MA (rep m.jenkins@unLYNCH-SYNDRO
NA
Cardoso F., CoNA
NA
NA
NA
Fauvet B., MbeNA
NA
NA
COLD SPRING Zhao, B; Li, L Guan, KL (reprin kuguan@ucsdYES-ASSOCIAT
AMER SOC CL Younes, A; GopYounes, A (repri ayounes@mdaSTEM-CELL TR
AMER SOC CL Hunger, SP; L Hunger, SP (repr stephen.hunge
STEM-CELL TR
COLD SPRING Fernandez, AF;Esteller, M (rep mesteller@idib
EMBRYONIC ST
NA
Shi H., Morice NA
NA
NA
AMER ASSOC Pritchard, CC; Tewari, M (repri mtewari@fhcrLUNG-CANCER;
NA
Iorio M.V., Cr NA
NA
NA
ELSEVIER SCI Fauser, BCJM; Fauser, BCJM (re b.c.fauser@um
QUALITY-OF-L
AMER MEDICABolton, KL; ChPharoah, PDP (repaul.pharoah@
BREAST-CANCE

ELSEVIER SCI Margolin, K; E Margolin, K (reprkmargoli@seatPROGNOSTIC-F

NA
Newton K., DixNA
NA
NA
NATURE PUBL Bryant, RJ; Pa Hamdy, FC (reprin
freddie.hamd DIAGNOSIS
AMER ASSOC Corcoran, RB; Engelman, JA (rejengelman@pa
WILD-TYPE BR
AMER SOC HEKochenderfer,Kochenderfer, JNkochendj@mail
CHRONIC LYMP
AMER MEDICAJoensuu, H; ErJoensuu, H (repr heikki.joensu KIT MUTATION
NA
Sun L., Wang H
NA
NA
NA
ELSEVIER SCI Elias-Miro, J; Isidori, G (reprin gino.isidori@lnSTANDARD-MOD
ELSEVIER SCI Stoop, EM; de Dekker, E (repri e.dekker@amcCOMPUTED TO
NATURE PUBL Sasaki, M; KnoMak, TW (reprinttmak@uhnres.ACUTE MYELOI
WILEY-BLACK Estey, EHEsteEstey, EH (repri eestey@u.wasHEMATOPOIETI
NATURE PUBL Benedito, R; RAdams, RH (reprirui.benedito TIP CELL-FOR
AMER SOC CL von Minckwitz,von Minckwitz, Ggunter.vonmi SURGICAL ADJ
CELL PRESS Cheng, LZ; Han
Cheng, LZ (repri lcheng@welch.
COPY NUMBER
NA
Kudo M., MeltoNA
NA
NA
PUBLIC LIBRA Skalsky, RL; CSkalsky, RL (rep bryan.cullen EPSTEIN-BARR
AMER SOC CL Lee, J; Lim, D Kang, WK (reprinwkkang@skkuADJUVANT CHE
AMER ASSOC Neckers, L; W Neckers, L (repr neckersl@mailHEAT-SHOCK-P
AMER SOC CL Sauer, R; Lier Rodel, C (reprin claus.roedel@TME TRIAL; R
SPRINGER
Kool, M; KorshKool, M (reprint m.kool@dkfz. BETA-CATENIN
NA
Guibert S., Fo NA
NA
NA
NA
Saffarzadeh M.NA
NA
NA
AMER SOC CL Oberholzer, PAGarraway, LA (relevi_garrawayNONMELANOMA
AMER COLL PHMoyer, VA
Moyer, VA (reprinNA
HUMAN-PAPILL
ELSEVIER SCI Pirker, R; Per Pirker, R (repri robert.pirker GROWTH-FACTO
AMER CHEMICZhang, F; BrauZhang, F (reprin zhang_fan@fuDRUG-DELIVER
NATL ACAD S Szerlip, NJ; P Brennan, CW (repcbrennan@msk
PHASE-II TRI
AMER SOC CL Aghajanian, C;Aghajanian, C (r aghajanc@msk
ONCOLOGY-GR
AMER ASSOC Greger, JG; EaGilmer, TM (repr tona.m.gilme FACIO-CUTANE
NA
Silverberg M.J.NA
NA
NA
ELSEVIER SCI Xing, HY; Bu, Bu, WB (reprint wbbu@mail.sic
RAY COMPUTE
NA
Friedlander M.NA
NA
NA
AMER ASSOC Sennino, B; Is McDonald, DM (re
donald.mcdonGROWTH-FACTO
WILEY-V C H Qin, W; Ding, D
Qin, W (reprint cheliub@nus. SEMICONDUCTO
NA
Deshpande V.,NA
NA
NA
NA
Liu S., Cipria NA
NA
NA
NA
Halliwell B.
NA
NA
NA
NA
Marin D., Ibra NA
NA
NA
AMER ASSOC Wilmott, JS; L Wilmott, JS (repr james.wilmot ANTIGEN-EXP
ELSEVIER SCI Yang, JCH; ShiMiller, VA (repr vmiller@foun ADVANCED SOL
AMER SOC CLIDrobits, B; H Sibilia, M (repr maria.sibilia PLASMACYTOID
NA
Ahlquist D.A., NA
NA
NA
NA
Saman S., KimNA
NA
NA

ELSEVIER SCI Trinh, QD; SamTrinh, QD (reprin trinh.qd@gmaRE COMPARATI

NA
Gossec L., Smo
NA
NA
NA
WILEY-V C H Zhang, ZJ; Wan
Wu, XC (reprint wuxc@nanoctrNEAR-INFRARE
AMER SOC CL Sperduto, PW;Sperduto, PW (repsperduto@mPARTITIONING
CELL PRESS Pylayeva-Gupta
Bar-Sagi, D (rep dafna.bar-sa COLONY-STIMU
AMER SOC CL Amir, E; Mille Amir, E (reprint eitan.amir@uhESTROGEN-REC
W B SAUNDERS
Lieberman, DA;
Lieberman, DA (rlieberma@ohsCOMPUTED TOM
AMER SOC HEKeats, JJ; Che Bergsagel, PL (r bergsagel.lei ACUTE LYMPHO
LIPPINCOTT WSchnitzbauer, Schlitt, HJ (rep hans.schlitt@kCONTRAST-ENH
ELSEVIER SCI Bang, YJ; Kim,Bang, YJ (reprint bangyj@snu.aPLUS OXALIPL
NA
Fassnacht M., NA
NA
NA
NA
Rivollier A., HeNA
NA
NA
WILEY-V C H Yang, K; Hu, LLLiu, Z (reprint
zliu@suda.eduGOLD NANOCAG
AMER SOC CL Han, JY; Park, Lee, JS (reprint jslee@ncc.re.kGROWTH-FACTO
NATL ACAD S Chakrabarty, AArteaga, CL (rep carlos.arteag BREAST-CANCE
GEORG THIEMPiscaglia, F; Piscaglia, F (rep fabio.piscagli POWER DOPPLE
CELL PRESS Gordon, SM; Ch
Reiner, SL (repr sreiner@colu MOUSE NK CEL
NA
Sen N., Paul BNA
NA
NA
NA
Yang X., Liu X.NA
NA
NA
AMER SOC CL Su, KY; Chen, H
Yu, SL (reprint a slyu@ntu.edu ACQUIRED-RES
ELSEVIER SCI Fizazi, K; Sch Fizazi, K (reprint karim.fizazi@ig
MITOXANTRONE
ROYAL SOC C Davey, NE; Van
Davey, NE (repri davey@embl. INTRINSICALL
NA
Gass M.L.S., MNA
NA
NA
NATURE PUBL Pena-LlopiS, SBrugarolas, J (re james.brugar TUMOR-SUPPRE
PERGAMON-ELAlmasieh, M; W
Di Polo, A (repri adriana.di.po OPEN-ANGLE G
AMER SOC CL Bachelot, T; BBachelot, T (rep thomas.bachelADVANCED SOL
B M J PUBLIS Yamauchi, M; M
Ogino, S (reprin shuji_ogino@dISLAND METHY
WILEY-V C H Chen, M; Wu, Zheng, NF (repri nfzheng@xmu.
HIGH-INDEX F
NATL ACAD S Kim, J; Coffey Matzuk, MM (reprmmatzuk@bcm
SURFACE EPIT
OXFORD UNIVRegan, MM; Ley
Regan, MM (reprimregan@jimmy
HOT FLASHES;
PERGAMON-ELRusso, M; Spag
Russo, GL (repringlrusso@isa.cn
CELL-CYCLE P
NA
Thoreen C.C., NA
NA
NA
NA
Tejpar S., Cel NA
NA
NA
AMER ASSOC Prieto, PA; Y Phan, GQ (reprinGiao.Phan@niLYMPHOCYTE-A
ELSEVIER SCI Hambrock, T; Hambrock, T (rept.hambrock@rRADICAL PROS
AMER SOC HERossi, D; Rasi Rossi, D (reprin rossidav@medHAZARDS REGR
NATURE PUBL Fujimoto, A; T Nakagawa, H (retashibat@ncc.B VIRUS-DNA;
NA
Ott J.J., Steve NA
NA
NA
AMER DIABET Currie, CJ; Po Currie, CJ (repri currie@cardiffMETAANALYSIS
KARGER
Pavel, M; BaudPavel, M (reprin marianne.pave
PANCREATIC
AMER ASSOC Clegg, NJ; WonSawyers, CL (repsawyersc@msk
ANDROGEN-REC
AMER ASSOC Maira, SM; PecMaira, SM (repri sauveur-micheVIVO ANTITUM
WILEY-BLACK Jones, S; Li, Vogelstein, B (r bertvog@gmaiHISTONE-MODI

NA
Hayden M.S., NA
NA
NA
OXFORD UNIVZhu, ZZ; Hou, Baccarelli,
L
A (re andrea.baccarSQUAMOUS-CEL
AMER MEDICATan, HJ; NortonMiller, DC (repr dcmiller@umi RENAL-CELL C
NATURE PUBL Koivunen, P; LKaelin, WG (repr william_kaeli HYPOXIA-INDU
NATL ACAD S Jaber, N; Dou,Zhang, JH (repri zhanja@uab.ePHOSPHATIDYL
NATURE PUBL Lai, SW; Chen,Sung, FC (reprin fcsung@mail. HEPATITIS-BNA
Yang Y., Shao NA
NA
NA
AMER SOC HEMakishima, H;Maciejewski, JP maciejj@ccf.o CHRONIC MYEL
NA
Liaw Y.-F., Ka NA
NA
NA
AMER SOC CL Kelly, WK; HalKelly, WK (repri wm.kevin.kell ENDOTHELIAL
ROYAL SOC C Noffke, AL; HaSadler, PJ (repr P.J.Sadler@WaRUTHENIUM(II
ELSEVIER SCI Decramer, M; D
J ecramer, M (repmarc.decrameINHALED ANTI
NA
Yang Y., Cui J. NA
NA
NA
AMER SOC CL Roberts, AW; Roberts, AW (reprroberts@wehi BH3 MIMETIC
AMER SOC CL Ishida, T; Joh Ishida, T (repri itakashi@med.MOLECULAR TA
ELSEVIER SCI Manson, JE; BaManson, JE (rep jmanson@rics.CORONARY-HEA
AMER CHEMICPan, LM; He, QJ
Shi, JL (reprint jlshi@sunm.shPORE COMPLEX
CELL PRESS Bonfils, G; Ja De Virgilio, C (r claudio.devirgAMINO-ACID;
AMER SOC HETefferi, A
Tefferi, A (repr tefferi.ayal
INTERNATIONA
AMER SOC HEPonader, S; ChBurger, JA (repr jaburger@mdaB-CELLS; ANT
ELSEVIER SCI Ge, L; Yan, JX; Yu, JH (reprint
ujn.yujh@gmaMICROFLUIDIC
NATURE PUBL Riley, KJ; Rabi Steitz, JA (repr joan.steitz@y EPSTEIN-BARR
NA
Inoki K., Kim J NA
NA
NA
AMER SOC CL Pro, B; AdvaniPro, B (reprint Barbara.pro@fNON-HODGKINS
ELSEVIER SCI Cheng, L; YangShao, MW (reprinmwshao@suda.
DRUG-DELIVE
AMER SOC HEde Rooij, MFM;Spaargaren, M (rmarcel.spaar TYROSINE KIN
NA
Hou J.-M., KrebNA
NA
NA
NA
Lim K., Lu T.- NA
NA
NA
WILEY-BLACK Yip, S; Butter Cairncross, JG ( jgcairnx@uca ANAPLASTIC O
AMER SOC CL Bendell, JC; R Baselga, J (repr jbaselga@partPOSITRON-EMI
SPRINGER
Neumann, A; We
Weill, A (reprint alain.weill@cnURINARY-BLAD
ELSEVIER SCI Miller, VA; Hi Yang, JCH (reprinchihyang@ntuGROWTH-FACTO
WILEY-BLACK Chen, X; Hu, ZZhang, CY (repri jfzhang@nju.eINTERNATIONA
ELSEVIER SCI de Lope, CR; TrBruix, J (reprint JBRUIX@clinicDONOR LIVERELSEVIER SCI Yang, K; Wan, Liu, Z (reprint
zliu@suda.eduOPTICAL-PROP
ELSEVIER SCI Center, MM; Jem
Jemal, A (reprin ahmedin.jemaUNITED-STATE
NA
Cedar H., Ber NA
NA
NA
WILEY-BLACK Tian, G; Gu, ZJGu, ZJ (reprint zjgu@ihep.ac.PHOTODYNAMI
NA
Haibe-Kains B.NA
NA
NA
NA
Friberg L., RosNA
NA
NA
ELSEVIER SCI Wang, YC; Lv, Ma, YM (reprint mym@jlu.edu.PARTICLE SWA
AMER SOC NEWang, B; Komer
Kantharidis, P (r Phillip.Kantha EPITHELIAL-M
ELSEVIER SCI Li, Y; Liu, Y; Chen, CY (reprin rsliu@ntu.ed TITANIUM-DIO

ROCKEFELLERMeredith, MM;Nussenzweig, MCnussen@rockef

IN-VIVO DEPL
ELSEVIER SCI Peng, C; Zheng
Shi, XY (reprint guixiangzhan X-RAY ATTENU
AMER SOC CL Schanz, J; Tuc Haase, D (reprin haase.onkologHEALTH-ORGAN
RADIOLOGICABerg, WA; Cosg
Berg, WA (reprin wendieberg@gTERM FOLLOWNA
Kumar S.K., LeNA
NA
NA
NA
Challand C., SNA
NA
NA
AMER CHEMICShimron, S; Wa
Willner, I (repri willnea@vms.hu
SURFACE-PLAS
WILEY-BLACK Heegaard, NHH
Harris, CC (repr Curtis_Harris PREDICTS SUR
NA
Togashi Y., So NA
NA
NA
W B SAUNDERS
Canto, MI; HruCanto, MI (repri mcanto@jhmiPAPILLARY MU
NATURE PUBL Xing, F; Persa Solit, DB (repri solitd@mskcc.RETINOBLASTO
NA
Papadopoulos NA
N
NA
NA
SOC NUCLEARDrzezga, A; SoDrzezga, A (repr a.drzezga@lrzCONTRAST-ENH
NA
Bennett C., VaNA
NA
NA
ELSEVIER SCI Untch, M; Loibvon Minckwitz, Ggunter.vonmi METASTATIC B
AMER ASSOC C
Liu, R; Chen, Zhang, CY (repri kzen@nju.eduCIRCULATING
AMER SOC CL Niikura, N; Li Ueno, NT (reprin nueno@mdand
DISTANT META
NA
Zen K., ZhangNA
NA
NA
ELSEVIER SCI Camidge, DR; Camidge,
B
DR (re ross.camidge EML4-ALK FUS
ELSEVIER SCI Falchook, GS; Falchook, GS (re gfalchoo@mdaSOMATIC MUTA
AMER SOC CL Janku, F; WhelKurzrock, R (rep rkurzroc@mdaCELL LUNG-CA
B M J PUBLIS Zheng, F; Liao,Xie, D (reprint xied@mail.sysEPITHELIAL-M
AMER ASSOC Bao, B; Ali, S Sarkar, FH (repr fsarkar@med.EPITHELIAL-M
ELSEVIER SCI Loeb, S; van Loeb, S (reprint stacyloeb@gmCANCER; PROP
AMER ASSOC Rekhtman, N; Rekhtman,
P
N (reprekhtman@msGROWTH-FACTO
OXFORD UNIVRae, JM; Drury,Rae, JM (reprint jimmyrae@umADJUVANT TRE
AMER ASSOC Kirkwood, JM; Kirkwood, JM (re KirkwoodJM@ SIGNAL-REGUL
NA
Ando N., Kato NA
NA
NA
B M J PUBLIS Kong, KL; Kwon
Guan, XY (reprin xyguan@hkucc
CANCER; GEN
ELSEVIER SCI Kantarjian, H; Kantarjian, H (r hkantarj@mdaACUTE LYMPHO
AMER SOC CL Karlan, BY; OzKarlan, BY (repr Beth.Karlan@cGYNECOLOGICNA
Sheng B., Wang
NA
NA
NA
ELSEVIER IRE Liu, HS; Zhu, Xiao, HS (reprin huasheng_xia CIRCULATING
AMER SOC CL Tveit, KM; GurTveit, KM (repri kjell.magne.t GROWTH-FACTO
NA
Blagosklonny NA
NA
NA
AMER SOC CL Chawla, SP; StDemetri, GD (repgdemetri@parGASTROINTEST
WILEY-BLACK Edeline, J; BouEdeline, J (repr j.edeline@renn
Y-90 RADIOEM
SPRINGER
Capper, D; Bervon Deimling, A andreas.vondeCLINICAL CHA
NA
Tan M.-H., Mest
NA
NA
NA
ELSEVIER SCI van den Eertwe
Gerritsen, WR (r winald.gerrit LYMPHOCYTE-A
AMER CHEMICDai, YL; Ma, P Cheng, ZY (repri zycheng@ciac.j
NEAR-INFRARE
SPRINGER TO Watanabe, T; IWatanabe, T (reptoshwatanabeTOTAL MESORE
NA
Joensuu H., Veh
NA
NA
NA

ELSEVIER SCI Rosso, R; GliksViskin, S (reprin samiviskin@g IDIOPATHIC V

WILEY-BLACK Jakob, JA; Bas Davies, MA (reprmdavies@mdaAMERICAN JO
AMER SOC CL Van Cutsem, E;
Shah, MA (reprinmas9313@med.
PACLITAXEL P
LIPPINCOTT WMcLeer-Florin,McLeer-Florin, A aflorin@chu-gEML4-ALK FUS
NA
Guo X., HuangNA
NA
NA
NATURE PUBL Vanhaesebroec
Vanhaesebroeck,bart.vanh@qmPROTEIN-KINA
ELSEVIER SCI Gill, IS; Pati Gill, IS (reprint gillindy@gmaiKIDNEY; COH
AMER SOC CLIHsu, SH; Wang,
Ghoshal, K (repr Joshua.MendeHEPATOCELLUL
AMER SOC HETiacci, E; Schi Falini, B (reprin etiacci@solidoACUTE LYMPHO
NA
Luo X., Lee Kr NA
NA
NA
NA
Extermann M.,NA
B
NA
NA
WILEY-BLACK Tang, SC; LagaSchinkel, AH (re a.schinkel@nkiRENAL-CELL C
NA
Hewitt M.J., M NA
NA
NA
NA
Kumar M., Kuma
NA
NA
NA
NA
Witkiewicz A.KNA
NA
NA
ELSEVIER SCI Madan, RA; Moh
Gulley, JL (repr gulleyj@mail. COLONY-STIMU
AMER SOC CL Sansone, P; B Bromberg, J (rep bromberj@msk
GROWTH-FACTO
GEORG THIEMDinis-Ribeiro, Dinis-Ribeiro, M mdinisribeiro GASTRIC INTE
AMER SOC CL Kaye, SB; LubiKaye, SB (reprin stan.kaye@rmHOMOLOGY-DIR
ALPHAMED PRBorger, DR; TaIafrate, AJ (repr aiafrate@partACUTE MYELOI
ROYAL SOC C Guo, ZQ; Nam,Park, S (reprint nanopark@ewh
LARGE EMISSI
NA
Papapoulos S.,NA
NA
NA
NA
Tefferi A.
NA
NA
NA
AMER SCIENTIWang, F; Ma, CHe, NY (reprint aNA
SINGLE-NUCLE
KOREAN CANCJung, KW; Park,
Park, S (reprint shpark@ncc.reTHYROID-CANC
AMER ASSOC Fanale, MA; FoFanale, MA (repr mfanale@mdan
STEM-CELL TR
ELSEVIER SCI Dittrich, R; L Dittrich, R (rep ralf.dittrich@ FERTILITY PR
NA
Roy M., Chakra
NA
NA
NA
NA
Sheppard K.E.,NA
NA
NA
AMER COLL PHKalager, M; A Kalager, M (repr mkalager@hspCARCINOMA IN

Funding
Agency and
Grant
Funding
Abstract
Number
Text
Year
The canonical Istituto Tosc We thank Pando
Accumulating LUNGevity
e
FouWe thank the m
Large intervenNational Inst We thank Y. Ch
Cancer-associa
Leukemia andM.E.F. is fund
Glioblastoma iAssociazione IWe thank L. Na
The systematic
NA
NA
We describe aInstitute of
The Institute
Activating mutNA
NA
Despite the prNetherlands OThe authors ar
The inference National Inst This work was
Activating B- NA
NA
Oncogenic muta
NIH [CA134502]
We thank membe
c-Myc (Myc) isNIH/NIGMS [K We thank Jenni
Tumours with m
NA
NA
Poor penetratiNational CancWe thank D. H
The somatic mu
Howard Hughes
We thank Tulli
TET2 is a clo NIH [R01 AI44This work was
Each year, theNA
NA
High-throughpu
NA
NA
Estimates of tNA
NA
BACKGROUNDMedarex;
An
Bris Supported by M
BACKGROUNDAmerican
Pat
SociSupported by a
Recent structuNIH [R01-AR0 This work was
A powerful way
National Inst This work was
BACKGROUNDPlexxikon;
Th
Ro Supported by
All cancers c Wellcome TrusThe authors ac
The Cancer Gen
US DepartmenWe thank the
BACKGROUNDPfizer;
Onc Massa Supported by
Next-generatioNational Hum We thank our
Cancer is driv Wellcome TrusThis work was
Massively par Washington Un
We thank the
Although recen
Wellcome TrusE. E. E. thank
Background: Si
Dendreon
Supported by
Background The
National Insti Funding Nation
Chemokine rece
Protein Struc This work was
We describe thUS National We thank the e
Background: No
Japan Society Supported by g

Volume
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010

Issue
465
141
464
18
468
466
140
464
12
463
NA
468
143
NA
328
17
468
NA
NA
127
363
363
141
463
363
463
17
363
20
463
464
11
363
375
330
7
362

7301
1
7291
6
7325
7308
2
7287
5
7279
NA
7326
2
NA
5981
3
7325
NA
NA
12
8
8
7
7283
9
7278
1
18
9
7278
7291
6
5
9725
6007
6
25

NA
NA
NA
Background: ANational Insti Supported by t
Up-to-date staCanceropole This work was
B-RAF is the mNIH; Cancer Co
We thank L. An
Background TrF Hoffmann-LaY-JB and JR a
DNA methylatio
NA
NA
Recruitment ofNational Inst We thank Garre
BACKGROUNDNovartis
Fin
Phar Supported by N
Cell adhesionsNA
NA
Background Pat
several pharmThis study was
BACKGROUNDNational
Oro
CancSupported by
Background Low
UK Medical ReThis collabora
The Internati NA
NA
Annotation of MSKCC ProstatThis work is d
Cells operate NA
NA
Sponges are an
Australian Re This study was
High-throughpu
Foundation forWe thank the r
Metastasis, thNational Inst This work was
The cancer gen
Wellcome TrusWe would like
When embryonic
NA
NA
Background: Th
National Cent Supported by g
We have profilNIH/NCI [U24 This work was
Malaria is a d NA
NA
Chronic fatiguNational Inst We thank Richa
Background: Th
NA
NA
Lung cancer isNA
NA
We demonstrate
NA
NA
Recently, more
NA
NA
Clear cell ren Wellcome TrusWe would like
Eukaryotic celNA
NA
In the domain CNRS; UniversWe acknowledge
Parkinson's di NA
NA
In addition t National Insti Funding for op
Monozygotic oNA
NA
Purpose Pazopa
GlaxoSmithKlin
Supported by G
Background Ass
British Heart The ERFC Coord
Copy number NA
va
NA
Influenza A vi NA
NA
DNA methylatiAlexander vonWe thank A. Cr
Although mamma
NA
NA
Background Col
Medical ReseaThis trial is
Epithelial-to- NA
NA
One of the mos
Gordon and BeWe thank the G

2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010

141
363
46
467
376
NA
141
362
NA
11
363
376
464
18
NA
466
11
467
463
NA
363
17
NA
107
NA
465
NA
NA
463
3
9
NA
38
NA
28
375
NA
NA
28
NA
375
NA
465

2
23
4
7315
9742
NA
3
5
NA
2
1
9753
7291
1
NA
7307
10
7319
7283
NA
25
5
NA
36
NA
7297
NA
NA
7279
104
2
NA
NA
NA
6
9709
NA
NA
10
NA
9726
NA
7298

It is unclear NA
NA
Background Ola
AstraZeneca AT has receive
Chromatin play
US National I This work was
Innate immune
NA
NA
Pancreatic canWellcome TrusThis work was
Genome-scaleNA
s
NA
Focal adhesionNIH [CA14386The authors a
Although genoNational Hear We thank the
Background: In
NHS Foundation
AC, DC and SW
Autophagy, a NA
NA
Ovarian clear Dr. Miriam an We thank Y. He
Somatic cells NA
NA
Introduction: National CancNational Canc
Modifications NA
NA
Initially thou Multiple Scler This work was
Background: Pa
Vertex PharmaSupported by
Background: Ma
Heart and Str We acknowledg
Alzheimer's diNA
NA
Background Cab
Sanofi-AventisSanofi-Aventis
Follicular ly National CancThis study was
Glioblastoma (New York StatWe would like
Solid tumors, NA
NA
MicroRNAs (miR
Hope Funds foWe thank X. Li
Melanomas are
NIH [P50 CA 0We thank J. Ha
We report a seNational Cance
This work was
Defective DNANational Insti We would like
Epigenetic proCanadian Inst We are gratefu
Parkinson'??sNA
NA
The question oAmerican Canc
We thank J. B
Background Pre
ImClone SysteThis study wa
Aberrant activTuberous Scle We thank Drs.
BRAF is an attNational CancWe thank T. N
Immune homeost
NA
NA
Because of theEuropean Comm
We would like
Polycomb prote
Natural Scien S. Orkin gener
Abnormalities Leukemia Rese
This work was
Background FoMerck Serono;DP has receiv
Although speciCariparo Found
This work is s
This brief per NA
NA
Proliferating NA
NA
Intracellular NA
NA
Background MDV
Medivation; N Support for t
EpidemiologicNatural Scien We thank Davi

2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010

NA
376
42
NA
467
NA
12
42
5
22
330
NA
12
NA
20
362
67
NA
376
42
468
NA
467
141
42
141
468
NA
466
11
39
18
NA
7
40
42
11
141
70
NA
NA
375
140

NA
9737
4
NA
7319
NA
6
4
1
2
6001
NA
5
NA
10
14
5
NA
9747
2
7325
NA
7311
4
7
2
7327
NA
7302
1
2
6
NA
4
6
8
8
7
2
NA
NA
9724
2

MicroRNAs (miR
Life Sciences We thank Johan
Background: Th
University Co Supported by
Expression of National Cance
We wish to ack
Epidermal grow
NA
NA
Purpose To dev
Hironobu SasaResearch Fund
BACKGROUNDBritish
Ov
Colum Supported by
Fully human mNA
NA
In the domain CNRS; UniversWe acknowledge
Sirtuins catal NA
NA
Purpose Progra
Melanoma Rese
Supported in p
Context MastePublic Health This study wa
Background Vit
Novartis; Roc TJW has serve
MicroRNAs (miR
Department ofM.T. acknowle
Gene expressio
National Inst The MAQC-II pr
Currently, the NA
NA
MicroRNAs (miR
Life Sciences We thank C. L.
Cocaine-induce
NA
NA
Breast cancersBreakthrough We thank the B
Alzheimer's diNA
NA
Rare circulati Prostate Cance
We express our
BACKGROUNDCancer
Ac
RegistSupported by
Background: We
GlaxoSmithKliSupported by G
Background Ola
AstraZeneca MWA has receiv
The different NA
NA
We describe aNA
NA
Impaired selecJapan ScienceWe thank T. Ko
In development
NA
NA
Dying cells re Ligue NationalG.K. and L.Z.
Mesenchymal Dutch
ce
Cancer We
S thank E. Sc
MicroRNAs (miR
National Natu We would like
The ovarian hoAustralian Re We are gratefu
We investigat Howard Hughes
This work was
Objective: OurNA
NA
Clinical managNA
NA
Ovarian cancer[DOD-OCRP 0Supported by
Cysteine is th NA
NA
Purpose PrecliGlaxoSmithKliSupported by
The neural steState of Calif We thank M. Ba
The epithelial Broad Institu We thank the m
The existence Ministry of Ed This work was
Reproductive h
Canadian BreaThis work was
Background: My
Novartis; Bri Drs. Bradley,
As the result Leukemia andWe thank Dr. M

2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010

12
362
38
NA
28
363
9
9
NA
28
304
376
50
28
28
28
NA
7
NA
107
363
362
376
104
NA
12
NA
140
464
39
465
18
95
NA
34
NA
28
17
107
285
465
363
107

3
14
5
NA
16
16
10
2
NA
19
9
9736
4
8
11
4
NA
3
NA
43
13
13
9737
NA
NA
3
NA
6
7290
1
7299
5
6
NA
3
NA
7
4
35
23
7299
12
5

Graphene is a NA
NA
In an effort t NA
NA
Background Hig
Boehringer In PMR and BN hav
EpidemiologicAmylin Pharmac
The American C
Background FirF Hoffmann-La- F Hoffmann-L
CD4+ T helperNA
NA
The ability to NA
NA
Cancer-associNational Cance
We thank Z. We
From the earliDepartment ofAcknowledgeme
Background Kno
MSD; Merck; SYLQ has recei
Purpose This rAmgen; DaiichSupported by
Malignant glioNational Inst Supported by N
Germ-line muta
Dutch Cancer We wish to tha
Background: Ge
Division of C Supported in
Transcription NA
NA
Brain metastas
German Cancer
W. and J.H. re
Personalized cItalian Associ Supported by g
The target of NA
NA
The aim of thiNA
NA
Tumor cells di National Insti We thank the m
Background Aft
University Co Funding Univer
MET amplificatNational Inst This study is
A transient in National Insti We thank Phili
Two abundant American Canc
We thank Kris
The study of gKWF [PF-HUBRN.B. and H.C.
Objectives: ToDepartment ofDr Weinstock
Polycomb group
NA
NA
Damage to mito
NA
NA
Animal experim
NA
NA
Background: De
UK Medical ReThis work was
Sequence polym
National Hear We thank G. O
We develop fas
National Scie Friedman was
EpidemiologicAmylin; BayerDr. Giovannucc
The ataxia-telNA
NA
The His274??NA
NA
Luminal cells Ruth L. Kirsc We thank B. An
In myelodysplDutch OrganizWe thank R. Wo
The four recepDepartment ofWe acknowledge
BACKGROUNDPolish
Alt Ministr Supported by t
Endogenous reNA
NA
The stromal mi
NA
NA
We hypothesize
National Inst The authors ar
Blood vessel nFundacao paraThis study was

2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010

NA
463
376
33
11
NA
NA
17
15
11
28
60
17
362
NA
16
28
NA
37
140
376
17
39
141
6
146
NA
NA
102
7
464
33
60
NA
NA
329
42
464
362
NA
NA
17
116

NA
7280
9754
7
6
NA
NA
2
2
11
35
3
6
11
NA
1
7
NA
1
1
9735
1
4
7
1
3
NA
NA
11
NA
7287
1
4
NA
NA
5991
8
7291
19
NA
NA
1
5

Otto Warburg's
LUNGevity FouWe grateful to
NA
NA
NA
Purpose Panit Amgen, Thousa
Supported by
While the longDanish ResearThanks to the
Purpose The efNA
NA
Background: HSeattle Genet Supported by
Background Hum
European Union
European Union
Breast cancer Wellcome TrusThis work was
The connection
NA
NA
Cellular senesNIH; AndersonWe are gratefu
Chronic lymphNA
NA
Although biome
Soochow Unive
This work was
NA
Siteman Cance
The ACSM Canc
The sirtuin ge National Ins This research
Rationale: MicDeutsche ForsThis study was
Recent studiesMinistry of Ed This study was
Autophagy is tNA
NA
Monocytes areNA
NA
High-resolutioHoward Hughes
We thank Jess
Background: Pr
National Inst Supported by
Context and ob
NA
NA
Mutations in Canadian Inst Tak Mak is su
Purpose Therap
National Cance
Supported by
Antibodies andNA
NA
Chromosomal NIH
re [P50CA695
We thank R. Me
Various types National Insti We thank Drs.
Purpose The risanofi-aventi Supported by a
[No abstract aNA
NA
The mammalian
Canadian Canc
Rapamycin was
MicroRNAs and
National CancThis work was
NMDA receptorNA
NA
In order to be National Insti SHDPL thanks t
Background: Ne
Novartis
Supported by
MicroRNA (miRScience and TGrant sponsor
Background The
US National C The SWOG-8814
Background: Vo
NA
NA
Background Neo
Merck-Serono;We thank all p
Chronic myeloiNA
NA
Background Ang
Pfizer; Astra IS received an
The three-dime
NA
NA
Tumour-necrosi
NA
NA
Context Patie Merck Serono;Dr Siena repor
Chronic diseasNA
NA

2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010

107
4
28
143
28
363
11
42
138
464
17
10
42
17
107
127
NA
NA
107
363
58
207
28
10
17
107
28
NA
328
140
NA
4
363
127
11
NA
11
NA
11
NA
NA
304
29

19
1
31
1
20
19
3
6
6
7287
1
9
7
1
5
4
NA
NA
9
14
3
2
7
5
5
28
10
NA
5982
5
NA
1
19
1
1
NA
1
NA
7
NA
NA
16
2

When oxygen Avon

is
FoundatiWe thank D. Bl
Polycomb group
Eve Appeal; UWe thank all t
The mechanisms
NIH-NCI [RO1 We are gratefu
The formationNA
NA
Muscle wasting
NA
NA
NA
Fate Therapeut
S.D. is suppor
BACKGROUND:
Battelle
Mi
Biol K. Wang, rese
By properly coJulius Brown We thank the J
MedulloblastoNational Inst R.J.G. holds t
Antibodies to NA
NA
The transcriptWellcome TrusWe would like
Purpose MutatiPfizer
Supported by P
Background Ima
French MinistrFrench Ministr
To elucidate t National Natu The authors ar
Bone marrow en
Starr Stem CeJ.M.B. is supp
Background Pro
GlaxoSmithKliHL holds pate
DNA double-str
NA
NA
BACKGROUNDDeutsche
Des
ForsSupported by g
A simple synthNational Natu This work was
Although recurUS National I We thank R. B.
Highly versati Korean Minist T.H. thanks th
The tumor supp
Science Founda
We thank D. Go
Despite the hiNIH [R01 CA12We thank G. Be
Transcatheter BiocompatibleThe study was
Alternative spNA
NA
The EML4 (echi
Ministry of HeSupported in p
Gold nanopartiNA
NA
Rationale: MicBritish Heart This work was
Background IpiBristol-Myers We thank Amit
Smoking is a lOxford UniverGlaxoSmithKlin
Purpose Recent
National Natu Supported in
BACKGROUNDCentocor
Bi
ReseWe thank C. Ar
RIG-I detects NIH [RO1-AI09We thank Fran
Members of the
NA
NA
Purpose CisplaNational CancSupported by
UnderstandingState of Texa The authors w
Molecular medi
NA
NA
Although it i NA
NA
Neuroendocrine
NA
NA
Chemokines, sm
NA
NA
DNA cytosine-National Insti Funding for op
BACKGROUND:
Novartis
A
OncoFinancial supp
?-Synuclein iNA
NA

2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010

463
20
32
NA
NA
7
56
132
468
NA
6
28
11
31
6
11
NA
362
6
16
132
11
120
33
NA
363
NA
107
11
42
28
362
141
NA
28
141
NA
NA
39
16
38
116
NA

7279
4
1
NA
NA
6
11
5
7327
NA
4
3
11
13
3
8
NA
10
4
7
2
2
3
1
NA
18
NA
6
2
5
10
2
2
NA
7
3
NA
NA
6
11
11
18
NA

Purpose We ass
NA
NA
Context In theAstraZeneca; Dr Chlebowski
Background: We
National Inst This work was
Recent evidenc
NA
NA
Background The
NA
NA
Context PatienVarian MedicaFinancial Dis
Mesoporous silNA
NA
The aim of theNA
NA
Purpose Prior National Cance
Supported by
The epithelial National Scie We would like
This review ai NA
NA
Objective: To NA
NA
Fragile X syndNA
NA
Tumors with mu
National Inst We acknowledge
Background Aft
Dutch Cancer The PORTEC-2 s
Nanowire fieldNA
NA
Background-Tel
National Heal This research
OBJECTIVE. The
GE HealthcareSupported by
The presence The Virginia We thank M. W
Background Des
NA
NA
Purpose A phas
F. Hoffmann-L Supported by
The residual pNA
NA
Lung cancer isNational Inst We are gratefu
Carbonic anhyd
European UnioI am particula
Purpose Bevaci
National Can Supported in
Background Sen
US Public HeaUS Public Hea
Dysfunctional Association N We are indebte
Long-term pote
NA
NA
Objective: TheHealth Researc
Supported by H
Background: Be
AstraZeneca; E
MR has receive
Gene-modifiedBundesministeWe are indebt
Lung cancer reNA
NA
Monozygotic (M
Spanish Minis We thank Marin
Purpose The pr
NA
NA
Purpose PersisCougar BiotecSupported by
Cancer suscept
US National C We thank Z. C
Background: Ov
National Inst Supported by g
Metastasis is National Cance
This work was
The catalogueWellcome TrusFunding for o
Bone marrow tr
NA
NA
MicroRNA (miRN
La Ligue NatioWe thank Annic
Influenza vir NA
NA
Purpose To anNational CancSupported in

2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010

28
304
5
NA
92
303
6
NA
28
12
NA
NA
NA
107
375
NA
121
194
464
NA
28
NA
18
20
28
11
11
NA
251
21
16
NA
20
28
28
42
363
330
38
NA
107
NA
28

1
15
1
NA
5
11
16
NA
20
10
NA
NA
NA
33
9717
NA
3
1
7288
NA
13
NA
3
12
13
10
5
NA
3
9
2
NA
2
9
9
5
22
6009
NA
NA
1
NA
14

BACKGROUND:
NA
T
NA
BACKGROUNDNational
Pri
CancSupported by
Purpose PertuF. Hoffmann-L Supported by
Targeting the University of We thank K. Sh
There is a gro Wellcome TrusThe study was
Rationale: TheConselho NaciSupported by
Purpose: To exNIH [CA101860
NIH grant CA10
Rationale: TheNA
NA
Purpose SelectAstraZeneca; Research Fund
Purpose To concore Clinical The Early Brea
microRNA (miRN
Ministry of S This work was
Biomedical nan
NSF; NIH; MurThis work was
Granulomas, oNA
NA
Upconversion NA
l
NA
The mammalian
NA
NA
Overexpression
U.S. Public H This study wa
Purpose In a pCelgene, Summi
Supported by
Germline mutat
German Cancer
We thank all t
We conductedNA
a
NA
TranscriptionaNA
NA
Whereas cell cNA
NA
Purpose Neoadj
Roche; Sanofi-Supported in p
A novel electr National Inst The work was
This study ai Urologic Rese Grant sponsor
Cancer stem ce
Accelerate Br We acknowledg
The performanc
Cleveland Cli This paper wa
BACKGROUNDVertex
& A PharmaSponsored by
Background His
Dutch Health Funding Dutch
Enhancers dete
European Comm
This work was
BACKGROUNDCanadian
Th
BreaSupported by
Wnt/beta-cateDeutsche ForsWe thank H. Cl
Purpose No est
Novartis Phar Supported by
The first enanNA
NA
Purpose Progno
Canadian Breas
Supported by a
The characteriNational HealtThis project w
Macroautophag
NA
NA
Objective: TheNovartis; Ital A. K. and S. L
Purpose The pr
French Progra Supported by u
Substantial prSanofi-AventisBM has been on
Background Ana
National CancWe thank Karen
Background: Th
NA
NA
The platinum-b
NA
NA
Vaccination wiNA
NA

2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010

NA
363
28
16
20
181
16
NA
28
28
31
46
NA
NA
70
4
28
42
42
NA
NA
28
82
126
28
21
138
11
32
362
327
28
NA
28
207
NA
95
28
375
11
NA
NA
107

NA
10
7
2
4
1
1
NA
15
3
6
7
NA
NA
1
8
4
5
3
NA
NA
10
7
5
1
1
2
5
3
6
5964
1
NA
20
6
NA
7
13
9719
2
NA
NA
9

Background LitNA
NA
Background Mic
Breakthrough Funding Break
Arsenic, an an863 Program [We thank E.-D
Curcumin, a ye
NA
NA
Background The
NA
NA
5q-syndrome iCanadian Inst We thank R. De
We have shown
NA
NA
We geneticallyNA
NA
BACKGROUND:
NA
W
NA
The interactioNA
NA
Colitis-associ NA
NA
The primary cNational CancThe Alpha-Toc
Objective: To NA
NA
Computed tomog
NA
NA
MCL1 is essenNA
NA
The current stNA
NA
Rationale: MulNA
NA
Purpose In theAstraZeneca Supported by
The aberrant aNA
NA
Mitochondrial NA
NA
Uncontrolled eNational Ins This work was
Purpose Trast Genentech, SoSupported by
Purpose Bevaci
National Can Supported in
Pulmonary func
Academy of FiK2007-66X-202
Purpose Panit Amgen, ThousSupported by
The livers of NA
NA
In the classic NIH [HL03778We are indebte
We have derive
NA
NA
Background Bis
Celgene; OrthGJM has partic
Purpose In theDepartment ofSupport for Ca
Purpose To ana
BundesministeSupported in
Aims As part oNIAAA [HHSN26
The authors ar
Background: UNational Inst Supported by
RANK ligand ( NA
NA
The present arNA
NA
MicroRNA-155Ministry
(
of S Grant Support
Smoking is a US National I We thank all
The serine/thrNA
NA
Fanconi anemia
Medical ReseaWe thank affec
In 2009, the ANA
NA
Purpose To evaBristol-Myers Supported by B
Purpose: TherNA
NA
Purpose ThereAstraZeneca Supported fin

2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010

NA
11
328
NA
102
16
NA
NA
102
NA
NA
19
17
NA
463
NA
NA
28
NA
NA
207
28
28
42
28
NA
329
NA
376
28
28
105
363
NA
NA
70
42
NA
42
60
28
NA
28

NA
4
5975
NA
5
1
NA
NA
7
NA
NA
13
2
NA
7277
NA
NA
5
NA
NA
8
16
13
1
31
NA
5988
NA
9757
7
22
5
23
NA
NA
8
5
NA
5
2
6
NA
5

MicroRNAs (miR
NIH NRSA [F32We acknowledg
In an attempt Center for CanThis work was
The "serrated NA
NA
PEGylated gold
National Cance
We thank Debbi
Activation of NA
NA
Purpose GlioblNational Inst Supported by
Objective. To NA
NA
Clinical-grade NA
NA
The Yes-associNIH
We thank Drs.
Recent reportsMinistry of Ed We thank Ayako
Between 2% to
NA
NA
A role for B- National Insti We thank L. Ho
Most patients Rockefeller UnThe Laboratory
Tumor suppress
NIH [1R43CA1NIH grant 1R4
Leukemia stem
NIH [5P01CA66
We thank D. Fi
We recently deNational Inst This work was
Chronically a Cancer ResearThe authors t
First- and sec NA
NA
Targeted ther MassachusettsIntramural fun
Successful traNIH [CA119397
This study wa
Background: So
NA
NA
Background Col
Central ReseaThis study was
The National LNA
NA
The selective National CancPublic Health
Background an
National Insti Supported by f
Purpose AbiratCougar BiotecSupported by C
Purpose: ContrNA
NA
Mesoporous silUS Public HeaThis study wa
Whereas in mos
NA
NA
Engineered nan
NA
NA
Purpose The pNational Insti Supported by G
Mounting evide
NIH; Center foThis research
Howorgan sizeNA
NA
Purpose This pBayer HealthCSupported by
Purpose The co
National CancSupported, in
Background Th
GlaxoSmithKliLG has served
Purpose: Recen
National CancGrant Support
Induced pluripNA
NA
Chronic mucocu
NA
NA
Context Adjuva
Cancer Researc
This study was
Androgen recep
Howard Hughes
We thank Alan
We have evalua
NSF [DMR-0804
This work was
Purpose InvasNA
NA

2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010

29
18
138
107
107
28
NA
NA
24
18
NA
463
207
70
327
30
17
19
70
4
NA
102
NA
3
252
28
77
132
NA
NA
28
7
NA
28
28
375
16
NA
NA
304
107
10
28

11
4
6
3
29
17
NA
NA
1
1
NA
7277
2
14
5973
17
2
NA
13
2
NA
2
NA
6
3
9
3
36
NA
NA
1
6
NA
11
22
9712
5
NA
NA
10
39
1
16

Constitutive J Chambers Medi

This work was
Purpose PatienNA
NA
The AssociazioComitato M. LThis work was
T-cell immunotNational Inst The authors th
Mesoporous silNA
NA
Based on micro
NA
NA
CD20 is an imp
NA
NA
BACKGROUNDMDS
& A Nordion The authors di
Breast cancer NA
NA
Acquiring the NA
NA
Colon cancer sNA
NA
The BRAFV600E
NA
NA
MicroRNAs (miR
Ministry of Ed Grants-in-Aid
MicroRNAs areNA
NA
Pathways thatAssociazione We thank the D
Purpose To tesRadiation The Supported by
Transient induNA
NA
Each year the NA
NA
Purpose To dev
Vered Stearns;Research Fundi
Nonalcoholic sMikati FoundatSupported by t
Purpose Patiensanofi-aventisEmployment or
Metformin, anItalian LeagueItalian League
BACKGROUNDNetherlands
The
OSupported by t
Radiotherapy rNA
NA
Objectives: WeNA
NA
The tumor supp
NA
NA
Tumor hypoxiaNA
NA
Background: In
NA
NA
Purpose New tr
NA
NA
Mitochondrial Programme Hos
This work was
Purpose NeratiWyeth ResearSupported by
Purpose RituxiF. Hoffmann-L Supported by
Background VaAstraZeneca RSH received
A novel "strucNA
NA
Purpose: To inNA
NA
Purpose: We inNA
NA
Hard spheres a
NA
NA
Recipients of Bristol- Myers The BENEFIT-EX
The proinflamm
NA
NA
Tumor growth NA
NA
BiodegradableNational Natu This work was
Purpose To es Polish Minist Supported by
Inflammatory N
pA
NA

2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010

115
28
115
115
NA
NA
NA
138
NA
NA
NA
NA
31
NA
140
28
NA
60
28
51
28
3
362
NA
NA
NA
NA
NA
28
19
28
28
11
NA
NA
NA
82
10
NA
NA
31
28
NA

15
9
16
5
NA
NA
NA
1
NA
NA
NA
NA
5
NA
1
7
NA
2
23
6
22
11
2
NA
NA
NA
NA
NA
10
15
8
10
7
NA
NA
NA
1
3
NA
NA
8
3
NA

OBJECTIVE - ToMerck Serono,This study was

Purpose: This NA
NA
Microsatellite NA
NA
Antibodies thaNA
NA
Introduction: UK Medical ReThe MRC CLASIC
Patients with NA
NA
Progression ofNIH-NCI [PO1 We would like
Purpose: Appro
National CancGrant Support
High-risk typeNA
NA
Inflammatory N
mA
NA
Heterozygous Bundesministe
p
This work was
Background MRI
National Inst This project w
Ten percent ofNA
NA
A potential pl National Basi This work was
Inorganic/orgaBiophysical I Support from
CD11b+/Gr-1+NA
NA
Gold nanocages
NIH [DP1 OD00
This work was
Rare-earth upcNA
NA
(Figure PresenNA
NA
Purpose To defNA
NA
A20 negativelNIH [RO1GM0 We thank S. C.
Background. We
NA
NA
The identific NA
NA
Fibrosis is re NA
NA
Innate immune
National Cance
We thank Keni
Myeloid-deriveNA
NA
The long-termNA
NA
Purpose: Epid NA
NA
Melatonin (N-aNA
NA
Background: Th
NA
NA
Purpose: The G
NA
NA
In biology-ori NA
NA
Th17, Th22, an
NA
NA
Numerous studi
NA
NA
The aggressive
NA
NA
OBJECTIVE - Se
NA
NA
The J wave, alNA
NA
Trastuzumab-ba
NA
NA
We investigateMinistry of Ed Grant SupportM
One year of trGilead ScienceHui Zhang, Rob
Pancreatic ca NA
NA
Background: PNA
NA
Targeted theraNA
NA

2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010

33
NA
138
NA
97
NA
120
16
263
NA
20
375
NA
4
5
NA
6
NA
NA
28
327
NA
NA
NA
24
NA
NA
NA
NA
58
NA
NA
NA
NA
NA
33
NA
NA
70
52
NA
NA
NA

6
NA
6
NA
11
NA
8
5
2
NA
1
9714
NA
10
1
NA
7
NA
NA
18
5969
NA
NA
NA
3
NA
NA
NA
NA
3
NA
NA
NA
NA
NA
2
NA
NA
6
3
NA
NA
NA

Recent evidenc
NIH [CA129765
Thanks are du
MicroRNAs (miNA
NA
Researchers ha
NA
NA
Adoptive transCenter for CanThis work was
Ataxia-telang National Inst We thank Drs.
Systemic lupus
NA
NA
Curcumin induc
NA
NA
Pheochromocyt
NA
NA
Purpose: RadicNA
NA
Rattle-type FeNA
NA
MicroRNA-21 (m
NA
NA
INTERMACS has
NA
NA
PhotodynamicNA
t
NA
Metastasis resNebraska Resea
Nebraska Resea
Myeloid-deriveNA
NA
We report the F. Hoffmann-L This study was
Liraglutide is NA
NA
Transient induNA
NA
Background:Pre
NA
NA
Background: ANA
NA
Background The
AstraZeneca; JC has receiv
DNA double-str
NA
NA
Recent studiesNA
NA
Gonadotropin-r
NA
NA
WHO grading of
NA
NA
[No abstract aNA
NA
Each year, theNA
NA
Epigenetic patDon Monti Mem
We thank B. M
MYC contribute
Chambers Medi
We are gratefu
Mechanotransdu
MICINN (SpaniWethank J. Mas
The applicati NA
NA
Malignant tranNIH [CA142805
We thank K. Ch
Cancer cells aS. G. Komen foWe thank membe
Here, we demo
Harvard CatalyWe thank Pando
1DH1 and 1DH2
Chinese Minis We thank memb
Reactive oxyge
University of We thank J. J
Mutations in t California Bre We thank B. Mi
Cancer stem ce
US National I We thank K. C
Recurrent chroNA
NA
Macrophages,NIH [NIH PO1 This work was
By analyzing gNIH [U54CA12We thank James
Current models
National Heal We thank the C
Activation of Helmholtz AssWe thank K. Ra

2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011

120
NA
NA
116
107
NA
NA
NA
NA
NA
NA
NA
NA
70
NA
116
NA
2
NA
NA
11
9
NA
NA
NA
NA
60
478
146
146
NA
475
476
147
19
475
477
17
NA
475
147
108
478

2
NA
NA
20
9
NA
NA
NA
NA
NA
NA
NA
NA
14
NA
12
NA
6
NA
NA
12
4
NA
NA
NA
NA
5
7370
6
1
NA
7355
7360
2
1
7354
7363
2
NA
7355
2
19
7368

Upon the aberHelmholtz AssWe thank D. La

The global burNA
NA
Background The
Taiwan Departm
Taiwan Departm
We designed aNational Inst Supported in
Each year, theNA
NA
BACKGROUNDNational
Th
CancFunded by the
Background: Al
National Cance
This study was
Chromatin profNA
NA
Here, we pres Canadian Inst We thank all P
A catalogue o USA National We thank J.
The mission ofNational HumaFunded by the
Genomic analys
NCI; DepartmeWe thank M. R
Context The inNational Cance
All authors ha
Induced pluripNA
NA
Advanced ageEllison
i
Medic We thank W. Zh
Tumor immunoth
Alliance for Supported in
An ageing worlSusan G. Kome
The authors w
Defined transcNIH [R01 HL094
We thank J. M.
Background Tre
Bayer; Sanofi-This study was
The generation
Ministry of E We thank J. Ni
Multiple myeloMultiple Myel This project
Retrotransposo
Wellcome TrusJ.K.B. is supp
There has beeNA
NA
Background InVertex PharmaSupported by
BACKGROUNDOrtho
Bio Biotech Supported by O
Prostate canc Prostate CancWe thank R. Le
The retrovirusCenter for Ca We thank W. Sh
Homeostasis of
NA
NA
Cells perceiveTelethon and PWe thank G. Sc
Telomere dysfu
Deutsche ForsWe thank C. B
Background Low
Merck/ScherinFunding Merck/
The efficacy aTerry Fox FounJennerex Inc.
Microglial cel NA
NA
BACKGROUNDBristol-Myers
Ipi
Supported by
Genome-wide Helmholtz
as
ZenWe acknowledg
Chronic lympho
Spanish MinistThis work was
Enzymes cataly
NA
NA
Context: SurviNA
NA
A significant NA
NA
Methylation a NA
NA
The genetics oWellcome TrusP.A.F. and M.R
Rising prevaleNational Coll This work was
Reactive oxyge
NA
NA

2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011

479
61
378
365
61
365
171
NA
146
474
9
472
306
NA
479
3
469
471
377
146
471
479
470
364
364
470
333
469
474
470
377
477
NA
364
477
475
NA
NA
NA
NA
469
378
NA

7374
2
9798
8
4
5
18
NA
3
7353
4
7341
14
NA
7372
95
7328
7336
9759
4
7339
7374
7333
25
21
7333
6038
7330
7350
7334
9784
7362
NA
26
7362
7354
NA
NA
NA
NA
7331
9793
NA

MyelodysplastMinistry of HeThis work was

Mammalian geno
NA
NA
Parkinson's di NA
NA
Purpose Recent
National Cance
Supported by t
In addition t National Insti Funding for op
Head and neckCarlos Slim H We thank the B
BACKGROUNDSwedish
In
Cancer
Supported by g
Engineered bioBauer Fellows We thank M. Le
Background Obs
European UnioEuropean Union
Induced pluripNew Energy and
We thank T. Ya
Context SentinNational CancThis study wa
Adenosine mono
NA
NA
Aims: To proviNA
NA
Cancer is dri Wellcome TrusThis work was
Background Bre
Susan G Komen
Funding Susan
The prevalent NA
NA
BACKGROUNDFrench
Da
governFunded by the
Over the last NA
NA
Background Act
F Hoffmann-LaWe thank patie
Medulloblastom
National CancWe thank J. Pt
Head and neckNational Inst We thank our p
Circulating miNIH, NHLBI DI This study was
COSMIC (http:Wellcome TrusThe Wellcome
Induced pluripNA
NA
The decade siNA
NA
Nanomedicines
National CancThis work was
BACKGROUNDClinical
Acc
Insti Supported by t
DNA methylatiNIH [CA78412,We thank Drs.
Genomic stabilNIH/NICHD; HaWe would like
The burden ofPfizer; Novar RS has receiv
Tumor heteroge
US National We thank C. A
Long noncodinNA
NA
Many tumoursCanadian
a
Inst We would like
BACKGROUND:
NA
Ma
NA
5-methylcytosNA
NA
Xenograft studGerman MinistThis work was
EncapsulationNIH/Roadmap This
f
work was
Resveratrol is NA
NA
Tuberous sclerNA
NA
This review ouNA
NA
5-hydroxymeth
National Scie We thank B. Re
Background: Ev
Novartis OncoSupported by
High-fat diet US National InWe thank V. Di

2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011

478
474
NA
29
39
333
364
333
378
474
305
NA
NA
144
378
NA
364
NA
12
331
333
13
39
NA
470
10
365
146
8
12
43
NA
469
NA
NA
17
10
NA
NA
NA
473
364
12

7367
7351
NA
32
NA
6046
18
6047
9809
7350
6
NA
NA
1
9801
NA
19
NA
8
6016
6046
4
NA
NA
7333
7
15
1
1
10
8
NA
7330
NA
NA
9
5
NA
NA
NA
7347
6
5

The prognosisNA
NA
Context WholeCelgene; NovaAll authors ha
Follicular ly National CancThis study wa
Immunosuppres
Abramson Fami
We thank C. Ab
BACKGROUNDCDC
MosFoundatioDr. Gupta repo
Pancreatic ne Caring for Ca We thank M. Wh
BACKGROUNDNational
Vas
CancFunded by the
Background Bon
Amgen; Novart
KF has receiv
The generation
NA
NA
Neural circuit National Inst This work was
BACKGROUNDSanofi-Aventi
Tr
Supported by S
Preclinical st NA
NA
BACKGROUNDNovartis
Dat
Phar Supported by
BACKGROUNDNational
The
HumaSupported by
Reactome (httNational HumaNational Huma
The evolution Tuberous Scle We thank membe
Background: Th
Pfizer; Novart Supported by P
Triple-negativ NIH [CA95131We thank Carl
MicroRNAs (miR
Dietmar-Hopp Dietmar-Hopp
MicroRNAs (miR
NA
NA
Activated RASNA
NA
The activated NIH, National This research
Background: TrBiPar SciencesSupported by B
Background: Th
European CollWe gratefully
Activation of National Inst This work is
Immune-regula
American Canc
This work was
Zinc-finger nuNA
NA
BACKGROUNDRoche;
Ang Nationa
Supported by
The let-7 tumoUS NIH; GraduWe thank John
Over the past NA
NA
Background ExSwedish NatioWe thank the S
Little is know Kay Kendall L This work is
Chromosomal Nachmias
in
Found
The authors th
Background: In
NA
NA
Macromolecular
NA
NA
The UN High-Le
Wellcome Trust
PA has receive
BACKGROUNDMerck;
The NationFunded by Merc
Members of the
NA
NA
Background Tam
Canadian Cance
Supported by t
Somatic cells NA
NA
Abnormal epigChina NationaThis work was
Intra-abdomina
NA
NA
The simple yetNA
NA

2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011

17
305
476
331
364
331
365
377
NA
334
365
NA
365
365
39
332
364
121
39
NA
NA
470
364
21
19
1
NA
365
147
NA
377
469
145
NA
NA
377
365
NA
364
NA
43
NA
NA

10
15
7360
6024
8
6021
26
9768
NA
6052
14
NA
15
7
NA
6035
6
7
16
NA
NA
7332
3
10
1
1
NA
26
1
NA
9760
7330
3
NA
NA
9775
17
NA
25
NA
4
NA
NA

BACKGROUNDNational
Mye
Inst Supported by g
Recent advance
NA
NA
Lung cancers h
Uniting Again This study is
Alternative spNIH, the NatioWe thank A. Ra
Recent studiesNA
NA
The 12th St Ga
SONK; United Support for t
Purpose The ad
Merck KGaA, DSupported by
Background AsCancer ResearCancer Resear
The mammalian
National Inst We thank membe
ImmunologicalUS National InThis research
BACKGROUNDBroad
Th Institu Supported by
Protein aggregEU; Deutsche We thank C.G.
Intestinal epi American HearWe thank the E
After breast-c NA
NA
The challengeDanish NationThe authors wi
Mutations in gNIH-National This study was
Human induced
CIRM; JDRF; NThe authors wi
Diffuse large US National I We would like
This documentInfectious Dis Infectious Dis
Most tumors ex
US National I Microscopy dat
Context Screen
National Cance
The National C
Background- TNA
NA
Background Can
Department ofMAR is the Nat
Selective autoNA
NA
The applicatioNA
NA
The mammaryTELEVIE;
e
Port We thank our c
Sex in mammals
NIH [GM59152]
We thank M. Tr
Sperm and eggs
NA
NA
DNA methylatiNA
NA
Background Hai
Associazione Supported by A
Geographic atNational Eye We thank M. Ch
The pyruvate k
NHLBI [N01-H We thank Kare
The epigenome
NA
NA
NA
Caring for CarN.P., K.W.K.,
BACKGROUNDLarry
& A L. Hillb Supported by t
BACKGROUNDBritish
The Heart Supported by g
BACKGROUND:
NA
Im
NA
While the numMax Planck SoWe thank Pete
Warburg's obse
NA
NA
The heterotrimMRC
We thank M. W
Purpose Recent
Canadian Inst Supported by a
Individual canNA
NA
Transitional c National High This work was

2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011

364
17
3
479
NA
22
29
378
332
17
365
144
334
NA
43
3
13
43
52
43
305
NA
377
NA
NA
479
476
NA
NA
364
471
145
NA
333
141
364
NA
7
NA
472
29
NA
43

26
3
75
7371
NA
8
15
9793
6035
10
26
1
6061
NA
4
70
5
9
4
9
22
NA
9760
NA
NA
7372
7358
NA
NA
24
7338
5
NA
6041
1
9
NA
NA
NA
7342
11
NA
9

Estrogen recep
The Universit We thank G. Br
Objective: OurNA
NA
NA
Alexander vonThe authors th
The small inteNA
NA
Background Sti
National Cance
Supported by t
Polarization Swedish Cance
This study wa
The last decadNA
NA
Background Th
American Cance
The American C
Context and ob
GSK; Astra ZeI certify that
Excessive andUS National The authors t
Mislocated enzNA
NA
A detailed undNational Inst Supported by t
Whereas chrom
NIH [5P01CA92
We thank Barry
Current Food aDyax; AstraZeR.K.J. receiv
A frequent com
H.G. Palmer ( We thank Genen
DNA methylatiFondo de InveThis work was
Noncoding RNAs
US National I We thank K. R
Alzheimer's diNA
NA
Innate lymphoiNA
NA
The target of Swiss NationaWe thank Rache
Prostate canceNIH [P50-CA92The authors wo
Autophagy is aNIH [R37 CA5 We thank M. K
Background Dys
Dana-Farber DSupported in p
We recently p Harvard Catal We thank Pando
Effective clin Damon Runyon
The authors a
PhotodynamicFund
t
for Scie Supported by
Interactions o Ludwig CenterWe are gratefu
Autophagy is Public Health We apologize
During develop
Stand Up to CWe thank K. Sh
Background: Re
European Uni This study was
Somatic loss-oNIH/NCI [P30 We would like
Cytosine methNA
NA
Genetic variatNational Inst This work was
BACKGROUNDNational
Cor
Mult Supported by g
BACKGROUND:
NA
A
NA
Purpose: FocalNA
NA
MicroRNAs (miR
American Canc
We thank the F
Osteoporosis iNA
NA
Inflammatory National Insti We thank L. Co
Background Aus
Australian Re JMLB, DMG, and
BACKGROUND:
NA
Al
NA
Although immu
National Inst This work was
Hyaluronic aciNA
NA

2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011

43
59
54
NA
364
19
NA
103
59
29
NA
29
147
108
8
6
29
NA
NA
144
19
25
365
147
470
61
20
124
144
6
20
NA
471
365
NA
NA
108
NA
470
377
NA
475
NA

1
1
1
NA
22
1
NA
9
6
11
NA
22
1
6
5
6
8
NA
NA
5
5
5
22
2
7333
4
5
2
5
6
1
NA
7340
23
NA
NA
12
NA
7335
9783
NA
7355
NA

p53-binding pNA
NA
TET family en NIH [AI44432,We thank P. Ga
The effective Emerald FoundWe thank J. La
Cancer cells wBreast CancerWe thank Aviv
A major goal iNA
NA
Background InCancer ResearFunding Cancer
The developmen
German Bundes
This work was
Background Cel
National Hear Supported by a
The efficacy oAssociazione IThis work was
The incidence National HumaWe thank V. M
Purpose This sAmgen, Thousa
Supported by
The vertebrateNA
NA
Rapamycin was
National Inst This work was
Macroautophagy
Dana-Farber CWe thank Drs.
BACKGROUND:
NA
Tr
NA
Background The
Pfizer Inc.; P Pfizer Inc.BIR
Purpose Adopti
NA
NA
Regulatory T (NA
NA
Endocrine tumo
National Inst We thank the p
Caspase-8 hasNA
NA
Loss-of-funct INSERM; Insti We thank Dr. R
TDP-43 is a prNA
NA
BACKGROUNDWellcome
Mye
TrusSupported by g
The epithelial National Inst We thank Brian
Tumor heteroge
NA
NA
B-cell non-HodNIH [PO1-CA09
We thank Q. Sh
Background SyPfizer; HumanSVN has recei
A two-dimensio
Royal Society;G.E. acknowled
The World Heal
Associazione SThe preparator
Notch signalli National Inst We thank G. Fi
Background Xer
Cancer ResearPARSPORT was
Tumor cells exNational Scie We thank Fred
Purpose Regula
National HealtSupported by t
Purpose: MostNA
NA
Each year the NA
NA
Reactive oxygNational Insti This research
Hepatitis C vi European ReseThis work was
Cell therapy cNA
NA
Purpose: To upNA
NA
Background ALK
V Foundation Pfizer Inc, V
Purpose The Na
Public Health Supported by
Control of int Japanese SociWe thank V. To
Bacterial and applied scien The Dutch Tec

2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011

NA
8
471
146
NA
377
29
365
108
43
29
NA
66
25
NA
378
29
NA
331
NA
20
NA
365
145
NA
471
377
11
117
473
12
19
29
17
NA
208
17
NA
NA
12
29
334
39

NA
2
7336
4
NA
9783
3
18
9
5
9
NA
2
7
NA
9807
7
NA
6018
NA
1
NA
15
6
NA
7337
9767
12
19
7346
2
3
3
13
NA
3
5
NA
NA
11
1
6060
NA

Microtubules hNational Heal We thank P. Ek

G-quadruplexes
US National I Research in t
High-throughpu
The Paul G. AlThis work was
The pathogenes
National Insti This study was
Measles virus BMG [2510-FSBWe thank J. Br
The cytokine rNA
NA
Completion ofDanish CancerWe thank J. E
We have usedNIH [CA12976This work was
The majority oNA
NA
SHARPIN is a uNA
NA
Employing ther
NA
NA
Trastuzumab is
US National I We thank Astr
Gastric cancerNA
NA
Climate change
Natural Scien We thank C. Wh
Background-Tra
Edwards Lifes The SOURCE Re
A defining chaDFG; BMBF; E Work supporte
We report thatUS National InWe thank J. Ki
O-GlcNAcylatio
NA
NA
PPAR?? is the NA
NA
Cpdm (chronicNA
NA
Alzheimer's diNA
NA
Context The r Health Servic This work was
The cytidine dNational Insti We thank D. Sc
Background Sub
NA
NA
Objectives: OuAbbott; Astell I certify that
The intracellu NA
NA
The BiomarkerBristol-Myers A. Tsao recei
Context Severe
Pfizer; Brist All authors ha
The echinoderm
V Foundation fThis study was
The Tet familyNA
NA
Tumors are oftAmerican Cance
We thank Maria
Nanomaterials,
NA
NA
Background Eve
Novartis Phar Novartis Pharm
The outcome of
NA
NA
Targeted delivNational CancThis research
Bevacizumab,Centre
a
de RecWe thank A. Mu
We developedEnsysce
n
BioscThis work was
Purpose The aGenentech; R Hope S. Rugo,
Hastening posAzienda Ospeda
This work was
Purpose This pGenentech, SoSupported by
Background: DN
Sir Henry Wel We thank Jose
Carcinoma-assNational Inst We would like
Although the rDepartment ofWe thank S. Ky

2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011

471
10
29
208
480
140
13
71
NA
NA
NA
17
43
332
124
711
17
NA
NA
NA
NA
305
12
12
59
NA
1
306
108
NA
108
NA
378
NA
108
108
133
29
117
29
12
19
17

7336
4
7
7
7378
6
3
2
NA
NA
NA
4
12
6025
4
###
7
NA
NA
NA
NA
13
1
2
4
NA
1
23
18
NA
4
NA
9808
NA
5
9
17
4
14
10
1
2
9

Purpose Medull[NIH-R01-109Supported by
Tobacco smokin
German Resear
This work was
Background Hel
Axcan PharmaThe authors th
Clever combina
NA
NA
Purpose: To prNA
NA
Vaccine and laCanadian Inst The experiment
Glioblastoma (American BraiWe thank Drs.
BACKGROUNDNational
It
CancSupported by g
NA
NIH Post-Gen We would like
Common fragile
ARC(AssociatioWe thank E. Bl
FADD is a comm
NA
NA
A key questionNA
NA
Objective: Th NA
NA
The relations NA
NA
Hutchinson-GilCIRM [TG2-011
We thank L. Co
Pulmonary fibrNA
NA
Chemotherapy-i
Gilead Scienc J. Peter Donn
We have observ
NA
NA
Background Chr
Netherlands OSupported by
Medicine can b
NA
NA
Myocardial infNA
NA
This first up NA
NA
MicroRNAs areResearch CounWe are gratef
OBJECTIVE-Some
Takeda Global This study was
Next-generati Canada Resear
S.A.J.R.A. wa
Excessive or i National Inst This work was
The immune sy
NA
NA
The Wnt/beta-c
Cancer PrevenWe thank Drs.
Mutations in i Wellcome TrusWe thank the s
Hydrogen sulfiNA
NA
A 42 kb regio Ministry of Ed We thank Howar
A better underCancer Resea We would like
Recent morphol
US DepartmenThis study is
Imatinib theraLeukemia andWe thank Chri
Background The
National Inst Supported by
Context: The EPfizer FoundatI certify that
InflammasomeNA
NA
Enormous effor
NA
NA
Over the past NA
NA
Yolk/shell or NA
NA
BACKGROUNDPublic
Ret Health Supported by
The full scale National 115 We thank Ms.
The conversion
Creative Rese This work was

2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011

29
88
377
NA
NA
7
108
365
43
470
NA
NA
96
NA
472
NA
47
NA
365
NA
NA
NA
44
34
117
208
NA
108
12
NA
30
43
42
121
364
59
NA
NA
NA
NA
364
19
6

11
4
9769
NA
NA
8
11
2
6
7332
NA
NA
2
NA
7342
NA
1
NA
1
NA
NA
NA
5
4
8
6
NA
28
5
NA
16
3
7
1
22
4
NA
NA
NA
NA
5
2
7

Upconversion Soochow
n
Unive
This work was
Graphene andNA
i
NA
Purpose This sDutch Genomic
RNA isolation
The intestinal Timothy Murph
We thank Drs.
Cell prolifera NA
NA
Background Ola
AstraZeneca; KAG and AO ha
AntineoplasticLigue NationalG.K. and L.Z.
Deregulated on
European Uni We thank Julia
Purpose Myelof
TargeGen; CytResearch Fundi
An obligate in David and LucWe thank Pete
Background Cur
NA
NA
Although antirNA
NA
Liver fibrosis German-Resear
Supported by t
Satellite repe Pancreatic Ca This work was
Unique spindleNSFC [208730Financial sup
OligodendroglVirginia; D.
We thank M. Wh
Control of genNA
NA
Gene expressiNA
NA
In addition to NA
NA
Purpose To assNational Heal Supported by P
Background: Th
European Comm
European Comm
A healthy 61-yNA
NA
Context SomeUS
m Food and DThis study was
Purpose After NA
NA
A major challeNA
NA
Background: Mu
Medical ReseaI certify that
Object. The vaNA
NA
Background Tre
Roche; Michel LG has receive
Epidemiologica
Director's CanAssociate Prof
Context: New Idmmatics; Baye
I certify that
Fanconi anemia
Deutsche ForsWe are gratefu
Epigenetic mod
NA
NA
Background Tre
Roche; Eisai; JC has receive
We reviewed av
NA
NA
In recent yearCapes; CNPq S.F. Medeiros
p53 suppresseNational CancThis work was
Pooled data onBill & Melinda Grant sponsor:
Relapsed acute
ALSAC of St J We thank T. Je
Alterations i NIH [R01HL08This work was
Background Hum
Merck; Nationa
ARC receives s
Autophagy is aMinistry of Ed We thank N. Mi
Recent advance
NA
NA
The past couplNational Natu This work was

2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011

32
NA
29
108
43
12
334
42
29
17
NA
NA
53
331
133
333
17
NA
NA
29
22
NA
305
29
13
59
115
12
128
59
43
NA
377
NA
403
208
128
471
25
377
25
NA
152

4
NA
1
1
7
9
6062
1
7
2
NA
NA
1
6017
4
6048
9
NA
NA
10
12
NA
22
13
2
4
1
3
6
6
2
NA
9769
NA
###
5
4
7337
7
9769
8
NA
1

Background Pre
European Comm
This study wa
Chronic lympho
American Physi
Foremost we th
Anaplastic lymNIH [R01CA13This study wa
This study addMelanoma Rese
K.S.M. Smalle
MicroRNAs (miR
NRSA [F32CA1We would like
Background The
Dutch Cancer The Dutch Can
The growth facNIH [AR050620
We thank P. Le
Alteration of NIH [F32 CA11We appreciate
Chronic obstruNA
NA
Context Solid Bristol-Myers All authors h
Here we report973 Project The authors a
Rationale: A gBaxter Health Baxter Health
Patients and mMerck KGaA, The authors t
Inflammasomes
Public Health This study was
Physiological Ministry of Ed We thank Karen
Mutations in DNA
NA
OBJECTIVES: To
NA
NA
Purpose OlderAbraxis BioSc Research Fund
Purpose The reAstraZeneca; Research Fund
Background: Th
NA
NA
DNA has a stroNA
NA
Purpose Antibo
United KingdoSupported by
Circulating miGerman Federa
Grant sponsor
PhosphatidylinNA
NA
We present a rGunnar BirgegResearch Fund
B1 cells diffe Donald and Bar
This work was
The hepatic peNA
NA
Background: Ne
National CancThis publicati
Purpose: We reNA
NA
Background: Co
German Resear
Grant Support
Background InCancer AustralFunding Cancer
Purpose This ENational CancSupported by
Somatic mutatSkeletal Canc We are gratefu
Purpose The Av
Genentech; F. Supported by
Purpose The pr
Institut Natio Supported by I
Purpose: The Genentech; P. LoRusso rec
Purpose BlinatInterdisciplin This work was
Ankylosing spoNA
NA
Background Hy
Pfizer Inc.; P This work was
Molecular imaNA
NA
Breast carcinoEgyptian MinisSupported by t
Metformin is tWellcome TrusWe are gratefu
Purpose The trAbraxis BioSc Sponsored by

2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011

103
117
71
71
19
12
332
19
NA
306
32
109
22
9
19
NA
NA
29
29
NA
NA
29
128
117
29
208
NA
59
NA
154
12
29
224
29
29
17
29
NA
103
NA
29
43
29

3
2
18
7
6
6
6028
6
NA
17
11
4
7
5
4
NA
NA
25
21
NA
NA
4
3
2
6
1
NA
4
NA
1
7
2
3
30
6
8
18
NA
9
NA
15
2
34

The epithelia National Brea We thank R. A

One strategy iNA
NA
In 2005, seve Pfizer; Merck JM is a consul
The biomedical
National Natu We gratefully
Purpose c-METArQule
Lecia V. Sequi
Thiopurine meNA
NA
We report the National Inst This work was
Objective To Human Genome
Supported by
Substantial prNational CancThis work was
Purpose TrastuGenentech [35Research Fund
Background &am
NA
NA
Adenocarcinoma
NA
NA
The tumor micr
Association poThis work was
Objectives: ToNA
NA
Carbonic anhyd
Canadian BreaThis work was
Curcumin (difeNA
NA
Purpose BRAF National Insti Supported by
The ability to National Insti The authors th
BACKGROUND.
NA
Te
NA
Background Ana
AstraZeneca; Funding AstraZ
Upconversion National
n
Natu This work was
Preclinical d National Cent This study wa
Background Con
NIH/National This research
Carney-StratakGIST; St. Bald This work was
Missense mutaBundesministeWe would like
Purpose This oGenentech; Am
Supported in
Purpose: Long-Robert Wood Jo
Supported by a
Purpose We ass
Patrick C. Wa Supported by
Purpose To st Dieter-Schlag Supported by t
The epithelial NA
NA
[No abstract aNA
NA
Background: Sc
University of Dr. Miller rec
Purpose ResistAbbott LaboratSupported by A
Purpose: HSP90
Kosan Bioscie S. Modi has R
Patients with Procter and G The authors di
We have obtain
NA
NA
MicroRNAs (miR
European Comm
Grant sponsor
Jack of all tr NA
NA
Graphene, whos
National Natu This work was
Graphene, whos
National Natu This work was
Background &NA
A
NA
Purpose The Dy
NA
NA
Background The
Varian MedicaMS has been a

2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011

13
NA
46
21
29
NA
118
63
378
29
NA
42
71
NA
71
NA
29
11
117
12
32
10
12
108
121
29
185
29
29
NA
NA
70
29
17
140
NA
128
NA
6
6
NA
29
12

3
NA
5
16
24
NA
18
12
9791
25
NA
1
4
NA
9
NA
15
5
2
7
26
3
7
1
3
2
3
16
21
NA
NA
7
7
15
6
NA
6
NA
2
2
NA
4
8

Gold nanostruc
NA
NA
Colorectal canU.S. National This work was
Hereditary pheFondo de InveThis work was
Graphene is a NA
NA
Common acquire
Max-Kade FellWe are indebte
Purpose: Bevac
NA
NA
The signaling Exelixis, Inc.; The financial
Background: Me
National HealtThis study was
Purpose An Ame
Genentech; A Employment or
There is a str Instituto de This research
B-cell recepto NA
NA
Metal-organic NA
NA
Background: Pr
NA
NA
In adults, humNA
NA
A new lung ade
NA
NA
Objective The Taiwan NationThis research
Purpose Melano
Novartis; Pro Research Fund
P53 phosphoryNational Inst The work was
[No abstract aNA
NA
Numerous studi
State Key BasThis study wa
Background: IsNA
NA
The RotterdamErasmus Medica
The Rotterdam
OBJECTIVE - ToNA
NA
Purpose: FactoPfizer; Sanofi Financial inte
Purpose To invNA
NA
The Japan Canc
3rd-term Comp
The study was
Context: To syNHMRC [301200
Thorp is supp
Due to their uNA
NA
Small-molecule
W.W. Smith FoWe gratefully
Background: In
NA
NA
Rapid diagnosiBill & Melind This research
A novel methoNational Natu The authors t
The availabili NA
NA
Blood plateletNA
NA
Context Provi Fondation de This work was
Targeted T celLeukemia andThis work was
Introduction: Pfizer Inc.
Supported by
BACKGROUNDBARRX
& A Medical
The authors d
The lifespan oLugli FoundatiThe production
Purpose A phas
National Inst Supported by G
Efficient deli National Basi This work was
Prognostic facNA
NA
Purpose: AbiraCougar BiotecR.B. Montomer

2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011
2011

NA
60
43
NA
43
NA
10
11
29
30
NA
NA
NA
NA
NA
20
29
83
NA
50
59
26
NA
185
29
41
41
166
29
NA
17
5
35
105
305
121
6
141
10
29
133
NA
17

NA
3
7
NA
10
NA
12
NA
15
22
NA
NA
NA
NA
NA
3
21
3
NA
2
1
8
NA
2
20
1
2
###
11
NA
3
4
1
NA
22
5
3
2
1
3
44
NA
18

Background: Th
Korea Institu Supported by
Background: La
NA
NA
Anthraquinones
National Scie This work was
Purpose This pNational Cance
This work was
Background Eff
NA
NA
Introduction: NA
NA
[No abstract aNA
NA
Glioblastoma m
James S. McDoThe authors th
Recent studiesBrussels Regi C.B. is invest
Clinical respo Wellcome TrusWe thank P. Lo
The concept thKWF (the DutcWe thank C. K
CD47, a "don'tJoseph and LaWe thank Libu
Drug resistancHoward Hughes
We thank all
Inflammation a
NIH [T32 DK00We thank M. Bo
Tumor-derivedChildren's Ca We dedicate th
Metastatic groSwiss League We are gratefu
Melanoma is nNational HumaIllumina seque
Inhibition of EU [259015]; E
We thank P. Ku
Mutationally aNA
NA
Recurrent muta
National Cance
We thank membe
Elevated expreNational Inst We thank John
Crosstalk and NIH [CA11296We thank Sandr
An estimated Canadian Inst This work was
The human geno
NA
NA
Background: Re
NA
NA
Each year, theNA
NA
Background Str
US National InThe findings a
Background ToNA
NA
Background Qua
Lundbeck; Pran
A Davis is emp
Background Alt
US National C This study was
We report the NA
NA
Background: Ch
NA
NA
The elucidatioCancer ResearThe METABRIC
BACKGROUNDDepartment
The
ofSupported by
Calorie restri NA
NA
We analysed pUSA National We thank M. S
Objectives: AnNA
NA
Our previous National Natu We thank Dr D
BACKGROUND:
NA
A
NA
To characteri National Ins This work wa
BACKGROUNDMedical
In
ReseaSupported by
BACKGROUNDVeracyte
App
Supported by r
New DNA sequen
NA
NA

2011
2011
2011
2011
2011
2011
2011
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012

6
NA
24
43
NA
NA
NA
488
488
483
337
109
487
338
18
481
485
483
487
483
151
149
22
NA
NA
62
380
367
380
380
NA
NA
486
367
NA
490
NA
22
NA
487
366
367
NA

3
NA
1
1
NA
NA
NA
7412
7412
7391
6095
17
7408
6103
6
7379
7399
7387
7408
7390
1
4
2
NA
NA
1
9838
21
9859
9840
NA
NA
7403
3
NA
7418
NA
1
NA
7407
10
8
NA

Background Can
NA
NA
BACKGROUNDBristol-Myers
Pro
Supported by B
Each year, theNA
NA
BACKGROUNDBristol-Myers
Bl
Supported by B
Background Dai
AstraZeneca; This study was
Background It Deutsche KrebThis work was
BACKGROUND:
NA
Al
NA
The Gram-negat
NA
NA
Background Dai
NIHR; WellcomPMR is in rece
Background: In
NA
NA
Background Sta
British Heart The Clinical T
Background Rel
Bill & Melind E R Dorsey has
Lung squamous
NIH [U24 CA1 This study w
Exercise has bNational Inst We thank the U
BACKGROUNDDivision
The
of C Supported by
Background Re
GlaxoSmithKliSupported by
We describe an
NA
NA
BACKGROUNDNational
Reg
Inst Supported by
Human aging E
c uropean ReseWe thank Dr.
BACKGROUNDNational
In
CancSupported by
Cancer evolves
Wellcome TrusThis work was
BACKGROUNDF.The
Hoffmann-L Supported by
Primary triple BC Cancer AgeThe support o
Pancreatic ca National Heal This paper is
BACKGROUNDMedivation
Enz
anSupported by M
Background Sev
GlaxoSmithKlin
Dr. Schroder r
Most patients Washington Un
We thank the
BACKGROUNDSanofi;
The Sanofi Supported by S
Intestinal comNA
NA
BACKGROUNDGlaxoSmithKliSupported
Ac
by
Background Re
Novartis
Supported by N
The differenti Howard Hughes
This work was
Cancer metabol
NCI; NIH; UnivWe thank membe
All cancers caWellcome TrusThis work was
BACKGROUNDAsociacion
Col
EspSupported by g
Crohn's diseasNA
NA
Breast carcin Carlos Slim H We would like
Background Tra
F. Hoffmann-L Funded by F.
Mutationally cNA
NA
All cancers c Wellcome TrusThis work was
BACKGROUNDNational
Alt
Ins Supported by
Engineered traUS National I We thank T. Ca
Generation of NA
NA

2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012

13
366
NA
366
379
98
NA
NA
379
NA
380
380
489
481
366
367
NA
367
109
366
149
366
486
491
367
366
481
367
NA
367
366
21
21
149
366
NA
486
367
21
486
366
30
NA

8
26
NA
26
9826
12
NA
NA
9826
NA
9841
9859
7417
7382
25
18
NA
17
26
8
5
2
7403
7424
13
11
7382
4
NA
2
6
3
3
5
8
NA
7403
19
3
7403
3
5
NA

Despite recenNHGRI [U54 HG

We thank L. Am
BACKGROUNDHoffmann-La
Ap
Supported by
Context Human
Merck; Ohio StAll authors ha
Background It Advanced CellAdvanced Cell
Genomic rearrGerman Cancer
We thank Betti
Background Non
Berlin Heart HC E Canter has
Colorectal tumVirginia and The authors t
The American NA
C
NA
OligodendrogliNA
NA
Oestrogen rece
University of The authors wo
Glioblastoma m
Cole Foundati The authors ar
The cancer steTerry Fox Fou The authors ac
BACKGROUND:
NA
A
NA
Tumor heteroge
National Basi This work was
Background Re
Ariad PharmacFunded by Aria
Lung adenocarc
NCI [T32 CA92We thank all
Higher-order cNA
NA
Background The
National CancThis work was
The systematic
Novartis Insti We thank the s
To correlate t National HumaThis article i
Rapamycin, anNA
NA
Background: ANA
NA
MedulloblastoNIH [NHGRI U5This work was
Transposable eNA
NA
MedulloblastoSt Jude Child This research
We describe aNational CancThis work was
The extent to NIH [3P01CA09
This work was
Although thereNA
NA
Clear cell ren National Basi This work was
Based on stronNA
NA
Background Lon
Stroke Preven The study rece
Retinoblastoma
St Jude Child The WGS was su
A main limitatEuropean UnioWe are particu
The generation
J. David GladsThis work was
Neuroblastomai
Villa Joep Fo The research i
BACKGROUNDDutch
Th
Cancer Supported by
BACKGROUNDAvanir
BG- PharmaFunded by Biog
BACKGROUNDNational
Th
Inst Supported by
We describe thNA
NA
Background Che
Canadian Canc
The NCIC Clini
BACKGROUNDHoffmann-La
Cu
RSupported in p
The c-Myc HLHNIH, National We thank our c
This report pr NA
NA

2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012

150
366
307
379
148
380
486
62
NA
481
482
12
NA
148
367
150
NA
104
483
486
NA
NA
488
NA
488
30
148
NA
148
30
13
481
486
11
483
366
367
366
NA
366
366
151
NA

2
8
7
9817
###
9859
7404
1
NA
7381
7384
2
NA
5
22
6
NA
2
7391
7403
NA
NA
7409
NA
7409
5
5
NA
5
8
5
7381
7404
1
7391
22
12
12
NA
5
3
1
NA

Here we perforSpanish MinistWe are gratefu

BACKGROUNDNational
Ac
CancSupported by
Background We
GlaxoSmithKliThis study (NC
The involvemeHoward Hughes
We thank A. D'
Medulloblastom
PedBrain TumoWe thank GATC
BACKGROUND:
NA
Di
NA
Metastatic proNA
NA
Background Mod
Cancer ResearThis report i
Acetyl coenzym
National Inst We thank N. V
Background The
GlaxoSmithKlin
JB has receive
Non-alcoholic Cancer ResearWe thank E. Ey
Mouse embryoni
European UnioWe thank Eva
Background InNA
NA
The difficulty National CancWe thank M. Go
DNA methylatiNA
NA
BACKGROUNDGenentech
Alt
Supported by
CXCR1 is one o
NA
NA
Both genome-w
National Inst We thank A. Ka
Background Cer
GlaxoSmithKliDD, GD, FS, an
Applying a nexDana Farber/HWe would like
Ischemia-assoc
National CancWe thank Susa
Nanoparticles National Inst This work was
The US Nationa
NINDS
Funded by NI
The modificat NA
NA
Regulatory netBreast CancerWe thank Scott
The mammalian
American Canc
We thank M. Ba
We performedLudwig InstituWe thank E Sch
To identify s NA
NA
Decremental lo
Human FrontieWe thank M. Bh
Mitochondrial NIH [K08DK072
K. Uyeda and
Diversity and Associazione IThis work was
Telomerase act
NA
NA
Graphene quant
NA
NA
Aristolochic a National Inst We thank ShihThe intestinal NA
NA
Medulloblastom
National Inst M.D.T. holds a
Nanoparticles NA
NA
In eukaryotes,NA
NA
Background: To
National Inst This study wa
Most mutations
Washington Un
We thank the
Microvascular American HearWe acknowledg
Cell-cycle arr NIH/NCI [RO1 We thank Dr.
Metabolic reprNIH [K08HL107
We thank T. R.

2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012

44
366
13
482
488
NA
481
379
481
379
482
149
NA
18
NA
366
NA
483
13
18
149
7
490
NA
148
485
44
NA
149
481
122
NA
NA
109
NA
482
NA
492
7
150
109
149
336

1
12
1
7383
7409
NA
7380
9814
7381
9816
7384
3
NA
5
NA
23
NA
7390
1
3
7
6
7419
NA
5
7396
2
NA
1
7381
3
NA
NA
21
NA
7386
NA
7427
5
2
24
6
6084

Among the key

Glenn FoundatWe thank the
Background Dab
GlaxoSmithKliGlaxoSmithKli
TranscriptomicNA
NA
Cancer immuno
National CancWe are gratefu
The Hippo path
NA
NA
Objective: To NA
NA
BACKGROUNDNational
Be
CancSupported by
Effective targ Leukemia andWe thank K. Li
Context Recent
Amylin; JohnsoAll authors ha
Background Da
GlaxoSmithKlin
Funding GlaxoS
Background and
European FedeThe study was
Background Bev
Sanofi-AventisSupported by g
BACKGROUNDNovartis
Tre
Phar Supported by
Background Erl
Spanish Lung Spanish Lung C
MedulloblastoCIHR ClinicianM. D. T. is th
Guanine-rich Wellcome TrusWe thank Astr
BACKGROUND:
NA
Ac
NA
BACKGROUNDPeter
Wa and Hel Funded by the
Early T-cell
St Jude Child We thank the m
Metastasis and
NA
NA
Currently, no NA
NA
Wnts are lipid Howard Hughes
We gratefully
BACKGROUNDIncyte;
Rux Exelix Dr. Verstovsek
Checkpoints thDFG [Ru745-11
This work was
Cells are orga NA
NA
The functionalNIH [CA12555This work was
Metastasis is NIH [DK088945
We thank I. Be
Protein-foldin NA
NA
The identific Macrogen Inc We thank the l
Background: Pu
NA
NA
U1 snRNP (U1),
Association F We are gratefu
An extensive rNA
NA
To gain insig Carlos Slim H We thank the m
Background Bo
Amgen Inc.; AAmgen Inc.MRS
Extensive chaNA
NA
Through an intMinistry of E We thank M. Iw
Exogenous doub
US National I We thank Z. We
Recurrent chroStarr Foundat We thank membe
Degradation ofMarie Curie I We would like
BACKGROUNDAstraZeneca
Ola
Supported by
The tumor micr
National HumaThis work was
IMA901 is the German 'FordeWe thank all i
Cytotoxic CD8NA
NA

2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012

482
380
NA
482
NA
NA
366
485
307
379
19
366
366
13
488
8
NA
367
481
NA
NA
337
366
148
NA
21
148
NA
22
NA
150
NA
109
379
44
18
44
484
149
366
22
18
NA

7386
9839
NA
7385
NA
NA
4
7397
17
9829
1
4
9
3
7409
3
NA
9
7380
NA
NA
6090
9
5
NA
1
###
NA
3
NA
1
NA
10
9810
1
3
2
7392
6
15
2
8
NA

Background Mos
NA
NA
Just over 2 ye NA
NA
BACKGROUNDNational
Fam
Inst Supported by
BACKGROUNDGenentech;
Dys
NaSupported by G
Background Rad
Medical Resear
Medical Resear
Medulloblastom
NA
NA
Reversal of prNational Inst This work was
Kinase inhibit NIH [GM30324,
This work was
p53 is a frequ Breast CancerWe would like
Macrophages a
NA
NA
Cancer is a di NA
NA
Inhibition of National Inst We thank Dr.
The DNA-damage
FIRC (FondazioWe thank V. Da
A 37-year-old NA
NA
Pancreatic ducNational CancWe thank Rand
The involvemen
NA
NA
Background: PNA
NA
We identified National Insti This work was
CharacterizatiNational Inst The authors th
Objective: To NA
NA
Background: Se
NA
NA
Background End
Ovarian CanceThis work was
MyelodysplastiUS National I This work was
Human non-smal
Korean HealthThe authors th
Hepatocellula INCa; ICGC; L We warmly than
The blood vessDoD [W81XWHThe authors t
Lineage mappin
National CancA.E.P., Y.W.,
Despite declinNA
NA
Most anaplastiV Foundation We thank T. De
IL-17-producinNA
NA
Context ThereNational Inst All authors ha
BACKGROUNDNA
Pa
NA
BACKGROUND:
NA
Ge
NA
Gastric cance NUS GraduateWe thank S. T
Intestinal pha US National I We thank H. L
The aim was to
NA
NA
Background Rad
Cancer ResearFunded by Can
Burkitt's lympNA
NA
Self-assembly European ReseWe thank Z. T
Alternative c ERC (EuropeanWe thank all m
The abscopal e
National Inst Supported by g
AntiangiogenicBreast CancerWe thank Dr. J
BACKGROUND:
NA
It
NA

2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012

NA
NA
366
366
13
123
21
149
148
NA
NA
22
14
NA
21
NA
NA
18
487
NA
NA
13
44
44
44
7
149
62
4
NA
307
366
NA
44
13
22
366
NA
481
149
366
109
NA

NA
NA
2
23
6
4
3
2
###
NA
NA
1
4
NA
3
NA
NA
3
7406
NA
NA
4
1
8
6
6
1
2
120
NA
15
7
NA
5
5
4
16
NA
7382
3
10
8
NA

Tumor maintena
NIH [T32 CA00We thank Chri
Megalencephal
NA
NA
Background Da
National Cance
Funded by the
HepatocellularBayer ScherinAF has receive
The small inteNA
NA
Objective To i University of This study was
We characteriYale SPORE in This work was
We report tha NA
NA
While genetic Ludwig Instit This work was
The reactive tNA
NA
Neurotensin (N
National Inst This research
Because MYC p
The Sol GoldmThis work was
MicroRNAs (miNational Inst We thank Phylo
Background StRoche
LG is an advis
We detected clUS National I The GENEVA Co
Underlying mec
NA
NA
Tyrosine kinasNational Medi This study was
Identification Biomedical ReThis work is s
The cBio Cance
NA
NA
To assess the NA
NA
Glioblastoma (German Cancer
We thank Andr
Antibodies ag Institut de Sa This work was
PhosphoSitePlu
National Inst National Inst
Purpose Treatm
Sanofi; Regen Supported by
Although indivNational CancWe thank the m
Defective braiNA
NA
Little is know NA
NA
In the past deNA
NA
Acute promyelo
NA
NA
Background Cur
NA
NA
Background Rad
Merck Sharp Funding Merc
R-spondin protNA
NA
Background LeCelgene [MM-0
Funded by Celg
Identifying an National Inst The authors w
Background It French NationaSupported by t
The nuclear faNA
NA
SchistosomiasAustralian Re This project w
BCR-ABL tyrosiNational Inst This work was
Purpose: PatiePfizer; Eli Li R.C. Doebele h
The biogenesisNA
NA
Overcoming met
National Inst We thank B. V
The purpose oNA
NA
Rapamycin incr[AG022303]; This work was

2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012

149
NA
366
379
NA
345
44
NA
22
30
490
15
109
13
44
NA
18
148
NA
NA
22
18
40
30
22
NA
NA
NA
NA
NA
13
NA
366
488
366
NA
44
21
18
NA
485
38
11

3
NA
19
9822
NA
NA
9
NA
2
2
7421
1
31
1
6
NA
4
###
NA
NA
4
2
D1
28
2
NA
NA
NA
NA
NA
7
NA
19
7413
18
NA
2
2
5
NA
7400
4
4

Determining th
NA
NA
Breast cancer NA
NA
Background Hig
Programme Hos
Funded by the
Colorectal canU.S. National The work desc
Conventional p
Agency for Sc We thank Z.Q.
Targeted theraNational Inst This work is
Recent observa
NA
NA
In an analysis Intramural Re This research
Cancer-associAbramson Fami
We thank Carmi
By exome sequ
Ministry of HeWe thank all t
Pyruvate kinasNational Cance
We thank Micha
Purpose ThereNA
NA
Purpose Chromo
National Insti Supported by N
Current strateCancer Cente The authors wo
Background Paz
GlaxoSmithKliFunding Glaxo
Purpose: Poly(NA
NA
Susceptibility NA
NA
An update to tMerck and Com
P. Castle rece
Background PaEli Lilly and C Funding Eli Li
Prostate canc US National H We are gratefu
Background Hum
Zorg OnderzoeZorg Onderzoek
Background: Lo
Ultraviolet Fo The authors' r
The cytokine tThe Internati We thank C. Bl
Description: UUSPSTF
The USPSTF is
Sterile inflam NA
NA
Background Men
Australian Go Australian Gov
The circadian NA
NA
Inappropriate International We would like
Many synthetic
NA
NA
Although many
NA
NA
The programmed
NA
NA
Purpose To detNA
NA
The 1st inter NA
NA
Since the discNA
NA
Cell attachmen
NIH [P30 CA2 We thank Drs.
Purpose Brentu
Seattle GenetiResearch Fundi
Purpose To exaStatistics an Supported by
Most of the st European GranThis work was
The developmen
NA
NA
Circulating, c National Inst M. Tewari ack
When, ?20 ye
NA
NA
Polycystic ovaAndromed; ArdB.C.J.M.F. has
Context ApproTetraLogic; P All authors h

2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012

NA
44
366
22
18
483
NA
44
21
44
45
30
30
21
379
NA
NA
137
13
44
13
95
335
157
NA
13
NA
45
NA
NA
NA
30
NA
NA
26
30
30
22
NA
5
NA
97
307

NA
3
19
2
10
7391
NA
6
6
4
5
2
8
1
9829
NA
NA
4
3
6
1
1
6065
2
NA
5
NA
1
NA
NA
NA
9
NA
NA
1
18
14
2
NA
3
NA
1
4

Background Bra
Bristol-Myers Bristol-Myers
Inflammation iNA
NA
BACKGROUND:
National
Th
CancWe are gratef
BRAF mutationNIH Gastroint This study is
We conductedCenter
a
for CanThis work was
Context Adjuva
Scandinavian T
Shis study wa
The receptor-iNA
NA
We update inst
ESF [MTT8]; S We thank A. H
Background Scr
The NetherlanThe study was
Mutations in Feodor-Lynen We thank the A
Disease Overvi
NA
NA
Developing tisMax Planck SoWe thank M. S
Purpose The ex
NA
NA
The utility of Johns HopkinsWe thank Rama
Emerging evide
NA
NA
Epstein-Barr vNIH [R01-AI06This research
Purpose The AR
NA
NA
Heat shock pro
National CancIntramural Re
Purpose Preope
German Cancer
Supported by
Medulloblastom
Dutch Cancer Martin Sill a
Epigenetic repNA
NA
Neutrophils plNA
NA
Purpose RAF i National Inst Supported by
Methods: The Agency for HeThe USPSTF is
Background Fin
Merck Serono Regarding the
Nanorattles coNSFC [2110102
This work was
Glioblastoma (Leon Levy FouWe thank Agnes
Purpose This rGenentech
Supported by
Recent result NA
NA
Background. ANA
NA
Early diagnosiNational Natu This work was
microRNAs (miNA
NA
Invasion and m
NIH from the NThis work was
Light emissionSingapore NatW.Q and D. D
IgG4-related dNA
NA
Background: Ch
NA
NA
This article l NA
NA
Purpose: We stNA
NA
Purpose: To e National Heal This work is s
Background Afa
Boehringer In Boehringer In
Imiquimod is Austrian Scie We are thankf
Background &NA
A
NA
Recent demonst
NA
NA

2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012

13
NA
106
2
119
307
NA
709
13
488
87
484
30
10
NA
8
30
18
30
123
NA
NA
30
156
13
12
109
30
11
NA
33
NA
2
22
NA
NA
NA
NA
18
13
122
NA
NA

5
NA
4
3
12
12
NA
3
1
7413
1
7392
15
3
NA
1
3
1
16
4
NA
NA
3
12
1
1
8
17
4
NA
4
NA
3
4
NA
NA
NA
NA
5
5
2
NA
NA

Background: Pr
University of I certify that
Background: PNA
NA
X. Wu, C. ChenNational Basi Z. Zhang, L.
Purpose Our grUS Department
Supported in
Stromal respon
National Inst We thank L.J.
Purpose DecisCanadian BreaSupported by
NA
Olympus CorpThe authors di
Emerging evide
National Inst This work was
Objective: To NA
NA
Background D2
F Hoffmann-LaFunding F Hof
BACKGROUND:
NA
Ad
NA
Dendritic cel NA
NA
In this work, National Basi This work was
Purpose GefitiNational CancSupported in
We examined National
th
Inst This work was
NA
B-K Medical; BThe unrestrict
Natural killer NIH [AI042370We thank M. M
Nuclear factorNA
NA
A novel cell-t NA
NA
Purpose PatienNational Scie Supported by
Background Abi
Janssen ReseaKF served as c
Traditionally, NA
NA
Objective: Th NA
NA
The molecularGeneralitat V We recognize t
Glaucoma is aCanadian Inst We thank Dr. T
Purpose Cross-Novartis; Nov Employment or
Objective ColoUS National I This work was
The shape cont
MOST of ChinaWe thank the
Although ovariNational Cance
We thank Dr. R
Background Ad
Susan G. Komen
The translatio
Biochemical an
National ReseaC.S. is partia
The mTOR compl
NA
NA
Purpose: We i NA
NA
Purpose: TreatNIH
This work was
Background: Ac
Barentsz; Dut Dutch Cancer
Analysis of th Associazione IThis study was
HepatocellularNational Insti The supercomp
Objective: ChrNA
NA
OBJECTIVE-Type
European Found
This study was
NA
NA
NA
Continued reliASCO; AACR ISThis study was
Following the NA
NA
Mutations in t Virginia and Contract gran

2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012

61
NA
24
30
21
30
143
120
255
379
NA
NA
24
30
109
33
36
NA
NA
30
13
8
NA
44
31
30
61
24
109
104
83
NA
NA
18
61
119
44
NA
35
95
72
11
33

4
NA
11
4
6
6
3
5
3
9813
NA
NA
14
10
8
1
1
NA
NA
4
10
1
NA
7
2
22
6
7
10
6
1
NA
NA
7
1
2
7
NA
2
2
6
2
1

The ability to NA
NA
Background Est
National Insti Study 1: Nati
Context AlthouNational Inst All authors ha
The identifica National Insti We thank R. P.
A critical reg National Inst We thank Drs.
OBJECTIVES: Us
Department ofThis study was
Trading up: A NA
NA
MyelodysplastNational Inst This work was
Large volume NA
o
NA
Purpose A rand
National CancSupported in p
Bioorganometal
European ReseWe thank the E
Chronic obstruBoehringer-PfiMD has receiv
Highly amino-fNA
NA
Purpose BCL2 Abbott
o
LaboraResearch Fund
Purpose Adult Kyowa Hakko K
Supported by
Data from laboNational CancVITAL is supp
Most present nNational Natu This work was
The target of Canton of Fri We thank Tom D
On November NA
16
NA
B-cell recepto CLL Global ResThe study was
In this work, National NaturThis work was
Epstein-Barr vAmerican Canc
We thank Z Mou
The mammalian
NA
NA
Purpose System
Seattle GenetiResearch Fundi
Theranostics, National Basi This work was
Small-molecule
PharmacyclicsThis work was
Purpose: CircuNA
NA
Background-Klo
NA
NA
OligodendrogliBC Cancer FouWe would like
Purpose This pNovartis Phar Supported by
Previous studiNA
NA
Background Afa
Boehringer In Boehringer Ing
The detection The National Grant sponsor
HepatocellularInstituto de S Carlos Rodrigu
Photothermal N
t ational Basi This work was
Context: WideNA
NA
DNA methylatio
NA
NA
NA
National Basi This work was
Background Sin
NA
NA
Aims The impac
NA
NA
We have develo
National Natu The authors a
Synthesis andJuvenile Diab This study wa
With the develNational Basi This work was

2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012

NA
41
307
483
109
107
NA
119
NA
30
48
379
NA
30
30
33
134
46
119
119
33
31
NA
30
33
119
NA
NA
226
30
55
13
130
56
33
61
NA
24
NA
NA
183
23
33

NA
1
15
7390
6
1
NA
14
NA
13
43
9823
NA
5
8
1
13
1
12
5
4
9
NA
18
7
11
NA
NA
1
3
7
5
7
NA
7
6
NA
9
NA
NA
10
2
2

Classical den National Inst This work was

We report the National Natu This research
Purpose The ka
Instituto de Supported in
Purpose: To dePhilips Medic W.A.B Financia
Promising newNA
NA
Background: In
NA
NA
An enzyme-free
EU
This study was
Circulating miNIH; Statens SGrant sponsor
The promisingNA
NA
BACKGROUNDNational
&A
Cance
Supported by t
Identifying th AstraZeneca; David Solit h
Pharmacologica
NA
NA
The recently i DFG (Deutsche
We thank Colet
Background &NA
A
NA
Background We
Roche; GlaxoSBG received h
BACKGROUND:
Tianjin
De City Research Fund
Purpose We eva
National Inst Supported in
Specific and sNA
NA
Background ALK
Pfizer; Abbot DRC, Y-JB, ELK
Background ME
GlaxoSmithKliGlaxoSmithKli
Purpose MutatNational Cent Supported by
Background Rec
973 project o This study wa
The histone me
Puschelberg FThis work was
Background: Th
Dutch Cancer The ERSPC Rot
Purpose: TherNIH [P01 CA12The study was
Background Ad
Breast CancerThis work was
Purpose: To coAstraZeneca; L. Bastholt h
Background: Pa
NA
NA
Background ToHong Kong Res
This work was
Background The
Pfizer
This study was
Purpose To estAmgen [AMG38
Research Fund
Mitochondrial NA
NA
Recent studiesScience and TThis work was
Purpose The NO
Kjell Magne TvEmployment or
Cell cycle arr NA
NA
Purpose RidafoARIAD Pharmac
Supported by
BACKGROUND:
Bayer;
A
BMS Jean-Luc Raou
Brain metastaEuropean AssoDr. Preusser
Purpose: Age-NA
NA
Background The
Cell Genesys Cell Genesys
In this study National Basi This project
Colorectal canNA
NA
Background: Th
NA
NA

2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012

209
33
30
262
NA
NA
84
130
NA
142
31
NA
53
NA
13
58
30
NA
13
13
30
61
72
61
18
104
18
NA
61
13
30
NA
316
30
NA
30
118
123
NA
13
6
17
NA

6
4
8
2
NA
NA
2
6
NA
4
4
NA
6
NA
2
3
6
NA
10
8
8
2
1
6
4
6
2
NA
1
4
4
NA
2
15
NA
1
1
2
NA
5
4
1
NA

BACKGROUNDNA
Mea
NA
BACKGROUND:
The
T M.D. AndeThis work was
Purpose The AV
Genentech; F. Supported by G
Introduction: NA
NA
Gene therapy NA
h
NA
Over the past Cancer ResearWork in the la
Purpose: We pr
NA
NA
miR-122, an ab
NIH [CA122694
We thank the O
Hairy cell leu Associazione IThis work was
Cellular stres NA
NA
BACKGROUND:
NA
To
NA
Sunitinib is a Swiss NationaGrant sponsor
Background: Pr
NA
NA
A highly sele NA
NA
We have recent
NA
NA
Background The
US National InUS National In
The Janus kinaNational Inst Supported by
Atrophic gastrNA
NA
Purpose Olapar
AstraZeneca; Supported by
Cancers of oriAmgen; Bayer;Aram F. Hezel
We developedNational
a
Rese This work was
The 3-year FRNA
NA
Disease overviNA
NA
Hepatitis B vi National Key This research
Purpose This sNational CancThis work was
Purpose: The aSeattle GenetiM.A. Fanale, R
Objective: To Wilhelm SandeSupported by
Investigation NA
NA
The phosphatid
NA
NA
Background: PNorwegian ResNorwegian Res

2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012
2012

9
118
30
7
NA
13
187
122
119
NA
NA
130
NA
NA
NA
13
30
44
30
17
3
NA
NA
8
44
18
97
NA
NA
156

2
16
17
2
NA
3
3
8
1
NA
NA
1
NA
NA
NA
5
9
1
4
1
9
NA
NA
5
1
1
2
NA
NA
7

Beginning Ending
Scopus
page
page
citations
1033
U90
305
69
80
319
1071
U148
396
553
567
367
824
U121
254
869
U103
242
209
221
397
431
U132
385
468
U121
259
318
U68
215
NA
NA
454
968
U370
361
313
324
153
NA
NA
430
1031
1035
154
225
234
331
839
843
254
NA
NA
5836
NA
NA
837
2893
2917
2260
711
723
1430
733
742
703
1117
1134
432
899
905
548
809
819
1067
191
U73
510
98
110
766
1693
1703
996
1297
1303
572
184
U66
384
999
1005
376
446
450
323
411
422
906
1525
1535
282
1066
1071
144
461
U72
176
2380
2388
914

Web of
Science
Mendeley Altmetric.
citations
readers
com score
267
270
43.034
292
303
8.828
360
237
13.1
349
203
21.458
224
246
19.34
219
218
19
366
155
8.024
348
171
2
227
228
2
179
218
2
393
81
7.024
314
108
15.232
143
203
15.668
385
74
1
139
177
13.808
301
110
2.75
235
126
6.504
4982
166
8.556
710
1213
21.676
1676
374
NA
1221
174
42.68
518
206
188.048
388
630
1
492
439
21.24
972
124
36.546
441
317
58.994
687
262
16.096
814
113
32.618
510
310
23.41
344
333
50.448
349
348
29.02
286
358
5.624
776
6
20.724
241
245
50.252
460
255
32.738
165
352
24.616
698
60
2.25

210
2211
765
596
687
NA
432
402
NA
121
24
1670
993
11
NA
720
733
1114
893
NA
2424
510
NA
15874
NA
473
NA
NA
360
NA
172
NA
D5
NA
1061
132
NA
NA
1106
NA
1624
NA
609

217
2219
781
599
697
NA
445
415
NA
128
35
1681
998
22
NA
U3
739
U126
U61
NA
2433
522
NA
15879
NA
477
NA
NA
363
NA
178
NA
D16
NA
1068
140
NA
NA
U196
NA
1633
NA
612

232
317
783
434
705
435
260
523
172
763
557
628
315
412
139
208
147
350
202
204
364
375
224
135
149
220
297
242
295
308
408
462
280
172
564
422
284
207
134
214
411
230
132

218
193
480
386
556
397
240
404
155
584
463
469
279
374
126
190
130
315
197
186
359
342
206
125
95
208
264
209
273
278
367
414
203
149
454
384
274
178
125
187
337
211
129

282
159
124
208
110
236
306
146
317
83
152
94
250
216
320
191
294
173
276
245
105
184
168
0
58
197
205
231
172
178
125
96
214
191
59
88
107
222
255
174
6
194
197

36.074
82.938
6.28
18.904
7.4
1
7.344
25.376
17.78
NA
5.5
19.016
8.818
0.25
15.624
50.11
16.97
14.796
1
14.84
36.048
2.75
38.208
129.92
105.758
23.454
2.25
1.25
11.4
5.64
6.128
6.04
NA
24.814
1
12
30.272
NA
NA
16.448
46.398
NA
18

NA
235
343
NA
1109
NA
598
348
NA
124
228
NA
NA
NA
1352
1292
446
NA
1147
181
829
NA
86
583
570
243
1067
NA
133
21
171
683
NA
521
939
722
753
1195
440
NA
NA
1437
197

NA
244
U101
NA
1113
NA
U169
U110
NA
131
231
NA
NA
NA
1360
1303
457
NA
1154
U124
U128
NA
U119
594
U139
254
1073
NA
U155
28
183
695
NA
531
953
U109
762
U176
446
NA
NA
1446
208

222
374
140
280
237
242
123
171
153
288
230
210
281
114
191
351
321
249
477
258
253
132
216
221
201
217
221
113
158
369
198
294
216
203
148
254
336
156
203
143
180
346
267

202
316
128
228
225
221
117
159
134
262
211
200
244
105
159
274
268
218
406
245
227
76
195
198
183
205
206
107
147
315
185
260
204
189
133
247
282
132
188
5
162
299
247

144
76
226
159
170
169
213
171
37
143
116
171
139
220
135
78
115
145
20
92
101
117
153
148
126
144
38
135
121
71
143
87
114
111
160
94
75
161
132
200
149
51
93

21.548
18.304
1
1
1
1
7.8
14.05
76.052
NA
23.56
NA
NA
NA
20.714
13.656
1
2
7.056
18.524
17.09
40.51
1
2
14.624
NA
44.822
27.072
22.968
0.25
2
6.306
9
13.056
4.4
7.024
2
2
1.85
2
NA
7.056
3.25

247
1273
662
NA
2784
1532
767
172
NA
3167
967
180
298
827
1963
341
NA
403
NA
18392
1203
1192
245
S1
NA
213
NA
798
852
133
798
510
2536
NA
433
NA
1124
362
15449
17442
803
1117
2037

U52
1281
674
NA
2795
1543
774
178
NA
3175
975
188
301
U109
1972
U67
NA
417
NA
18397
1210
1202
251
S63
NA
U17
NA
804
U58
144
802
523
2559
NA
443
NA
1130
375
15454
17452
807
1127
2042

280
311
210
111
343
262
183
407
300
328
176
252
150
164
360
209
153
140
216
211
166
326
271
190
123
215
139
122
195
157
185
127
286
128
287
122
276
160
160
218
159
279
154

260
248
189
105
286
230
147
367
270
292
139
223
138
147
343
174
135
124
NA
189
130
286
226
151
102
189
132
120
175
143
168
112
243
83
237
115
219
137
150
186
134
250
135

91
58
129
178
65
61
146
9
24
63
42
95
151
125
30
118
114
108
129
96
25
47
51
79
154
108
140
148
99
120
115
114
46
113
65
145
76
126
122
75
104
14
126

1
13.296
1
1
1.25
18
NA
6.128
22.84
NA
44.446
3
NA
6.922
1.5
1
12.704
18
16.12
6.904
49.514
3.25
14.288
20.13
1
NA
1
NA
6.328
5.2
1
14.418
9.888
18
2
NA
NA
1
1
10.256
10.296
21.48
1

NA
501
1741
1674
521
NA
NA
135
117
1048
5132
166
688
986
NA
116
1254
NA
181
49
91
77
493
1253
25
283
NA
NA
1555
NA
409
1
207
NA
NA
568
665
1052
1795
NA
NA
13
829

NA
U116
1750
1685
529
NA
NA
147
134
1056
5139
193
U56
993
NA
U157
1261
NA
200
61
102
88
506
U268
36
287
NA
NA
1577
NA
U103
22
221
NA
NA
571
667
U122
1803
NA
NA
27
840

223
154
229
238
438
185
116
179
153
262
330
237
155
187
141
130
191
156
215
142
176
242
165
138
177
216
124
188
169
137
174
417
134
168
140
140
188
149
282
116
116
173
134

211
139
187
182
313
161
103
159
129
212
224
221
141
159
133
114
169
148
193
133
152
212
153
120
157
190
116
164
162
124
158
306
109
164
131
129
187
130
223
100
101
161
129

68
107
4
88
4
109
143
110
128
75
53
79
89
40
128
136
86
97
90
121
64
58
108
90
106
39
132
99
104
19
78
0
88
98
43
99
72
110
52
129
128
93
114

9
8.154
38.354
1.75
NA
1
1
1.25
NA
0.5
1
NA
14.464
29.762
NA
NA
7.808
9
NA
2
20.456
8.208
2
16.704
1
21.194
NA
1
1
45.288
11.716
NA
16.976
2
32.752
8.84
7.024
2
1
1
1.25
2
1

8788
28
4697
46
3239
1812
249
504
2101
374
28
3318
1409
41
677
759
NA
NA
4311
1324
398
339
1099
345
443
12704
1684
NA
1172
652
NA
365
1801
118
55
NA
38
NA
627
NA
NA
1812
154

8793
62
4705
58
3247
1821
257
U47
U119
U66
40
3323
1426
52
U257
767
NA
NA
4316
1334
406
344
1105
352
454
12709
1691
NA
1176
665
NA
379
1811
126
65
NA
47
NA
636
NA
NA
1820
159

173
285
324
243
285
241
226
219
189
118
179
269
217
152
205
173
190
135
122
171
355
181
296
139
169
129
188
134
151
129
126
141
198
223
249
184
240
137
149
117
150
219
204

151
192
248
214
237
194
208
204
154
112
170
253
185
137
184
163
164
125
119
157
286
164
247
119
151
110
151
112
141
118
112
127
171
186
218
145
179
123
118
88
134
183
151

99
60
29
45
44
34
47
69
91
114
85
4
47
73
74
88
82
94
110
20
4
59
29
105
88
107
80
104
91
103
103
99
52
61
45
75
58
97
55
113
88
39
70

0.5
NA
2
7.712
NA
14.298
8.296
NA
NA
2.5
1
15.738
10.954
12.458
NA
NA
0.5
6.024
1
29.33
NA
10
NA
NA
NA
1
1
1
1
1
2
NA
8.532
NA
NA
3
NA
1.25
18.314
NA
1
7.84
NA

364
440
67
NA
NA
651
1733
1517
1095
NA
382
466
1029
3657
251
725
NA
875
537
793
552
141
694
41
NA
1734
NA
810
155
436
1721
118
315
NA
1145
320
NA
NA
707
2927
NA
4256
NA

U114
446
78
NA
NA
655
1741
+
1099
NA
395
474
1035
3666
264
732
NA
885
544
U94
557
U59
705
52
NA
1739
NA
U359
164
U75
1726
128
330
NA
1153
327
NA
NA
712
2931
NA
4265
NA

141
141
136
124
117
136
134
164
140
168
124
224
232
149
128
265
111
253
223
128
200
198
151
250
171
238
115
198
182
165
219
227
129
113
213
136
126
118
132
158
127
277
136

117
127
124
117
93
121
118
149
121
145
119
183
192
130
112
222
97
222
204
124
173
165
151
206
145
178
NA
173
160
147
200
184
122
106
170
128
112
107
111
140
113
223
126

93
92
91
96
81
62
94
75
86
72
95
51
37
85
93
0
103
31
43
88
58
58
70
34
69
38
124
52
62
70
41
40
59
93
49
59
87
88
85
70
83
4
79

1
NA
1
1
10.8
13.352
NA
1
2
2
NA
NA
4
NA
1
12.492
NA
NA
0.25
1
NA
1
2.25
NA
1
2.5
1
1.25
NA
NA
NA
1
11.04
NA
NA
9
NA
1
NA
NA
1
5.008
NA

126
1684
NA
NA
1189
1070
1794
NA
3219
982
NA
NA
NA
14903
816
NA
384
191
610
NA
2144
NA
282
3467
2137
927
390
NA
499
1804
198
NA
170
1489
1496
454
2091
1410
D652
NA
264
NA
2348

131
1692
NA
NA
1196
1076
1805
NA
3226
992
NA
NA
NA
14908
823
NA
391
199
U175
NA
2150
NA
293
3474
2143
933
401
NA
505
1809
U105
NA
179
1495
1501
U136
2101
1413
D657
NA
269
NA
2355

288
163
169
150
165
290
183
254
216
129
110
132
112
124
139
119
183
136
124
120
222
117
130
138
227
169
138
263
169
212
204
124
156
207
208
126
172
151
147
109
173
115
181

235
131
146
129
137
241
171
194
171
117
99
107
98
113
123
96
170
115
112
95
180
91
114
137
174
130
130
239
158
151
188
81
138
178
180
109
161
129
124
97
138
111
175

7
23
63
59
32
4
51
24
40
77
89
41
74
80
71
86
4
76
64
50
35
87
76
67
34
56
66
3
52
43
34
66
57
36
35
72
24
57
64
81
53
73
40

0.5
19.984
NA
5.8
14.716
0.25
0.25
1
1
1
NA
16.888
5.784
NA
1
NA
19.056
NA
6.736
15.218
NA
NA
NA
NA
NA
2
1
1
NA
NA
NA
8.208
1.5
NA
NA
1
10
2
NA
NA
NA
1
NA

NA
943
1138
205
434
72
45
NA
2512
509
659
2523
NA
NA
288
4539
562
410
224
NA
NA
1638
2989
1166
5
128
513
439
317
513
459
69
NA
3271
1247
NA
3141
2181
1030
136
NA
NA
4275

NA
953
1144
U115
439
79
55
NA
2519
518
666
2558
NA
NA
298
4550
569
U65
U29
NA
NA
1644
2995
1176
16
138
U141
449
328
520
463
76
NA
3277
1260
NA
3148
2190
1047
146
NA
NA
4280

152
248
209
145
121
207
142
153
189
165
185
125
111
180
176
161
182
161
134
146
119
203
155
184
157
247
208
198
124
199
134
216
128
151
181
109
164
173
249
147
148
115
129

129
210
153
130
112
157
121
141
164
138
162
109
106
176
162
154
149
146
124
128
96
170
156
154
132
220
166
150
119
174
121
173
118
136
172
103
138
136
218
130
123
105
117

58
9
38
58
71
34
63
54
38
49
39
69
71
35
40
46
39
48
34
56
61
30
46
39
52
3
29
36
63
25
57
21
61
50
32
70
45
41
0
51
48
66
59

1
1.25
NA
1
NA
1
NA
NA
NA
1
NA
NA
1
NA
NA
NA
1.25
NA
11.5
0.25
4.992
NA
NA
NA
NA
0.25
NA
NA
NA
1.25
1
1
NA
NA
NA
NA
NA
1
NA
NA
2
NA
NA

NA
339
240
NA
325
49
NA
NA
1174
NA
NA
2739
242
NA
103
NA
NA
744
NA
NA
1589
2698
2137
36
4706
NA
229
NA
1989
1117
3636
817
2191
NA
NA
3119
448
NA
406
70
911
NA
767

NA
349
243
NA
339
U84
NA
NA
1179
NA
NA
2745
255
NA
U114
NA
NA
752
NA
NA
1597
2704
2143
U51
4713
NA
232
NA
1999
1123
3643
843
2199
NA
NA
3127
U135
NA
U63
98
917
NA
772

125
123
152
127
153
163
136
109
156
138
111
134
191
116
126
185
125
232
116
145
152
153
227
145
188
141
133
109
138
183
164
147
166
122
121
145
172
126
136
197
174
153
174

105
110
138
107
118
137
122
105
130
128
98
120
115
107
120
172
109
179
110
133
138
131
174
122
140
133
117
102
119
158
159
120
143
92
102
122
156
107
120
159
128
133
132

56
60
31
62
25
43
54
63
46
51
64
54
41
62
53
25
56
11
60
46
40
44
13
34
30
46
48
63
40
26
31
35
18
41
58
46
27
55
46
19
36
24
32

3.2
1
6.8
NA
11.25
NA
NA
1
NA
NA
1
NA
NA
NA
1
NA
1
NA
NA
NA
1
NA
NA
6.152
1
NA
2
NA
4
0.25
NA
4.95
7.274
8.464
NA
NA
1
NA
1
1
NA
6.656
1

1580
843
2088
1235
13075
2817
NA
NA
72
181
NA
88
291
5923
1650
5866
121
R227
5213
699
NA
89
NA
696
426
1481
655
12690
NA
NA
92
509
NA
1835
3617
377
1597
NA
NA
1073
16759
30
2712

1587
851
2100
1240
13080
2823
NA
NA
85
187
NA
U97
297
5930
1653
5875
134
R240
5219
708
NA
95
NA
706
433
1488
661
12697
NA
NA
98
515
NA
1842
3622
384
1604
NA
NA
1081
16765
35
2718

139
164
138
121
122
167
109
113
114
135
141
199
141
149
132
121
116
139
126
111
126
195
144
153
215
164
127
114
127
109
147
139
114
162
194
216
146
110
137
172
124
152
143

111
158
111
115
113
158
83
97
109
111
102
182
132
122
124
109
119
123
118
109
105
167
34
124
170
143
113
109
110
93
122
117
107
139
166
178
125
95
127
138
111
137
123

49
29
49
52
50
25
40
42
54
48
46
6
36
39
40
47
45
38
45
50
45
12
48
22
5
25
38
47
43
52
34
35
44
25
9
0
30
50
31
21
18
26
30

NA
NA
NA
NA
1
1
10
6.84
NA
NA
1.25
2
1
NA
1
1
1
1
NA
NA
1
NA
6.338
5.104
NA
NA
2
NA
NA
NA
NA
1
1
NA
NA
NA
1
NA
1
NA
9.708
NA
1

3109
1547
3206
925
NA
NA
NA
52
NA
NA
NA
NA
766
NA
62
1106
NA
99
3784
1972
3605
1451
129
NA
NA
NA
NA
NA
1749
3011
1301
1756
619
NA
NA
NA
789
547
NA
NA
2408
375
NA

3117
1553
3214
935
NA
NA
NA
64
NA
NA
NA
NA
776
NA
73
1111
NA
119
3796
1978
3610
1461
137
NA
NA
NA
NA
NA
1755
3020
1307
1765
626
NA
NA
NA
845
557
NA
NA
2416
379
NA

130
145
128
166
111
137
115
172
133
116
116
118
145
114
187
141
131
194
190
124
144
148
152
119
133
116
110
166
161
162
140
144
157
122
124
124
116
138
114
109
114
134
110

110
114
117
155
100
108
98
141
102
106
99
107
118
100
167
125
128
177
153
110
118
117
116
103
100
105
99
139
132
143
110
120
129
123
107
105
111
121
98
95
112
115
94

37
32
33
17
44
37
43
18
4
42
44
40
31
41
3
29
30
0
8
36
29
27
25
39
34
39
42
16
16
12
29
25
19
29
33
33
33
22
32
36
32
26
31

1
1
2
NA
1
NA
1
NA
15.044
NA
NA
0.5
NA
1
1
NA
NA
NA
NA
0.25
NA
0.5
1
NA
1
NA
NA
NA
1
1
NA
NA
NA
NA
NA
NA
NA
1
2
1
NA
NA
3

1304
NA
2073
NA
1638
NA
2715
1561
203
NA
245
563
NA
6001
42
NA
811
NA
NA
3061
1135
NA
NA
NA
241
NA
NA
NA
NA
340
NA
NA
NA
NA
NA
322
NA
NA
2339
886
NA
NA
NA

1308
NA
U87
NA
1645
NA
2730
1571
209
NA
254
571
NA
6013
47
NA
817
NA
NA
3068
1139
NA
NA
NA
255
NA
NA
NA
NA
345
NA
NA
NA
NA
NA
326
NA
NA
2349
893
NA
NA
NA

135
117
186
183
126
113
125
132
162
131
129
142
142
117
154
112
125
126
121
118
130
123
112
112
118
111
133
115
117
140
116
112
115
111
118
150
154
113
124
134
126
117
109

109
98
156
140
110
104
112
118
154
105
112
110
107
114
139
99
110
115
120
114
119
89
97
100
109
102
112
107
105
126
86
104
95
98
103
109
123
89
109
108
105
104
96

25
28
0
3
28
30
24
22
4
26
24
19
22
26
9
31
24
22
21
23
16
27
26
25
23
26
17
22
22
10
25
23
24
21
20
7
4
24
15
12
14
16
19

1
2.75
NA
1
NA
1
1
NA
NA
NA
NA
1
NA
NA
NA
NA
NA
NA
NA
NA
1
0.5
1
1
NA
NA
NA
NA
NA
NA
1
NA
0.25
1
NA
1
NA
NA
NA
NA
NA
NA
0.5

485
NA
NA
4099
4153
NA
NA
NA
NA
NA
NA
NA
NA
5649
NA
2040
NA
344
NA
NA
1135
662
NA
NA
NA
NA
277
524
903
148
NA
231
346
344
17
106
179
211
NA
222
370
7950
197

497
NA
NA
4102
4158
NA
NA
NA
NA
NA
NA
NA
NA
5669
NA
2045
NA
352
NA
NA
1141
669
NA
NA
NA
NA
300
U124
916
163
NA
234
U119
357
30
U128
U76
U105
NA
U129
381
7955
203

150
109
145
135
130
113
120
110
120
110
109
146
113
132
114
140
144
131
116
112
128
130
114
111
113
144
NA
157
168
72
87
119
124
110
257
145
67
207
117
172
90
142
98

129
88
132
127
124
97
101
98
103
108
98
121
111
114
107
111
87
128
97
81
111
109
100
96
99
NA
NA
142
154
65
1
112
112
89
239
126
66
175
111
148
76
128
90

0
22
0
3
5
17
14
15
10
13
16
0
11
5
11
1
9
0
9
13
0
0
5
3
1
13
0
211
195
245
130
228
163
210
154
137
154
151
142
159
124
144
150

NA
NA
NA
NA
NA
NA
NA
1
1
NA
NA
NA
NA
NA
NA
1
NA
NA
NA
NA
NA
NA
NA
1
1
NA
NA
50.588
33.936
12.38
67.786
7.25
31.85
14.366
3
31.936
31.042
2.25
21.788
3.5
34.12
12.5
16.268

547
69
1244
725
212
395
1625
NA
353
609
NA
90
1549
NA
232
NA
102
63
31
519
467
534
204
2405
1995
214
97
415
179
359
2181
99
NA
2517
54
101
NA
NA
NA
NA
539
815
NA

551
90
1253
733
236
409
1633
NA
358
615
NA
U119
1556
NA
U112
NA
U1700
U76
41
532
472
537
213
2416
2005
220
101
+
U212
365
2192
U102
NA
2526
U60
105
NA
NA
NA
NA
542
825
NA

82
4495
118
299
1396
596
86
386
192
657
227
268
175
297
154
204
133
358
274
88
262
94
216
701
572
263
114
261
156
190
385
101
209
558
132
264
208
249
133
238
234
190
110

75
2213
93
286
1156
446
66
340
177
528
86
252
150
275
139
116
111
319
245
71
255
87
171
545
488
234
98
165
143
162
293
90
181
457
106
249
191
224
120
209
223
149
95

138
430
60
328
163
147
61
606
618
395
540
488
57
362
195
205
369
293
103
151
310
181
229
63
71
221
34
292
327
278
57
138
223
62
276
130
259
126
152
235
211
102
273

25.004
47.232
533.016
305.61
43.458
195.278
326.406
13.5
48.576
48.498
48.218
33.5
240.9
80.812
180.828
164.736
73.858
39.592
137.266
139.312
26.25
111.186
60.39
31.592
34.392
33.208
142.54
6.328
3.5
16.022
71.14
91.95
29.884
22.054
18.15
45.58
1
47.5
60.392
1.5
9.282
67.98
7.352

64
390
NA
4294
D38
1157
1708
1307
2081
225
569
NA
NA
27
1461
NA
1817
NA
735
435
1154
423
D945
NA
198
545
1375
67
106
933
768
NA
362
NA
NA
1086
389
NA
NA
NA
394
514
408

69
+
NA
4301
D51
1160
1717
1311
2087
U268
575
NA
NA
40
1484
NA
1825
NA
742
439
1157
U182
D950
NA
203
552
1383
79
118
980
U77
NA
+
NA
NA
U91
397
NA
NA
NA
397
523
U61

195
107
139
165
229
234
220
94
85
82
398
249
216
284
98
280
395
222
355
194
176
189
262
168
147
85
140
154
219
122
129
96
144
225
290
98
148
122
92
175
181
460
158

190
100
138
134
194
199
178
84
77
71
319
233
156
287
81
250
299
205
256
175
156
171
237
151
117
67
108
152
209
94
123
74
144
166
259
85
133
95
80
158
173
371
142

156
261
172
32
214
144
159
109
10
236
40
170
136
15
60
103
4
172
99
162
122
185
123
190
162
110
36
157
108
82
172
188
159
44
11
143
128
5
137
161
130
9
144

35.06
10.466
39.6
94.688
NA
28.496
25.568
72.218
115.43
15.21
30.844
1
28.25
55.134
78.808
18.45
42.452
0.25
10.55
10.25
30.732
0.25
10.546
2.5
19.354
52.648
70.9
11.4
17.488
53.01
9.7
11.216
8.008
45.886
41.006
25.976
20.712
80.9
29.072
NA
10.048
7.306
10.344

1315
1577
298
1612
719
1199
2473
813
NA
98
1273
NA
1396
611
D691
1322
501
2750
7223
NA
NA
115
205
718
58
54
NA
2484
81
NA
139
356
435
NA
NA
1438
1576
NA
2381
NA
309
NA
NA

U202
1584
303
1616
729
1203
2483
822
NA
101
1283
NA
1405
619
D697
1326
513
2767
7233
NA
NA
U133
214
779
71
67
NA
2496
94
NA
146
+
446
NA
NA
1447
1585
NA
2391
NA
U51
NA
NA

118
90
179
181
116
212
183
365
91
89
199
163
117
110
199
148
376
146
156
124
185
143
269
106
163
136
83
187
88
144
154
181
76
172
127
245
113
131
162
85
146
79
106

99
82
178
166
97
190
141
273
70
75
156
139
74
94
166
134
305
118
124
109
162
131
209
76
138
117
68
153
78
123
124
172
73
134
113
210
87
124
124
79
148
62
96

53
91
81
145
77
130
25
46
158
113
45
27
51
45
138
130
34
104
157
170
126
138
55
152
141
133
139
35
133
132
66
120
156
58
137
51
0
122
49
142
115
105
143

58.93
47.148
29.4
2.75
47.516
2.5
56.328
10.958
17.6
36.05
42.8
56.034
58.55
58.856
NA
12.382
7.306
25.096
0.5
NA
5.6
8
19.458
11.75
2.5
11.296
19.8
42.428
19.78
7.936
35.08
1.5
9.546
32.99
6.256
18.322
69.238
9.296
37.216
10.77
7.024
29.25
5.184

2496
297
NA
74
NA
1736
2011
771
1317
1290
2497
67
1420
NA
371
NA
541
830
E56
869
2295
NA
127
NA
NA
189
101
NA
NA
2305
325
732
NA
425
150
829
NA
NA
NA
230
1408
NA
875

2506
303
NA
U99
NA
1747
2019
784
1322
U325
2506
78
1424
NA
U160
NA
U328
U33
E93
U79
2303
NA
138
NA
NA
U58
+
NA
NA
2315
+
744
NA
425
156
841
NA
NA
NA
233
1414
NA
U84

154
86
272
127
114
357
255
160
165
93
154
107
93
125
115
89
10
102
250
100
142
95
172
135
149
92
72
145
118
146
92
136
147
81
164
243
122
109
88
118
185
113
94

152
73
199
108
103
300
217
138
151
87
142
98
80
0
101
73
118
100
152
86
112
61
138
119
129
78
66
130
106
135
89
115
138
73
127
201
101
82
75
110
148
45
93

74
165
46
124
133
13
76
59
81
131
87
144
98
84
142
83
142
100
23
107
4
146
80
91
116
129
92
94
125
58
107
112
101
70
48
17
65
109
132
116
88
4
81

22.2
0.25
14.808
7.75
5.28
5.95
NA
27.208
15.558
9.65
15
1
24.308
36.85
NA
31.632
9
19.374
28.6
16.346
52.77
3
12.296
13.6
NA
6.75
26.014
8.7
1
22.504
12.872
2.35
2.5
30.958
24.724
20.25
24.738
8.85
2
1
1
57.602
20.12

27
61
3
NA
2119
31
NA
714
997
1005
NA
3085
107
2426
511
692
742
NA
NA
757
575
460
2055
382
269
250
576
161
782
NA
11
NA
597
2188
NA
NA
5003
NA
548
2085
NA
226
NA

U42
71
25
NA
2127
44
NA
736
1008
U73
NA
3096
119
2431
524
702
U134
NA
NA
768
586
470
2066
395
+
281
590
170
795
NA
24
NA
+
2197
NA
NA
5008
NA
553
2092
NA
U141
NA

115
359
212
124
159
98
172
152
217
82
105
181
71
95
87
101
94
230
77
113
136
145
101
79
88
174
75
94
110
79
105
260
96
90
106
176
261
178
111
96
116
71
101

94
292
196
117
134
89
155
126
183
74
101
160
65
86
79
87
80
0
61
108
120
133
86
71
80
146
66
84
103
67
112
232
82
72
84
141
232
147
92
78
105
70
98

109
3
59
85
60
95
85
75
66
72
85
77
108
120
124
120
117
112
59
107
73
86
40
97
115
73
97
115
90
65
89
7
93
42
40
74
26
67
81
27
51
109
104

5.68
NA
3
11.008
15.5
12.498
0.5
10.276
NA
25.528
13.748
1.5
11.398
1
1
NA
2.6
NA
31.398
1
11.458
3
33.35
12.25
2
2.5
12.64
0.5
7.048
25.514
6.55
10
9.25
33.05
30.4
1
1.1
2.5
10.458
36.898
20.752
4.85
NA

NA
200
104
633
NA
2103
255
1673
3713
442
1125
NA
191
717
NA
1931
917
NA
768
NA
25
NA
1384
926
NA
189
721
5111
5019
230
127
416
257
4550
NA
519
589
NA
NA
1004
11
1278
W339

NA
213
U128
644
NA
2114
U124
1683
3718
+
1132
NA
201
729
NA
1939
924
NA
772
NA
38
NA
1395
940
NA
U75
731
5116
5032
+
136
428
263
4557
NA
533
U109
NA
NA
1012
16
1283
W346

89
161
89
130
99
158
95
98
106
118
216
99
126
129
136
195
178
86
130
149
100
141
142
133
77
100
253
115
115
85
136
87
101
171
99
110
120
92
95
193
175
107
91

85
141
80
118
91
119
91
89
87
107
156
87
127
117
80
160
163
72
110
134
107
131
144
121
64
95
188
108
80
77
122
79
77
160
87
103
111
90
57
148
137
95
79

106
74
109
11
66
53
68
46
84
4
50
99
38
78
50
30
49
102
66
51
83
68
20
75
95
88
3
81
75
91
55
90
34
47
83
73
67
73
48
32
47
28
84

2
1
1.25
33.954
16.95
11.75
14.664
23.85
6.84
36.982
0.5
NA
18.28
1
16.568
8.75
2
NA
5.992
7.176
2
1
19.8
NA
4.45
1
9.072
NA
6.08
2.5
6.75
2.1
24.748
0.85
2
3
3.5
6.328
20.15
5.05
1.75
22.35
2

110
261
625
1389
530
1756
243
614
NA
NA
NA
461
1219
109
425
61
867
NA
NA
NA
NA
1315
62
160
572
NA
44
2594
7535
NA
1397
NA
2005
NA
1850
3749
6825
398
3921
1252
NA
257
1101

114
275
U108
1401
U153
U82
U380
624
NA
NA
NA
U101
U73
112
433
72
U256
NA
NA
NA
NA
1321
U85
174
583
NA
53
2605
7540
NA
1402
NA
2012
NA
1855
3754
6831
405
3928
1260
NA
272
U108

107
148
73
119
83
126
79
83
79
106
93
86
70
84
149
80
84
100
90
100
85
113
87
105
174
116
114
88
115
89
99
77
124
98
83
103
145
173
158
205
11
114
78

99
135
67
113
65
100
76
73
65
100
79
74
70
76
117
67
80
79
77
95
79
94
77
89
142
107
97
73
88
79
86
60
96
98
77
92
139
124
124
170
88
99
71

76
57
91
51
47
72
86
82
93
76
85
78
65
87
56
90
77
79
70
73
83
29
80
41
41
61
38
63
50
77
75
88
32
71
62
71
44
43
44
0
93
60
79

1
NA
1.75
8.208
19.794
NA
2
3.5
NA
NA
NA
4.25
11.874
NA
1
NA
3.5
1
5.7
1
NA
18.214
1
14.25
NA
2
13.264
8.25
9.056
1.35
NA
NA
14.35
NA
8
NA
1
NA
1
9
NA
1.5
0.5

1424
450
905
NA
NA
NA
4274
107
513
120
NA
NA
273
NA
221
NA
8
NA
54
NA
NA
NA
839
916
2451
1189
NA
11452
463
NA
1956
432
918
396
2128
584
NA
NA
NA
NA
412
232
418

1430
457
913
NA
NA
NA
4280
118
518
U138
NA
NA
288
NA
225
NA
32
NA
61
NA
NA
NA
847
922
2459
1201
NA
11457
469
NA
1962
448
931
409
2137
594
NA
NA
NA
NA
421
243
422

107
76
90
85
83
85
81
78
71
77
87
132
106
78
107
87
125
78
79
83
80
131
108
178
75
95
145
101
100
129
94
103
119
110
116
129
161
101
114
99
92
97
114

83
69
66
80
59
66
76
68
67
79
81
124
80
73
96
72
88
61
73
74
65
84
86
127
66
93
143
96
94
123
75
94
97
95
87
116
141
91
95
94
70
96
97

55
54
34
75
65
34
76
4
72
70
66
45
61
70
4
69
35
73
46
66
67
47
57
23
49
55
9
52
55
39
61
53
46
48
38
39
23
52
41
48
59
50
8

6.048
11.546
19
NA
6.75
18.894
NA
32.25
2.95
1
1.25
NA
1
1
23.196
NA
8.504
0.25
10.2
1
2
2.75
NA
1.75
9.25
1
9
1
NA
NA
0.25
NA
0.75
1
5.6
NA
NA
NA
2.5
1
NA
NA
16

1110
NA
17
179
969
852
1573
23
789
312
NA
NA
209
593
933
1453
2613
NA
NA
1239
2675
NA
2327
1715
81
477
3
236
1414
1009
142
NA
914
NA
139
875
927
235
1153
932
795
NA
2

1120
NA
24
184
980
861
1577
35
796
326
NA
NA
218
596
940
1455
2618
NA
NA
1246
2686
NA
2334
1721
97
494
8
244
1424
1018
U91
NA
923
NA
161
883
935
U127
1158
940
800
NA
12

111
129
101
87
90
116
92
82
135
80
173
141
124
69
117
66
85
81
90
139
120
171
128
127
97
95
83
98
105
124
109
146
117
143
82
79
140
90
100
75
106
108
85

96
103
77
74
69
102
101
72
118
70
2
121
96
67
98
65
79
72
78
110
90
127
104
100
88
76
71
84
83
103
95
135
82
117
81
74
111
86
97
67
91
101
79

46
39
51
55
55
29
33
56
29
58
48
20
39
39
40
38
53
56
31
30
24
14
4
33
46
50
53
44
16
34
40
15
38
13
49
51
25
43
39
9
38
34
46

NA
NA
1
1
1.25
5.25
6.2
1
1
0.25
2.75
3.25
NA
9.458
NA
10.4
NA
NA
9
NA
7.1
1.25
13
1
NA
NA
0.5
1
12.296
NA
NA
1.5
1
4.5
NA
0.25
0.25
1
0.25
19.402
NA
NA
NA

250
563
6051
2750
1116
575
478
792
NA
1891
2930
428
1535
363
456
NA
NA
3457
2866
NA
NA
369
608
591
761
67
NA
543
NA
22
681
134
334
3968
610
2502
2493
NA
763
NA
1949
117
4548

263
574
6060
2760
1122
582
484
804
NA
1901
2937
U235
1546
375
469
NA
NA
3465
2874
NA
NA
377
616
594
770
80
NA
552
NA
U156
692
141
343
3976
618
2511
2498
NA
773
NA
1955
U57
4554

102
113
89
91
99
79
80
87
78
82
84
82
125
71
75
84
122
104
176
135
99
112
92
114
108
105
96
111
78
149
111
160
88
101
73
113
113
101
107
125
75
88
108

95
101
67
82
86
67
75
76
63
70
78
72
96
69
70
79
91
87
135
121
86
102
71
99
85
99
83
92
63
122
84
119
86
67
70
94
103
84
82
112
77
72
75

37
30
40
40
38
46
35
42
14
24
43
17
27
46
44
42
29
25
0
16
35
27
40
21
31
25
34
25
35
9
28
4
22
36
42
25
22
24
27
16
38
33
6

NA
1
3.3
1
0.5
1.5
5
1
15.35
9.5
NA
12
NA
1
1.25
NA
NA
4
1
NA
NA
NA
NA
2
NA
1
NA
1
3.85
NA
0.5
1
5.08
NA
NA
NA
NA
2.75
1
NA
NA
1
9.806

317
NA
709
5845
3307
NA
4817
3918
607
3366
NA
1
1263
NA
3364
NA
2046
912
268
631
6145
558
663
314
397
142
869
2185
2889
NA
NA
663
909
5132
1807
NA
1327
NA
317
317
NA
392
763

U296
NA
718
5855
3315
NA
4828
3930
620
3373
NA
10
1271
NA
3376
NA
2051
920
275
641
6154
565
672
318
405
148
875
2190
2896
NA
NA
671
916
5139
U148
NA
1334
NA
324
324
NA
397
772

117
84
99
100
90
92
97
122
138
99
118
84
101
94
81
93
87
71
115
92
82
87
96
89
96
121
81
87
67
85
128
78
87
87
124
79
86
92
85
85
83
90
76

110
80
73
97
66
76
80
88
128
81
92
66
94
69
81
73
69
66
89
72
77
82
86
79
90
98
71
73
67
67
0
65
77
74
100
62
70
83
80
80
63
77
65

7
33
31
10
35
29
28
20
1
27
19
35
19
31
29
29
28
36
18
21
29
26
15
24
21
8
24
26
32
28
36
28
23
21
4
26
24
18
21
21
13
18
26

4
NA
NA
5.824
NA
1
0.25
NA
1.25
NA
NA
NA
1.5
NA
0.35
NA
1.5
NA
NA
3
NA
NA
3.25
1
NA
1.5
1.85
NA
0.25
NA
NA
0.5
NA
1.1
1
1
NA
0.25
NA
NA
5.72
1
NA

NA
397
663
NA
1018
NA
2298
NA
2121
2547
NA
NA
NA
NA
NA
236
2904
746
NA
136
128
657
NA
421
2773
139
207
8
1039
NA
372
3146
15
S13
2304
1822
459
460
52
330
17560
NA
5913

NA
411
U189
NA
U163
NA
2308
NA
2127
2557
NA
NA
NA
NA
NA
242
2909
752
NA
142
134
686
NA
427
2780
147
215
23
U117
NA
U174
3157
25
S33
2310
1826
465
468
77
336
17563
NA
5925

91
74
88
79
76
79
78
81
122
77
88
111
80
107
82
96
103
86
111
83
89
97
82
79
100
95
86
93
75
80
70
78
75
87
74
81
79
89
107
90
72
79
76

86
66
77
73
67
59
67
75
101
67
79
55
31
90
64
83
75
79
95
74
68
88
52
79
83
71
67
80
65
71
67
74
67
68
70
78
66
68
77
83
70
66
71

16
22
8
21
20
11
21
19
1
22
4
16
30
5
17
10
8
13
2
14
14
6
15
13
4
11
5
8
11
11
1
12
14
11
11
9
11
6
0
2
10
6
4

NA
1.5
4.6
NA
1.5
6.016
0.5
NA
NA
NA
5
NA
NA
0.25
1
NA
1
NA
NA
NA
NA
NA
2.25
NA
1
NA
3.7
NA
2.5
0.75
6.522
NA
0.25
NA
1
NA
0.5
1
NA
NA
NA
1
1

466
NA
20
1
NA
NA
NA
522
527
570
730
6662
500
120
883
85
502
100
505
474
56
780
299
NA
NA
10
219
1998
2224
499
NA
NA
346
203
NA
61
NA
107
NA
330
883
705
NA

472
NA
29
11
NA
NA
NA
+
+
U87
735
6667
U118
123
+
U95
506
U146
U1652
U130
67
794
306
NA
NA
29
229
2005
2260
505
NA
NA
352
213
NA
70
NA
126
NA
337
892
715
NA

81
95
74
88
88
77
88
102
83
125
104
37
108
52
92
105
82
142
77
119
51
53
60
448
38
2422
87
56
125
142
36
37
207
135
83
229
39
63
35
207
522
55
52

68
68
72
72
63
58
NA
88
67
121
85
32
96
42
77
95
76
128
71
115
48
44
48
395
30
1940
68
40
88
97
28
25
169
113
53
168
26
44
29
181
450
36
27

4
1
5
0
2
1
0
306
364
344
214
146
211
119
188
233
141
180
173
167
152
182
101
1454
21
13
199
108
79
179
50
83
455
116
220
133
53
11
58
234
226
66
83

0.75
NA
NA
NA
NA
NA
NA
100.406
76.44
44.286
75.72
108.318
60.65
110.562
58.748
31.7
69.65
28.478
41.45
3.5
25.45
11.75
30.474
435.014
624.676
101.734
480.518
501.31
496.228
447.524
507.1
464.114
212.674
358.318
271.13
276.172
348.01
348.024
291.418
134.67
61.516
225.392
207.516

790
2455
NA
2443
1602
920
NA
NA
1591
NA
581
2095
519
511
2345
1694
NA
1596
10522
687
NA
109
395
399
1187
981
506
319
NA
107
520
283
297
979
697
NA
405
1783
309
400
225
460
NA

801
2465
NA
2454
1612
925
NA
NA
1601
NA
590
2128
525
U126
2357
1703
NA
1606
10527
696
NA
119
399
405
1197
990
510
328
NA
114
529
296
308
993
706
NA
409
1791
322
+
233
+
NA

47
278
912
367
91
46
48
47
78
87
103
130
116
76
72
134
106
42
31
169
96
238
137
33
173
176
165
103
43
168
236
77
106
96
85
87
101
88
106
143
43
90
64

34
232
690
306
76
32
27
19
69
1
73
92
97
64
58
98
87
35
31
121
83
186
113
32
138
138
154
71
35
129
165
70
96
75
65
63
85
64
91
116
32
76
58

40
131
0
126
79
34
63
91
95
47
102
45
165
179
38
82
137
0
158
28
263
91
153
142
47
45
139
78
92
107
97
264
250
180
51
168
224
11
259
107
53
211
103

224.07
123.608
50.998
100.342
171.15
191.496
179.246
165.318
151.446
179.45
142.918
154.75
90.7
92.78
150.822
117.796
97.208
169.412
102.344
128.676
39.896
85.106
76.892
99.75
109.554
107.338
65.298
102.3
106.616
73.8
64.162
20.45
18.9
51.438
106.1
54.754
26.1
117.404
5.25
60.1
97.978
19.022
68.298

251
707
693
713
59
2163
537
30
NA
389
226
133
NA
873
2075
1107
NA
125
603
353
NA
NA
106
NA
43
413
908
NA
886
880
518
329
532
100
589
2074
1087
1090
NA
399
207
68
NA

263
714
703
720
71
2196
540
67
NA
U177
U119
143
NA
885
2088
1120
NA
132
607
360
NA
NA
110
NA
48
+
921
NA
895
887
527
334
U131
109
U107
2084
1097
1098
NA
408
215
79
NA

113
285
76
121
87
13
79
54
44
83
147
73
85
56
41
66
107
108
185
111
79
43
56
36
47
34
75
193
70
72
49
60
77
45
64
118
49
74
47
41
165
46
145

92
243
53
103
81
50
75
45
38
64
146
62
47
56
31
57
97
84
180
91
72
37
50
26
43
33
70
155
70
49
42
53
64
35
61
87
35
72
8
38
142
44
1

150
30
26
15
156
72
156
99
168
141
71
210
16
173
33
128
149
61
13
34
111
59
100
120
117
167
157
28
146
46
50
89
146
96
111
11
45
59
28
4
29
153
154

37.488
50.998
96.45
89.986
33.688
81.49
34.6
62.392
33.218
34.79
47.59
5.6
87.134
21.55
84.238
36.85
16.236
54.862
53.746
61.95
33.25
63.216
42.464
38
35.45
16.224
10.798
42.86
15.982
59.248
59.252
39.806
11.85
40.166
28.246
62.1
61.288
47.798
71.162
77.95
40.3
11.742
3.5

47
1079
100
53
100
NA
190
432
380
633
179
590
NA
829
NA
2171
NA
479
89
382
1536
389
187
NA
1015
55
133
NA
49
385
787
NA
NA
8241
NA
529
NA
108
NA
264
9342
1269
1040

52
1089
110
U70
105
NA
+
444
U166
640
U67
604
NA
U235
NA
2179
NA
U137
99
384
1548
393
191
NA
1028
U196
139
NA
62
U171
795
NA
NA
8246
NA
U254
NA
+
NA
278
9347
1283
1044

115
126
68
71
62
41
52
104
108
120
151
57
52
58
35
83
36
123
73
98
39
46
41
48
59
62
46
87
37
104
151
35
92
39
50
52
62
45
45
56
48
52
54

114
119
48
65
61
25
47
66
71
100
126
49
35
49
30
61
26
119
60
82
33
35
38
40
53
56
45
83
31
65
139
26
82
34
40
43
58
40
40
59
32
43
46

61
61
38
97
131
0
142
67
129
60
74
141
50
72
115
35
92
112
2
79
121
101
26
129
127
101
135
71
119
113
89
103
69
13
119
77
96
113
88
40
111
127
22

32.442
30.322
54.8
26.984
13.492
76.214
11.1
35.3
7.5
31.906
18.648
9.1
49.366
37.062
23.35
47.896
32.57
2.5
62.25
22.906
16.6
23.308
55.688
10
7.15
17.3
5.7
23.974
15
5.25
0.5
19.35
20.75
56.24
8.7
26.008
14.85
11.6
22
38.64
12
3
47.264

524
358
NA
400
NA
NA
310
260
1838
1893
155
299
787
239
49
301
NA
826
157
NA
NA
59
799
1001
NA
66
349
NA
436
NA
53
NA
3879
39
40
378
157
69
1245
1382
292
1254
NA

U247
365
NA
U149
NA
NA
320
U153
1847
1901
162
309
798
246
56
310
NA
833
163
NA
NA
64
807
1014
NA
81
361
NA
445
NA
64
NA
3884
46
U62
381
164
+
1256
1392
298
+
NA

38
140
35
51
35
48
57
37
35
114
57
76
123
265
36
42
39
44
134
37
44
41
132
37
39
41
115
36
55
36
36
36
67
107
57
114
36
50
39
61
65
42
45

31
90
25
50
30
27
41
42
33
95
36
58
94
197
33
40
30
39
132
29
20
34
106
31
33
33
97
35
47
28
34
28
64
83
42
91
34
44
35
55
54
33
41

99
24
105
73
127
31
21
78
19
23
52
21
14
15
84
55
23
38
27
108
12
88
35
98
113
94
76
79
75
34
92
104
102
33
103
69
88
100
109
34
47
55
100

17.75
31.2
15.75
24.45
5.25
44.7
45.898
23.274
49.55
31.216
31.908
39.848
33.3
4.75
19.6
30.5
45.75
37.45
20.6
9.05
50.638
16.5
19.35
11.75
4.75
12.5
4.25
19.15
17.09
38.664
12.498
7.85
0.75
23.5
3.75
5.25
10.78
2.75
1
28
22.112
23.55
2.5

NA
NA
141
2180
622
465
430
307
244
NA
NA
21
355
NA
418
NA
NA
375
239
NA
NA
385
53
852
694
383
146
118
NA
NA
1611
601
NA
570
449
746
1477
NA
492
NA
925
2784
NA

NA
NA
149
2188
632
472
446
321
258
NA
NA
35
+
NA
429
NA
NA
377
243
NA
NA
394
U77
+
U120
388
158
128
NA
NA
1620
609
NA
+
U45
757
1488
NA
U103
NA
931
2789
NA

37
71
52
54
40
78
46
36
34
93
43
36
37
40
70
37
56
79
97
95
37
55
55
37
57
48
57
59
91
72
47
54
38
44
41
64
45
38
47
35
61
53
37

7
47
46
42
31
64
46
32
32
87
29
34
32
30
59
25
48
67
84
65
26
42
33
31
48
44
52
45
58
61
46
39
30
42
36
50
31
30
45
31
56
40
29

14
91
12
24
36
59
56
100
76
11
60
82
63
63
49
72
46
54
10
51
16
23
55
79
75
55
79
17
23
54
32
21
36
73
83
56
29
72
39
83
12
13
30

44.474
2.6
38.606
33.596
31.2
13.04
19.992
3.85
14.25
28.15
19.55
9.25
17.002
16.75
15.85
13.6
18.258
9.95
24.698
9.45
35.56
28.4
15.35
7.2
4.6
14.35
2
29.3
21.408
9.35
23.356
28.2
24.45
6.25
3
10.156
25.996
8.15
19.25
3.25
27.55
29.586
25.35

656
NA
1770
1245
NA
NA
1006
NA
246
184
508
110
E2110
25
642
NA
521
259
NA
NA
425
221
D261
3499
398
NA
NA
NA
NA
NA
707
NA
1759
660
1663
NA
221
266
1472
NA
661
577
675

670
NA
1781
1255
NA
NA
+
NA
258
189
+
121
E2116
32
U58
NA
528
272
NA
NA
437
223
D270
3506
406
NA
NA
NA
NA
NA
715
NA
1769
+
1673
NA
225
281
1482
NA
+
591
682

54
36
100
143
70
54
62
72
40
51
36
51
39
127
32
43
45
50
58
40
43
43
103
53
41
42
41
96
44
35
52
39
84
38
41
67
43
51
102
42
37
62
41

46
27
80
128
61
43
51
58
33
43
33
49
40
99
31
39
32
46
52
23
42
37
79
40
32
37
32
94
35
22
49
41
64
35
32
57
34
46
75
37
33
51
37

71
42
16
19
69
18
11
64
45
68
11
56
57
38
62
50
67
54
52
36
55
67
47
26
65
44
67
15
61
16
35
61
9
37
6
57
46
49
17
61
56
42
22

3.75
20.166
17.55
5.55
0.25
26.1
27.246
2.5
17.05
4.5
31.83
8.608
10.45
1.5
9.6
12.504
5.85
9
7.45
19.75
8.5
3.75
0.25
19.5
4.45
12.692
3.5
12
5
26.924
13.5
4.25
18.6
14.75
27.85
NA
10.1
6.25
10.888
3.1
6.25
7.3
19.83

NA
312
1782
271
1580
613
NA
651
822
376
598
134
863
82
1879
NA
NA
516
247
685
78
91
225
120
NA
487
NA
75
NA
NA
NA
958
NA
NA
54
2183
1663
407
NA
492
NA
28
382

NA
U120
1791
282
U190
617
NA
U68
835
378
609
141
870
91
1886
NA
NA
542
255
U107
88
100
228
+
NA
500
NA
86
NA
NA
NA
964
NA
NA
68
2189
1669
419
NA
497
NA
U84
390

40
44
98
75
43
44
38
32
52
37
36
123
127
38
57
37
42
62
75
85
55
73
34
NA
35
54
36
40
41
44
65
33
37
55
37
85
45
38
76
45
46
63
49

36
39
77
69
31
35
28
32
41
34
32
77
101
34
48
27
39
54
55
76
54
47
31
97
29
49
29
35
35
15
57
33
26
49
34
58
37
35
69
42
35
45
41

64
33
1
41
7
50
68
61
55
31
58
26
17
51
2
10
36
47
38
0
21
9
50
0
56
19
35
49
29
31
38
15
20
43
53
26
15
9
25
45
47
35
25

2
14.2
17.25
3.5
25.85
6.6
NA
3.1
2.1
14.838
3.5
2.25
2.35
5.35
22.4
23.632
10.272
1.5
3.7
16.248
13.1
17
5.45
22.05
2.5
13.3
10.804
3.5
11.5
12.55
1.75
17.8
15.85
0.5
NA
3.25
14.75
18.276
3
1
0.75
2.5
8.75

459
NA
768
227
2709
1265
NA
222
55
656
90
110
1796
337
NA
NA
268
64
1926
473
NA
NA
316
880
33
61
3041
2039
909
NA
1079
NA
270
771
NA
NA
NA
NA
1386
539
575
NA
NA

465
NA
774
235
2720
1272
NA
228
64
+
99
+
1804
344
NA
NA
273
76
1933
484
NA
NA
321
U91
42
67
3046
2045
920
NA
1089
NA
287
779
NA
NA
NA
NA
1394
548
585
NA
NA

57
43
51
47
80
67
60
65
42
42
37
43
70
38
48
40
51
76
54
58
40
45
76
NA
77
50
37
80
43
39
63
40
42
42
70
44
44
62
56
51
35
35
49

49
21
37
44
72
53
49
61
39
42
33
35
54
37
34
32
31
68
35
46
32
30
66
62
59
41
34
62
37
28
54
31
35
34
47
29
35
50
53
41
37
28
35

19
50
34
42
25
25
36
19
16
4
48
37
34
28
42
41
38
26
41
34
40
44
21
0
20
38
43
7
35
16
28
32
33
14
23
13
38
19
25
32
33
16
36

9.4
1
5
1
1.1
4.75
1.25
6.5
13
17.75
0.5
4.25
0.25
8.05
1.25
2.5
2.5
0.25
0.25
1.25
2.35
0.25
2
19.5
3
0.25
0.25
7.5
2.5
12.1
1
4.6
3.25
11.5
3
12
0.5
4.85
2.5
1.5
3.25
11.5
0.5

679
NA
1418
419
836
587
844
1067
405
315
NA
NA
1868
1122
2718
33
55
NA
NA
433
983
268
NA
751
152
2718
847
862
3921
441
6
NA
NA
2039
177
521
760
NA
299
157
1494
317
100

685
NA
1423
425
847
592
857
1076
414
321
NA
NA
1872
1128
2723
59
67
NA
NA
440
992
281
NA
U174
181
2724
854
879
3926
451
15
NA
NA
2047
184
529
U182
NA
304
176
1503
328
103

37
41
55
43
36
48
64
37
49
77
42
44
47
56
44
76
35
38
37
51
44
43
83
35
50
81
48
39
38
57
41
57
36
46
39
52
42
45
50
53
54
44
44

35
28
48
44
31
40
45
34
38
57
29
38
43
39
37
54
31
31
27
38
34
39
0
33
46
58
42
37
31
51
32
49
28
35
33
44
40
30
46
42
44
38
39

12
35
31
23
32
24
0
34
32
9
4
29
29
23
33
20
31
35
18
25
5
31
30
29
25
0
7
31
30
10
31
10
26
21
18
21
8
29
3
24
6
27
22

12.092
2.35
NA
4.85
3.35
4.15
12
1.25
0.25
4.75
14.1
2
1
3
NA
NA
2.5
0.25
8
2
11.75
NA
1
2.35
0.5
6.25
8.758
NA
1.25
5.25
0.25
5.35
3.25
3.25
5.52
1.25
8.35
0.25
8.85
NA
7.208
NA
1.75

NA
126
1629
485
2003
46
NA
3203
NA
1534
5219
1341
NA
488
837
159
5722
105
2721
1182
1024
2207
NA
2190
2215
2590
NA
NA
7
282
1953
528
1620
S75
2206
1079
NA
1226
NA
NA
2063
252
402

NA
139
1635
U144
2008
52
NA
3210
NA
1540
5246
1351
NA
496
842
171
5725
110
2730
1189
1031
2221
NA
2196
2222
2594
NA
NA
16
290
1962
538
1628
S87
2214
1092
NA
1231
NA
NA
2070
265
411

90
36
38
61
34
56
46
48
46
66
36
55
53
76
42
56
38
35
38
49
54
33
43
57
42
44
38
41
38
61
45
74
37
42
46
52
40
54
35
60
32
43
44

77
39
33
57
31
49
38
48
36
60
34
40
51
68
33
40
33
32
32
45
43
33
36
46
40
37
28
34
36
44
32
50
32
38
34
46
34
48
27
35
33
35
36

0
28
9
7
30
13
24
18
24
5
27
0
17
5
17
18
17
25
22
17
17
25
21
12
20
20
24
18
20
13
14
7
22
19
19
14
20
10
16
11
21
17
17

1.5
NA
8.7
3.75
NA
2.6
0.25
1
NA
3
NA
8.6
NA
0.5
3.35
0.5
3.7
0.5
1.25
0.5
NA
NA
0.25
1.25
NA
NA
NA
1.5
0.5
NA
2.75
0.25
NA
NA
NA
NA
NA
1
3
1.25
NA
0.25
NA

1153
1107
820
435
NA
NA
1042
1378
NA
796
446
NA
845
NA
135
610
593
NA
1011
782
777
278
335
1110
1167
452
555
NA
33
403
362
NA
196
1755
NA
78
147
223
NA
509
3327
1
NA

1165
1119
829
449
NA
NA
1048
1386
NA
804
457
NA
855
NA
144
618
599
NA
1019
789
782
289
345
1114
1176
460
567
NA
42
411
371
NA
203
1762
NA
84
156
233
NA
517
3338
29
NA

39
49
48
53
37
37
42
33
36
44
34
36
43
41
48
36
42
39
55
48
58
41
49
42
52
48
48
41
38
38
38
37
38
52
35
41
51
44
36
42
39
35
35

37
46
44
38
33
32
36
33
27
34
34
21
34
29
42
32
38
38
34
36
48
33
39
37
47
45
35
27
33
33
31
33
32
36
32
32
37
35
30
34
37
33
28

13
10
6
11
14
14
16
19
20
13
18
20
14
3
1
15
9
14
7
5
4
14
9
9
7
5
11
15
9
7
10
8
12
5
13
10
7
9
10
7
9
11
11

2
1
3
1
2
2
NA
NA
NA
1.25
NA
0.5
0.5
5.8
4.25
0.75
1.85
NA
1.75
3
0.75
NA
0.5
1.5
NA
1.5
NA
NA
2
2.75
1.5
2.2
0.25
1.25
NA
0.5
NA
NA
1
1
NA
NA
0.5

225
4014
2119
348
NA
195
807
2871
192
NA
NA
223
NA
NA
NA
501
1005
74
372
72
2760
NA
NA
786
11
248
387
NA
NA
491

229
4023
2127
354
NA
203
814
2883
195
NA
NA
233
NA
NA
NA
508
1014
94
379
79
2765
NA
NA
790
24
255
390
NA
NA
U61

55
41
42
43
42
42
35
36
36
42
37
33
37
38
37
36
33
45
36
34
39
42
37
47
45
37
40
43
36
NA

44
33
31
33
34
35
32
34
31
34
25
31
25
32
29
31
31
33
31
31
38
26
23
39
33
34
31
NA
NA
NA

0
9
4
2
6
5
8
4
10
4
8
10
10
8
9
5
8
0
2
3
3
3
5
0
1
2
2
5
0
0

1
NA
2.25
2.75
1
1.25
1
2.25
NA
1.5
1.25
NA
0.25
NA
NA
1.5
0.5
2
2
1.5
NA
1
1
NA
0.5
0.5
NA
NA
NA
NA

Scopus.norm
0.052261823
0.054660727
0.067854695
0.062885538
0.043522961
0.041466758
0.068026045
0.065969842
0.044379712
0.036840302
0.077793009
0.061857437
0.026216587
0.073680603
0.026387937
0.056716929
0.043522961
1
0.143420151
0.387251542
0.245030843
0.120459219
0.074023304
0.093899931
0.182830706
0.087388622
0.131254284
0.170664839
0.098012337
0.065798492
0.06442769
0.055346127
0.155243317
0.048320768
0.024674435
0.030157642
0.156614119

WOS.norm
0.05359294
0.058611
0.07226014
0.07005219
0.04496186
0.04395825
0.07346447
0.06985147
0.04556403
0.03592935
0.07888398
0.0630269
0.02870333
0.0772782
0.02790044
0.0604175
0.04716981
1
0.14251305
0.33641108
0.2450823
0.10397431
0.07788037
0.09875552
0.19510237
0.08851867
0.13789643
0.1633882
0.10236853
0.06904858
0.07005219
0.05740666
0.15576074
0.04837415
0.0923324
0.03311923
0.14010438

Mendeley.
norm
0.18569464
0.20839065
0.16299862
0.13961486
0.16918845
0.14993122
0.10660248
0.1176066
0.1568088
0.14993122
0.05570839
0.07427785
0.13961486
0.05089409
0.12173315
0.07565337
0.0866575
0.11416781
0.83425034
0.25722146
0.11966988
0.14167813
0.43328748
0.30192572
0.08528198
0.21801926
0.18019257
0.07771664
0.21320495
0.22902338
0.23933975
0.24621733
0.00412655
0.16850069
0.17537827
0.24209078
0.04126548

Altmetric.
com.norm
0.0688901
0.0141321
0.0209709
0.0343506
0.0309601
0.0304158
0.0128451
0.0032017
0.0032017
0.0032017
0.0112442
0.0243838
0.0250818
0.0016008
0.0221043
0.0044023
0.0104118
0.0136967
0.0346996
NA
0.0683234
0.3010329
0.0016008
0.0340016
0.0585039
0.0944394
0.025767
0.0522159
0.0374754
0.0807587
0.0464561
0.0090031
0.0331756
0.0804449
0.052408
0.039406
0.0036019

total_rank
0.3604395
0.3357945
0.3240843
0.3069032
0.2886333
0.265772
0.2609381
0.2566296
0.2499542
0.2259025
0.2236296
0.223546
0.2196166
0.2034537
0.1981258
0.1971901
0.1877621
2.1278645
1.1548831
0.9808841
0.6781064
0.6671445
0.586792
0.5285828
0.521719
0.4883659
0.4751102
0.4639855
0.4510612
0.4446291
0.4202757
0.3679732
0.3483062
0.3456405
0.3447931
0.3447737
0.3415858

0.039753256
0.054318026
0.134167238
0.074366004
0.120801919
0.074537354
0.044551062
0.089616175
0.029472241
0.130740233
0.095442084
0.107607951
0.053975326
0.070596299
0.023817683
0.03564085
0.025188485
0.059972584
0.034612748
0.034955449
0.062371487
0.06425634
0.038382454
0.023132282
0.025531186
0.037697053
0.050891021
0.041466758
0.050548321
0.052775874
0.069910898
0.079163811
0.047978067
0.029472241
0.096641535
0.072309801
0.048663468
0.0354695
0.022960932
0.036668951
0.070424949
0.039410555
0.022618232

0.04375753
0.03873946
0.09634685
0.07747892
0.11160177
0.07968687
0.04817342
0.08109193
0.031112
0.117222
0.09293456
0.0941389
0.05600161
0.07507025
0.02529105
0.03813729
0.02609394
0.06322762
0.03954235
0.0373344
0.07205941
0.06864713
0.04134886
0.02509033
0.01906865
0.0417503
0.05299077
0.04195102
0.05479727
0.05580088
0.0736652
0.08309916
0.04074669
0.02990767
0.09112806
0.07707748
0.05499799
0.03572862
0.02509033
0.03753513
0.06764352
0.04235247
0.02589322

0.19394773
0.10935351
0.08528198
0.14305365
0.07565337
0.16231087
0.21045392
0.10041266
0.21801926
0.05708391
0.1045392
0.06464924
0.17193948
0.14855571
0.22008253
0.13136176
0.20220083
0.11898212
0.18982118
0.16850069
0.07221458
0.12654746
0.11554333
0
0.03988996
0.13548831
0.14099037
0.15887208
0.11829436
0.12242091
0.08596974
0.06602476
0.14718019
0.13136176
0.04057772
0.0605227
0.0735901
0.15268226
0.17537827
0.11966988
0.00412655
0.13342503
0.13548831

0.0577483
0.1327696
0.0100532
0.0302621
0.0118461
0.0016008
0.0117565
0.0406227
0.0284628
NA
0.0088046
0.0304414
0.0141161
0.0004002
0.0250114
0.0802176
0.0271661
0.0236859
0.0016008
0.0237563
0.0577067
0.0044023
0.0611645
0.2079798
0.1693006
0.0375459
0.0036019
0.002001
0.0182495
0.0090287
0.0098099
0.009669
NA
0.039723
0.0016008
0.01921
0.0484603
NA
NA
0.0263305
0.0742753
NA
0.0288149

0.3352069
0.3351806
0.3258493
0.3251607
0.3199032
0.3181359
0.3149349
0.3117434
0.3070663
0.3050461
0.3017204
0.2968375
0.2960325
0.2946225
0.2942026
0.2853575
0.2806493
0.2658682
0.2655771
0.2645469
0.2643522
0.2638532
0.2564391
0.2562024
0.2537904
0.2524815
0.248474
0.2442909
0.2418894
0.2400263
0.2393557
0.2379567
0.2359049
0.2304647
0.2299481
0.2291199
0.2257119
0.2238804
0.2234295
0.2202044
0.2164703
0.2151881
0.2128147

0.038039753
0.06408499
0.023989034
0.047978067
0.040610007
0.041466758
0.02107608
0.029300891
0.026216587
0.049348869
0.039410555
0.03598355
0.048149417
0.019533927
0.032727896
0.060143934
0.055003427
0.04266621
0.081734064
0.044208362
0.043351611
0.022618232
0.037011652
0.037868403
0.034441398
0.037183002
0.037868403
0.019362577
0.027073338
0.063228239
0.033927347
0.050376971
0.037011652
0.034784099
0.025359836
0.043522961
0.057573681
0.026730637
0.034784099
0.024503084
0.030843043
0.059287183
0.045750514

0.04054597
0.06342834
0.02569249
0.04576475
0.04516259
0.0443597
0.02348454
0.03191489
0.02689683
0.05258932
0.04235247
0.04014452
0.04897632
0.02107587
0.03191489
0.05499799
0.05379366
0.04375753
0.08149338
0.04917704
0.04556403
0.01525492
0.03914091
0.03974308
0.03673224
0.04114813
0.04134886
0.02147732
0.02950622
0.06322762
0.03713368
0.05218788
0.04094741
0.03793657
0.02669611
0.04957848
0.05660377
0.02649538
0.03773585
0.00100361
0.03251706
0.06001606
0.04957848

0.09903714
0.0522696
0.15543329
0.10935351
0.11691885
0.11623109
0.14649244
0.1176066
0.02544704
0.09834938
0.07977992
0.1176066
0.09559835
0.15130674
0.09284732
0.05364512
0.07909216
0.0997249
0.01375516
0.06327373
0.06946355
0.08046768
0.10522696
0.10178817
0.0866575
0.09903714
0.0261348
0.09284732
0.08321871
0.04883081
0.09834938
0.05983494
0.0784044
0.07634113
0.11004127
0.06464924
0.05158184
0.11072902
0.09078404
0.13755158
0.10247593
0.03507565
0.06396149

0.0344947
0.0293016
0.0016008
0.0016008
0.0016008
0.0016008
0.0124865
0.0224917
0.1217463
NA
0.0377156
NA
NA
NA
0.0331596
0.0218609
0.0016008
0.0032017
0.0112955
0.0296538
0.0273582
0.0648496
0.0016008
0.0032017
0.0234105
NA
0.0717524
0.0433377
0.0367679
0.0004002
0.0032017
0.0100948
0.0144075
0.0209004
0.0070437
0.0112442
0.0032017
0.0032017
0.0029615
0.0032017
NA
0.0112955
0.0052027

0.2121175
0.2090845
0.2067156
0.2046972
0.2042923
0.2036584
0.2035395
0.201314
0.2003068
0.2002876
0.1992585
0.1937347
0.1927241
0.1919165
0.1906497
0.190648
0.1894901
0.1893503
0.1882781
0.1863129
0.1857374
0.1831904
0.1829803
0.1826013
0.1812417
0.1773683
0.1771045
0.1770249
0.1765661
0.1756869
0.1726121
0.1724946
0.1707709
0.1699622
0.1691409
0.1689949
0.168961
0.1671567
0.1662655
0.1662599
0.165836
0.1656744
0.1644932

0.047978067
0.053289925
0.03598355
0.019019877
0.058773132
0.044893763
0.031357094
0.069739548
0.051405072
0.056202879
0.030157642
0.04318026
0.025702536
0.028101439
0.061686086
0.0358122
0.026216587
0.023989034
0.037011652
0.036154901
0.02844414
0.055860178
0.046435915
0.032556546
0.02107608
0.036840302
0.023817683
0.020904729
0.033413297
0.026901988
0.031699794
0.02176148
0.049006169
0.021932831
0.049177519
0.020904729
0.047292666
0.027416038
0.027416038
0.037354352
0.027244688
0.047806717
0.026387937

0.05218788
0.04977921
0.03793657
0.02107587
0.05740666
0.0461662
0.02950622
0.0736652
0.0541951
0.058611
0.02790044
0.04476114
0.02769972
0.02950622
0.06884785
0.03492573
0.02709755
0.0248896
NA
0.03793657
0.02609394
0.05740666
0.04536331
0.03030911
0.02047371
0.03793657
0.02649538
0.02408671
0.03512646
0.02870333
0.0337214
0.02248093
0.04877559
0.01665998
0.04757126
0.0230831
0.04395825
0.027499
0.03010839
0.0373344
0.02689683
0.05018065
0.02709755

0.06258597
0.03988996
0.08872077
0.12242091
0.04470426
0.04195323
0.10041266
0.00618982
0.01650619
0.04332875
0.02888583
0.065337
0.10385144
0.08596974
0.02063274
0.08115543
0.0784044
0.07427785
0.08872077
0.06602476
0.01719395
0.03232462
0.03507565
0.05433288
0.10591472
0.07427785
0.09628611
0.10178817
0.06808803
0.08253095
0.07909216
0.0784044
0.03163686
0.07771664
0.04470426
0.0997249
0.0522696
0.0866575
0.08390647
0.05158184
0.07152682
0.00962861
0.0866575

0.0016008
0.0212846
0.0016008
0.0016008
0.002001
0.0288149
NA
0.0098099
0.036563
NA
0.0711505
0.0048025
NA
0.0110809
0.0024012
0.0016008
0.0203369
0.0288149
0.0258054
0.0110521
0.0792635
0.0052027
0.0228727
0.0322247
0.0016008
NA
0.0016008
NA
0.0101301
0.0083243
0.0016008
0.0230808
0.015829
0.0288149
0.0032017
NA
NA
0.0016008
0.0016008
0.0164181
0.0164821
0.0343858
0.0016008

0.1643527
0.1642437
0.1642417
0.1641175
0.1628851
0.1618281
0.161276
0.1594044
0.1586693
0.1581426
0.1580944
0.1580809
0.1572537
0.1546583
0.1535679
0.1534942
0.1520555
0.1519714
0.1515378
0.1511684
0.1509955
0.1507942
0.1497475
0.1494232
0.1490653
0.1490547
0.1482
0.1467796
0.1467578
0.1464606
0.1461142
0.1457276
0.1452476
0.1451244
0.1446547
0.1437127
0.1435205
0.1431734
0.1430317
0.1426887
0.1421505
0.1420018
0.1417438

0.038211103
0.026387937
0.039239205
0.040781357
0.075051405
0.031699794
0.019876628
0.030671693
0.026216587
0.044893763
0.056545579
0.040610007
0.026559287
0.032042495
0.024160384
0.022275531
0.032727896
0.026730637
0.036840302
0.024331734
0.030157642
0.041466758
0.02827279
0.023646333
0.030328992
0.037011652
0.02124743
0.032213845
0.028958191
0.023474983
0.029814942
0.07145305
0.022960932
0.02878684
0.023989034
0.023989034
0.032213845
0.025531186
0.048320768
0.019876628
0.019876628
0.029643592
0.022960932

0.04235247
0.02790044
0.03753513
0.03653151
0.06282617
0.03231634
0.02067443
0.03191489
0.02589322
0.04255319
0.04496186
0.0443597
0.02830189
0.03191489
0.02669611
0.02288238
0.03392212
0.02970695
0.03873946
0.02669611
0.03050984
0.04255319
0.03071056
0.02408671
0.03151345
0.03813729
0.02328382
0.03291851
0.03251706
0.0248896
0.03171417
0.06142112
0.02187876
0.03291851
0.02629466
0.02589322
0.03753513
0.02609394
0.04476114
0.02007226
0.02027298
0.03231634
0.02589322

0.04676754
0.0735901
0.00275103
0.0605227
0.00275103
0.07496561
0.09834938
0.07565337
0.08803301
0.05158184
0.03645117
0.05433288
0.06121045
0.02751032
0.08803301
0.09353508
0.05914718
0.06671252
0.06189821
0.08321871
0.04401651
0.03988996
0.07427785
0.06189821
0.07290234
0.02682256
0.09078404
0.06808803
0.07152682
0.0130674
0.05364512
0
0.0605227
0.06740028
0.02957359
0.06808803
0.04951857
0.07565337
0.03576341
0.08872077
0.08803301
0.06396149
0.0784044

0.0144075
0.0130532
0.0613982
0.0028015
NA
0.0016008
0.0016008
0.002001
NA
0.0008004
0.0016008
NA
0.0231544
0.0476439
NA
NA
0.0124993
0.0144075
NA
0.0032017
0.0327466
0.0131396
0.0032017
0.0267403
0.0016008
0.033928
NA
0.0016008
0.0016008
0.0724984
0.0187553
NA
0.0271757
0.0032017
0.0524304
0.0141513
0.0112442
0.0032017
0.0016008
0.0016008
0.002001
0.0032017
0.0016008

0.1417386
0.1409316
0.1409236
0.140637
0.1406286
0.1405826
0.1405013
0.140241
0.1401428
0.1398292
0.1395594
0.1393026
0.139226
0.1391116
0.1388895
0.138693
0.1382965
0.1375576
0.137478
0.1374482
0.1374306
0.1370495
0.1364629
0.1363715
0.1363456
0.1358995
0.1353153
0.1348212
0.1346029
0.1339304
0.1339296
0.1328742
0.1325381
0.1323073
0.1322877
0.1321216
0.1305118
0.1304802
0.1304461
0.1302705
0.1301837
0.1291231
0.1288594

0.029643592
0.048834818
0.055517478
0.041638108
0.048834818
0.041295408
0.038725154
0.037525703
0.032385195
0.020219328
0.030671693
0.046093215
0.037183002
0.026045236
0.035126799
0.029643592
0.032556546
0.023132282
0.020904729
0.029300891
0.060829335
0.031014393
0.050719671
0.023817683
0.028958191
0.022104181
0.032213845
0.022960932
0.025873886
0.022104181
0.02159013
0.024160384
0.033927347
0.038211103
0.04266621
0.031528444
0.041124058
0.023474983
0.025531186
0.020047978
0.025702536
0.037525703
0.034955449

0.03030911
0.03853874
0.04977921
0.04295464
0.04757126
0.03894019
0.0417503
0.04094741
0.03091128
0.02248093
0.03412284
0.05078282
0.03713368
0.027499
0.03693296
0.03271778
0.03291851
0.02509033
0.02388599
0.03151345
0.05740666
0.03291851
0.04957848
0.02388599
0.03030911
0.02207949
0.03030911
0.02248093
0.02830189
0.02368527
0.02248093
0.02549177
0.03432357
0.0373344
0.04375753
0.02910478
0.03592935
0.02468888
0.02368527
0.01766359
0.02689683
0.03673224
0.03030911

0.06808803
0.04126548
0.01994498
0.03094911
0.03026135
0.02338377
0.03232462
0.0474553
0.06258597
0.0784044
0.05845942
0.00275103
0.03232462
0.05020633
0.05089409
0.0605227
0.05639615
0.06464924
0.07565337
0.01375516
0.00275103
0.04057772
0.01994498
0.07221458
0.0605227
0.0735901
0.05502063
0.07152682
0.06258597
0.07083907
0.07083907
0.06808803
0.03576341
0.04195323
0.03094911
0.05158184
0.03988996
0.06671252
0.03782669
0.07771664
0.0605227
0.02682256
0.04814305

0.0008004
NA
0.0032017
0.0123456
NA
0.0228887
0.0132805
NA
NA
0.0040021
0.0016008
0.0251939
0.0175355
0.0199431
NA
NA
0.0008004
0.0096434
0.0016008
0.0469523
NA
0.0160083
NA
NA
NA
0.0016008
0.0016008
0.0016008
0.0016008
0.0016008
0.0032017
NA
0.0136583
NA
NA
0.0048025
NA
0.002001
0.0293176
NA
0.0016008
0.0125505
NA

0.1288412
0.128639
0.1284433
0.1278875
0.1266674
0.126508
0.1260806
0.1259284
0.1258824
0.1251067
0.1248548
0.1248209
0.1241768
0.1236937
0.1229538
0.1228841
0.1226716
0.1225153
0.1220449
0.1215218
0.120987
0.1205189
0.1202431
0.1199183
0.11979
0.1193746
0.1191444
0.1185695
0.1183626
0.1182293
0.1181118
0.1177402
0.1176726
0.1174987
0.1173728
0.1170176
0.1169434
0.1168774
0.1163607
0.1154282
0.1147229
0.113631
0.1134076

0.024160384
0.024160384
0.023303633
0.02124743
0.020047978
0.023303633
0.022960932
0.028101439
0.023989034
0.02878684
0.02124743
0.038382454
0.039753256
0.025531186
0.021932831
0.045407814
0.019019877
0.043351611
0.038211103
0.021932831
0.034270048
0.033927347
0.025873886
0.04283756
0.029300891
0.040781357
0.019705278
0.033927347
0.031185744
0.02827279
0.037525703
0.038896504
0.022104181
0.019362577
0.036497601
0.023303633
0.02159013
0.020219328
0.022618232
0.027073338
0.02176148
0.047464016
0.023303633

0.02348454
0.02549177
0.0248896
0.02348454
0.0186672
0.02428744
0.02368527
0.02990767
0.02428744
0.02910478
0.02388599
0.03673224
0.03853874
0.02609394
0.02248093
0.04456042
0.01947009
0.04456042
0.04094741
0.0248896
0.03472501
0.03311923
0.03030911
0.04134886
0.02910478
0.03572862
NA
0.03472501
0.03211562
0.02950622
0.04014452
0.03693296
0.02448816
0.0212766
0.03412284
0.02569249
0.02248093
0.02147732
0.02228021
0.02810116
0.02268165
0.04476114
0.02529105

0.06396149
0.06327373
0.06258597
0.06602476
0.05570839
0.04264099
0.06464924
0.05158184
0.05914718
0.04951857
0.065337
0.03507565
0.02544704
0.05845942
0.06396149
0
0.07083907
0.0213205
0.02957359
0.0605227
0.03988996
0.03988996
0.04814305
0.02338377
0.0474553
0.0261348
0.08528198
0.03576341
0.04264099
0.04814305
0.02819807
0.02751032
0.04057772
0.06396149
0.03370014
0.04057772
0.05983494
0.0605227
0.05845942
0.04814305
0.05708391
0.00275103
0.05433288

0.0016008
NA
0.0016008
0.0016008
0.017289
0.0213743
NA
0.0016008
0.0032017
0.0032017
NA
NA
0.0064033
NA
0.0016008
0.0199976
NA
NA
0.0004002
0.0016008
NA
0.0016008
0.0036019
NA
0.0016008
0.0040021
0.0016008
0.002001
NA
NA
NA
0.0016008
0.0176732
NA
NA
0.0144075
NA
0.0016008
NA
NA
0.0016008
0.008017
NA

0.1132072
0.1129259
0.11238
0.1123576
0.1117125
0.1116063
0.1112954
0.1111918
0.1106253
0.1106118
0.1104704
0.1101903
0.1101424
0.1100845
0.1099761
0.1099658
0.109329
0.1092325
0.1091323
0.108946
0.108885
0.1085374
0.1079279
0.1075702
0.1074618
0.1066469
0.1065881
0.1064168
0.1059424
0.1059221
0.1058683
0.1049406
0.1048432
0.1046007
0.1043206
0.1039813
0.103906
0.1038202
0.1033579
0.1033176
0.1031279
0.1029931
0.1029276

0.049348869
0.027930089
0.028958191
0.025702536
0.02827279
0.04969157
0.031357094
0.043522961
0.037011652
0.022104181
0.018848526
0.022618232
0.019191227
0.02124743
0.023817683
0.020390679
0.031357094
0.023303633
0.02124743
0.020562029
0.038039753
0.020047978
0.022275531
0.023646333
0.038896504
0.028958191
0.023646333
0.045065113
0.028958191
0.036326251
0.034955449
0.02124743
0.026730637
0.0354695
0.03564085
0.02159013
0.029472241
0.025873886
0.025188485
0.018677176
0.029643592
0.019705278
0.031014393

0.04716981
0.02629466
0.0293055
0.02589322
0.027499
0.04837415
0.03432357
0.03894019
0.03432357
0.02348454
0.01987154
0.02147732
0.01967082
0.02268165
0.02468888
0.01926937
0.03412284
0.0230831
0.02248093
0.01906865
0.03613007
0.01826576
0.02288238
0.027499
0.03492573
0.02609394
0.02609394
0.0479727
0.03171417
0.03030911
0.03773585
0.01625853
0.02769972
0.03572862
0.03613007
0.02187876
0.03231634
0.02589322
0.0248896
0.01947009
0.02769972
0.02228021
0.03512646

0.00481431
0.01581843
0.04332875
0.04057772
0.02200825
0.00275103
0.03507565
0.01650619
0.02751032
0.05295736
0.06121045
0.02819807
0.05089409
0.05502063
0.04883081
0.05914718
0.00275103
0.0522696
0.04401651
0.0343879
0.02407153
0.05983494
0.0522696
0.04607978
0.02338377
0.03851444
0.04539202
0.00206327
0.03576341
0.02957359
0.02338377
0.04539202
0.0392022
0.02475929
0.02407153
0.04951857
0.01650619
0.0392022
0.04401651
0.05570839
0.03645117
0.05020633
0.02751032

0.0008004
0.031991
NA
0.0092848
0.0235578
0.0004002
0.0004002
0.0016008
0.0016008
0.0016008
NA
0.0270348
0.0092592
NA
0.0016008
NA
0.0305054
NA
0.0107832
0.0243614
NA
NA
NA
NA
NA
0.0032017
0.0016008
0.0016008
NA
NA
NA
0.0131396
0.0024012
NA
NA
0.0016008
0.0160083
0.0032017
NA
NA
NA
0.0016008
NA

0.1021334
0.1020342
0.1015924
0.1014583
0.1013379
0.101217
0.1011565
0.1005702
0.1004464
0.1001469
0.0999305
0.0993284
0.0990153
0.0989497
0.0989382
0.0988072
0.0987364
0.0986563
0.0985281
0.09838
0.0982413
0.0981487
0.0974275
0.0972251
0.097206
0.0967682
0.0967331
0.0967019
0.0964358
0.096209
0.0960751
0.0960376
0.0960338
0.0959574
0.0958424
0.0945883
0.0943031
0.094171
0.0940946
0.0938557
0.0937945
0.0937926
0.0936512

0.026045236
0.042494859
0.0358122
0.024845785
0.020733379
0.0354695
0.024331734
0.026216587
0.032385195
0.02827279
0.031699794
0.02141878
0.019019877
0.030843043
0.030157642
0.027587389
0.031185744
0.027587389
0.022960932
0.025017135
0.020390679
0.034784099
0.026559287
0.031528444
0.026901988
0.042323509
0.03564085
0.033927347
0.02124743
0.034098698
0.022960932
0.037011652
0.021932831
0.025873886
0.031014393
0.018677176
0.028101439
0.029643592
0.04266621
0.025188485
0.025359836
0.019705278
0.022104181

0.02589322
0.04215175
0.03071056
0.02609394
0.02248093
0.03151345
0.02428744
0.02830189
0.03291851
0.02769972
0.03251706
0.02187876
0.0212766
0.03532718
0.03251706
0.03091128
0.02990767
0.0293055
0.0248896
0.02569249
0.01926937
0.03412284
0.03131273
0.03091128
0.02649538
0.04415897
0.03331995
0.03010839
0.02388599
0.03492573
0.02428744
0.03472501
0.02368527
0.02729827
0.03452429
0.02067443
0.02769972
0.02729827
0.04375753
0.02609394
0.02468888
0.02107587
0.02348454

0.03988996
0.00618982
0.0261348
0.03988996
0.04883081
0.02338377
0.04332875
0.03713893
0.0261348
0.03370014
0.02682256
0.0474553
0.04883081
0.02407153
0.02751032
0.03163686
0.02682256
0.03301238
0.02338377
0.03851444
0.04195323
0.02063274
0.03163686
0.02682256
0.03576341
0.00206327
0.01994498
0.02475929
0.04332875
0.01719395
0.0392022
0.01444292
0.04195323
0.0343879
0.02200825
0.04814305
0.03094911
0.02819807
0
0.03507565
0.03301238
0.04539202
0.04057772

0.0016008
0.002001
NA
0.0016008
NA
0.0016008
NA
NA
NA
0.0016008
NA
NA
0.0016008
NA
NA
NA
0.002001
NA
0.0184095
0.0004002
0.0079913
NA
NA
NA
NA
0.0004002
NA
NA
NA
0.002001
0.0016008
0.0016008
NA
NA
NA
NA
NA
0.0016008
NA
NA
0.0032017
NA
NA

0.0934292
0.0928375
0.0926576
0.0924305
0.0920451
0.0919675
0.0919479
0.0916574
0.0914385
0.0912735
0.0910394
0.0907528
0.0907281
0.0902417
0.090185
0.0901355
0.089917
0.0899053
0.0896438
0.0896243
0.0896046
0.0895397
0.0895089
0.0892623
0.0891608
0.088946
0.0889058
0.088795
0.0884622
0.0882194
0.0880514
0.0877804
0.0875713
0.0875601
0.0875469
0.0874947
0.0867503
0.0867408
0.0864237
0.0863581
0.0862628
0.0861732
0.0861664

0.02141878
0.02107608
0.026045236
0.02176148
0.026216587
0.027930089
0.023303633
0.018677176
0.026730637
0.023646333
0.019019877
0.022960932
0.032727896
0.019876628
0.02159013
0.031699794
0.02141878
0.039753256
0.019876628
0.024845785
0.026045236
0.026216587
0.038896504
0.024845785
0.032213845
0.024160384
0.022789582
0.018677176
0.023646333
0.031357094
0.028101439
0.025188485
0.02844414
0.020904729
0.020733379
0.024845785
0.029472241
0.02159013
0.023303633
0.033755997
0.029814942
0.026216587
0.029814942

0.02107587
0.02207949
0.02769972
0.02147732
0.02368527
0.027499
0.02448816
0.02107587
0.02609394
0.02569249
0.01967082
0.02408671
0.0230831
0.02147732
0.02408671
0.03452429
0.02187876
0.03592935
0.02207949
0.02669611
0.02769972
0.02629466
0.03492573
0.02448816
0.02810116
0.02669611
0.02348454
0.02047371
0.02388599
0.03171417
0.03191489
0.02408671
0.02870333
0.01846648
0.02047371
0.02448816
0.03131273
0.02147732
0.02408671
0.03191489
0.02569249
0.02669611
0.02649538

0.03851444
0.04126548
0.0213205
0.04264099
0.01719395
0.02957359
0.03713893
0.04332875
0.03163686
0.03507565
0.04401651
0.03713893
0.02819807
0.04264099
0.03645117
0.01719395
0.03851444
0.00756534
0.04126548
0.03163686
0.02751032
0.03026135
0.00894085
0.02338377
0.02063274
0.03163686
0.03301238
0.04332875
0.02751032
0.01788171
0.0213205
0.02407153
0.01237964
0.02819807
0.03988996
0.03163686
0.01856946
0.03782669
0.03163686
0.0130674
0.02475929
0.01650619
0.02200825

0.0051227
0.0016008
0.0108856
NA
0.0180093
NA
NA
0.0016008
NA
NA
0.0016008
NA
NA
NA
0.0016008
NA
0.0016008
NA
NA
NA
0.0016008
NA
NA
0.0098483
0.0016008
NA
0.0032017
NA
0.0064033
0.0004002
NA
0.0079241
0.0116444
0.0135494
NA
NA
0.0016008
NA
0.0016008
0.0016008
NA
0.0106551
0.0016008

0.0861318
0.0860219
0.0859511
0.0858798
0.0851051
0.0850027
0.0849307
0.0846826
0.0844614
0.0844145
0.084308
0.0841866
0.0840091
0.0839949
0.0837288
0.083418
0.0834128
0.0832479
0.0832216
0.0831788
0.0828561
0.0827726
0.0827631
0.082566
0.0825486
0.0824934
0.0824882
0.0824796
0.081446
0.0813532
0.0813368
0.0812708
0.0811716
0.0811187
0.081097
0.0809708
0.0809553
0.0808941
0.080628
0.0803391
0.0802667
0.080074
0.0799194

0.023817683
0.028101439
0.023646333
0.020733379
0.020904729
0.02861549
0.018677176
0.019362577
0.019533927
0.023132282
0.024160384
0.034098698
0.024160384
0.025531186
0.022618232
0.020733379
0.019876628
0.023817683
0.02159013
0.019019877
0.02159013
0.033413297
0.024674435
0.026216587
0.036840302
0.028101439
0.02176148
0.019533927
0.02176148
0.018677176
0.025188485
0.023817683
0.019533927
0.027758739
0.033241947
0.037011652
0.025017135
0.018848526
0.023474983
0.029472241
0.02124743
0.026045236
0.024503084

0.02228021
0.03171417
0.02228021
0.0230831
0.02268165
0.03171417
0.01665998
0.01947009
0.02187876
0.02228021
0.02047371
0.03653151
0.02649538
0.02448816
0.0248896
0.02187876
0.02388599
0.02468888
0.02368527
0.02187876
0.02107587
0.03352067
0.00682457
0.0248896
0.03412284
0.02870333
0.02268165
0.02187876
0.02207949
0.0186672
0.02448816
0.02348454
0.02147732
0.02790044
0.03331995
0.03572862
0.02509033
0.01906865
0.02549177
0.02769972
0.02228021
0.027499
0.02468888

0.03370014
0.01994498
0.03370014
0.03576341
0.0343879
0.01719395
0.02751032
0.02888583
0.03713893
0.03301238
0.03163686
0.00412655
0.02475929
0.02682256
0.02751032
0.03232462
0.03094911
0.0261348
0.03094911
0.0343879
0.03094911
0.0082531
0.03301238
0.01513067
0.00343879
0.01719395
0.0261348
0.03232462
0.02957359
0.03576341
0.02338377
0.02407153
0.03026135
0.01719395
0.00618982
0
0.02063274
0.0343879
0.0213205
0.01444292
0.01237964
0.01788171
0.02063274

NA
NA
NA
NA
0.0016008
0.0016008
0.0160083
0.0109497
NA
NA
0.002001
0.0032017
0.0016008
NA
0.0016008
0.0016008
0.0016008
0.0016008
NA
NA
0.0016008
NA
0.0101461
0.0081706
NA
NA
0.0032017
NA
NA
NA
NA
0.0016008
0.0016008
NA
NA
NA
0.0016008
NA
0.0016008
NA
0.0155409
NA
0.0016008

0.079798
0.0797606
0.0796267
0.0795799
0.0795751
0.0791244
0.0788558
0.0786682
0.0785516
0.0784249
0.078272
0.0779584
0.0770159
0.0768419
0.076619
0.0765376
0.0763126
0.0762422
0.0762245
0.0752865
0.0752159
0.0751871
0.0746574
0.0744075
0.0744019
0.0739987
0.0737796
0.0737373
0.0734146
0.0731078
0.0730604
0.0729746
0.0728734
0.0728531
0.0727517
0.0727403
0.072341
0.0723051
0.0718881
0.0716149
0.0714481
0.0714259
0.0714255

0.022275531
0.024845785
0.021932831
0.02844414
0.019019877
0.023474983
0.019705278
0.029472241
0.022789582
0.019876628
0.019876628
0.020219328
0.024845785
0.019533927
0.032042495
0.024160384
0.022446881
0.033241947
0.032556546
0.02124743
0.024674435
0.025359836
0.026045236
0.020390679
0.022789582
0.019876628
0.018848526
0.02844414
0.027587389
0.027758739
0.023989034
0.024674435
0.026901988
0.020904729
0.02124743
0.02124743
0.019876628
0.023646333
0.019533927
0.018677176
0.019533927
0.022960932
0.018848526

0.02207949
0.02288238
0.02348454
0.031112
0.02007226
0.02167804
0.01967082
0.02830189
0.02047371
0.0212766
0.01987154
0.02147732
0.02368527
0.02007226
0.03352067
0.02509033
0.02569249
0.0355279
0.03071056
0.02207949
0.02368527
0.02348454
0.02328382
0.02067443
0.02007226
0.02107587
0.01987154
0.02790044
0.02649538
0.02870333
0.02207949
0.02408671
0.02589322
0.02468888
0.02147732
0.02107587
0.02228021
0.02428744
0.01967082
0.01906865
0.02248093
0.0230831
0.01886793

0.02544704
0.02200825
0.02269601
0.01169188
0.03026135
0.02544704
0.02957359
0.01237964
0.00275103
0.02888583
0.03026135
0.02751032
0.0213205
0.02819807
0.00206327
0.01994498
0.02063274
0
0.00550206
0.02475929
0.01994498
0.01856946
0.01719395
0.02682256
0.02338377
0.02682256
0.02888583
0.01100413
0.01100413
0.0082531
0.01994498
0.01719395
0.0130674
0.01994498
0.02269601
0.02269601
0.02269601
0.01513067
0.02200825
0.02475929
0.02200825
0.01788171
0.0213205

0.0016008
0.0016008
0.0032017
NA
0.0016008
NA
0.0016008
NA
0.0240829
NA
NA
0.0008004
NA
0.0016008
0.0016008
NA
NA
NA
NA
0.0004002
NA
0.0008004
0.0016008
NA
0.0016008
NA
NA
NA
0.0016008
0.0016008
NA
NA
NA
NA
NA
NA
NA
0.0016008
0.0032017
0.0016008
NA
NA
0.0048025

0.0714029
0.0713372
0.071315
0.071248
0.0709543
0.0706001
0.0705505
0.0701538
0.0700972
0.0700391
0.0700095
0.0700074
0.0698515
0.0694051
0.0692273
0.0691957
0.0687721
0.0687698
0.0687692
0.0684864
0.0683047
0.0682143
0.0681238
0.0678877
0.0678464
0.0677751
0.0676059
0.0673487
0.0666877
0.066316
0.0660135
0.0659551
0.0658626
0.0655386
0.0654208
0.0650193
0.0648528
0.0646653
0.0644147
0.0641059
0.0640231
0.0639257
0.0638394

0.023132282
0.020047978
0.031871145
0.031357094
0.02159013
0.019362577
0.02141878
0.022618232
0.027758739
0.022446881
0.022104181
0.024331734
0.024331734
0.020047978
0.026387937
0.019191227
0.02141878
0.02159013
0.020733379
0.020219328
0.022275531
0.02107608
0.019191227
0.019191227
0.020219328
0.019019877
0.022789582
0.019705278
0.020047978
0.023989034
0.019876628
0.019191227
0.019705278
0.019019877
0.020219328
0.025702536
0.026387937
0.019362577
0.02124743
0.022960932
0.02159013
0.020047978
0.018677176

0.02187876
0.01967082
0.03131273
0.02810116
0.02207949
0.02087515
0.02248093
0.02368527
0.03091128
0.02107587
0.02248093
0.02207949
0.02147732
0.02288238
0.02790044
0.01987154
0.02207949
0.0230831
0.02408671
0.02288238
0.02388599
0.01786431
0.01947009
0.02007226
0.02187876
0.02047371
0.02248093
0.02147732
0.02107587
0.02529105
0.01726214
0.02087515
0.01906865
0.01967082
0.02067443
0.02187876
0.02468888
0.01786431
0.02187876
0.02167804
0.02107587
0.02087515
0.01926937

0.01719395
0.01925722
0
0.00206327
0.01925722
0.02063274
0.01650619
0.01513067
0.00275103
0.01788171
0.01650619
0.0130674
0.01513067
0.01788171
0.00618982
0.0213205
0.01650619
0.01513067
0.01444292
0.01581843
0.01100413
0.01856946
0.01788171
0.01719395
0.01581843
0.01788171
0.01169188
0.01513067
0.01513067
0.00687758
0.01719395
0.01581843
0.01650619
0.01444292
0.01375516
0.00481431
0.00275103
0.01650619
0.01031637
0.0082531
0.00962861
0.01100413
0.0130674

0.0016008
0.0044023
NA
0.0016008
NA
0.0016008
0.0016008
NA
NA
NA
NA
0.0016008
NA
NA
NA
NA
NA
NA
NA
NA
0.0016008
0.0008004
0.0016008
0.0016008
NA
NA
NA
NA
NA
NA
0.0016008
NA
0.0004002
0.0016008
NA
0.0016008
NA
NA
NA
NA
NA
NA
0.0008004

0.0638058
0.0633783
0.0631839
0.0631224
0.0629268
0.0624713
0.0620067
0.0614342
0.0614211
0.0614045
0.0610913
0.0610795
0.0609397
0.0608121
0.0604782
0.0603833
0.0600045
0.0598039
0.059263
0.0589201
0.0587665
0.0583103
0.0581439
0.0580583
0.0579165
0.0573753
0.0569624
0.0563133
0.0562545
0.0561577
0.0559335
0.0558848
0.0556803
0.0547344
0.0546489
0.0539964
0.0538278
0.0537331
0.0534426
0.0528921
0.0522946
0.0519273
0.0518144

0.025702536
0.018677176
0.024845785
0.023132282
0.022275531
0.019362577
0.020562029
0.018848526
0.020562029
0.018848526
0.018677176
0.025017135
0.019362577
0.022618232
0.019533927
0.023989034
0.024674435
0.022446881
0.019876628
0.019191227
0.021932831
0.022275531
0.019533927
0.019019877
0.019362577
0.024674435
NA
0.026901988
0.02878684
0.012337217
0.014907471
0.020390679
0.02124743
0.018848526
0.044037012
0.024845785
0.011480466
0.0354695
0.020047978
0.029472241
0.015421522
0.024331734
0.016792324

0.02589322
0.01766359
0.02649538
0.02549177
0.0248896
0.01947009
0.02027298
0.01967082
0.02067443
0.02167804
0.01967082
0.02428744
0.02228021
0.02288238
0.02147732
0.02228021
0.01746287
0.02569249
0.01947009
0.01625853
0.02228021
0.02187876
0.02007226
0.01926937
0.01987154
NA
NA
0.02850261
0.03091128
0.01304697
0.00020072
0.02248093
0.02248093
0.01786431
0.0479727
0.02529105
0.01324769
0.03512646
0.02228021
0.02970695
0.01525492
0.02569249
0.01806503

0
0.01513067
0
0.00206327
0.00343879
0.01169188
0.00962861
0.01031637
0.00687758
0.00894085
0.01100413
0
0.00756534
0.00343879
0.00756534
0.00068776
0.00618982
0
0.00618982
0.00894085
0
0
0.00343879
0.00206327
0.00068776
0.00894085
0
0.14511692
0.13411279
0.16850069
0.08940853
0.1568088
0.11210454
0.14442916
0.10591472
0.09422283
0.10591472
0.10385144
0.09766162
0.10935351
0.08528198
0.09903714
0.10316369

NA
NA
NA
NA
NA
NA
NA
0.0016008
0.0016008
NA
NA
NA
NA
NA
NA
0.0016008
NA
NA
NA
NA
NA
NA
NA
0.0016008
0.0016008
NA
NA
0.0809828
0.0543258
0.0198183
0.1085139
0.011606
0.0509864
0.0229975
0.0048025
0.0511241
0.049693
0.0036019
0.0348789
0.0056029
0.0546203
0.0200104
0.0260423

0.0515958
0.0514714
0.0513412
0.0506873
0.0506039
0.0505246
0.0504636
0.0504365
0.0497149
0.0494674
0.0493521
0.0493046
0.0492081
0.0489394
0.0485766
0.0485578
0.0483271
0.0481394
0.0455365
0.0443906
0.044213
0.0441543
0.043045
0.0419534
0.0415227
0.0336153
0
0.2815043
0.2481367
0.2137031
0.2130306
0.2112864
0.2068193
0.2041395
0.2027269
0.1954838
0.1803358
0.1780493
0.1748687
0.1741356
0.1705787
0.1690717
0.1640633

0.01405072
0.770219328
0.020219328
0.051233722
0.239204935
0.102124743
0.014736121
0.066141193
0.032899246
0.112577108
0.038896504
0.045921864
0.029986292
0.050891021
0.026387937
0.034955449
0.022789582
0.061343386
0.046949966
0.015078821
0.044893763
0.016106923
0.037011652
0.120116518
0.098012337
0.045065113
0.019533927
0.044722413
0.026730637
0.032556546
0.065969842
0.017306374
0.0358122
0.095613434
0.022618232
0.045236463
0.03564085
0.04266621
0.022789582
0.040781357
0.040095956
0.032556546
0.018848526

0.0150542
0.44419912
0.0186672
0.05740666
0.23203533
0.08952228
0.01324769
0.06824568
0.0355279
0.10598153
0.01726214
0.0505821
0.03010839
0.05519872
0.02790044
0.02328382
0.02228021
0.06403051
0.04917704
0.01425131
0.05118426
0.01746287
0.03432357
0.10939382
0.09795263
0.04696909
0.01967082
0.03311923
0.02870333
0.03251706
0.05881172
0.01806503
0.03633079
0.09173023
0.0212766
0.04997993
0.03833802
0.04496186
0.02408671
0.04195102
0.04476114
0.02990767
0.01906865

0.09491059
0.2957359
0.04126548
0.22558459
0.11210454
0.10110041
0.04195323
0.41678129
0.42503439
0.27166437
0.37138927
0.33562586
0.0392022
0.24896836
0.13411279
0.14099037
0.25378267
0.20151307
0.07083907
0.10385144
0.21320495
0.12448418
0.15749656
0.04332875
0.04883081
0.1519945
0.02338377
0.20082531
0.22489684
0.1911967
0.0392022
0.09491059
0.15337001
0.04264099
0.18982118
0.08940853
0.1781293
0.0866575
0.1045392
0.16162311
0.14511692
0.07015131
0.18775791

0.0400272
0.0756104
0.8532679
0.4892296
0.0695689
0.3126069
0.5225205
0.0216112
0.0777619
0.077637
0.0771888
0.0536278
0.3856399
0.1293663
0.2894749
0.2637143
0.1182341
0.0633801
0.2197395
0.2230148
0.0420218
0.1779899
0.0966741
0.0505734
0.0550557
0.0531604
0.2281823
0.0101301
0.0056029
0.0256485
0.113883
0.1471963
0.0478392
0.0353047
0.0290551
0.0729658
0.0016008
0.0760394
0.0966773
0.0024012
0.0148589
0.1088244
0.0117693

0.1640427
1.5857647
0.9334199
0.8234546
0.6529137
0.6053543
0.5924575
0.5727794
0.5712234
0.5678601
0.5047367
0.4857576
0.4849368
0.4844244
0.477876
0.462944
0.4170866
0.390267
0.3867056
0.3561964
0.3513048
0.3360438
0.3255059
0.3234125
0.2998515
0.2971891
0.2907708
0.288797
0.2859337
0.2819188
0.2778668
0.2774783
0.2733522
0.2652894
0.2627711
0.2575907
0.253709
0.250325
0.2480928
0.2467567
0.2448329
0.2414399
0.2374444

0.033413297
0.018334476
0.023817683
0.02827279
0.039239205
0.040095956
0.037697053
0.016106923
0.01456477
0.01405072
0.068197395
0.04266621
0.037011652
0.048663468
0.016792324
0.047978067
0.067683345
0.038039753
0.060829335
0.033241947
0.030157642
0.032385195
0.044893763
0.02878684
0.025188485
0.01456477
0.023989034
0.026387937
0.037525703
0.020904729
0.022104181
0.016449623
0.024674435
0.038553804
0.04969157
0.016792324
0.025359836
0.020904729
0.015764222
0.029986292
0.031014393
0.07882111
0.027073338

0.03813729
0.02007226
0.02769972
0.02689683
0.03894019
0.0399438
0.03572862
0.0168607
0.01545564
0.01425131
0.06403051
0.04676837
0.03131273
0.05760739
0.01625853
0.05018065
0.06001606
0.04114813
0.05138499
0.03512646
0.03131273
0.03432357
0.04757126
0.03030911
0.02348454
0.01344841
0.02167804
0.03050984
0.04195102
0.01886793
0.02468888
0.01485347
0.02890406
0.03331995
0.05198715
0.01706142
0.02669611
0.01906865
0.01605781
0.03171417
0.03472501
0.07446809
0.02850261

0.10729023
0.17950481
0.11829436
0.02200825
0.14718019
0.09903714
0.10935351
0.07496561
0.00687758
0.16231087
0.02751032
0.11691885
0.09353508
0.01031637
0.04126548
0.07083907
0.00275103
0.11829436
0.06808803
0.11141678
0.08390647
0.12723521
0.08459422
0.130674
0.11141678
0.07565337
0.02475929
0.10797799
0.07427785
0.05639615
0.11829436
0.12929849
0.10935351
0.03026135
0.00756534
0.09834938
0.08803301
0.00343879
0.09422283
0.11072902
0.08940853
0.00618982
0.09903714

0.0561251
0.0167543
0.0633929
0.1515794
NA
0.0456172
0.04093
0.1156087
0.1847838
0.0243486
0.049376
0.0016008
0.0452234
0.0882602
0.1261582
0.0295353
0.0679584
0.0004002
0.0168888
0.0164085
0.0491967
0.0004002
0.0168824
0.0040021
0.0309825
0.0842805
0.1134988
0.0182495
0.0279953
0.08486
0.0155281
0.0179549
0.0128194
0.0734557
0.0656436
0.0415832
0.0331564
0.1295071
0.0465393
NA
0.0160851
0.0116957
0.016559

0.2349659
0.2346658
0.2332046
0.2287573
0.2253596
0.2246941
0.2237092
0.223542
0.2216818
0.2149615
0.2091142
0.2079543
0.2070829
0.2048474
0.2004745
0.1985331
0.1984089
0.1978825
0.1971911
0.1961937
0.1945735
0.1943442
0.1939416
0.193772
0.1910723
0.187947
0.1839252
0.1831252
0.1817499
0.1810288
0.1806155
0.1785565
0.1757514
0.1755908
0.1748877
0.1737863
0.1732453
0.1729193
0.1725842
0.1724295
0.1712331
0.1711747
0.1711721

0.020219328
0.015421522
0.030671693
0.031014393
0.019876628
0.036326251
0.031357094
0.062542838
0.015592872
0.015250171
0.034098698
0.027930089
0.020047978
0.018848526
0.034098698
0.025359836
0.06442769
0.025017135
0.026730637
0.02124743
0.031699794
0.024503084
0.046093215
0.018163125
0.027930089
0.023303633
0.01422207
0.032042495
0.015078821
0.024674435
0.026387937
0.031014393
0.013022618
0.029472241
0.02176148
0.041980809
0.019362577
0.022446881
0.027758739
0.01456477
0.025017135
0.013536669
0.018163125

0.01987154
0.01645925
0.03572862
0.03331995
0.01947009
0.03813729
0.02830189
0.05479727
0.01405058
0.0150542
0.03131273
0.02790044
0.01485347
0.01886793
0.03331995
0.02689683
0.06122039
0.02368527
0.0248896
0.02187876
0.03251706
0.02629466
0.04195102
0.01525492
0.02769972
0.02348454
0.01364914
0.03071056
0.01565636
0.02468888
0.0248896
0.03452429
0.01465275
0.02689683
0.02268165
0.04215175
0.01746287
0.0248896
0.0248896
0.01585709
0.02970695
0.0124448
0.01926937

0.03645117
0.06258597
0.05570839
0.0997249
0.05295736
0.08940853
0.01719395
0.03163686
0.10866575
0.07771664
0.03094911
0.01856946
0.03507565
0.03094911
0.09491059
0.08940853
0.02338377
0.07152682
0.10797799
0.11691885
0.0866575
0.09491059
0.03782669
0.1045392
0.09697387
0.0914718
0.09559835
0.02407153
0.0914718
0.09078404
0.04539202
0.08253095
0.10729023
0.03988996
0.09422283
0.03507565
0
0.08390647
0.03370014
0.09766162
0.07909216
0.07221458
0.09834938

0.0943369
0.0754759
0.0470644
0.0044023
0.076065
0.0040021
0.0901715
0.0175419
0.0281746
0.0577099
0.0685155
0.0897009
0.0937286
0.0942184
NA
0.0198215
0.0116957
0.0401744
0.0008004
NA
0.0089646
0.0128066
0.0311489
0.0188098
0.0040021
0.018083
0.0316964
0.06792
0.0316644
0.0127042
0.0561571
0.0024012
0.0152815
0.0528114
0.0100148
0.0293304
0.1108383
0.0148813
0.0595765
0.0172409
0.0112442
0.0468243
0.0082987

0.1708789
0.1699427
0.1691731
0.1684615
0.1683691
0.1678741
0.1670245
0.1665189
0.1664838
0.1657309
0.164876
0.1641009
0.1637057
0.162884
0.1623292
0.1614867
0.1607275
0.1604037
0.1603986
0.160045
0.159839
0.158515
0.1570199
0.156767
0.1566057
0.156343
0.155166
0.1547446
0.1538714
0.1528515
0.1528267
0.1504709
0.1502471
0.1490704
0.1486808
0.1485386
0.1476637
0.1461243
0.145925
0.1453244
0.1450605
0.1450203
0.1440806

0.026387937
0.014736121
0.046607265
0.02176148
0.019533927
0.061172036
0.043694311
0.027416038
0.02827279
0.015935572
0.026387937
0.018334476
0.015935572
0.02141878
0.019705278
0.015250171
0.001713502
0.017477724
0.04283756
0.017135024
0.024331734
0.016278273
0.029472241
0.023132282
0.025531186
0.015764222
0.012337217
0.024845785
0.020219328
0.025017135
0.015764222
0.023303633
0.025188485
0.013879369
0.028101439
0.041638108
0.020904729
0.018677176
0.015078821
0.020219328
0.031699794
0.019362577
0.016106923

0.03050984
0.01465275
0.0399438
0.02167804
0.02067443
0.06021678
0.0435568
0.02769972
0.03030911
0.01746287
0.02850261
0.01967082
0.01605781
0
0.02027298
0.01465275
0.02368527
0.02007226
0.03050984
0.01726214
0.02248093
0.01224408
0.02769972
0.02388599
0.02589322
0.01565636
0.01324769
0.02609394
0.0212766
0.02709755
0.01786431
0.0230831
0.02769972
0.01465275
0.02549177
0.04034524
0.02027298
0.01645925
0.0150542
0.02207949
0.02970695
0.00903252
0.0186672

0.05089409
0.11348006
0.03163686
0.08528198
0.0914718
0.00894085
0.0522696
0.04057772
0.05570839
0.09009629
0.05983494
0.09903714
0.06740028
0.05777166
0.09766162
0.05708391
0.09766162
0.06877579
0.01581843
0.0735901
0.00275103
0.10041266
0.05502063
0.06258597
0.07977992
0.08872077
0.06327373
0.06464924
0.08596974
0.03988996
0.0735901
0.07702889
0.06946355
0.04814305
0.03301238
0.01169188
0.04470426
0.07496561
0.09078404
0.07977992
0.0605227
0.00275103
0.05570839

0.0355384
0.0004002
0.0237051
0.0124064
0.0084524
0.0095249
NA
0.0435554
0.0249057
0.015448
0.0240124
0.0016008
0.038913
0.0589906
NA
0.0506375
0.0144075
0.0310145
0.0457837
0.0261672
0.0844758
0.0048025
0.0196838
0.0217713
NA
0.0108056
0.041644
0.0139272
0.0016008
0.0360251
0.0206059
0.003762
0.0040021
0.0495585
0.0395789
0.0324168
0.0396013
0.0141673
0.0032017
0.0016008
0.0016008
0.092211
0.0322087

0.1433303
0.1432691
0.141893
0.1411279
0.1401325
0.1398546
0.1395207
0.1392489
0.139196
0.1389427
0.1387379
0.1386433
0.1383066
0.138181
0.1376399
0.1376243
0.1374679
0.1373403
0.1349496
0.1341544
0.1340395
0.1337375
0.1318764
0.1313755
0.1312043
0.130947
0.1305026
0.1295162
0.1290665
0.1280297
0.1278245
0.1271776
0.1263538
0.1262337
0.1261845
0.126092
0.1254833
0.1242694
0.1241187
0.1236796
0.1235303
0.1233571
0.1226912

0.019705278
0.061514736
0.036326251
0.02124743
0.027244688
0.016792324
0.029472241
0.026045236
0.037183002
0.01405072
0.017991775
0.031014393
0.012165867
0.016278273
0.014907471
0.017306374
0.016106923
0.039410555
0.013193968
0.019362577
0.023303633
0.024845785
0.017306374
0.013536669
0.015078821
0.029814942
0.012851268
0.016106923
0.018848526
0.013536669
0.017991775
0.044551062
0.016449623
0.015421522
0.018163125
0.030157642
0.044722413
0.030500343
0.019019877
0.016449623
0.019876628
0.012165867
0.017306374

0.01886793
0.058611
0.03934163
0.02348454
0.02689683
0.01786431
0.031112
0.02529105
0.03673224
0.01485347
0.02027298
0.03211562
0.01304697
0.01726214
0.01585709
0.01746287
0.01605781
0
0.01224408
0.02167804
0.02408671
0.02669611
0.01726214
0.01425131
0.01605781
0.0293055
0.01324769
0.0168607
0.02067443
0.01344841
0.02248093
0.04656764
0.01645925
0.01445203
0.0168607
0.02830189
0.04656764
0.02950622
0.01846648
0.01565636
0.02107587
0.01405058
0.01967082

0.07496561
0.00206327
0.04057772
0.05845942
0.04126548
0.065337
0.05845942
0.05158184
0.04539202
0.04951857
0.05845942
0.05295736
0.07427785
0.08253095
0.08528198
0.08253095
0.08046768
0.07702889
0.04057772
0.0735901
0.05020633
0.05914718
0.02751032
0.06671252
0.07909216
0.05020633
0.06671252
0.07909216
0.06189821
0.04470426
0.06121045
0.00481431
0.06396149
0.02888583
0.02751032
0.05089409
0.01788171
0.04607978
0.05570839
0.01856946
0.03507565
0.07496561
0.07152682

0.0090927
NA
0.0048025
0.0176219
0.0248129
0.0200072
0.0008004
0.0164501
NA
0.040866
0.0220082
0.0024012
0.0182463
0.0016008
0.0016008
NA
0.0041622
NA
0.0502629
0.0016008
0.0183423
0.0048025
0.0533877
0.0196102
0.0032017
0.0040021
0.0202345
0.0008004
0.0112826
0.0408436
0.0104854
0.0160083
0.0148077
0.0529074
0.0486652
0.0016008
0.0017609
0.0040021
0.0167415
0.0590674
0.0332204
0.007764
NA

0.1226315
0.122189
0.1210481
0.1208133
0.1202199
0.1200008
0.1198441
0.1193683
0.1193073
0.1192887
0.1187324
0.1184886
0.1177369
0.1176722
0.1176474
0.1173002
0.1167946
0.1164394
0.1162786
0.1162315
0.115939
0.1154916
0.1154665
0.1141107
0.1134304
0.1133288
0.113046
0.1128602
0.1127038
0.1125329
0.1121686
0.1119413
0.111678
0.1116668
0.1111994
0.1109544
0.1109327
0.1100884
0.1099362
0.1097429
0.1092486
0.1089461
0.108504

0.015250171
0.027587389
0.015250171
0.022275531
0.016963674
0.027073338
0.016278273
0.016792324
0.018163125
0.020219328
0.037011652
0.016963674
0.02159013
0.022104181
0.023303633
0.033413297
0.030500343
0.014736121
0.022275531
0.025531186
0.017135024
0.024160384
0.024331734
0.022789582
0.013193968
0.017135024
0.043351611
0.019705278
0.019705278
0.01456477
0.023303633
0.014907471
0.017306374
0.029300891
0.016963674
0.018848526
0.020562029
0.015764222
0.016278273
0.033070596
0.029986292
0.018334476
0.015592872

0.01706142
0.02830189
0.01605781
0.02368527
0.01826576
0.02388599
0.01826576
0.01786431
0.01746287
0.02147732
0.03131273
0.01746287
0.02549177
0.02348454
0.01605781
0.03211562
0.03271778
0.01445203
0.02207949
0.02689683
0.02147732
0.02629466
0.02890406
0.02428744
0.01284625
0.01906865
0.03773585
0.02167804
0.01605781
0.01545564
0.02448816
0.01585709
0.01545564
0.03211562
0.01746287
0.02067443
0.02228021
0.01806503
0.01144119
0.02970695
0.027499
0.01906865
0.01585709

0.07290234
0.05089409
0.07496561
0.00756534
0.04539202
0.03645117
0.04676754
0.03163686
0.05777166
0.00275103
0.0343879
0.06808803
0.0261348
0.05364512
0.0343879
0.02063274
0.03370014
0.07015131
0.04539202
0.03507565
0.05708391
0.04676754
0.01375516
0.05158184
0.065337
0.0605227
0.00206327
0.05570839
0.05158184
0.06258597
0.03782669
0.06189821
0.02338377
0.03232462
0.05708391
0.05020633
0.04607978
0.05020633
0.03301238
0.02200825
0.03232462
0.01925722
0.05777166

0.0032017
0.0016008
0.002001
0.0543546
0.0271341
0.0188098
0.0234746
0.0381798
0.0109497
0.0592019
0.0008004
NA
0.0292632
0.0016008
0.0265225
0.0140073
0.0032017
NA
0.0095922
0.0114876
0.0032017
0.0016008
0.0316964
NA
0.0071237
0.0016008
0.0145227
NA
0.009733
0.0040021
0.0108056
0.0033617
0.0396173
0.0013607
0.0032017
0.0048025
0.0056029
0.0101301
0.0322567
0.0080842
0.0028015
0.0357785
0.0032017

0.1084156
0.1083842
0.1082746
0.1078807
0.1077555
0.1062202
0.1047861
0.1044733
0.1043473
0.1036496
0.1035127
0.1025146
0.1024799
0.1008347
0.1002719
0.1001689
0.1001199
0.0993395
0.0993392
0.0989912
0.0988979
0.0988234
0.0986874
0.0986589
0.0985009
0.0983272
0.0976735
0.0970917
0.097078
0.0966085
0.0964241
0.0960245
0.0957631
0.0951018
0.0947121
0.0945318
0.0945249
0.0941656
0.0929886
0.09287
0.0926114
0.0924389
0.0924233

0.018334476
0.025359836
0.012508568
0.020390679
0.01422207
0.02159013
0.013536669
0.01422207
0.013536669
0.018163125
0.015935572
0.014736121
0.011994517
0.01439342
0.025531186
0.013708019
0.01439342
0.017135024
0.015421522
0.017135024
0.01456477
0.019362577
0.014907471
0.017991775
0.029814942
0.019876628
0.019533927
0.015078821
0.019705278
0.015250171
0.016963674
0.013193968
0.02124743
0.016792324
0.01422207
0.017649075
0.024845785
0.029643592
0.027073338
0.035126799
0.001884853
0.019533927
0.013365319

0.01987154
0.02709755
0.01344841
0.02268165
0.01304697
0.02007226
0.01525492
0.01465275
0.01304697
0.02007226
0.01585709
0.01485347
0.01405058
0.01525492
0.02348454
0.01344841
0.01605781
0.01585709
0.01545564
0.01906865
0.01585709
0.01886793
0.01545564
0.01786431
0.02850261
0.02147732
0.01947009
0.01465275
0.01766359
0.01585709
0.01726214
0.01204336
0.01926937
0.01967082
0.01545564
0.01846648
0.02790044
0.0248896
0.0248896
0.03412284
0.01766359
0.01987154
0.01425131

0.0522696
0.0392022
0.06258597
0.03507565
0.03232462
0.04951857
0.05914718
0.05639615
0.06396149
0.0522696
0.05845942
0.05364512
0.04470426
0.05983494
0.03851444
0.06189821
0.05295736
0.05433288
0.04814305
0.05020633
0.05708391
0.01994498
0.05502063
0.02819807
0.02819807
0.04195323
0.0261348
0.04332875
0.0343879
0.05295736
0.05158184
0.0605227
0.02200825
0.04883081
0.04264099
0.04883081
0.03026135
0.02957359
0.03026135
0
0.06396149
0.04126548
0.05433288

0.0016008
NA
0.0028015
0.0131396
0.0316868
NA
0.0032017
0.0056029
NA
NA
NA
0.0068035
0.0190083
NA
0.0016008
NA
0.0056029
0.0016008
0.0091247
0.0016008
NA
0.0291575
0.0016008
0.0228118
NA
0.0032017
0.0212334
0.0132068
0.0144971
0.0021611
NA
NA
0.0229719
NA
0.0128066
NA
0.0016008
NA
0.0016008
0.0144075
NA
0.0024012
0.0008004

0.0920764
0.0916596
0.0913444
0.0912876
0.0912805
0.091181
0.0911404
0.0908739
0.0905451
0.090505
0.0902521
0.0900382
0.0897576
0.0894833
0.089131
0.0890546
0.0890115
0.0889258
0.0881449
0.0880108
0.0875058
0.087333
0.0869846
0.086866
0.0865156
0.0865088
0.0863722
0.0862672
0.0862539
0.0862257
0.0858077
0.08576
0.085497
0.085294
0.0851253
0.0849464
0.0846084
0.0841068
0.0838251
0.0836571
0.0835099
0.0830722
0.0827499

0.018334476
0.013022618
0.015421522
0.01456477
0.01422207
0.01456477
0.013879369
0.013365319
0.012165867
0.013193968
0.014907471
0.022618232
0.018163125
0.013365319
0.018334476
0.014907471
0.02141878
0.013365319
0.013536669
0.01422207
0.013708019
0.022446881
0.018505826
0.030500343
0.012851268
0.016278273
0.024845785
0.017306374
0.017135024
0.022104181
0.016106923
0.017649075
0.020390679
0.018848526
0.019876628
0.022104181
0.027587389
0.017306374
0.019533927
0.016963674
0.015764222
0.016620973
0.019533927

0.01665998
0.01384986
0.01324769
0.01605781
0.01184263
0.01324769
0.01525492
0.01364914
0.01344841
0.01585709
0.01625853
0.0248896
0.01605781
0.01465275
0.01926937
0.01445203
0.01766359
0.01224408
0.01465275
0.01485347
0.01304697
0.0168607
0.01726214
0.02549177
0.01324769
0.0186672
0.02870333
0.01926937
0.01886793
0.02468888
0.0150542
0.01886793
0.01947009
0.01906865
0.01746287
0.02328382
0.02830189
0.01826576
0.01906865
0.01886793
0.01405058
0.01926937
0.01947009

0.03782669
0.03713893
0.02338377
0.05158184
0.04470426
0.02338377
0.0522696
0.00275103
0.04951857
0.04814305
0.04539202
0.03094911
0.04195323
0.04814305
0.00275103
0.0474553
0.02407153
0.05020633
0.03163686
0.04539202
0.04607978
0.03232462
0.0392022
0.01581843
0.03370014
0.03782669
0.00618982
0.03576341
0.03782669
0.02682256
0.04195323
0.03645117
0.03163686
0.03301238
0.0261348
0.02682256
0.01581843
0.03576341
0.02819807
0.03301238
0.04057772
0.0343879
0.00550206

0.0096818
0.0184832
0.0304158
NA
0.0108056
0.0302461
NA
0.0516268
0.0047224
0.0016008
0.002001
NA
0.0016008
0.0016008
0.0371329
NA
0.0136135
0.0004002
0.0163285
0.0016008
0.0032017
0.0044023
NA
0.0028015
0.0148077
0.0016008
0.0144075
0.0016008
NA
NA
0.0004002
NA
0.0012006
0.0016008
0.0089646
NA
NA
NA
0.0040021
0.0016008
NA
NA
0.0256133

0.082503
0.0824946
0.0824688
0.0822044
0.0815746
0.0814423
0.0814039
0.0813923
0.0798553
0.0787949
0.0785591
0.0784569
0.077775
0.077762
0.0774877
0.0768148
0.0767674
0.0762159
0.0761547
0.0760684
0.0760364
0.0760345
0.0749702
0.074612
0.0746068
0.074373
0.0741464
0.07394
0.0738296
0.0736156
0.0735146
0.0729682
0.0726983
0.0725304
0.0724389
0.0722106
0.0717077
0.0713355
0.0708027
0.0704448
0.0703925
0.0702782
0.0701194

0.019019877
0.022104181
0.017306374
0.014907471
0.015421522
0.019876628
0.015764222
0.01405072
0.023132282
0.013708019
0.029643592
0.024160384
0.02124743
0.011823167
0.020047978
0.011309116
0.01456477
0.013879369
0.015421522
0.023817683
0.020562029
0.029300891
0.021932831
0.02176148
0.016620973
0.016278273
0.01422207
0.016792324
0.017991775
0.02124743
0.018677176
0.025017135
0.020047978
0.024503084
0.01405072
0.013536669
0.023989034
0.015421522
0.017135024
0.012851268
0.018163125
0.018505826
0.01456477

0.01926937
0.02067443
0.01545564
0.01485347
0.01384986
0.02047371
0.02027298
0.01445203
0.02368527
0.01405058
0.00040145
0.02428744
0.01926937
0.01344841
0.01967082
0.01304697
0.01585709
0.01445203
0.01565636
0.02207949
0.01806503
0.02549177
0.02087515
0.02007226
0.01766359
0.01525492
0.01425131
0.0168607
0.01665998
0.02067443
0.01906865
0.02709755
0.01645925
0.02348454
0.01625853
0.01485347
0.02228021
0.01726214
0.01947009
0.01344841
0.01826576
0.02027298
0.01585709

0.03163686
0.02682256
0.03507565
0.03782669
0.03782669
0.01994498
0.02269601
0.03851444
0.01994498
0.03988996
0.03301238
0.01375516
0.02682256
0.02682256
0.02751032
0.0261348
0.03645117
0.03851444
0.0213205
0.02063274
0.01650619
0.00962861
0.00275103
0.02269601
0.03163686
0.0343879
0.03645117
0.03026135
0.01100413
0.02338377
0.02751032
0.01031637
0.0261348
0.00894085
0.03370014
0.03507565
0.01719395
0.02957359
0.02682256
0.00618982
0.0261348
0.02338377
0.03163686

NA
NA
0.0016008
0.0016008
0.002001
0.0084044
0.0099251
0.0016008
0.0016008
0.0004002
0.0044023
0.0052027
NA
0.0151406
NA
0.0166486
NA
NA
0.0144075
NA
0.0113659
0.002001
0.0208108
0.0016008
NA
NA
0.0008004
0.0016008
0.0196838
NA
NA
0.0024012
0.0016008
0.0072037
NA
0.0004002
0.0004002
0.0016008
0.0004002
0.0310593
NA
NA
NA

0.0699261
0.0696012
0.0694385
0.0691885
0.0690991
0.0686997
0.0686584
0.068618
0.0683634
0.0680488
0.0674597
0.0674057
0.0673394
0.0672348
0.0672291
0.0671395
0.066873
0.0668458
0.0668058
0.0665299
0.0664991
0.0664223
0.0663698
0.0661306
0.0659214
0.0659211
0.065725
0.0655152
0.0653397
0.0653056
0.0652561
0.0648323
0.0642429
0.0641322
0.0640094
0.063866
0.0638634
0.0638581
0.0638279
0.0635488
0.0625637
0.0621626
0.0620587

0.017477724
0.019362577
0.015250171
0.015592872
0.016963674
0.013536669
0.013708019
0.014907471
0.013365319
0.01405072
0.01439342
0.01405072
0.02141878
0.012165867
0.012851268
0.01439342
0.020904729
0.017820425
0.030157642
0.023132282
0.016963674
0.019191227
0.015764222
0.019533927
0.018505826
0.017991775
0.016449623
0.019019877
0.013365319
0.025531186
0.019019877
0.027416038
0.015078821
0.017306374
0.012508568
0.019362577
0.019362577
0.017306374
0.018334476
0.02141878
0.012851268
0.015078821
0.018505826

0.01906865
0.02027298
0.01344841
0.01645925
0.01726214
0.01344841
0.0150542
0.01525492
0.01264552
0.01405058
0.01565636
0.01445203
0.01926937
0.01384986
0.01405058
0.01585709
0.01826576
0.01746287
0.02709755
0.02428744
0.01726214
0.02047371
0.01425131
0.01987154
0.01706142
0.01987154
0.01665998
0.01846648
0.01264552
0.02448816
0.0168607
0.02388599
0.01726214
0.01344841
0.01405058
0.01886793
0.02067443
0.0168607
0.01645925
0.02248093
0.01545564
0.01445203
0.0150542

0.02544704
0.02063274
0.02751032
0.02751032
0.0261348
0.03163686
0.02407153
0.02888583
0.00962861
0.01650619
0.02957359
0.01169188
0.01856946
0.03163686
0.03026135
0.02888583
0.01994498
0.01719395
0
0.01100413
0.02407153
0.01856946
0.02751032
0.01444292
0.0213205
0.01719395
0.02338377
0.01719395
0.02407153
0.00618982
0.01925722
0.00275103
0.01513067
0.02475929
0.02888583
0.01719395
0.01513067
0.01650619
0.01856946
0.01100413
0.0261348
0.02269601
0.00412655

NA
0.0016008
0.0052827
0.0016008
0.0008004
0.0024012
0.0080041
0.0016008
0.0245727
0.0152079
NA
0.01921
NA
0.0016008
0.002001
NA
NA
0.0064033
0.0016008
NA
NA
NA
NA
0.0032017
NA
0.0016008
NA
0.0016008
0.0061632
NA
0.0008004
0.0016008
0.0081322
NA
NA
NA
NA
0.0044023
0.0016008
NA
NA
0.0016008
0.0156977

0.0619934
0.0618691
0.0614916
0.0611633
0.061161
0.0610232
0.0608379
0.0606491
0.0602122
0.0598154
0.0596234
0.0594046
0.0592576
0.0592534
0.0591642
0.0591363
0.0591155
0.0588806
0.058856
0.0584238
0.0582973
0.0582344
0.0575258
0.05705
0.0568877
0.0566581
0.0564934
0.0562811
0.0562456
0.0562092
0.0559382
0.0556539
0.0556039
0.0555141
0.055445
0.0554244
0.0551677
0.0550755
0.054964
0.0549038
0.0544417
0.0538277
0.0533843

0.020047978
0.01439342
0.016963674
0.017135024
0.015421522
0.015764222
0.016620973
0.020904729
0.023646333
0.016963674
0.020219328
0.01439342
0.017306374
0.016106923
0.013879369
0.015935572
0.014907471
0.012165867
0.019705278
0.015764222
0.01405072
0.014907471
0.016449623
0.015250171
0.016449623
0.020733379
0.013879369
0.014907471
0.011480466
0.01456477
0.021932831
0.013365319
0.014907471
0.014907471
0.02124743
0.013536669
0.014736121
0.015764222
0.01456477
0.01456477
0.01422207
0.015421522
0.013022618

0.02207949
0.01605781
0.01465275
0.01947009
0.01324769
0.01525492
0.01605781
0.01766359
0.02569249
0.01625853
0.01846648
0.01324769
0.01886793
0.01384986
0.01625853
0.01465275
0.01384986
0.01324769
0.01786431
0.01445203
0.01545564
0.01645925
0.01726214
0.01585709
0.01806503
0.01967082
0.01425131
0.01465275
0.01344841
0.01344841
0
0.01304697
0.01545564
0.01485347
0.02007226
0.0124448
0.01405058
0.01665998
0.01605781
0.01605781
0.01264552
0.01545564
0.01304697

0.00481431
0.02269601
0.0213205
0.00687758
0.02407153
0.01994498
0.01925722
0.01375516
0.00068776
0.01856946
0.0130674
0.02407153
0.0130674
0.0213205
0.01994498
0.01994498
0.01925722
0.02475929
0.01237964
0.01444292
0.01994498
0.01788171
0.01031637
0.01650619
0.01444292
0.00550206
0.01650619
0.01788171
0.02200825
0.01925722
0.02475929
0.01925722
0.01581843
0.01444292
0.00275103
0.01788171
0.01650619
0.01237964
0.01444292
0.01444292
0.00894085
0.01237964
0.01788171

0.0064033
NA
NA
0.0093232
NA
0.0016008
0.0004002
NA
0.002001
NA
NA
NA
0.0024012
NA
0.0005603
NA
0.0024012
NA
NA
0.0048025
NA
NA
0.0052027
0.0016008
NA
0.0024012
0.0029615
NA
0.0004002
NA
NA
0.0008004
NA
0.0017609
0.0016008
0.0016008
NA
0.0004002
NA
NA
0.0091567
0.0016008
NA

0.0533451
0.0531472
0.0529369
0.0528059
0.0527407
0.0525649
0.0523362
0.0523235
0.0520276
0.0517917
0.0517532
0.0517126
0.0516429
0.0512773
0.0506432
0.0505333
0.0504158
0.0501728
0.0499492
0.0494617
0.0494513
0.0492484
0.0492308
0.0492143
0.0489576
0.0483075
0.0475984
0.0474419
0.0473373
0.0472704
0.0466921
0.0464699
0.0461815
0.0459648
0.0456716
0.045464
0.0452929
0.045204
0.0450655
0.0450655
0.0449652
0.0448576
0.0439513

0.015592872
0.012679918
0.015078821
0.013536669
0.013022618
0.013536669
0.013365319
0.013879369
0.020904729
0.013193968
0.015078821
0.019019877
0.013708019
0.018334476
0.01405072
0.016449623
0.017649075
0.014736121
0.019019877
0.01422207
0.015250171
0.016620973
0.01405072
0.013536669
0.017135024
0.016278273
0.014736121
0.015935572
0.012851268
0.013708019
0.011994517
0.013365319
0.012851268
0.014907471
0.012679918
0.013879369
0.013536669
0.015250171
0.018334476
0.015421522
0.012337217
0.013536669
0.013022618

0.01726214
0.01324769
0.01545564
0.01465275
0.01344841
0.01184263
0.01344841
0.0150542
0.02027298
0.01344841
0.01585709
0.01103974
0.0062224
0.01806503
0.01284625
0.01665998
0.0150542
0.01585709
0.01906865
0.01485347
0.01364914
0.01766359
0.01043758
0.01585709
0.01665998
0.01425131
0.01344841
0.01605781
0.01304697
0.01425131
0.01344841
0.01485347
0.01344841
0.01364914
0.01405058
0.01565636
0.01324769
0.01364914
0.01545564
0.01665998
0.01405058
0.01324769
0.01425131

0.01100413
0.01513067
0.00550206
0.01444292
0.01375516
0.00756534
0.01444292
0.0130674
0.00068776
0.01513067
0.00275103
0.01100413
0.02063274
0.00343879
0.01169188
0.00687758
0.00550206
0.00894085
0.00137552
0.00962861
0.00962861
0.00412655
0.01031637
0.00894085
0.00275103
0.00756534
0.00343879
0.00550206
0.00756534
0.00756534
0.00068776
0.0082531
0.00962861
0.00756534
0.00756534
0.00618982
0.00756534
0.00412655
0
0.00137552
0.00687758
0.00412655
0.00275103

NA
0.0024012
0.0073638
NA
0.0024012
0.0096306
0.0008004
NA
NA
NA
0.0080041
NA
NA
0.0004002
0.0016008
NA
0.0016008
NA
NA
NA
NA
NA
0.0036019
NA
0.0016008
NA
0.0059231
NA
0.0040021
0.0012006
0.0104406
NA
0.0004002
NA
0.0016008
NA
0.0008004
0.0016008
NA
NA
NA
0.0016008
0.0016008

0.0438591
0.0434595
0.0434003
0.0426323
0.0426274
0.0425752
0.0420571
0.042001
0.0418655
0.0417731
0.0416911
0.0410637
0.0405632
0.0402385
0.0401897
0.0399872
0.0398062
0.0395341
0.039464
0.0387042
0.0385279
0.0384111
0.0384065
0.0383346
0.0381469
0.0380949
0.0375464
0.0374954
0.0374656
0.0367253
0.0365713
0.0364719
0.0363285
0.0361219
0.0358967
0.0357256
0.0351501
0.0346267
0.0337901
0.033457
0.0332654
0.0325117
0.0316258

0.013879369
0.016278273
0.012679918
0.015078821
0.015078821
0.013193968
0.015078821
0.017477724
0.01422207
0.02141878
0.017820425
0.006339959
0.018505826
0.008910212
0.015764222
0.017991775
0.01405072
0.024331734
0.013193968
0.020390679
0.008738862
0.009081563
0.010281014
0.076764907
0.006511309
0.415010281
0.014907471
0.009595613
0.02141878
0.024331734
0.006168609
0.006339959
0.0354695
0.023132282
0.01422207
0.039239205
0.006682659
0.010795065
0.005997258
0.0354695
0.089444825
0.009424263
0.008910212

0.01364914
0.01364914
0.01445203
0.01445203
0.01264552
0.01164191
NA
0.01766359
0.01344841
0.02428744
0.01706142
0.00642312
0.01926937
0.00843035
0.01545564
0.01906865
0.01525492
0.02569249
0.01425131
0.0230831
0.00963469
0.00883179
0.00963469
0.07928543
0.00602168
0.38940185
0.01364914
0.0080289
0.01766359
0.01947009
0.00562023
0.00501807
0.03392212
0.02268165
0.0106383
0.0337214
0.00521879
0.00883179
0.00582096
0.03633079
0.09032517
0.00722601
0.00541951

0.00275103
0.00068776
0.00343879
0
0.00137552
0.00068776
0
0.21045392
0.25034388
0.23658872
0.14718019
0.10041266
0.14511692
0.08184319
0.12929849
0.16024759
0.09697387
0.12379642
0.11898212
0.11485557
0.1045392
0.12517194
0.06946355
1
0.01444292
0.00894085
0.13686382
0.07427785
0.05433288
0.12310867
0.0343879
0.05708391
0.31292985
0.07977992
0.15130674
0.0914718
0.03645117
0.00756534
0.03988996
0.16093535
0.15543329
0.04539202
0.05708391

0.0012006
NA
NA
NA
NA
NA
NA
0.1607329
0.1223674
0.0708944
0.1212148
0.1733987
0.0970903
0.176991
0.0940456
0.0507463
0.1114978
0.0455884
0.0663544
0.0056029
0.0407411
0.0188098
0.0487837
0.6963834
1
0.1628588
0.7692276
0.802512
0.7943766
0.7164098
0.8117808
0.7429676
0.3404549
0.5736062
0.434033
0.4421044
0.5571048
0.5571272
0.4665106
0.2155838
0.0984767
0.3608142
0.3321978

0.0314802
0.0306152
0.0305707
0.0295308
0.0290999
0.0255236
0.0150788
0.4063282
0.4003818
0.3531893
0.3032769
0.2865744
0.2799824
0.2761747
0.2545639
0.2480543
0.2377773
0.2194091
0.2127818
0.1639323
0.1636539
0.161895
0.1381629
1.8524337
1.0269759
0.9762118
0.934648
0.8944144
0.8877918
0.8833203
0.8579576
0.8114095
0.7227764
0.6992
0.6102001
0.6065368
0.6054574
0.5843194
0.5182188
0.4483194
0.4336799
0.4228565
0.4036114

0.008053461
0.047635367
0.156271419
0.062885538
0.015592872
0.007882111
0.008224812
0.008053461
0.013365319
0.014907471
0.017649075
0.022275531
0.019876628
0.013022618
0.012337217
0.022960932
0.018163125
0.00719671
0.005311857
0.028958191
0.016449623
0.040781357
0.023474983
0.005654558
0.029643592
0.030157642
0.02827279
0.017649075
0.00736806
0.02878684
0.040438657
0.013193968
0.018163125
0.016449623
0.01456477
0.014907471
0.017306374
0.015078821
0.018163125
0.024503084
0.00736806
0.015421522
0.010966415

0.00682457
0.04656764
0.1384986
0.06142112
0.01525492
0.00642312
0.00541951
0.00381373
0.01384986
0.00020072
0.01465275
0.01846648
0.01947009
0.01284625
0.01164191
0.01967082
0.01746287
0.00702529
0.0062224
0.02428744
0.01665998
0.0373344
0.02268165
0.00642312
0.02769972
0.02769972
0.03091128
0.01425131
0.00702529
0.02589322
0.03311923
0.01405058
0.01926937
0.0150542
0.01304697
0.01264552
0.01706142
0.01284625
0.01826576
0.02328382
0.00642312
0.01525492
0.01164191

0.02751032
0.09009629
0
0.0866575
0.05433288
0.02338377
0.04332875
0.06258597
0.065337
0.03232462
0.07015131
0.03094911
0.11348006
0.12310867
0.0261348
0.05639615
0.09422283
0
0.10866575
0.01925722
0.18088033
0.06258597
0.10522696
0.09766162
0.03232462
0.03094911
0.09559835
0.05364512
0.06327373
0.0735901
0.06671252
0.18156809
0.17193948
0.12379642
0.03507565
0.11554333
0.15405777
0.00756534
0.1781293
0.0735901
0.03645117
0.14511692
0.07083907

0.3586979
0.1978754
0.0816391
0.1606305
0.273982
0.3065525
0.2869424
0.264646
0.2424393
0.2872689
0.2287874
0.2477284
0.1451953
0.148525
0.2414404
0.1885714
0.1556135
0.2711998
0.1638353
0.2059884
0.0638667
0.1362402
0.123091
0.1596828
0.1753773
0.1718299
0.104531
0.1637649
0.1706741
0.1181412
0.1027124
0.032737
0.0302557
0.0823435
0.169848
0.0876518
0.0417817
0.1879438
0.0084044
0.0962099
0.1568461
0.030451
0.1093335

0.4010863
0.3821747
0.3764091
0.3715946
0.3591627
0.3442415
0.3439154
0.3390992
0.3349915
0.3347017
0.3312405
0.3194195
0.298022
0.2975025
0.2915543
0.2875993
0.2854623
0.2854218
0.2840353
0.2784912
0.2778566
0.276942
0.2744746
0.2694221
0.2650452
0.2606363
0.2593134
0.2493104
0.2483412
0.2464114
0.2429828
0.2415496
0.2396277
0.2376437
0.2325354
0.2307482
0.2302072
0.2234342
0.2229625
0.2175869
0.2070885
0.2062443
0.2027809

0.019362577
0.048834818
0.013022618
0.020733379
0.014907471
0.002227553
0.013536669
0.009252913
0.007539411
0.01422207
0.025188485
0.012508568
0.01456477
0.009595613
0.00702536
0.011309116
0.018334476
0.018505826
0.031699794
0.019019877
0.013536669
0.00736806
0.009595613
0.006168609
0.008053461
0.005825908
0.012851268
0.033070596
0.011994517
0.012337217
0.008396162
0.010281014
0.013193968
0.007710761
0.010966415
0.020219328
0.008396162
0.012679918
0.008053461
0.00702536
0.02827279
0.007882111
0.024845785

0.01846648
0.04877559
0.0106383
0.02067443
0.01625853
0.01003613
0.0150542
0.00903252
0.00762746
0.01284625
0.0293055
0.0124448
0.00943396
0.01124047
0.0062224
0.01144119
0.01947009
0.0168607
0.03613007
0.01826576
0.01445203
0.00742674
0.01003613
0.00521879
0.00863107
0.00662385
0.01405058
0.031112
0.01405058
0.00983541
0.00843035
0.0106383
0.01284625
0.00702529
0.01224408
0.01746287
0.00702529
0.01445203
0.00160578
0.00762746
0.02850261
0.00883179
0.00020072

0.10316369
0.02063274
0.01788171
0.01031637
0.10729023
0.04951857
0.10729023
0.06808803
0.11554333
0.09697387
0.04883081
0.14442916
0.01100413
0.11898212
0.02269601
0.08803301
0.10247593
0.04195323
0.00894085
0.02338377
0.07634113
0.04057772
0.06877579
0.08253095
0.08046768
0.11485557
0.10797799
0.01925722
0.10041266
0.03163686
0.0343879
0.06121045
0.10041266
0.06602476
0.07634113
0.00756534
0.03094911
0.04057772
0.01925722
0.00275103
0.01994498
0.10522696
0.10591472

0.0600119
0.0816391
0.1544
0.1440523
0.0539288
0.1304516
0.0553887
0.099879
0.0531764
0.0556929
0.0761835
0.0089646
0.1394867
0.0344979
0.1348507
0.0589906
0.0259911
0.0878247
0.0860382
0.0991714
0.0532276
0.1011981
0.0679776
0.0608315
0.0567494
0.0259719
0.0172858
0.0686116
0.0255845
0.094846
0.0948524
0.0637226
0.0189698
0.0642989
0.045217
0.0994115
0.0981117
0.0765165
0.1139183
0.1247847
0.0645134
0.0187969
0.0056029

0.2010047
0.1998823
0.1959427
0.1957765
0.192385
0.1922339
0.1912698
0.1862524
0.1838866
0.1797351
0.1795083
0.1783472
0.1744896
0.1743161
0.1707945
0.1697739
0.1662716
0.1651445
0.1628089
0.1598408
0.1575574
0.1565706
0.1563852
0.1547499
0.1539016
0.1532772
0.1521656
0.1520514
0.1520422
0.1486555
0.1460668
0.1458524
0.1454227
0.1450597
0.1447687
0.1446591
0.1444822
0.1442261
0.1428347
0.1421885
0.1412338
0.1407378
0.1365641

0.019705278
0.02159013
0.011651816
0.012165867
0.010623715
0.00702536
0.008910212
0.017820425
0.018505826
0.020562029
0.025873886
0.009766964
0.008910212
0.009938314
0.005997258
0.01422207
0.006168609
0.02107608
0.012508568
0.016792324
0.006682659
0.007882111
0.00702536
0.008224812
0.010109664
0.010623715
0.007882111
0.014907471
0.006339959
0.017820425
0.025873886
0.005997258
0.015764222
0.006682659
0.008567512
0.008910212
0.010623715
0.007710761
0.007710761
0.009595613
0.008224812
0.008910212
0.009252913

0.02288238
0.02388599
0.00963469
0.01304697
0.01224408
0.00501807
0.00943396
0.01324769
0.01425131
0.02007226
0.02529105
0.00983541
0.00702529
0.00983541
0.00602168
0.01224408
0.00521879
0.02388599
0.01204336
0.01645925
0.00662385
0.00702529
0.00762746
0.0080289
0.0106383
0.01124047
0.00903252
0.01665998
0.0062224
0.01304697
0.02790044
0.00521879
0.01645925
0.00682457
0.0080289
0.00863107
0.01164191
0.0080289
0.0080289
0.01184263
0.00642312
0.00863107
0.00923324

0.04195323
0.04195323
0.0261348
0.06671252
0.09009629
0
0.09766162
0.04607978
0.08872077
0.04126548
0.05089409
0.09697387
0.0343879
0.04951857
0.07909216
0.02407153
0.06327373
0.07702889
0.00137552
0.05433288
0.08321871
0.06946355
0.01788171
0.08872077
0.08734525
0.06946355
0.09284732
0.04883081
0.08184319
0.07771664
0.06121045
0.07083907
0.0474553
0.00894085
0.08184319
0.05295736
0.06602476
0.07771664
0.0605227
0.02751032
0.07634113
0.08734525
0.01513067

0.0519341
0.0485404
0.0877255
0.0431968
0.0215984
0.1220056
0.0177692
0.0565093
0.0120062
0.0510761
0.0298523
0.0145676
0.0790266
0.05933
0.0373794
0.0766733
0.052139
0.0040021
0.0996517
0.0366686
0.0265738
0.0373121
0.089147
0.0160083
0.0114459
0.0276944
0.0091247
0.0383783
0.0240124
0.0084044
0.0008004
0.0309761
0.0332172
0.0900307
0.0139272
0.0416344
0.0237723
0.0185696
0.0352183
0.0618561
0.01921
0.0048025
0.0756616

0.136475
0.1359697
0.1351468
0.1351221
0.1345625
0.1340491
0.133775
0.1336572
0.1334841
0.1329758
0.1319113
0.1311438
0.12935
0.1286222
0.1284905
0.127211
0.1268002
0.125993
0.1255791
0.1242531
0.123099
0.1216831
0.1216815
0.1209828
0.1195392
0.1190221
0.1188867
0.1187766
0.118418
0.1169884
0.1157852
0.1130312
0.112896
0.1124788
0.1123668
0.112133
0.1120627
0.1120259
0.1114806
0.1108046
0.110199
0.109689
0.1092785

0.006511309
0.023989034
0.005997258
0.008738862
0.005997258
0.008224812
0.009766964
0.006339959
0.005997258
0.019533927
0.009766964
0.013022618
0.02107608
0.045407814
0.006168609
0.00719671
0.006682659
0.007539411
0.022960932
0.006339959
0.007539411
0.00702536
0.022618232
0.006339959
0.006682659
0.00702536
0.019705278
0.006168609
0.009424263
0.006168609
0.006168609
0.006168609
0.011480466
0.018334476
0.009766964
0.019533927
0.006168609
0.008567512
0.006682659
0.010452365
0.011137766
0.00719671
0.007710761

0.0062224
0.01806503
0.00501807
0.01003613
0.00602168
0.00541951
0.00822963
0.00843035
0.00662385
0.01906865
0.00722601
0.01164191
0.01886793
0.03954235
0.00662385
0.0080289
0.00602168
0.00782818
0.02649538
0.00582096
0.00401445
0.00682457
0.0212766
0.0062224
0.00662385
0.00662385
0.01947009
0.00702529
0.00943396
0.00562023
0.00682457
0.00562023
0.01284625
0.01665998
0.00843035
0.01826576
0.00682457
0.00883179
0.00702529
0.01103974
0.01083902
0.00662385
0.00822963

0.06808803
0.01650619
0.07221458
0.05020633
0.08734525
0.0213205
0.01444292
0.05364512
0.0130674
0.01581843
0.03576341
0.01444292
0.00962861
0.01031637
0.05777166
0.03782669
0.01581843
0.0261348
0.01856946
0.07427785
0.0082531
0.0605227
0.02407153
0.06740028
0.07771664
0.06464924
0.0522696
0.05433288
0.05158184
0.02338377
0.06327373
0.07152682
0.07015131
0.02269601
0.07083907
0.0474553
0.0605227
0.06877579
0.07496561
0.02338377
0.03232462
0.03782669
0.06877579

0.0284147
0.0499459
0.0252131
0.0391403
0.0084044
0.0715571
0.0734749
0.0372577
0.0793211
0.0499715
0.0510793
0.0637899
0.0533076
0.0076039
0.0313763
0.0488253
0.073238
0.0599511
0.0329771
0.0144875
0.0810628
0.0264137
0.0309761
0.0188098
0.0076039
0.0200104
0.0068035
0.0306559
0.0273582
0.0618945
0.0200072
0.0125665
0.0012006
0.0376195
0.0060031
0.0084044
0.0172569
0.0044023
0.0016008
0.0448232
0.0353976
0.0376995
0.0040021

0.1092365
0.1085061
0.108443
0.1081216
0.1077685
0.1065219
0.1059144
0.1056731
0.1050096
0.1043925
0.1038357
0.1028973
0.1028802
0.1028705
0.1019404
0.1018776
0.1017607
0.1014535
0.1010029
0.1009263
0.1008698
0.1007863
0.0989424
0.0987724
0.0986271
0.0983088
0.0982485
0.0981827
0.0977983
0.0970671
0.0962741
0.0958822
0.0956786
0.09531
0.0950395
0.0936593
0.0907728
0.0905774
0.0902744
0.0896991
0.089699
0.0893468
0.0887183

0.006339959
0.012165867
0.008910212
0.009252913
0.00685401
0.013365319
0.007882111
0.006168609
0.005825908
0.015935572
0.00736806
0.006168609
0.006339959
0.00685401
0.011994517
0.006339959
0.009595613
0.013536669
0.016620973
0.016278273
0.006339959
0.009424263
0.009424263
0.006339959
0.009766964
0.008224812
0.009766964
0.010109664
0.015592872
0.012337217
0.008053461
0.009252913
0.006511309
0.007539411
0.00702536
0.010966415
0.007710761
0.006511309
0.008053461
0.005997258
0.010452365
0.009081563
0.006339959

0.00140506
0.00943396
0.00923324
0.00843035
0.0062224
0.01284625
0.00923324
0.00642312
0.00642312
0.01746287
0.00582096
0.00682457
0.00642312
0.00602168
0.01184263
0.00501807
0.00963469
0.01344841
0.0168607
0.01304697
0.00521879
0.00843035
0.00662385
0.0062224
0.00963469
0.00883179
0.01043758
0.00903252
0.01164191
0.01224408
0.00923324
0.00782818
0.00602168
0.00843035
0.00722601
0.01003613
0.0062224
0.00602168
0.00903252
0.0062224
0.01124047
0.0080289
0.00582096

0.00962861
0.06258597
0.0082531
0.01650619
0.02475929
0.04057772
0.03851444
0.06877579
0.0522696
0.00756534
0.04126548
0.05639615
0.04332875
0.04332875
0.03370014
0.04951857
0.03163686
0.03713893
0.00687758
0.03507565
0.01100413
0.01581843
0.03782669
0.05433288
0.05158184
0.03782669
0.05433288
0.01169188
0.01581843
0.03713893
0.02200825
0.01444292
0.02475929
0.05020633
0.05708391
0.03851444
0.01994498
0.04951857
0.02682256
0.05708391
0.0082531
0.00894085
0.02063274

0.0711953
0.0041622
0.0618016
0.0537815
0.0499459
0.0208748
0.0320038
0.0061632
0.0228118
0.0450634
0.0312962
0.0148077
0.0272173
0.0268139
0.0253732
0.0217713
0.029228
0.0159283
0.0395373
0.0151278
0.0569255
0.0454636
0.0245727
0.011526
0.0073638
0.0229719
0.0032017
0.0469043
0.0342706
0.0149678
0.037389
0.0451434
0.0391403
0.0100052
0.0048025
0.016258
0.0416152
0.0130468
0.030816
0.0052027
0.0441029
0.0473622
0.040581

0.0885689
0.088348
0.0881982
0.0879709
0.0877816
0.0876641
0.0876336
0.0875307
0.0873305
0.0860271
0.0857507
0.084197
0.0833091
0.0830183
0.0829104
0.0826479
0.0800951
0.0800523
0.0798965
0.0795287
0.0794884
0.0791366
0.0784475
0.0784212
0.0783473
0.0778552
0.0777391
0.0777384
0.0773238
0.076688
0.0766839
0.0766674
0.0764326
0.0761813
0.0761378
0.075775
0.0754933
0.0750983
0.0747245
0.0745063
0.0740488
0.0734135
0.0733747

0.009252913
0.006168609
0.017135024
0.024503084
0.011994517
0.009252913
0.010623715
0.012337217
0.00685401
0.008738862
0.006168609
0.008738862
0.006682659
0.02176148
0.005483208
0.00736806
0.007710761
0.008567512
0.009938314
0.00685401
0.00736806
0.00736806
0.017649075
0.009081563
0.00702536
0.00719671
0.00702536
0.016449623
0.007539411
0.005997258
0.008910212
0.006682659
0.01439342
0.006511309
0.00702536
0.011480466
0.00736806
0.008738862
0.017477724
0.00719671
0.006339959
0.010623715
0.00702536

0.00923324
0.00541951
0.01605781
0.02569249
0.01224408
0.00863107
0.01023685
0.01164191
0.00662385
0.00863107
0.00662385
0.00983541
0.0080289
0.01987154
0.0062224
0.00782818
0.00642312
0.00923324
0.01043758
0.00461662
0.00843035
0.00742674
0.01585709
0.0080289
0.00642312
0.00742674
0.00642312
0.01886793
0.00702529
0.0044159
0.00983541
0.00822963
0.01284625
0.00702529
0.00642312
0.01144119
0.00682457
0.00923324
0.0150542
0.00742674
0.00662385
0.01023685
0.00742674

0.04883081
0.02888583
0.01100413
0.0130674
0.0474553
0.01237964
0.00756534
0.04401651
0.03094911
0.04676754
0.00756534
0.03851444
0.0392022
0.0261348
0.04264099
0.0343879
0.04607978
0.03713893
0.03576341
0.02475929
0.03782669
0.04607978
0.03232462
0.01788171
0.04470426
0.03026135
0.04607978
0.01031637
0.04195323
0.01100413
0.02407153
0.04195323
0.00618982
0.02544704
0.00412655
0.0392022
0.03163686
0.03370014
0.01169188
0.04195323
0.03851444
0.02888583
0.01513067

0.0060031
0.0322823
0.0280946
0.0088846
0.0004002
0.0417817
0.0436162
0.0040021
0.0272941
0.0072037
0.0509544
0.0137799
0.0167287
0.0024012
0.015368
0.0200168
0.0093649
0.0144075
0.0119262
0.0316164
0.0136071
0.0060031
0.0004002
0.0312162
0.0071237
0.0203177
0.0056029
0.01921
0.0080041
0.0431007
0.0216112
0.0068035
0.0297754
0.0236122
0.0445831
NA
0.0161684
0.0100052
0.0174298
0.0049626
0.0100052
0.0116861
0.0317445

0.0733201
0.0727563
0.0722915
0.0721476
0.0720941
0.0720453
0.0720421
0.0719977
0.0717211
0.0713412
0.0713122
0.0708687
0.0706424
0.0701691
0.0697146
0.0696009
0.0695785
0.0693471
0.0680655
0.0678463
0.0672321
0.0668777
0.066231
0.0662084
0.0652764
0.0652025
0.0651312
0.0648439
0.0645221
0.064518
0.0644284
0.063669
0.0632049
0.0625959
0.0621581
0.0621239
0.0619979
0.0616774
0.0616536
0.0615393
0.0614834
0.0614325
0.0613272

0.00685401
0.007539411
0.016792324
0.012851268
0.00736806
0.007539411
0.006511309
0.005483208
0.008910212
0.006339959
0.006168609
0.02107608
0.02176148
0.006511309
0.009766964
0.006339959
0.00719671
0.010623715
0.012851268
0.01456477
0.009424263
0.012508568
0.005825908
NA
0.005997258
0.009252913
0.006168609
0.00685401
0.00702536
0.007539411
0.011137766
0.005654558
0.006339959
0.009424263
0.006339959
0.01456477
0.007710761
0.006511309
0.013022618
0.007710761
0.007882111
0.010795065
0.008396162

0.00722601
0.00782818
0.01545564
0.01384986
0.0062224
0.00702529
0.00562023
0.00642312
0.00822963
0.00682457
0.00642312
0.01545564
0.02027298
0.00682457
0.00963469
0.00541951
0.00782818
0.01083902
0.01103974
0.01525492
0.01083902
0.00943396
0.0062224
0.01947009
0.00582096
0.00983541
0.00582096
0.00702529
0.00702529
0.00301084
0.01144119
0.00662385
0.00521879
0.00983541
0.00682457
0.01164191
0.00742674
0.00702529
0.01384986
0.00843035
0.00702529
0.00903252
0.00822963

0.04401651
0.02269601
0.00068776
0.02819807
0.00481431
0.0343879
0.04676754
0.04195323
0.03782669
0.0213205
0.03988996
0.01788171
0.01169188
0.03507565
0.00137552
0.00687758
0.02475929
0.03232462
0.0261348
0
0.01444292
0.00618982
0.0343879
0
0.03851444
0.0130674
0.02407153
0.03370014
0.01994498
0.0213205
0.0261348
0.01031637
0.01375516
0.02957359
0.03645117
0.01788171
0.01031637
0.00618982
0.01719395
0.03094911
0.03232462
0.02407153
0.01719395

0.0032017
0.0227318
0.0276143
0.0056029
0.0413815
0.0105655
NA
0.0049626
0.0033617
0.0237531
0.0056029
0.0036019
0.003762
0.0085644
0.0358586
0.0378308
0.0164437
0.0024012
0.0059231
0.0260103
0.0209709
0.0272141
0.0087245
0.0352983
0.0040021
0.021291
0.0172954
0.0056029
0.0184095
0.0200904
0.0028015
0.0284948
0.0253732
0.0008004
NA
0.0052027
0.0236122
0.0292568
0.0048025
0.0016008
0.0012006
0.0040021
0.0140073

0.0612982
0.0607954
0.06055
0.0605021
0.0597862
0.0595181
0.0588991
0.0588221
0.0583283
0.0582381
0.0580846
0.0580153
0.0574883
0.056976
0.0566358
0.0564679
0.0562279
0.0561886
0.0559489
0.05583
0.0556771
0.0553465
0.0551607
0.0547684
0.0543347
0.0534468
0.0533565
0.0531823
0.0524052
0.0519612
0.0515152
0.0510895
0.0506871
0.0496337
0.0496157
0.0492911
0.0490661
0.0489832
0.0488689
0.048691
0.0484326
0.0479012
0.047827

0.009766964
0.00736806
0.008738862
0.008053461
0.013708019
0.011480466
0.010281014
0.011137766
0.00719671
0.00719671
0.006339959
0.00736806
0.011994517
0.006511309
0.008224812
0.00685401
0.008738862
0.013022618
0.009252913
0.009938314
0.00685401
0.007710761
0.013022618
NA
0.013193968
0.008567512
0.006339959
0.013708019
0.00736806
0.006682659
0.010795065
0.00685401
0.00719671
0.00719671
0.011994517
0.007539411
0.007539411
0.010623715
0.009595613
0.008738862
0.005997258
0.005997258
0.008396162

0.00983541
0.00421518
0.00742674
0.00883179
0.01445203
0.0106383
0.00983541
0.01224408
0.00782818
0.00843035
0.00662385
0.00702529
0.01083902
0.00742674
0.00682457
0.00642312
0.0062224
0.01364914
0.00702529
0.00923324
0.00642312
0.00602168
0.01324769
0.0124448
0.01184263
0.00822963
0.00682457
0.0124448
0.00742674
0.00562023
0.01083902
0.0062224
0.00702529
0.00682457
0.00943396
0.00582096
0.00702529
0.01003613
0.0106383
0.00822963
0.00742674
0.00562023
0.00702529

0.0130674
0.0343879
0.02338377
0.02888583
0.01719395
0.01719395
0.02475929
0.0130674
0.01100413
0.00275103
0.03301238
0.02544704
0.02338377
0.01925722
0.02888583
0.02819807
0.0261348
0.01788171
0.02819807
0.02338377
0.02751032
0.03026135
0.01444292
0
0.01375516
0.0261348
0.02957359
0.00481431
0.02407153
0.01100413
0.01925722
0.02200825
0.02269601
0.00962861
0.01581843
0.00894085
0.0261348
0.0130674
0.01719395
0.02200825
0.02269601
0.01100413
0.02475929

0.0150478
0.0016008
0.0080041
0.0016008
0.0017609
0.0076039
0.002001
0.0104054
0.0208108
0.0284147
0.0008004
0.0068035
0.0004002
0.0128867
0.002001
0.0040021
0.0040021
0.0004002
0.0004002
0.002001
0.003762
0.0004002
0.0032017
0.0312162
0.0048025
0.0004002
0.0004002
0.0120062
0.0040021
0.01937
0.0016008
0.0073638
0.0052027
0.0184095
0.0048025
0.01921
0.0008004
0.007764
0.0040021
0.0024012
0.0052027
0.0184095
0.0008004

0.0477176
0.047572
0.0475535
0.0473719
0.0471149
0.0469167
0.0468767
0.0468546
0.0468398
0.0467928
0.0467766
0.0466439
0.0466175
0.0460819
0.0459362
0.0454773
0.0450981
0.0449537
0.0448765
0.0445564
0.0445494
0.044394
0.0439149
0.043661
0.0435943
0.0433321
0.0431383
0.0429734
0.0428684
0.0426771
0.0424921
0.0424485
0.0421207
0.0420594
0.0420494
0.0415112
0.0414999
0.0414913
0.0414299
0.041378
0.0413227
0.0410312
0.0409812

0.006339959
0.00702536
0.009424263
0.00736806
0.006168609
0.008224812
0.010966415
0.006339959
0.008396162
0.013193968
0.00719671
0.007539411
0.008053461
0.009595613
0.007539411
0.013022618
0.005997258
0.006511309
0.006339959
0.008738862
0.007539411
0.00736806
0.01422207
0.005997258
0.008567512
0.013879369
0.008224812
0.006682659
0.006511309
0.009766964
0.00702536
0.009766964
0.006168609
0.007882111
0.006682659
0.008910212
0.00719671
0.007710761
0.008567512
0.009081563
0.009252913
0.007539411
0.007539411

0.00702529
0.00562023
0.00963469
0.00883179
0.0062224
0.0080289
0.00903252
0.00682457
0.00762746
0.01144119
0.00582096
0.00762746
0.00863107
0.00782818
0.00742674
0.01083902
0.0062224
0.0062224
0.00541951
0.00762746
0.00682457
0.00782818
0
0.00662385
0.00923324
0.01164191
0.00843035
0.00742674
0.0062224
0.01023685
0.00642312
0.00983541
0.00562023
0.00702529
0.00662385
0.00883179
0.0080289
0.00602168
0.00923324
0.00843035
0.00883179
0.00762746
0.00782818

0.0082531
0.02407153
0.0213205
0.01581843
0.02200825
0.01650619
0
0.02338377
0.02200825
0.00618982
0.00275103
0.01994498
0.01994498
0.01581843
0.02269601
0.01375516
0.0213205
0.02407153
0.01237964
0.01719395
0.00343879
0.0213205
0.02063274
0.01994498
0.01719395
0
0.00481431
0.0213205
0.02063274
0.00687758
0.0213205
0.00687758
0.01788171
0.01444292
0.01237964
0.01444292
0.00550206
0.01994498
0.00206327
0.01650619
0.00412655
0.01856946
0.01513067

0.0193572
0.003762
NA
0.007764
0.0053628
0.0066434
0.01921
0.002001
0.0004002
0.0076039
0.0225717
0.0032017
0.0016008
0.0048025
NA
NA
0.0040021
0.0004002
0.0128066
0.0032017
0.0188098
NA
0.0016008
0.003762
0.0008004
0.0100052
0.0140201
NA
0.002001
0.0084044
0.0004002
0.0085644
0.0052027
0.0052027
0.0088366
0.002001
0.0133669
0.0004002
0.0141673
NA
0.0115388
NA
0.0028015

0.0409756
0.0404791
0.0403794
0.0397823
0.039762
0.0394033
0.0392089
0.0385493
0.0384321
0.0384289
0.0383404
0.0383135
0.0382303
0.0380447
0.0376622
0.0376168
0.0375422
0.0372054
0.0369458
0.0367619
0.0366125
0.0365167
0.0364556
0.036328
0.0357951
0.0355265
0.0354895
0.0354299
0.0353675
0.0352858
0.0351692
0.0350444
0.0348732
0.034553
0.0345227
0.034186
0.0340946
0.0340776
0.0340314
0.0340181
0.03375
0.0337363
0.0332997

0.015421522
0.006168609
0.006511309
0.010452365
0.005825908
0.009595613
0.007882111
0.008224812
0.007882111
0.011309116
0.006168609
0.009424263
0.009081563
0.013022618
0.00719671
0.009595613
0.006511309
0.005997258
0.006511309
0.008396162
0.009252913
0.005654558
0.00736806
0.009766964
0.00719671
0.007539411
0.006511309
0.00702536
0.006511309
0.010452365
0.007710761
0.012679918
0.006339959
0.00719671
0.007882111
0.008910212
0.00685401
0.009252913
0.005997258
0.010281014
0.005483208
0.00736806
0.007539411

0.01545564
0.00782818
0.00662385
0.01144119
0.0062224
0.00983541
0.00762746
0.00963469
0.00722601
0.01204336
0.00682457
0.0080289
0.01023685
0.01364914
0.00662385
0.0080289
0.00662385
0.00642312
0.00642312
0.00903252
0.00863107
0.00662385
0.00722601
0.00923324
0.0080289
0.00742674
0.00562023
0.00682457
0.00722601
0.00883179
0.00642312
0.01003613
0.00642312
0.00762746
0.00682457
0.00923324
0.00682457
0.00963469
0.00541951
0.00702529
0.00662385
0.00702529
0.00722601

0
0.01925722
0.00618982
0.00481431
0.02063274
0.00894085
0.01650619
0.01237964
0.01650619
0.00343879
0.01856946
0
0.01169188
0.00343879
0.01169188
0.01237964
0.01169188
0.01719395
0.01513067
0.01169188
0.01169188
0.01719395
0.01444292
0.0082531
0.01375516
0.01375516
0.01650619
0.01237964
0.01375516
0.00894085
0.00962861
0.00481431
0.01513067
0.0130674
0.0130674
0.00962861
0.01375516
0.00687758
0.01100413
0.00756534
0.01444292
0.01169188
0.01169188

0.0024012
NA
0.0139272
0.0060031
NA
0.0041622
0.0004002
0.0016008
NA
0.0048025
NA
0.0137671
NA
0.0008004
0.0053628
0.0008004
0.0059231
0.0008004
0.002001
0.0008004
NA
NA
0.0004002
0.002001
NA
NA
NA
0.0024012
0.0008004
NA
0.0044023
0.0004002
NA
NA
NA
NA
NA
0.0016008
0.0048025
0.002001
NA
0.0004002
NA

0.0332784
0.033254
0.0332522
0.032711
0.032681
0.032534
0.032416
0.03184
0.0316143
0.0315938
0.0315626
0.0312203
0.0310103
0.030911
0.0308752
0.0308046
0.0307501
0.0304147
0.0300661
0.029921
0.0295759
0.0294724
0.0294372
0.0292543
0.0289808
0.0287213
0.0286377
0.0286308
0.0282929
0.028225
0.0281648
0.0279306
0.0278938
0.0278916
0.0277741
0.0277721
0.0274337
0.027366
0.0272234
0.0268727
0.02655
0.0264854
0.0264573

0.006682659
0.008396162
0.008224812
0.009081563
0.006339959
0.006339959
0.00719671
0.005654558
0.006168609
0.007539411
0.005825908
0.006168609
0.00736806
0.00702536
0.008224812
0.006168609
0.00719671
0.006682659
0.009424263
0.008224812
0.009938314
0.00702536
0.008396162
0.00719671
0.008910212
0.008224812
0.008224812
0.00702536
0.006511309
0.006511309
0.006511309
0.006339959
0.006511309
0.008910212
0.005997258
0.00702536
0.008738862
0.007539411
0.006168609
0.00719671
0.006682659
0.005997258
0.005997258

0.00742674
0.00923324
0.00883179
0.00762746
0.00662385
0.00642312
0.00722601
0.00662385
0.00541951
0.00682457
0.00682457
0.00421518
0.00682457
0.00582096
0.00843035
0.00642312
0.00762746
0.00762746
0.00682457
0.00722601
0.00963469
0.00662385
0.00782818
0.00742674
0.00943396
0.00903252
0.00702529
0.00541951
0.00662385
0.00662385
0.0062224
0.00662385
0.00642312
0.00722601
0.00642312
0.00642312
0.00742674
0.00702529
0.00602168
0.00682457
0.00742674
0.00662385
0.00562023

0.00894085
0.00687758
0.00412655
0.00756534
0.00962861
0.00962861
0.01100413
0.0130674
0.01375516
0.00894085
0.01237964
0.01375516
0.00962861
0.00206327
0.00068776
0.01031637
0.00618982
0.00962861
0.00481431
0.00343879
0.00275103
0.00962861
0.00618982
0.00618982
0.00481431
0.00343879
0.00756534
0.01031637
0.00618982
0.00481431
0.00687758
0.00550206
0.0082531
0.00343879
0.00894085
0.00687758
0.00481431
0.00618982
0.00687758
0.00481431
0.00618982
0.00756534
0.00756534

0.0032017
0.0016008
0.0048025
0.0016008
0.0032017
0.0032017
NA
NA
NA
0.002001
NA
0.0008004
0.0008004
0.0092848
0.0068035
0.0012006
0.0029615
NA
0.0028015
0.0048025
0.0012006
NA
0.0008004
0.0024012
NA
0.0024012
NA
NA
0.0032017
0.0044023
0.0024012
0.0035218
0.0004002
0.002001
NA
0.0008004
NA
NA
0.0016008
0.0016008
NA
NA
0.0008004

0.0262519
0.0261078
0.0259856
0.0258752
0.0257941
0.0255934
0.0254269
0.0253458
0.0253433
0.0253059
0.0250301
0.0249394
0.0246217
0.0241944
0.0241464
0.0241087
0.0239755
0.0239387
0.0238646
0.0236921
0.0235247
0.0232778
0.0232146
0.0232145
0.0231585
0.0230974
0.0228154
0.0227612
0.0225266
0.0223517
0.0220125
0.0219877
0.0215877
0.0215761
0.0213612
0.0211265
0.0209799
0.0207545
0.0206687
0.0204364
0.0202992
0.0201864
0.0199832

0.009424263
0.00702536
0.00719671
0.00736806
0.00719671
0.00719671
0.005997258
0.006168609
0.006168609
0.00719671
0.006339959
0.005654558
0.006339959
0.006511309
0.006339959
0.006168609
0.005654558
0.007710761
0.006168609
0.005825908
0.006682659
0.00719671
0.006339959
0.008053461
0.007710761
0.006339959
0.00685401
0.00736806
0.006168609
NA

0.00883179
0.00662385
0.0062224
0.00662385
0.00682457
0.00702529
0.00642312
0.00682457
0.0062224
0.00682457
0.00501807
0.0062224
0.00501807
0.00642312
0.00582096
0.0062224
0.0062224
0.00662385
0.0062224
0.0062224
0.00762746
0.00521879
0.00461662
0.00782818
0.00662385
0.00682457
0.0062224
NA
NA
NA

0
0.00618982
0.00275103
0.00137552
0.00412655
0.00343879
0.00550206
0.00275103
0.00687758
0.00275103
0.00550206
0.00687758
0.00687758
0.00550206
0.00618982
0.00343879
0.00550206
0
0.00137552
0.00206327
0.00206327
0.00206327
0.00343879
0
0.00068776
0.00137552
0.00137552
0.00343879
0
0

0.0016008
NA
0.0036019
0.0044023
0.0016008
0.002001
0.0016008
0.0036019
NA
0.0024012
0.002001
NA
0.0004002
NA
NA
0.0024012
0.0008004
0.0032017
0.0032017
0.0024012
NA
0.0016008
0.0016008
NA
0.0008004
0.0008004
NA
NA
NA
NA

0.0198569
0.019839
0.019772
0.0197697
0.0197487
0.0196618
0.0195233
0.0193461
0.0192686
0.0191736
0.0188611
0.0187545
0.0186358
0.0184365
0.0183507
0.018231
0.0181794
0.0175363
0.0169682
0.0165128
0.0163734
0.0160796
0.0159962
0.0158816
0.0158228
0.0153405
0.0144519
0.0108069
0.0061686
0